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Abstract 
Atonal homolog 1 (Atoh1) is a basic helix-loop-helix (bHLH) transcription factor 
required for the formation of sensory hair cells in the inner ear (Bermingham et al. 
1999). Understanding the Atoh1 regulatory network is crucial for the development of 
new therapies to treat hearing loss. However, to date, little is known about the 
mechanisms controlling ATOH1 expression.  
The loss of sensory hair cells can cause deafness and balance disorders. In the 
mammalian inner ear, the loss of ATOH1 expression in adults has been linked with a 
limited capacity to regenerate hair cells (Wang et al. 2010). However, in non-
mammalian vertebrates, ATOH1 expression re-activates spontaneously after hair cell 
damage and new hair cells can be formed throughout life (Cafaro et al. 2007) (Daudet et 
al. 2009).  
In this thesis, I aimed to identify regulatory elements responsible for ATOH1 expression 
through a comparative analysis of avian and mammalian ATOH1 gene loci. A 
bioinformatic approach was used to identify evolutionary conserved non-coding 
ATOH1 DNA sequences including those that are conserved between avian and 
mammals and those that are specific to both groups. Putative transcription factor 
binding sites predicted within these conserved elements were then investigated using 
EMSA analysis and reporter gene assays. These experiments suggest that the E2F1 
transcription factor activates the chick ATOH1 gene and that this activation occurs 
predominantly via a direct interaction with a regulatory region that is conserved 
between avian species but absent from mammals. E2F transcription factors control cell 
cycle progression so the identification of this family as novel regulators of the chick 
ATOH1 expression links avian ATOH1 re-activation to cell proliferation. If confirmed, 
this would provide a possible mechanism to explain the different regenerative 
capabilities of mammalian and non-mammalian sensory cells and therefore contribute to 
the design of therapies for the regeneration of hair cells after damage. 
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Chapter 1
1 General Introduction  
1.1 The study of the inner ear and hearing loss 
Hearing loss is the most common form of sensory impairment in humans. According to 
the World Health Organization (WHO), 360 million people worldwide have a moderate 
to profound hearing loss and 1 in 500 children are born with impaired hearing 
(Thompson et al. 2001). In addition to congenital hearing loss, the problem is increasing 
due to additional environmental and lifestyle factors.  The unsafe use of personal audio 
devices, such as smartphones, and the exposure to noisy environments like 
entertainment venues, could bring negative consequences. It has been estimated that 
over 1 billion teenagers and young adults are at risk of hearing loss (WHO data from 
February 2015).  
Noise-induced hearing loss however, is not the only cause of deafness. Other conditions 
such as age related hearing loss (ARHL), genetic disorders, certain infectious diseases 
as well as the use of particular drugs are also very important factors that contribute to 
hearing loss (Liu and Yan 2007; Uchida et al. 2011; Van Eyken et al. 2007; Brown 
1981). 
Identifying and addressing hearing loss early will bring many benefits to enhance 
quality of life of those affected by a deafness condition. However, to achieve this, it is 
crucial to understand how the hearing system works in order to develop new therapies 
and approaches that can contribute to improve patient lives. Of course, this is not an 
easy achievement. The inner ear is a small and fragile structure which can easily be 
damaged. In addition, the location of the inner ear within the temporal bone makes 
access to the different ear structures a very challenging task.  New technologies based 
on regenerative medicine and gene therapy are being developed and it is hoped that 
these could be alternative routes for restoring lost auditory function and overcome some 
of the obstacles to the study of the hearing system.    
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1.2 General anatomy and function of the 
mammalian ear  
The ear anatomy is possibly the most complex sensory system in the human body. The 
mammalian ear is formed by a three-dimensional structure responsible for balance and 
sound detection located inside the temporal bone. Anatomically and functionally the 
mammalian ear is divided in three interconnected structures: the outer, the middle and 
the inner ear.     
1.2.1 The outer ear 
The outer ear consists of an external cartilaginous structure called the pinna followed by 
the ear canal or external auditory meatus which leads to the eardrum or tympanic 
membrane (Haines 2013; Purves et al. 2008) (Figure 1.1).  The function of the external 
part of the ear is mainly focused on the collection of the sound waves over the area of 
the pinna structure (Faddis 2008). As the outer ear narrows into the ear canal, the 
pressure gained at the tympanic membrane increases the energy to be transferred into 
the middle ear. The increase in sound pressure in humans at the tympanic membrane 
produces a broad peak of 15-20dB at 2.5Hz (Wiener and Ross 1946). Another important 
function of the outer ear is sound localization (Pickles 1998). As the ear pinna and 
concha (funnel-like opening to the outer ear canal) are shaped in folded cartilage, this 
structure reflects and attenuates the sound waves and helps the brain to determine the 
location of the sound. As we have two ears, the difference in the sound waves travelling 
along the ear canal and consequently the movements of the eardrum in both ears 
followed by mechanotransduction and neural processing will be interpreted by the brain 
to locate the sound (Pickles 1998).   
1.2.2 The middle ear 
The middle ear is formed by the internal part of the tympanic membrane, the auditory 
ossicles and the oval window (Figure 1.1).  As the sound waves travel into the ear canal, 
the pressure gained produces the vibration of the tympanic membrane which 
subsequently is transformed as mechanical pressure into the cochlear fluids. In this 
process, the three ossicle bones, the malleus, incus and the stapes, amplify the pressure 
wave  in  to  the  cochlea  (Haines  2013;  Purves  et al. 2008).  The tip of the  malleus is  
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pushed by the tympanic membrane and the mechanical movement is transferred to the 
incus and then to the stapes, the smallest bone in the human body. The stapes is attached 
to an aperture in the wall of the cochlea, known as the oval window. The main function 
of the middle ear is to reduce the magnitude of movements between the air environment 
in the outer ear while increasing the force in the fluid environment of the inner ear, a 
function known as the impedance matching (Pickles 1998). Since the area of the 
tympanic membrane is larger than the stapes footplate in the cochlea, the force collected 
over the tympanic membrane is concentrated and transferred to the cochlea with a 
higher pressure. In addition, the arm of the incus is shorter than that of the malleus, 
which increases the force, reduces the velocity at the stapes and contributes to the 
impedance match (Pickles 1998).   
 
 
Figure 1.1. Anatomy of the mammalian ear. The ear is divided into the outer, middle and inner ear. 
In the outer ear are found the pinna, the external auditory meatus or ear canal and the tympanic 
membrane that separates the outer and middle ear. The three ossicle bones, the malleus, incus and the 
stapes comprise the middle ear. The cochlea, the vestibular system and the auditory nerve form the 
main structures of the inner ear (Figure reproduced from Kelley, 2006).   
Picture removed for copyright purposes 
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1.2.3 The inner ear 
The mammalian inner ear consists of two sensory organs, the cochlea and the vestibular 
system, interconnected by a series of canals and enclosed in the temporal bone, the 
hardest bone in the human body (Frisch et al. 1998).   
1.2.3.1 The cochlea 
The human cochlea is formed by a coiled structure with approximately 2
1/2
 to 2
3/4
 turns 
from base to apex (Hardy 1938). The cochlea is bisected from its basal end to almost the 
apical end (Purves et al. 2008) by three different compartments: the scala media (also 
known as the cochlear duct), the scala vestibuli and the scala tympani (Figure 1.2a). In 
cross section, the scala media is bounded by the basilar membrane, the Reissner’s 
membrane and the stria vascularis in the external part. This compartment is filled by the 
endolymph, a fluid rich in potassium and with different chemical properties in 
comparison to the perilymph, the fluid that fills the scala vestibuli and scala tympani 
which contains a high concentration of sodium (Forge and Wright 2002). It is essential 
for the correct function of the ear that these two fluids remain in separate compartments. 
Resting on the basilar membrane is the organ of Corti, the sensory epithelium for 
hearing (Figure 1.2b). The organ of Corti is composed of inner hair cells (IHC) and 
outer hair cells (OHC) separated by supporting cells (the pillar cells). The inner and 
outer hair cells are separated by the tunnel of Corti which is formed by filamentous 
arches of inner and outer pillar cells. In most mammals, a single row of IHC and three 
rows of OHC are found. Other supporting cells are also found in the epithelium of the 
organ of Corti such as the Deiters’ cells which are found between the OHC providing 
mechanical support and the Hensen cells which are located on the outside of the OHC 
providing mechanical loading to the cells of the organ of Corti in response to sound 
stimulation (Forge and Wright 2002). The remaining cells resting on the floor of the 
basilar membrane are the inner sulcus cells, inner phalangeal, Claudius and Boettcher 
cells whose functions have been less studied but are possibly involved in ion transport 
processes.     
The tectorial membrane is the gel-like tissue that extends outwards over the sensory 
epithelium from the limbus of the spiral lamina (Haines 2013). Since the tectorial 
membrane is in contact with the taller stereocilia of the OHC, the displacement of the 
basilar membrane in response to sound-induced motion produces deflections of the 
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stereocilia and therefore the depolarization of the OHC (Dallos 1992). The IHC are also 
in contact with the tectorial membrane via a ridge located along the middle and inner 
part of the tectorial membrane. The matrix and the small fibres found in the tectorial 
membrane are formed by collagen type II, V and IX (Richardson et al. 1987; Slepecky 
et al. 1992) and different glycoproteins which are unique to the inner ear and not found 
anywhere else in the human body. These glycoproteins are otogelin (Cohen-Salmon et 
al. 1997) and α- and β-tectorin (Legan et al. 1997; Legan et al. 2000) which are detected 
during the development of the cochlea and that upon damage are not replaced.  Another 
important structure of the cochlea is the stria vascularis. The stria vascularis is located 
in the lateral wall of the scala media (Figure 1.2) and is responsible for the production 
and maintenance of the potassium concentration of the endolymphatic fluid (Forge and 
Wright 2002).  
The cochlear duct spirals around the modiolus, a spongy bone structure that houses the 
spiral ganglion, the group cochlea-vestibular nerves and fibres involved in sending the 
electrical signals to the brain.  
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a) 
b) 
 
 
 
 
 
Figure 1.2. General anatomy of the cochlea.  a) Cross section of the cochlea showing the three main 
compartments of the cochlear duct: the scala vestibuli, the cochlear duct or scala media and the scala 
tympani. The organ of Corti is located between the tectorial membrane and the basilar membrane (figure 
reproduced from OpenStax College CCBY 3.0). b) Diagram showing the different cell types and 
structures of the organ of Corti (figure reproduced from Anatomy of the auditory system. Clinical Gate, 
http://clinicalgate.com/anatomy-of-the-auditory-system/).  
 
Picture removed for copyright purposes 
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a) 
b) 
UtricleSacculeCristae
1.2.3.2 The vestibular system 
 The vestibular system is formed by a network of interconnected chambers, also known 
as the labyrinth which comprises the otolith organs (the utricle and the saccule) and 
three semicircular canals (Figure 1.3). The utricle and saccule are the main components 
to respond to linear acceleration of the head and static head position, whereas the 
semicircular canals respond to the rotational accelerations of the head (Purves et al. 
2008). The labyrinth, as the cochlear duct, is filled with endolymph, a solution high in 
potassium and low in sodium. At the base of the labyrinth, enlarged structures are 
found, denominated as ampullae or cristae (crista ampullaris). These structures, as well 
as the saccule and utricle contain vestibular hair cells. The vestibular hair cells are 
Figure 1.3. Anatomy of the mammalian vestibular system. a) The vestibular system in mammals 
consists of two otolith organs, the utricle and saccule, and three semicircular canals. Vestibular hair cells 
are found in the utricle, saccule and in three enlarged structures at the base of the semicircular canals 
called ampullae or cristae. The vestibular organ is innervated by primary afferent nerves that join with 
those in the cochlear system to the vestibulocochlear VIII cranial nerve. (Figure reproduced from 
Purves, 4
th
 Edition) b) Orientation of the vestibular hair cells. In the cristae (ampulla) hair cell bundles 
are orientated in the same direction whereas in the saccule and utricle, the striola separates hair cells 
with opposing hair cell bundle polarities. (Image reproduced from Peripheral Vestibular Apparatus, 
Encyclopedia of Neuroscience, J. David Dickman). 
Picture removed for copyright purposes 
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similar in structure and function to the cochlear hair cells. However, the hair cell 
bundles of the vestibular hair cells have a specific orientation and therefore they can 
respond to displacements in all directions. For example, the hair cells in the cristae are 
all polarized in the same direction whereas the hair cells in the saccule and utricle are 
separated by the striola, a curved dividing ridge that separates hair cells with opposite 
polarities (Figure 1.3b). The directional polarization of the vestibular hair cells enables 
the linear and rotational acceleration function of this organ.  
1.3 Hair cells and mechanoelectrical transduction 
Hair cells are responsible for converting mechanical stimulus into an electrical signal. 
(Purves et al. 2008). The hair cells are flask-shaped epithelia cells with a bundle of hair-
like stereocilia. Each hair cell contains from 30 to a few hundred stereocilia and a single 
and taller kinocilium which is only present during the hair cell development and in the 
mouse, which disappears shortly after birth (Purves et al. 2008). At the top of the 
stereocilia, an individual hair bundle is connected by an extracellular structure 
denominated “tip-link” (Pickles 1993). When sound waves are transmitted into the 
cochlea, the displacement of the basilar membrane in response to fluid movements in 
the scala tympani bends the taller stereocilia of the hair cells in the organ of Corti 
against the tectorial membrane. This causes the opening of the K
+
 channels, allowing 
the entry of K
+
 flow into the hair cells body. This event results in the depolarization of 
the hair cell and consequently the opening of the voltage-gated Ca
2+
 channels at the base 
of the hair cell membrane. The resultant intake of Ca
2+
 into the hair cell body causes 
synaptic vesicles to fuse to the hair cell membrane and the release of a neurotransmitter 
from the basal end of the hair cell onto the auditory nerve ending. The neurotransmitter 
will produce the depolarization of the afferent nerve fibre and an action potential will be 
transmitted along the cochlear nerve to the brain. As the movement toward the tallest 
stereocilia depolarizes the hair cell, the movement in the opposite direction leads to the 
closing of the K
+
 channels and therefore to the hyperpolarization of the cell (Haines 
2013).   
The ion transfer is possible because of the electrical gradient across the membrane of 
the stereocilia. The endolymph fluid (high in K
+
) in the scala media and the perilymph 
fluid (high in Na
+
) creates a potential difference of +80mV between both compartments 
whereas inside of the hair cell is about 45mV more negative than in the perilymph and 
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about 150mV more negative than in the endolymph. The large potential difference 
between the endolymph and the hair cell body is therefore the driving force responsible 
for the mechanoelectrical transduction of the cochlea. This is known as the 
endocochlear potential.  
Signals from the auditory system travel to the auditory cortex via sensory neurons 
which have their cell body in the spiral ganglion. The central axons innervating the 
cochlea and vestibular system form the vestibulocochlear nerve (VIII cranial nerve) and 
is responsible for transmitting the sound and balance sensation to the brain (Kingsley 
1999).   
1.4 Inner ear development 
The formation of the organ responsible for hearing and balance occurs under a series of 
events and signals that transforms a very simple cellular epithelium in a complex three 
dimensional structure.  
1.4.1 Early inner ear development 
In vertebrates, the inner ear arises from the otic placode, a thickened primordium of the 
embryonic ectoderm located close to the hindbrain (Torres and Giráldez 1998). The first 
morphological event during the early development of the inner ear is the otic placode 
induction. The process of placode induction was reviewed by Ohyama et al. 2007, and 
proposed to occur in several different steps (Figure 1.4a). The first step is the formation 
of a “pre-placodal domain” followed by a second step based on the induction of the 
“pre-otic field” within the pre-placodal domain which will be refined into the otic 
placode (Ohyama et al. 2007). The different craniofacial organs, including ear, nose, 
lens, trigeminal and epibranchial ganglia arise from this initial pre-placodal domain.   
The otic placode is defined by the expression of early specific molecular markers 
including the transcription factors PAX8 (Pfeffer et al. 1998; Heller and Brändli 1999) 
and PAX2 (Nornes et al. 1990; Krauss et al. 1991; Groves and Bronner-Fraser 2000), 
FOXI1 (Nissen et al. 2003; Solomon et al. 2003) and SOX9 (Wright et al. 1995; Saint-
Germain et al. 2004). A few other signalling molecules and additional transcription 
factors markers were also examined in the otic placode in different vertebrate species 
and included EYA1, GATA3, NKX5.1/HMX3, GBX2, SOX3, DLX, BMP4 and BMP7 
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a) Otic placode induction                      b) Morphogenesis of the chick inner ear 
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(Kelley et al. 2005). During the early induction of the otic placode a number of 
fibroblast growth factors (FGFs) have also been described for being necessary during 
the early development of the inner ear in fish, chick and mouse. Different members of 
the FGF family such as FGF10, FGF19 and FGF15 are produced from the underlying 
mesenchyme of the otic placode to contribute to the otic induction (Maroon et al. 2002; 
Léger and Brand 2002).   
As the embryonic development progresses the otic placode invaginates to form the otic 
cup, a structure that soon closes to form the otic vesicle or otocyst (Alvarez and 
Navascués 1990; Bancroft and Bellairs 1977; Torres and Giráldez 1998). At this stage, 
the otic vesicle undergoes an intensive proliferative growth before cellular 
differentiation begins.  
 
 
 
 
 
 
 
 
Figure 1.4. Development of the inner ear. a) Cranial placode 
development. The first step during the early inner development is 
otic placode induction. According to the model reviewed by 
Ohyama, the first step is the formation of a “pre-placodal 
domain”, a narrow band of ectoderm in the neural plate. The 
second step is based on the induction of the “pre-otic field” 
within the pre-placodal domain which will be refined into the 
different craniofacial placodes including the otic placode. Figure 
adapted from Ohyama et. al, 2007. b) Summary of the chick inner 
development. The otic placode invaginates after its induction to 
form the otic cup at E2.5 which in turn pinches off to form the otic 
vesicle or otocyst (E3.5). By E10 the different structures of the 
mature inner ear are already formed. Adapted from Daudet et. al,  
2005.  
 
 
Picture removed for copyright purposes 
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1.4.2 From the otic placode to the otocyst 
Following the induction of the otic placode, the otocyst also known as the otic vesicle is 
formed. This process occurs in a similar pattern in amphibians, birds and mammals. 
However, the process of morphogenesis has been well studied in chick since it provides 
a good insight of the mechanism of morphogenesis in vertebrates. Also because the 
chick otic epithelium can be easily manipulated both in ovo and in vitro, the chick has 
been used as a model to study the morphogenesis of the inner ear.  
The major event of the transformation of the otic placode consists in the bending of the 
placode epithelium to form an otic cup first, followed by the fusion of the rim cells, 
closing the pit which results in the formation of the otocyst (Kelley 2006) (Figure 1.4b).   
The formation of the otic vesicle undergoes a process of rapid cell proliferation which is 
controlled by different growth-factors. Among all of growth-factors, the insulin growth-
factors (IGF) were studied for playing important roles during the formation of the otic 
vesicle. For instance IGF-I was described for inducing DNA synthesis to increase the 
number of mitotic cells of the cochlea-vestibular ganglion (León et al. 1995b). In 
addition, IGF-II also was seen to induce the cellular growth of the otic vesicle although 
with a lower potency. The action of the IGFs promotes the rapid induction of the c-fos 
gene which was suggested to contribute the pattern proliferative growth of the otic 
vesicle (Represa et al. 1990; León et al. 1995a).  
As the morphogenesis continues, the otic epithelium diversifies and differentiates into 
the different patches that will later form the sensory organs. One of the first events that 
occur during the differentiation process is the production of retinoic acid in the otocyst. 
The retinoic acid downregulates the production of growth factors produced during the 
process of cell proliferation and stimulates the differentiation of the sensory epithelium 
(Represa et al. 1990). In addition, the retinoic acid is also able to downregulate the c-fos 
genes in parallel to the inhibition of cell proliferation (León et al. 1995a). Following the 
inhibition of the cell proliferation process is the differentiation of the cells of the otocyst 
into the three major cell lineages: proneural cells (the future neuronal cells), prosensory 
(future hair and supporting cells) and nonsensory cells (formed by other cells derived 
from the otocyst).  
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Figure 1.5. Morphogenesis of the inner ear. a) Compartment-boundary model. In this model, the 
otocyst is compartmentalized in three different boundaries, A-P (anterior-posterior), M-L (medial-lateral) 
and D-V (dorsal-ventral), dividing the otocyst in eight compartments. Several genes are expressed in the 
different parts of the otocyst which will define the predicted fate map and the different sensory organ 
regions arisen from the early markers. Adapted from Fekete and Wu, 2002. b) Sensory organ formation of 
the mouse inner ear and the main genes expressed in the different sensory patches. Adapted from Bok et. 
al, 2007. c) Development time series of the chick and mouse inner ear development. Lateral views of 
paint-filled inner ears. Adapted from Brigande et. al, 2000 (scale bar=1mm) and Cantos et. al, 2000 (scale 
bar=100μm). Arrowheads identify the proximal region of the cochlea. Abbreviations: aa, anterior 
ampulla; AC, anterior crista; asc, anterior semicircular canal; co, cochlea; cds, cochleosaccular duct; ed, 
endolymphatic duct; es endolymphatic sac; la, lateral ampulla; LC, lateral crista; lsc, lateral semicircular 
canal; oC/BP, organ of Corti/basilar papilla; pa, posterior ampulla; psc, posterior semicircular canal; s, 
saccule; SM, saccular macula; u, utricle; UM, utricular macula; usd, utriculosaccular duct. Orientation: D, 
dorsal; A, anterior.  
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The model proposed by Fekete and Wu defined the regional compartmentalization to 
establish a fate map of the different cell types in the inner ear (Figure 1.5a). According 
to this model, the axial identity of the otocyst is defined by the formation of three main 
boundaries: the anterior-posterior (A-P), the medial- lateral (M-L) and the dorsal-ventral 
boundary (D-V) (Fekete and Wu 2002).  
The definition of the A-P axis was suggested as being marked by the expression of 
several neural/sensory markers such as Fgf10, Lunatic fringe (Lfng), Delta1, 
Neurogenin1 (Ngn1) and NeuroD in the anterior region whereas the posterior axis is 
defined by the formation of the posterior-cochleovestibular ganglion and the expression 
of Irx1, Lmx1b, HNK-1 and Hairy 1 (Myat et al. 1996; Morsli et al. 1998; Cole et al. 
2000; Alsina et al. 2004; Alsina 2007). However, transplantation studies conducted in 
chick demonstrate that the formation of the A-P boundary and the expression of the 
specific markers occurs gradually until the otic cup is half-closed (Wu et al. 1998; Bok 
et al. 2005). Signals from the hindbrain are also thought to contribute to the formation 
of the A-P axis since each rhombomere in the hindbrain expresses a unique profile of 
genes that will coordinate the location of the sensory ganglia along the A-P axis 
(Trainor and Krumlauf 2000; Graham et al. 2004). In mouse, the Tbx1 gene is expressed 
in the posterior half of the otic cup and therefore is also considered for being an 
important factor to contribute to the identity of the A-P axis (Vitelli et al. 2003; Raft et 
al. 2004; Arnold et al. 2006). 
The D-V axis is also defined by different genetic markers. The dorsal vestibular region 
is characterized by the expression of Dlx5, Dlx6, Hmx2, Hmx3 and Gbx2 whereas the 
ventral auditory and neurosensory region expresses among other the Lfng, Ngn1, 
NeuroD1, Sox2 and Six1 genes (Fekete and Wu 2002). As with the A-P patterning, the 
development of the D-V axis is also influenced by different signal molecules produced 
by the adjacent tissues. Wnts signalling molecules secreted by the dorsal neural tube 
and Sonic hedgehog (Shh) produced by the floor plate and notochord are known for 
contributing to establish the D-V axis (Liu et al. 2002; Riccomagno et al. 2002; Bok et 
al. 2005; Riccomagno et al. 2005).  
 
The M-L is the last axis to be defined since the lateral region does not exist until the otic 
cup closes (Bok J. 2007). However, the signals and markers expressed in the M-L axis 
are not that well defined. The Gbx2 and Pax2 genes are associated with this medial 
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patterning (Groves and Bronner-Fraser 2000; Hidalgo-Sánchez et al. 2000; Burton et al. 
2004; Lin et al. 2005).      
It is possible that the hindbrain also plays a role in the development of the M-L axis 
since hindbrain mutants lacked the mature medial structures as well as the 
endolymphatic duct (Deol 1964; Mansour et al. 1993; Mark et al. 1993; Choo et al. 
2006).     
 
The model proposed by Fekete and Wu contributed to the understanding of how the 
different boundaries are formed during the inner ear development. Many of the 
compartmentalisations described in this model are observed during the inner ear 
formation in chick. However, how boundaries are specifically formed and maintained 
throughout development is still debated in the field.  
1.4.3 Late morphogenesis and sensory development of the inner 
ear 
The late morphogenesis of the inner ear is characterized by the formation of the six 
sensory organs: utricle, saccule, three cristae and the auditory organ. The molecular 
mechanisms to define the sensory organs are thought to involve Sox2, Six1 and the 
Notch signalling pathway (Kelley 2006). 
1.4.3.1 Crista and semicircular canal formation 
The structure that forms the cristae and semicircular canals derive from the vertical and 
horizontal pouches of the developing otocyst (Bok J. 2007). As a result of the formation 
of different morphological changes in the otic epithelium, the development of a tube-
shaped canal will define the formation of the semicircular canals. Wnt signalling 
molecules from the hindbrain are thought to regulate expression of different genes such 
as Gbx2, Dlx5 and Dlx6 which participate in the development of the semicircular canals 
and cristae (Riccomagno et al. 2005). Studies with knockout mice for these genes 
revealed structural malformations in the semicircular canals and cristae (Merlo et al. 
2002; Lin et al. 2005; Robledo and Lufkin 2006). In addition, the expression of Bmp4 in 
the cristae of different species linked this gene to the formation of semicircular canals 
and crista (Chang et al. 2008; Gerlach et al. 2000) but other genes including Sox2, 
Jagged1 and Fgf10 were also considered to be important in this process (Pauley et al. 
2003; Kiernan et al. 2005; Brooker et al. 2006; Kiernan et al. 2006).         
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1.4.3.2 Utricle and saccule formation 
The formation of the utricle and saccule share a common origin with the neural cells of 
the cochleovestibular ganglion (Bok J. 2007). After the formation of the otocyst, the 
neurosensory region expressing Lfng in the prosensory domain segregates to form the 
utricular macula, the saccular macula and the organ of Corti. This event occurs around 
E12 in mouse, and by E13 the utricle and saccule are completely separated to each other 
(Morsli et al. 1998) (Figure 1.5b). It is not clear how this segregation occurs but studies 
in mice with double knockout for Hmx2 and Hmx3 (Wang et al. 2004) and for Otx1 and 
Otx2 (Morsli et al. 1999) failed to form a complete separation of these organs linking 
therefore these genes with the segregation process of these sensory patches. Gata3 is the 
only known gene that is expressed in the utricle and not in the saccule (Bok J. 2007).   
1.4.3.3 Cochlear patterning  
In mice, the development of the cochlea begins with the formation of the cochlear duct 
from the postero-lateral region of the otocyst (Bok J. 2007) (Figure 1.5b). By embryonic 
day 12, the cochlear duct descend to the ventral-medial position to form the L-shaped 
duct characteristic of mammalian species (Bok J. 2007). On the contrary, in birds, the 
cochlear duct remains relatively straight (Dooling and Fay 2000) (Figure 1.5c).    
In mouse, between E12-E14, the nascent cells that will form the organ of Corti, exit the 
cell cycle and minimal cell proliferation is conducted in the cochlear epithelium (Jones 
and Chen 2007; Ruben J, 1967). The elongation of the cochlear duct continues until 
approximately one and three quarters turns in the mature mouse (Bok J. 2007). In cross 
sections, the cochlear duct is a triangular shaped structure defined by three walls: the 
basilar membrane where the organ of Corti is located, the thin medial wall denominated 
Reissner’s membrane and the lateral wall which consists of the stria vascularis and the 
spiral ligament (Bok J. 2007). Among all the genes expressed in the developing 
cochlear duct, Otx2 is known for being expressed in the Reissner’s membrane (Morsli et 
al. 1999), Pax2 in the stria vascularis (Burton et al. 2004) and Atoh1 in the developing 
hair cell epithelium of the organ of Corti (Bermingham et al. 1999).  
1.4.4 Summary of inner ear development 
The formation of the inner ear is a complex process defined and controlled by multiple 
genes and signalling pathways. Some of these signals and genes are well studied, 
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especially in chick, a species that has served as a model to describe the inner ear 
patterning (reviewed in Fekete and Wu, 2002). However, it is still not clear how the 
different signals regulate the regional identity and whether the modification of these 
pathways can alter the normal development of the inner ear. Solving all these questions 
could have a big impact and contribute to the understanding of the formation of this 
system but also would help in the design of future regenerative strategies in the inner 
ear epithelium. 
1.5 Development of auditory hair cells 
During the formation of the inner ear, different developmental processes take place in 
the cochlea and vestibular system to give rise to the hair cells. There are four types of 
hair cells in mammals: inner hair cells (IHCs) and outer hair cells (OHCs) which are 
located in the cochlea to perform the auditory transduction and the vestibular hair cells 
Type I and Type II which are required for balance sensation (Kingsley 1999).  
1.5.1 Early cellular differentiation of the primordium cochlear 
epithelium 
The early formation of the cochlear epithelium begins from the ventromedial axis of the 
otocyst before E12 in the mouse inner ear (Morsli et al. 1998). Between E12 and E14, 
the cells located in the primordial epithelium that will form the organ of Corti, exit the 
cell cycle (Ruben 1967)  and therefore at this point of the development, the progenitor 
cells undergo the last mitosis. The exit of the cell cycle requires p27
Kip1
, a cyclin-
dependent kinase inhibitor that functions as an inhibitor of cell cycle progression (Chen 
and Segil 1999). Immunohistochemistry experiments identified a zone of non-
proliferating cells (ZNPC) in the sensory primordium epithelium which failed to 
incorporate BrdU and that correlated with the onset of p27
Kip1
 expression (Figure 1.6a) 
(Chen et al. 2002). In addition, the experiments conducted by Chen and Segil also 
concluded that the deletion of p27
Kip1
 prolonged the division of cells of the developing 
neuroepithelium in the mutant mice in comparison to their wild type littermates. 
Therefore p27
Kip1 
was suggested to be involved in determining the size of progenitor 
population by controlling exit from the cell cycle (Chen and Segil 1999) but not 
necessarily required for the formation of hair cells. However, homozygous p27
Kip1
 
mutant mice have a severe hearing impairment suggesting that p27
Kip1 
could be involved 
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in the correct control of the cell cycle during development to produce functional hair 
cells.  
At later stages, in differentiated hair cells, p27
Kip1
 is rapidly downregulated although its 
expression continues in the supporting cells (Figure 1.6b)  (Chen and Segil 1999). 
Based on these observations, p27
Kip1
 is considered as the cellular marker of terminal 
mitosis and possibly necessary for controlling the cell cycle during the differentiation of 
hair cells.  
As the development of the cochlea continues, it is thought that cells in the ZNPC will 
develop into either hair cells or supporting cells (Kelley 2007). The earliest hair cell 
marker expressed in the ZNPC is the basic helix-loop-helix transcription factor Atoh1 
(formerly known as Math1 in mammals) (Chen et al. 2002). Within the ZNPC region, 
the first cells expressing Atoh1 are located in the epithelium close to the base of the 
cochlear duct and near the medial border of the ZNPC (Figure 1.6c). Since ATOH1 was 
observed within the borders of the ZNPC, it was suggested that only cells that have 
exited the cell cycle express ATOH1. Experiments where pregnant mice were injected 
with the cell division marker BrdU showed that cells in the primordium epithelium fail 
to incorporate BrdU in this region and therefore become postmitotic between E12.5 and 
E13.5 before expressing ATOH1 (Chen et al. 2002). Later in development, at about 
E15.5, the early hair cell-specific marker MyosinVIIa was detected near the base of the 
cochlea (Chen et al. 2002). From this point the differentiation of the hair cells spreads 
longitudinally towards the apex and also to the base (hook region) of the cochlea.  
By E16, the cochlear cells that express Atoh1 are committed to developing as hair cells, 
whereas Atoh1 negative cells will develop as supporting cells (Kelley 2007).  
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Figure 1.6. Early cellular differentiation of the primordium cochlear epithelium. a) Onset of the 
cyclin-dependent kinase inhibitor p27Kip
1
 expression. A zone of non-proliferating cells (ZNPC) was 
identified in the sensory primordium of the cochlea. Between E12.5 and E14.5, the ZNPC region is 
marked by the lack of BrdU incorporation (in green) and the upregulation of p27Kip
1
 expression (in red). 
Adapted from Chen et.al, 2002. Scale bar: 50μm. b) p27Kip1 (in red) and myosin VIIa expression (in 
green) through the basal (right) and apical (left) turns of the E15.5 cochlea. As hair cells differentiate, 
p27Kip
1
 is downregulated and myosin VIIa is upregulated along the basal-to-apical axis of the cochlea. 
Adapted from Chen et al. 1999. Scale bar: 50μm. c) Model of organ of Corti development. Between 
E12.5 and E13.5, a zone of non-proliferating cells (ZNPC) (in yellow) in the prosensory domain can be 
observed which lacks BrdU incorporation (in blue) and an upregulation of the CDK inhibitor p27Kip
1 
(in 
green) is observed. Between E13.5 and E14.5, ATOH1 expression (Math1 in the figure) begins in the 
base of the cochlea (in red) within the ZNPC. As cellular differentiation progresses between E14.5 and 
E15.5, myosin VIIa (in red) was seen as an early marker of hair cell differentiation in the base of the 
cochlea. Adapted from Chen et. al, 2002.   
 
 
 
 
a) b) 
c) 
apical basal
apical basal
Picture removed for copyright purposes 
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1.5.2 Specification of hair cells and supporting cells: Id proteins 
and Notch signalling  
The Id proteins and the Notch signalling pathway play a major role to limit Atoh1 
expression to hair cells and not to supporting cells. Id proteins (inhibitors of 
differentiation and DNA binding) are, like Atoh1, bHLH molecules. However, the 
proteins lack the basic DNA binding domain in their sequence and consequently form 
an heterodimer with other factors, the E-proteins (E47, E12, E2-2, HEP) in order to bind 
DNA and to become functionally active (Kelley 2007). In the cochlea there are four 
types of Id genes: Id1, Id2 and Id3 are expressed between E12 and E14 in the 
epithelium of the otic vesicle and Id4 is detected in the otic vesicle and in part of the 
VIIIth ganglion (Jen et al. 1997) (Jones et al. 2006). The downregulation of the Id 
proteins correlates with the upregulation of Atoh1 which suggest that the loss of Id 
proteins could influence the onset of Atoh1 expression (Kelley 2007).  
The Notch signalling pathway has been suggested as the primary mechanism specifying 
hair cells versus supporting cells although this event has been questioned in the past 
decade. The classical Notch signalling has been associated with inhibitory interactions 
to determine cell fate (Fekete 1996). In this model, cells that commit to a primary cell 
fate, in this case developing hair cells, express two of the Notch ligands, Jag2 and 
Delta-like1 (Dll1) (Kelley 2006). These ligands mediate the process of lateral inhibition 
right after the exit of cell cycle (Fekete 1996) by acting on the Notch1 receptor of their 
adjacent cells. The activation of the Notch1 receptor initiates the expression of the 
Notch target genes Hes1 and Hes5 (Lanford et al. 2000). Hes1 and Hes5 are inhibitors 
of Atoh1 expression leading to the inhibition of the hair cell fate and subsequently these 
cells will develop as supporting cells (Figure 1.7). The Notch signalling interactions 
have therefore been associated with the cellular mosaic of hair cells and supporting cells 
of the developing inner ear epithelium.  
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Figure 1.7. The Notch signalling pathway. Interactions between individual cells determine whether they 
will commit to a hair cell or supporting cell fate. The developing hair cells express the Jagged2 (JAG2) 
and delta 1 (DLL1) ligands which bind to the Notch1 ligand in adjacent cells. This binding mediates the 
activation of the Notch1 intracellular domain (N1-ICD) which upregulates the expression of hairy and 
enhancer of split (HES1) and HES5 proteins. Consequently, the HES genes block the expression of the 
prosensory gene Atoh1, leading to the inhibition of hair cell fate. Therefore inhibited cells will develop as 
supporting cells. Figure adapted from Kelley et al. 2006.   
 
 
1.5.3 Hair cell differentiation 
Each hair cell is separated from its neighbours by surrounding supporting cells in a way 
that hair cells do not contact each other (Bryant et al. 2002). In the vestibular system of 
both mammals and birds two types of hair cells are formed: Type I and Type II 
(Bergström 1973). Type I hair cells are pear shaped and are connected in the basolateral 
portion by a single afferent nerve ending. Type II hair cells, on the other hand, have a 
cylindrical shape and contact both afferent and efferent nerve endings (Kelley et al. 
2005).  
Supporting cell             Hair cell             Supporting cellPicture removed for copyright purposes 
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In the organ of Corti, there are also two types of hair cells: a single row of flask-shaped 
inner hair cells (IHC) containing mainly afferent innervation and three rows (in some 
cases four) of outer hair cells (OHC) with a cylindrical shaped with mainly efferent 
innervation (Kelley et al. 2005).  
It is possible that all factors that are required for the differentiation of hair cells reside in 
the sensory epithelium. Once the sensory epithelium is specified, the differentiation 
process requires the activation of the transcription factor POU4F3 (also known as 
Brn3c/Brn3.1) (Fekete and Wu 2002). In mouse, Pou4f3 was shown to be uniquely 
expressed in both cochlear and vestibular hair cells of the inner ear (Erkman et al. 1996; 
Xiang et al. 1997). If Pou4f3 is not activated, developing hair cells die followed by 
supporting cells and neurons (Erkman et al. 1996; Xiang et al. 1998). Studies using 
Pou4f3 null mutant mice concluded that although some of the early hair cell markers 
were still expressed in these cells, no hair cell bundles were seen on the apical surface 
of the sensory epithelia (Xiang et al. 1998). Moreover, the loss of hair cell bundles 
seems complete in post-natal and adult stages (Erkman et al. 1996). In addition, an 
increase of cell death was observed in Pou4f3 null mutant mice in the vestibular sensory 
epithelium (Xiang et al. 1998). In humans, POU4F3 was also suggested to play roles in 
maintaining hair cells and promoting their survival (Ryan 1997). Studies conducted in 
three human families with mutations in the POU4F3 coding sequence showed an 
autosomal dominant late-onset hearing loss (Collin et al. 2008; Vahara et al. 1998; 
Weiss et al. 2003). The mutations were shown to be caused by an amino acid 
substitution or protein truncation in the POU domain of POU4F3 that confers the 
nuclear localization signal of this transcription factor (Collin et al. 2008; Vahava et al. 
1998; Weiss et al. 2003). A more recent study which combines linkage analysis and 
whole-exome sequencing in a Korean family identified a novel POU4F3 mutation in 
the POU homeodomain of the POU4F3 gene (Kim et al. 2013). Different hypothesis 
have been proposed to explain the deafness due to POU4F3 mutations, however 
haploinsufficiency, a condition where a single copy of the gene is not sufficient to 
maintain the wild type phenotype, seems to be the most probable explanation. 
Altogether, and based on this evidence, POU4F3 seems to be critical for the maturation 
of hair cells in humans.   
Downstream targets of POU4F3 are also known for playing roles in hair cell 
development and survival. To date, there is evidence that POU4F3 regulates brain 
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derived neurotrophic factor (BDNF) and neurotrophin 3 (Clough et al. 2004), Gfi1 
(Hertzano et al. 2004), Lhx3 (Hertzano et al. 2007), Caprin-1 (Towers et al. 2011) and 
Nr2f2 (Tornari et al. 2014). In vitro and in vivo analysis showed that POU4F3 binds to 
specific elements within the promoters of these genes. However, the identification of 
downstream targets of POU4F3 in the inner ear has limitations since the ongoing hair 
cell death makes the comparison of gene expression in wild type cochlear tissue and 
mutant Pou4f3 mice a difficult task to identify downstream genes. However, POU4F3 
and its target genes are possibly only one of the mechanisms involved in determining 
and maintaining hair cell fate (see section 1.7.4).  
In addition to POU4F3, BARHL1 is another transcription factor essential for the 
survival and maintenance of hair cells since its loss in mouse causes the degeneration of 
hair cells and consequently profound deafness (Li et al. 2002). Expression of BARHL1 
in mouse hair cells was observed at a later stage in comparison to the expression of 
POU4F3 (Li et al. 2002; Xiang et al. 1998). Therefore, it has been suggested that 
BARHL1 could play a role in long-term maintenance of cochlear hair cells. Studies 
conducted in cell lines derived from the organ of Corti (OC-1 and OC-2) found that 
BARHL1 acts as a repressor of transcription (Sud et al. 2005).       
GFI1 is also a critical transcription factor for the correct development of cochlear hair 
cells (reviewed by Jafar-Nejad and Bellen, 2004; Möröy et al. 2005; Kazanjian et al., 
2006). In mouse, Gfi1 is expressed in the developing cochlear and vestibular hair cells 
and if absent, outer hair cells are lost (Wallis et al. 2003; Hertzano et al. 2004). In 
humans, the mutation of GFI1 causes severe congenital neutropenia linking this gene to 
deficiencies in pathways involved in myeloid differentiation (Person et al. 2003). 
However, patients with dominant negative mutations in the GFI1 gene have not been 
found to have a hearing loss (Möröy 2005). 
The upstream control of Pou4f3, Barhl1 and Gfi1 expression is suggested to be 
conducted by direct and/or indirect interactions with ATOH1 to regulate the hair cell 
phenotype (Masuda et al. 2011; Ikeda et al. 2014; Chellappa et al. 2008; Wallis et al. 
2003; Shroyer et al. 2005). Co-transfection in HEK293 and VOT-E36 cells, in addition 
to chromatin immunoprecipitation experiments demonstrated that ATOH1 regulates 
Pou4f3 through direct binding at the distal enhancer in the 3’ region of Pou4f3 (Masuda, 
2011). The spatial and temporal regulation of Barhl1 is also crucial for its normal 
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function which was suggested to be controlled by BARHL1 itself but also by ATOH1. 
Studies with Atoh1-lacZ null mice showed that Barhl1 expression was absent in 
cochlear hair cells in comparison to wild-type mice where Barhl1 expression followed 
that of Atoh1 expression in hair cells (Chellappa et al. 2008). These data suggest the 
possibility of a direct and/or indirect activation of Barhl1 expression by ATOH1 in 
cochlear hair cells. A similar pattern was observed for Gfi1 expression. The expression 
of Gfi1 in the inner ear was drastically reduced in Atoh1 mutant mice after E14.5 
suggesting that ATOH1 is possibly required for the maintenance of Gfi1 expression 
(Wallis et al. 2003).  
Another gene associated with hearing loss in humans is the transcription factor LHX3. 
Recessive mutations were found in the human LHX3 and linked to sensorineural hearing 
loss (Rajab et al. 2008). LHX3 expression was observed in the sensory epithelium of 
human embryonic and fetal tissues overlapping with the expression of SOX2 (Rajab et 
al. 2008). A more recent study conducted on a child revealed a novel mutation in LHX3 
also associated with sensorineural hearing loss and pituitary hormone deficiencies 
(Bonfig et al. 2011).  
GATA3 may be also involved in hair cell differentiation. Epithelial cells in the dorsal 
part of the cochlear duct express GATA3, however its expression is specifically 
downregulated in both hair cells and supporting cell as they differentiate (Rivolta et al. 
1998). In humans, haploinsufficiency of GATA3 is associated with hearing loss (Bilous 
et al. 1992; Van Esch et al. 2000).   
Besides the need for these transcription factors, as development progresses, myosinVIIa 
(an actin binding motor protein) begins to be expressed at the base of the cochlea at 
E15.5 whereas p27
Kip1
 is downregulated at the same time (Chen et al. 2002). This event 
indicates the initiation of hair cell differentiation in a base-apical gradient. By E17, the 
entire length of the cochlear organ is patterned with one row of IHCs and three rows of 
OHCs. Between E14-18 a bilayer of hair cells and supporting cells is observed, 
characteristic of the mature organ of Corti (Chen et al. 2002). Other proteins expressed 
in the sensory epithelium that are specific to hair cells are calmodulin and calretinin 
(Zheng and Gao 1997).  
As discussed in section 1.4.2, retinoic acid is secreted during the early development of 
the otocyst and contributes to its differentiation. It is expressed in the developing 
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cochlea and is known for playing roles during hair cell development (Bryant et al. 
2002). Studies with cochlear cultures produced the extra rows of IHC and OHC after the 
addition of retinoic acid (Kelley et al. 1993). Thyroid hormone receptors are also 
expressed in the inner ear at early stages and some members become restricted to the 
cochlear epithelium once differentiated (Bradley et al. 1994). Chemically induced 
hypothyroidism has been linked with a delay in the maturation of most of the cochlear 
cells (Rüsch et al. 2001).   
1.5.4 Maturation of the hair cells 
The development of the hair cell bundle is considered a characteristic of its maturation 
(Gowri et al. 2007). As described in section 1.3, hair cell bundles are required for the 
mechanoelectrical transduction process (Pickles 1998). The formation of the hair cell 
bundle begins with the formation of small stereocilia over the apical surface, clustered 
around the kinocilium to form a short bundle. Between P0 and P4, the kinocilium 
migrates to one side of the cell and the stereocilia begin to elongate in a staircase pattern 
with adjacent rows of stereocilia organized by increasing heights. At this point the 
kinocilium is eccentrically located with the tallest rows of stereocilia. The position of 
the kinocilium marks the polarity of the hair cell bundle. By P4-P6, the stereocilia grow 
to their final height and width and the bundle acquire the characteristic W-shape found 
in OHC and the relatively straight shape found in IHC  (Goodyear et al. 2005). Later on 
in the development, at about P6, the kinocilium is lost (Lelli et al. 2009). Functional 
maturation occurs at around P10-12 for IHCs and at P8 for OHCs, with the apical hair 
cell stereocilia longer than the ones at the base due to the faster growth rate at that end 
(Kelley et al. 2005; Lelli et al. 2009; Goodyear et al. 2005).   
Little is known about the molecular mechanisms that control the formation of the hair 
cell bundle although the actin cytoskeleton is thought to be involved (Bryant et al. 
2002).  
1.6 Atoh1 
The discovery of Atoh1 as a gene required for the formation of hair cells led to 
numerous investigations focused on the study of this gene, not only for its essential 
requirement during hair cell development but also because its potential capacity to 
restore hearing.  
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1.6.1 Initial studies 
The study of Atoh1 began with the work conducted in Drosophila in the early 1990s. 
During development in Drosophila, a number of proneural genes encoding basic-helix-
loop-helix transcription factors (bHLH) denoted as the Aschaete-Scute complex (ASC), 
were shown to be required for the normal development of the nervous system. Atoh1, 
named atonal (ato) in Drosophila, was originally identified as a new ASC gene, for 
sharing many of the structural features of the bHLH proteins. Experiments conducted 
with ato mutants showed that the majority of the external sense organs in Drosophila 
were missing which  demonstrated the importance of atonal during neurogenesis 
(Jarman et al. 1993; Jarman et al. 1994). Based on these initial studies, this new 
candidate was defined as a proneural gene necessary and sufficient for the formation of 
the mechanoreceptor neurons and photoreceptor cells.   
Following the studies in Drosophila, a screen using mouse embryonic tissue was 
conducted in order to characterize the murine Atoh1, formerly known as Math1. One 
clone obtained from this screen showed a high homology with the amino acid sequence 
of the atonal product in Drosophila confirming therefore the identification of the mouse 
Atoh1 (Akazawa et al. 1995). The mouse Atoh1 (atonal bHLH transcription factor 1) is a 
member of the bHLH family located on chromosome 6 (6:64,729,125-64,731,245 
forward strand- Ensembl release 86). A typical bHLH member contains a basic domain 
at the amino-terminal which mediates the binding to DNA and a HLH domain, 
consisting of two α-helices separated by a variable loop region, at the carboxyl-terminal 
end which facilitates interactions with other protein subunits (Jones, 2004). The mouse 
Atoh1 open frame consists of a single exon of 1053 bp that produces a protein of 351 
amino acids long and 37 kDa in size (Akazawa et al. 1995).   
Four years after characterizing the mouse Atoh1, studies conducted by Bermingham’s 
group confirmed the importance of this gene for the formation of hair cells 
(Bermingham et al. 1999). A transgenic mouse was generated by replacing the Atoh1 
coding region with the lacZ reporter gene in order to study the expression of Atoh1, in 
heterozygous Atoh1 mice (Atoh1
+/β-Gal
) and the homozygous mutants (Atoh1
 β-Gal/β-Gal
). 
The heterozygous mice appeared normal and the expression of the β-Gal reproduced the 
pattern observed in the Atoh1 wild-type mice. However, the homozygous mutant mice 
die shortly after birth and lack cerebellar granule neurons (Bermingham et al. 1999). In 
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the sensory epithelium at early stages in development (E12.5), both heterozygous and 
homozygous mice showed β-Gal staining before the differentiation of hair cells (Figure 
1.8a). However by E18.5 when hair cells are formed, β-Gal was restricted to hair cells 
in the heterozygous Atoh1
+/β-Gal
 mice whereas no specific staining was found in the 
homozygous Atoh1
 β-Gal /β-Gal
 mutant mice (Figure 1.8a). When the sensory epithelium 
was analysed in detail at the same stage (E18.5) by electron microscopy, it was 
confirmed that the   Atoh1
 β-Gal /β-Gal
 mutants lacked hair cells and only non-specialized 
epithelial cells were present. However, supporting cells appeared normal. In the 
vestibular system of the Atoh1
 β-Gal /β-Gal
 mutants, the crista and utricle were smaller in 
comparison to wild types and as in the cochlear epithelium, hair cells were absent. In 
addition, immunohistochemistry results with specific hair cell markers such as 
MyosinVI and Calretinin demonstrated that these markers were absent in the Atoh1
 β-Gal 
/β-Gal
 mutants confirming that hair cells did not develop in the sensory epithelium 
(Figure 1.8b).  
In summary, the studies of Bermingham et al. demonstrated for the first time that Atoh1 
is an essential gene necessary for the formation of hair cells. 
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Figure 1.8. Atoh1 is required for the formation of hair cells. a) Inner ear β-Gal staining (blue) before 
and after hair cell fate in heterozygous transgenic mice (Atoh1
+/β-Gal
) and homozygous mutants         
(Atoh1 
β-Gal /β-Gal
). At E12.5, before the formation of hair cells, β-Gal staining was observed in both 
heterozygous and homozygous mutants. However, once the sensory epithelium differentiates, β-Gal 
staining is restricted to hair cells in heterozygous mice and no specific β-Gal staining was found in 
homozygous mutants. Original magnification at E12.5 is x100, at E18.5 is x630 and insets at E18.5 is 
x160. b) Myosin VI and Calretinin were used as specific hair cell markers for immunohistochemistry 
studies in wild type and Atoh1 
β-Gal /β-Gal
 mutants. At E13.5, Myosin VI was found in wild type embryos 
but not in Atoh1 
β-Gal /β-Gal
 mutants. At E16.5, similar results were obtained with Calretinin staining only 
visible in wild type animals but absent in Atoh1 
β-Gal /β-Gal
 mutants. Figures adapted from Bermingham et 
al. 1999. Scale bars for MyosinVI and Calretinin expression are 50μm and 100μm respectively.  
 
Atoh1+/β-Gal Atoh1 β-Gal/ β-Gal mutants 
E12.5
E18.5
a) 
b) 
Wild type                          Atoh1 β-Gal/ β-Gal mutants 
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1.6.2 Expression of Atoh1 in the developing inner ear 
The spatial and temporal expression of Atoh1 has been described using four different 
techniques: in situ hybridization (ISH), immunohistochemistry, reporter gene studies 
and more recently by q-PCR. The use of these four different approaches to study Atoh1 
expression could explain the discrepancies among different studies which are influenced 
by the limitations of the technique used.    
Based on the initial experimental data conducted by Jarman et al., atonal expression 
was analysed by in situ hybridization and showed that atonal was expressed in the 
epidermal and subepidermal epithelium of Drosophila. The ectodermal patches where 
atonal was expressed were therefore defined as putative proneural clusters (Jarman et 
al. 1993).  
Following this work, the expression of Atoh1 was analysed in embryonic mice. At early 
stages of the mouse development (E9.5), Atoh1 mRNA was detected by in situ 
hybridization in the cranial ganglions as well as the dorsal wall of the neural tube. By 
E10.5, Atoh1 was strongly expressed in the central neural systems and later on by E13, 
was notably detected in the dorsal part of the hindbrain and neural tube. However by 
E18 expression was restricted to the cerebellum and was downregulated in the spinal 
cord. On post-natal day 3 (P3), mRNA expression was decreased and only seen in the 
external granular layer of the cerebellum and by P28, Atoh1 mRNA is no longer 
detected in the nervous system (Akazawa et al. 1995).  
 
In the mammalian inner ear, Atoh1 expression was first described by the studies 
conducted by Bermingham et. al. 1999 where the β-galactosidase reporter marker was 
used in order to show Atoh1 expression patterns along different stages (see section 
1.6.1). The findings of these studies showed that Atoh1 was first expressed in the otic 
vesicle at E12.5 before cochlear hair cells are formed and that its expression was seen 
throughout the sensory epithelium of vestibular organs and cochlea at E14.5. At later 
stages, approximately by E18.5, Atoh1 expression was restricted to hair cells        
(Figure 1.9a) (Bermingham et al. 1999).  
Using in situ hybridization Atoh1 mRNA expression was observed in the cochlea 
between E12.5 and E13 (Lanford et al. 2000) (Figure 1.9a). By E15, Atoh1 transcript 
was detected along the cochlear duct and by E17, Atoh1 expression was restricted to one 
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single row of inner hair cells and the three rows of outer hair cells.  A more recent study 
detected Atoh1 mRNA in the cochlea later than E13.5 and its downregulation was 
observed between E17-E18.5 showing a basal-apical gradient (Pan et al. 2012). In post-
natal stages, Atoh1 mRNA expression was still detected at P4 (Pan et al. 2012) and 
shortly after expression was no longer seen. Similar results were described using the 
same approach by Woods et al., where expression of Atoh1 mRNA was first detected in 
the developing cochlea at E13.5 (Woods et al. 2004).  
ATOH1 protein expression has also been assessed by immunohistochemistry. Studies 
conducted with anti-ATOH1 antibodies showed that ATOH1 expression begins in 
vestibular hair cells by E12.5 and in the cochlear hair cells, ATOH1 expression was not 
observed before E13.5 (Chen et al. 2002) (Figure 1.9b). Additional 
immunohistochemistry studies also showed ATOH1 expression in inner and outer hair 
cells at E16 and its expression was still observed at P0 (Driver et al. 2013) (Figure 
1.9b). The differences found between Atoh1 mRNA and protein expression may be due 
to the delay in the translation process or conditioned by the specificity of the anti-
ATOH1 antibody. Data collected by in situ hybridization suggested that Atoh1 mRNA 
was expressed in a greater population of cells than the cells that were fated to 
differentiate into hair cells.  
Other studies conducted with a reporter mouse line where GFP was driven by the Atoh1 
enhancer (Helms et al. 2000) reproduced Atoh1 mRNA expression although with a 
delay in expression in the cochlear system. Atoh1 expression from the reporter in the 
vestibular system was seen at the same stages observed using in situ hybridization 
(Matei et al. 2005) (Figure 1.9c). However, in the cochlea Atoh1-GFP expression was 
not observed at E13.5, suggesting that the Atoh1-GFP reporter was not able to 
reproduce the onset of endogenous Atoh1 expression (Matei et al. 2005).  In fact, Atoh1-
GFP expression from the reporter did not begin until E14.5 in the mid-basal region of 
the developing cochlea. Later in development and using the same reporter, Atoh1 
activity was detected in the single row of IHC and in the three rows of OHCs at E15.5 
matching Atoh1 mRNA and protein expression observed using in situ hybridization and 
immunohistochemistry (Chen et al. 2002). Therefore, the activity of the mouse Atoh1-
GFP reporter recapitulated endogenous Atoh1 expression only after E14.5 (Figure 1.9c).  
More recently, Atoh1 mRNA levels were quantified by q-PCR from mouse cochleae 
(Stojanova et al. 2015). This study revealed that Atoh1 mRNA in the developing mouse 
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cochlea starts at E13.5 and levels were found to peak at around E17.5. After that, Atoh1 
mRNA levels decreased until P6 the latest stage analysed in this study.  
 
In  non-mammalian  vertebrates,  such  as  chicken  and  zebrafish,  ATOH1 expression  
has  also been described in the embryonic inner ear and lateral line respectively.    
In zebrafish, Atoh1 expression was detected by in situ hybridization in the posterior 
lateral line primordium which contains sensory hair cells surrounded by supporting hair 
cells (Itoh and Chitnis 2001).  
As in zebrafish, Atoh1 expression in the chick embryo was also detected by in situ 
hybridization at early stages of ear development (Figure 1.9d). At E4, Atoh1 can be 
detected in the nascent anterior and posterior cristae of the otocyst (Pujades et al. 2006), 
showing the typical expression mosaic of hair cells and supporting cells that results 
from lateral inhibition (see section 1.5.2). ATOH1 protein was also detected by 
immunohistochemistry at a similar stage in the superior crista of chick, reproducing the 
expression observed by in situ hybridization (stage 23; 3.5-4 days of development) 
(Stone et al. 2003) (Figure 1.9d).  
 
      
 
 
4
8
 
 
Figure 1.9. Atoh1 expression in mouse and chick. a) mRNA Atoh1 expression shown by in situ hybridization in mouse. Atoh1 mRNA is detected in the developing 
cochlea by E13 whereas other studies detected mRNA expression at E13.5 only on the vestibular system (adapted from Landford et al., 2000 and Pan et al. 2010). 
Arrowheads mark Atoh1 mRNA expression. Scale bar = 250μm and 100μm respectively. b) ATOH1 protein expression detected by immunohistochemistry in mouse is 
observed in the vestibular system at E12.5 and its expression is detected in the cochlea later at around E13.5. In post-natal stages, ATOH1 is still observed at P0, matching 
mRNA expression. By P5, ATOH1 expression was no longer detected (adapted from Chen et al., 2002 and Driver et al. 2013). Scale bars = 50μm. Arrowheads mark 
ATOH1 protein expression c) Studies with a reporter mouse line where GFP was driven by the Atoh1 enhancer reproduced Atoh1 mRNA expression in the vestibular 
system and in some delaminating cells (arrows in A). However, in the cochlea Atoh1-GFP activity was not observed until E14.5 (adapted from Matei et al. 2005 and Chen 
et al. 2002). Scale bars = 100μm. d) In chick, Cath1 (chick Atoh1 homologue) mRNA was detected in the otic vesicle at E3 and by E4 the hair cell/supporting cell mosaic 
was visible (adapted from Pujades et al., 2006) Scale bar= 100μm. ATOH1 protein was also examined by immunohistochemistry and observed in the superior crista at E4 
(arrowheads) (adapted from Stone et al., 2003). Abbreviations: AC, anterior crista; HC, horizontal crista; PC, posterior crista; S, saccule; U, utricle; cvg, cochleo-
vestibular ganglion; cg, cochlear.  
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1.6.3 The role of Atoh1 in the inner ear 
Atoh1 expression has been shown to be necessary for the formation and development of 
hair cells, hence homozygous Atoh1 mutant mice do not develop differentiated hair cells 
(Bermingham et al. 1999). However, the precise role of Atoh1 in hair cell development 
has been discussed in several publications and four different roles have been proposed: 
The first is Atoh1 as a proneural gene. Atoh1 is involved in the development of different 
neuronal subtypes such as cerebellar granules, brainstem neurons, neural tube and inner 
ear hair cells. (Helms et al. 1998; Bermingham et al. 2001; Machold et al. 2005; Ben-
Arie et al. 1997). Studies conducted in mouse concluded that the lack of Atoh1 produces 
the loss of granule cells and germinal cells in the cerebellum (Ben-Arie et al. 1997) as 
well as the loss of hair cells in the inner ear (Bermingham et al. 1999). Other studies 
conducted in Drosophila with the  homolog Atoh1 (atonal) demonstrated that the 
absence of atonal leads to the entire loss of the  lineage associated with 
mechanosensory organs (Jarman AP 1998).  
 
In the inner ear, since the development of the prosensory epithelium is part of the 
process of neurogenesis, Atoh1 is also defined as a prosensory gene. This second role 
suggests that although Atoh1  is  required  for  the  specification  of  hair  cells,  as it  is  
expressed  before  hair  cells  are formed it could have a prosensory function defining 
the group of cells that will form the prosensory epithelia that contains both 
mechanosensory hair cells and non-sensory supporting cells. In Drosophila atonal is 
also expressed before cell fate specification (Jarman et al. 1995), supporting also the 
prosensory role of atonal. Some parallels were also found in zebrafish, where the Atoh1 
genes, Atoh1a and Atoh1b, are involved in establishing the prosensory domain that 
triggers the fate specification in the preotic placode (Millimaki et al. 2007).  
 
The third proposed role of Atoh1 suggests that it could operate as a commitment factor 
for hair cells. To support this hypothesis, in vitro studies with cochlear epithelium 
demonstrated that although Atoh1 is expressed in prosensory  domain  it  is  not  directly  
required  for  generating  supporting  cells (Woods et al. 2004). Supporters of this model 
suggest that the absence of Atoh1 causes the complete loss of both hair cells and 
supporting cells. However the loss of supporting cells in Atoh1 mutants is thought to be 
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a consequence of the loss of hair cells, which may generate inductive signals that are 
required for supporting cell formation (Woods et al. 2004). The absence of Atoh1 and 
the loss of supporting cells could therefore be an indirect consequence of the disruption 
of the Notch signalling pathway (described in section 1.5.2).  
    
The final hypothesis proposes Atoh1 as a differentiation factor of hair cells. As 
previously discussed, in vitro studies with mouse tissue concluded that Atoh1 was not 
directly involved in the specification of the sensory primordium within the cochlea (see 
section 1.5.1). Atoh1 is not expressed until shortly after, in a non-proliferation zone in 
which cells have exited the cell cycle. Moreover, the expression of ATOH1 is observed 
in a subpopulation of cells that go on to differentiate exclusively into hair cells.    
In support of this model, Atoh1-null mutant mice were analysed and it was observed 
that the prosensory domain developed normally even though hair cells fail to  
differentiate (Chen et al. 2002). Therefore it is possible that Atoh1 is only necessary for 
the differentiation of hair cells. Moreover, the same study showed using a EGFP-
reporter mouse that Atoh1 is only expressed in cells that go on to differentiate into hair 
cells.  
The experimental data collected to investigate the role of Atoh1, are based on different 
approaches and therefore depending on the technique used, the data were consistent 
with one of these four hypotheses (Kelley 2006). For instance, ATOH1 protein 
expression was detected in progenitor cells that have exited the cell cycle and therefore 
expressed in cells that have differentiated into hair cells (Chen et al. 2002). However, 
mRNA expression data demonstrated that Atoh1 transcripts were expressed a bit earlier 
in the cochlear developing epithelium suggesting a prosensory role for Atoh1 (Lanford 
et al. 2000). It remains unexplored whether Atoh1 is the only factor capable of 
generating hair cells or whether other mechanisms can also contribute to this process. 
Atoh1 upstream regulatory factors presumably play important roles in the regulation of 
the expression of Atoh1 and consequently in the formation of hair cells. 
1.6.4 Atoh1 function in other tissues 
Atoh1 is expressed in various other tissues (Table 1.1) and Atoh1 tissue-specific 
regulatory targets are still being investigated. In addition to the nervous system, one the 
best characterized systems where Atoh1 is expressed is the intestine. Atoh1 mutant mice 
lack goblet cells and epithelial cells are maintained in a proliferative state (Yang et al. 
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2001). Furthermore, Atoh1 is described as having roles in cell fate by specifying the 
subgroup of secretory cells that form paneth cells, goblet cells and enteroendocrine 
cells. This mechanism was suggested to occur through the induction of Neurogenin 3 
and Gfi1 (Yang et al. 2001; Shroyer et al. 2005; Bjerknes and Cheng 2006). Ectopic 
Atoh1 expression in the intestine results in additional secretory cells (VanDussen and 
Samuelson 2010). In addition, Atoh1 can arrest cell cycle during the development of the 
intestine by repressing the transcription factor RBP-Jκ but also can regulate genes 
involved in the progression of the cell cycle such as p57
kip
 and p27
kip 
(Kazanjian et al. 
2010; Kim and Shivdasani 2011; Peignon et al. 2011). One of the main conclusions 
from studies in different systems is that Atoh1 activity can vary depending on the tissue. 
In the developing cerebellum, Atoh1 maintains cells in a proliferative state whereas in 
the intestine causes cell cycle arrests and differentiation (reviewed in Mulvaney, 2012). 
Atoh1 has also been suggested to act as an oncogene in medulloblastoma arising from 
the external granular layer (Briggs et al. 2008; Zhao et al. 2008; Ayrault et al. 2010). By 
contrast in other tissues such as the intestine, Atoh1 can function as a tumor suppressor 
gene inhibiting the proliferation of colon cancer cells (Leow et al. 2004; Bossuyt et al. 
2009). The apoptotic role of Atoh1 in the intestine was suggested to be conducted 
through the JNK/MAPK pathway (Bossuyt et al. 2009; VanDussen and Samuelson 
2010).   
 
 
Table 1.1. Summary of Atoh1 expression. Atoh1 mRNA expression in normal human tissues detected 
by microarray, RNA sequencing or SAGE (Serial Analysis of Gene Expression). Adapted from 
GeneCardsSuite (http://www.genecards.org/cgi-bin/carddisp.pl?gene=ATOH1).  
 
 
Major system Major tissues 
Immune system 
 
Bone marrow, whole blood, white blood cells, lymph node, thymus 
Nervous system 
 
Brain, cortex, cerebellum, retina, inner ear, spinal cord, tibial nerve 
Muscle 
 
Heart, artery, smooth muscle, skeletal muscle 
Internal Small intestine, colon, adipocyte, kidney, liver, lung, spleen, stomach, 
oesophagus, bladder 
Secretory 
 
Pancreas, thyroid, salivary gland, adrenal gland, pituitary, breast, skin 
Reproductive 
 
Ovary, uterus, placenta, prostate, testis 
 
Picture removed for copyright purposes 
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In summary, Atoh1 has diverse biological functions which are dependent on both the 
cell type and the developmental stage. Some targets of ATOH1 are suggested to be 
common to various tissues whereas others are restricted to specific cells. In the nervous 
system, Atoh1 directs the specification of different neural subtypes including the 
granule layer of the cerebellum (Ben-Arie el al. 1997), hindbrain neurons (Ben-Arie et 
al., 1997; Machold and Fishell, 2005; Wang et al., 2005; Maricich et al., 2009b; Rose et 
al., 2009), sensory hair cells (Bermingham et al., 1999; Zheng and Gao, 2000; 
Izumikawa et al., 2005; Raft et al., 2007) and Merkel cells in the skin and vibrissae 
(Ben-Arie et al., 2000; Maricich et al., 2009; Morrison et al., 2009; Van Keymeulen et 
al., 2009). Some neuronal subtype-specific targets of Atoh1 are Rassf4, Selm, Atoh1 and 
Grem2, those enhancers are bound by ATOH1 in the cerebellar tissue but not in the 
dorsal neural tube (Lai, et al. 2011). However, other targets of Atoh1 such as Rab5 and 
Selm are transcribed in the neural tube but not in other developmental tissues (Lai, et al. 
2011).     
1.7 Transcription factors and regulatory 
mechanisms of gene expression 
The control of gene expression is critical for the correct control of biological 
mechanisms in both prokaryotic and eukaryotic organisms. According to the central 
dogma of biology which states that genetic information is processed from DNA to RNA 
and then to proteins, the regulation of gene expression can be controlled at different 
levels but the predominant mechanism is that of transcriptional regulation (reviewed in 
Kornberg 1999).  
The mechanism that regulates the basal gene expression at the transcription level occurs 
by the action of transcription factors and additional regulatory proteins on core 
promoters, cis-regulatory elements or other enhancer elements that control the rate of 
transcription and hence expression of specific genes (see section 1.7.1). However, 
epigenetic regulation can also control gene expression by several different mechanisms 
including nucleosome occupancy, post-transcriptional modifications of histones, DNA 
methylation and nuclear regulatory non-coding RNAs (reviewed in Doetzlhofer and 
Avraham 2016).  
The organization of the chromatin allows DNA to be tightly packed within eukaryotic 
nuclei. Heterochromatin, the highly condensed form of chromatin, is in general 
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inaccessible to DNA binding proteins and can lead to transcriptional silencing (Grewal 
and Moazed 2003). By contrast, euchromatin is more accessible to the different 
transcriptional apparatus. Nucleosome, are the basic units of chromatin packing.  
Nucleosomes cores are composed of 145-147 bps of DNA, assembled into an octamer 
of two copies of histone proteins H2A, H2B, H3 and H4 (Luger et al. 1997). 
Nucleosomes repress transcription by different mechanisms. For instance, they can 
occlude protein binding to DNA and consequently interfere in the binding of 
transcription factors, polymerases and other DNA-modifying enzymes (Workman and 
Kingston 1998). Interactions of nucleosomes with additional chromosomal proteins 
within heterochromatin have also been suggested to repress gene expression (Grunstein 
1998).  
Histone modifications also control gene expression. The core histones present in 
nucleosomes undergo modifications at different positions across their N-terminal ends. 
These include acetylation, methylation, phosphorylation and ubiquitination (reviewed in 
Doetzlhofer and Avraham 2016). One of the best characterized systems of histone 
modifications is DNA methylation at CpG dinucleotides which is associated with gene 
silencing (Bird 2002). DNA methylation occurs during the replication of the DNA and 
it is based on a covalent chemical modification caused by the addition of a methyl group 
at the 5’ position of the cytosine ring by DNA methyltransferases (Das and Singal 
2004). This modification occurs more frequently at CpG sites, where a guanine 
nucleotide follows a cytosine nucleotide (Cedar 1988). It has been suggested that this 
DNA methylation inhibits gene expression by affecting protein-DNA interactions that 
are required for transcription (Siegfried and Simon 2010).   
RNA also can participate in the regulation of gene expression. Small RNAs and non-
coding RNAs have recently emerged as regulators of gene expression by controlling 
genome stability and for participating in the recruitment of histone and chromatin-
modifying complexes (Holoch and Moazed 2015).   
In eukaryotic cells, mRNAs carry a 5’ 7-methylguanosine cap and a 3’ poly (A) tail 
which protect the RNA chain from degradation (reviewed by Day and Tuite 1998) and 
therefore influence the intrinsic stability of the RNA transcript. In mammals, 
microRNAs (miRNAs) can target the 3’ untranslated region (UTR) which leads to a 
reduction in gene expression by translational suppression and mRNA destabilization 
(Guo et al. 2010). In addition, alternative splicing can lead to the production of various 
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mRNA isoforms and therefore can play an important role in regulating gene expression 
(Chen and Manley 2009).  
Furthermore, expressed proteins can be regulated by post-translational modifications as 
well as by the rate of protein degradation. For instance, changes in the amino acid 
properties, such as the addition of a phosphate group, can alter the function and activity 
of a protein (Prabakaran et al. 2012).  
1.7.1 Transcriptional control of gene expression 
The core promoter is defined as the centre of the basal transcriptional machinery 
(Juven-Gershon and Kadonaga 2010) and it is a determining factor in the transcription 
of any gene (reviewed by Heintzman and Ren 2006). The DNA region containing the 
core promoter is typically located ~40 bp upstream and/or downstream of the 
transcription start site (TSS) of specific genes. The majority of the transcription factors 
that are required for the basal transcriptional machinery interact directly or indirectly 
with the core promoter to initiate gene transcription. The study of core promoters has 
led to the discovery of various sequence motifs which play a role in basal transcription. 
Among others, these include: the TATA box sequence (also named the Goldberg-
Hogness box after its discoverers) which is present in approximately 24% of human 
genes (Yang et al. 2007), BREu (upstream TFIIB Recognition Element), InR (Initiator), 
MTE (Motif Ten Element), DPE (Downstream Promoter Element), DCE (Downstream 
Core Element) and XCPE1 (X Core Promoter Element 1) (Juven-Gershon and 
Kadonaga 2010). To prepare the promoter for the initiation of the transcription, 
sequence specific transcription factors bind to these regions in the promoter to form the 
pre-initiation complex (PIC) (Sainsbury et al. 2015). This process requires factors such 
as TFIIA, TFIIB, TFIID, TFIIE, TFIIF and TFIIH which are known as “general” or 
“basal” transcription factors (Figure 1.10) (Juven-Gershon and Kadonaga 2010). The 
initial step for the assembly of the PIC is the binding of TFIID (Sainsbury et al. 2015). 
Following this, a series of different steps occur including promoter melting and 
clearance before functional RNA polymerase II elongation is achieved. Once RNA 
polymerase II has been tethered to the promoter, it must be released from the complex 
to initiate the transcription (Alberts et al. 2002). After RNA polymerase II escapes from 
the promoter, TFIID, TFIIE, TFIIH remain on the core promoter sequence and 
subsequent re-initiation only requires de novo recruitment of the complex containing                     
RNA polymerase II- TFIIF and TFIIB (reviewed in Maston et al. 2006).  
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The effect of the basal transcription factors is complemented by other transcription 
factors, co-factors and protein complexes which have the ability to bring distal 
regulatory regions in the surrounding DNA sequence, such as enhancer elements, into 
close proximity to the promoter region to influence the rate of transcription. Enhancers 
and promoters can be separated from a few kb to over 1000 kb however, it is still 
unclear which molecules are involved in the communication of these two regulatory 
elements, when it takes place and whether this is the same for all classes of enhancers 
(reviewed in Vernimmen and Bickmore 2015).  
Transcription factors are classified based on their sequence similarity and their DNA 
binding domains (Stegmaier et al. 2004). The helix-turn helix, zinc finger, leucine 
zipper, winged helix and helix-loop-helix domains are some of the most commonly 
 
Figure 1.10. Initiation of transcription. In eukaryotic genes, the assembly of the RNA polymerase II 
requires the presence of “basal” or “general” transcription factors (TFIIA, TFIIB, TFIID, TFIIE, TFIIF 
and TFIIH) that recognize specific DNA sequence motif such as the TATA box in the promoter to initiate 
the transcriptional machinery as part of the pre-initiation complex. Additional transcription factors bind to 
distal regions of the promoter such as enhancers that contribute to the regulation of gene expression. This 
mechanism is conducted by the Mediator complex which adopts distinct functions at the appropriate 
stages of the transcription. Interactions between transcription factors and the Mediator complex generate 
structural changes in the genomic DNA sequence to facilitate interactions between the enhancer and the 
promoter region. Figure adapted from Web textbook CSLS. University of Tokyo (http://csls-text3.c.u-
tokyo.ac.jp/active/10_03.html).   
Basal (general) 
transcription 
factors: TFIIA, 
TFIIB, TFIID, TFIIE, 
TFIIF and TFIIH 
Enhancer Transcription factor
Mediator complex
RNA polymerase II
TATA box
Promoter region                     Gene coding sequence
Picture removed for copyright purposes 
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known (reviewed in Guasconi et al. 2003). The function of these transcription factors is 
to bind to specific sites in DNA regulatory regions to activate or repress transcription 
and consequently regulate gene expression. In addition to their DNA binding domains, 
transcription factors can also contain separate conserved domains that confer activation 
or repression often via interactions with other regulatory proteins. This includes the 
Mediator, a complex of 26 subunits in mammals that communicates regulatory signals 
from DNA-bound transcription factors to the RNA polymerase II (Allen and Taatjes 
2015). The Mediator is crucial for the organization of different regulatory elements such 
as enhancers in the genomic DNA to generate gene loops that enable coordinated 
regulation of transcription (Plank and Dean 2014).   
1.7.2 Regulation of Atoh1 
Transcription factors, as well as being regulators of gene expression are also themselves 
subject to tightly controlled mechanisms of gene regulation. Atoh1 is involved in the 
differentiation of auditory hair cells, neurons and secretory cells in the intestine 
(Mulvaney and Dabdoub 2012). Therefore, Atoh1 expression must be tightly regulated 
since aberrant Atoh1 activity results in several deficiencies during neurosensory 
development.  
The transcriptional regulation of Atoh1 has been studied in different organisms over the 
past twenty years. Investigations of how Atoh1 is regulated began with the studies 
conducted in Drosophila where enhancer elements located, both up and downstream of 
the atonal coding sequence were identified that control atonal expression in several 
tissues (Sun et al. 1998). Regulation of atonal expression via the upstream region of the 
atonal sequence was shown to be tissue-specific, controlling the expression of 
chordotonal precursors such as the leg, wing and antennal discs, among others. 
Meanwhile, the downstream enhancer of the atonal region was shown to contribute to 
the initial phase of atonal expression in the leg and disc wing and partially the 
expression in the antennal and eye disc (Sun et al. 1998).  
The evolutionary conservation of the Drosophila atonal sequence across different 
species, including mouse (Ben-Arie et al. 1996) suggested that similar regulatory 
mechanisms could control the expression of Atoh1 in mammals.   
The first study conducted in mouse identified a 21 kb region, flanking the Atoh1 coding 
sequence shown to be sufficient to drive a lacZ reporter  gene in some but not all, Atoh1 
expressing regions in the developing nervous system (Helms and Johnson 1998). These 
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studies utilized a transgenic mouse in which the Atoh1 coding sequence was replaced by 
the lacZ reporter sequence, flanked by the 15 kb and 6 kb sequence upstream and 
downstream of the mouse Atoh1 coding region respectively. This transgenic mouse 
showed similar expression to endogenous ATOH1 in the neural tube between E9.5 to 
E11.5, the external germinal layer of the cerebellum at E13-E15 and in developing hair 
cells and the semicircular canal. The correlation between the expression of endogenous 
ATOH1 and the lacZ transgene in different regions, confirmed the importance of the 
Atoh1 flanking regions in the control Atoh1 expression. 
 
However, there are other Atoh1 tissue specific regions where the Atoh1/lacZ transgene 
expression does not reflect endogenous ATOH1 protein expression detected by 
immunohistochemistry. That includes the Merkel cells of the hairy skin and the cranial 
ganglia, the first region expressing ATOH1 at E9-E9.5 (Akazawa et al. 1995). The 
absence of lacZ expression in these regions suggested the existence of additional 
regulatory regions outside the 15 kb upstream and 6 kb downstream flanking sequences 
of the mouse Atoh1 gene. In addition, expression of the lacZ transgene was seen in 
differentiated neurons in the neural tube at E11.5. At this stage (E11.5), endogenous 
ATOH1 expression is not expected in the differentiated neurons derived from Atoh1 
progenitor cells in the neural tube which suggests that negative regulatory regions are 
also missing from the Atoh1/lacZ transgene (Helms and Johnson 1998). However, 
Helms et al., also suggested that the stability of the lacZ mRNA or the β-Gal protein in 
the Atoh1/lacZ transgenic mouse could be responsible for these discrepancies. To 
investigate this possibility, a new transgenic line was generated where the lacZ gene 
was replaced with an epitope-tagged ATOH1 protein (Helms et al. 2000) with the Atoh1 
flanking regions still maintained. The stability of this new transgenic mouse was 
intended to be similar to the stability of endogenous ATOH1 protein. Expression of the 
transgene re-capitulated endogenous ATOH1 protein expression in the dorsal region of 
the neural tube (Helms et al. 2000). However, expression of this reporter was also found 
outside the Atoh1 expressing regions further suggesting that additional regulatory 
elements exist outside the 15 kb and 6 kb sequences flanking the mouse Atoh1.  
Additional experiments conducted by Helms et al., with a lacZ transgene line containing 
only the 6 kb downstream region of the mouse Atoh1 coding sequence (without the     
15 kb upstream region) were sufficient to re-capitulate endogenous Atoh1 expression in 
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the neural tube at E10.5 (the only Atoh1 expressing region analysed in these 
experiments). In contrast, a similar reporter gene incorporating the 15 kb upstream 
sequence alone failed to show reporter activity.  
The 6 kb 3’ region flanking sequence has been refined further. An additional transgene 
generated with a 1.7 kb fragment located 3.4 kb downstream of the Atoh1 mouse 
sequence was found to reproduce endogenous mouse Atoh1 expression in the neural 
tube. This 1.7 kb sequence was found to contain two shorter conserved regulatory 
elements that regulate Atoh1 expression in multiple tissues and were defined as mouse 
Atoh1 enhancer A and enhancer B (Helms et al. 2000).   
Enhancer A is sufficient on its own to drive expression in multiple Atoh1 tissue-specific 
regions, including the ear epithelium, but not in the neural tube. In contrast, enhancer B 
on its own showed lacZ activity in all the Atoh1 expressing regions but also in other 
tissues where Atoh1 is not expressed.  
The sequence of the two mouse Atoh1 enhancers were investigated by the same group 
and sequence homology was not found between both enhancers in spite of having some 
redundant functions. As a result of this analysis, an E-box site located in the enhancer B 
(Figure 1.11) was demonstrated to be necessary for the expression of the lacZ transgene 
in the neural tube. In addition, this E-box sequence was shown to bind ATOH1 and its 
co-factor, E12/E47 (Akazawa et al. 1995), in electrophoretic mobility shift assays 
(EMSAs).   
Subsequent experiments by Helms et. al. 2000, on an ATOH1 mutant background 
confirmed that ATOH1 is required for Atoh1/lacZ transgene expression in an auto-
regulatory feedback loop controlling its own expression.  
The requirement of ATOH1 for the expression of Atoh1 in the mouse inner ear was also 
demonstrated by studies conducted with an Atoh1-GFP BAC transgenic mouse. This 
transgenic mouse expressing GFP under the control of the Atoh1 enhancers matched the 
endogenous Atoh1 mRNA expression in wild type animals but failed to express GFP in 
mutant animals lacking endogenous ATOH1 at stages E13.5 through E15.5. This 
confirms the need for ATOH1 to initiate Atoh1 enhancer activity (Raft et al. 2007). 
However, GFP expression was persistent in the hindbrain in Atoh1 mutant animals 
supporting the hypothesis that additional regulatory elements lie outside the Atoh1 A 
and B enhancers necessary for endogenous regulation of mouse Atoh1.  
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Little is known about the mechanisms controlling the basal transcription of Atoh1. 
According to experiments conducted by Helms et al., the activity of the Atoh1 
enhancers is independent from the Atoh1 promoter sequences immediately 5’ of the start 
of transcription since 3’ enhancer activity is observed when using other promoters such 
as the β-globin basal promoter (Helms et al. 2000). However, these experiments were 
limited to the spiral neural tube and hindbrain. The murine Atoh1 promoter containing 
the 226 bp upstream region of the Atoh1 transcription start site has recently been tested 
in cells within the prosensory domain of the developing cochlea (Abdolazimi, 2016). In 
this study it was suggested that the Atoh1 promoter contains Hes/Hey binding sites that 
are required for timely repression of Atoh1 within the cells of the prosensory domain 
that will form supporting cells. Therefore, based on these recent results, it is possible 
that the mouse Atoh1 promoter does contribute to the temporal and spatial control of 
Atoh1 expression in prosensory progenitors of the inner ear.   
In summary, evidence to date suggests that murine Atoh1 expression is strongly 
controlled by the presence of two 3’ enhancers, enhancer A and enhancer B, which are 
sufficient to drive Atoh1 expression in several Atoh1 tissue-specific regions. However, 
very recent investigations raise the possibility that the Atoh1 proximal promoter could 
have roles in Atoh1 expression to select the hair cell and supporting cell fate 
(Abdolazimi, 2016). It has also been suggested that additional regulatory elements, not 
explored in previous studies, might also be involved in the regulation of Atoh1 (Helms 
et al. 1998; Helms et al. 2000). ATOH1 appears to play a role in regulating its own 
expression via enhancer B (Helms et al. 2000). However, little is known about the 
mechanisms initiating Atoh1 enhancer activity before ATOH1 is produced.  
1.7.3 Transcription factors binding Atoh1 enhancers 
As described previously, the heterodimer formed by ATOH1/E47 binds to an E-box site 
located in the mouse Atoh1 enhancer to control its own expression (Akazawa et al. 
1995) (Helms et al. 2000). However, ATOH1 is not the only transcription factor binding 
to the Atoh1 enhancers. A number of other transcription factors have also been shown to 
activate or repress ATOH1 expression by binding to the 3’ enhancers.  
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In a screen to identify transcription factors involved in the regulation of Atoh1, the zinc-
finger transcription factor ZIC1 was shown to downregulate the activity of the mouse 
Atoh1 enhancer in the neural tube (Ebert et al. 2003). EMSA analysis demonstrated that 
ZIC1 binds to the mouse Atoh1 enhancer B at a site 30 bp from the previously identified 
E-box site (Figure 1.11). Moreover, EMSA probes designed to the homologous sites 
within the human and chick Atoh1 enhancers confirmed that the binding of ZIC1 is 
conserved among these species. In chick, electroporated ZIC1 also represses the 
expression of endogenous chick ATOH1 in neural tubes. In addition, Ebert et al. 
showed that the mutation or deletion of the ZIC1 binding site in the mouse Atoh1 
enhancer produced the loss of the enhancer activity.  
A number of other transcription factors have been linked to regulation of Atoh1 though 
with less experimental evidence than that for ZIC1 and ATOH1 itself and largely in 
non-auditory tissues. Hypermethylated in cancer-1 (HIC-1), a zinc-finger transcriptional 
repressor that is hypermethylated in various human cancers has been shown to be a 
specific repressor of Atoh1 (Briggs et al. 2008). The upregulation of Atoh1 commonly 
found in medulloblastoma cancers was suggested to be modulated by HIC-1 via 
epigenetic silencing.   
CDX2 is a caudal-related homeobox transcription factor expressed in the nuclei of 
embryonic and adult mucosal epithelial cells of the intestine (Meyer and Gruss 1993). 
Reporter gene assays in IEC-6 intestinal epithelial cells demonstrated that CDX2 
activates the transcriptional activity of Atoh1. The site of CDX2 binding was in the 
mouse Atoh1 enhancer B downstream of the E-box sequence (Mutoh et al. 2006b) 
(Figure 1.11). Also in the intestinal epithelium, the hepatocyte nuclear factors Hnf1α 
and β, have been implicated in the regulation of Atoh1 expression (D'Angelo et al. 
2010). β-catenin, a key mediator of the Wnt signalling pathway, was also found to 
activate the expression of Atoh1 in mouse neuroblastoma cells and neural progenitor 
cells (Shi et al. 2010). The interaction between β-catenin and Atoh1 was through Tcf-
Lef binding sites located in the mouse Atoh1 3’ enhancers (Figure 1.11) as 
demonstrated by ChIP assays. Moreover, the mutation of the Tcf-Lef binding sites 
reduced the transcriptional activation of the mouse 3’ Atoh1 enhancers confirming the 
direct interaction. 
  
 
 
 
Figure 1.11. Schematic representation of the mouse Atoh1 locus on chromosome 6.  Location of the two conserved regulatory regions, enhancer A and enhancer B, (in 
blue) downstream of the Atoh1 coding sequence (in red). The Atoh1 enhancers A and B were demonstrated to be sufficient to control Atoh1 expression (Helms et al. 2000). 
The position of known transcription factors within the 3’ enhancer sequences are indicated within the boxed panels. An E-box sequence (CATATG) located in the enhancer B 
is required for the binding of ATOH1 to control its own expression. The binding sites of other transcription factors demonstrated to bind the Atoh1 enhancers such as SOX2 
and β-catenin in the enhancer A and SIX1, ZIC1, HIC1 and CDX2 in the enhancer B are marked in colours. Figure reproduced from Groves et al. 2013.  
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In addition, silencing β-catenin expression produced a decrease of mouse Atoh1 mRNA 
levels in Neuro2a cells and neural progenitor cells based on RT-PCR results. Since the 
expression of bHLH genes, including Atoh1 is partly regulated by the Notch pathway, 
the authors of this study proposed that β-catenin could potentially contribute to the 
initial up-regulation of Atoh1 after Notch signalling inhibition.  
Within the inner ear, the expression of Atoh1 has recently been demonstrated to be 
dependent on the co-operation of three transcription factors: SOX2, EYA1 and SIX1 
(Ahmed et al. 2012). EYA1 is a transcriptional co-activator that along with its co-factor, 
the homeodomain protein SIX1 plays essential roles during sensory development (Xu et 
al. 1999) (Zheng et al. 2003), whereas SOX2 is required for specifying precursors 
within the prosensory domain (Kiernan et al. 2005). The expression of SIX1 in the 
organ of Corti transiently increased in parallel with hair cell differentiation with an 
onset of expression slightly earlier than that of Atoh1 (at E13.25). SOX2 expression is 
observed in the GER epithelium by E13.5 in post-mitotic cells but by E16.5 has 
becomes restricted to supporting cells. Finally, EYA1 expression was observed in the 
cochlear epithelium between 12.5-13.5 overlapping with SOX2 expression, although 
later on EYA1 becomes restricted to differentiated hair cells.  
In order to determine whether these transcription factors were required for murine Atoh1 
expression, mouse cochlear explants were electroporated with an Atoh1-GFP construct 
and different combinations of SOX2, EYA1 and SIX1 expression constructs. The 3’ 
Atoh1 enhancer AB construct was activated by both SOX2 and SIX1. Moreover, 
electroporation with the individual Atoh1 enhancer A or enhancer B constructs showed 
that SOX2 activates the mouse Atoh1 enhancer A, whereas SIX1 activates the mouse 
Atoh1 enhancer B. Using SOX2 and SIX1 antibodies in ChIP analysis confirmed the 
presence of SOX2 and SIX1 binding sites in enhancer A and B respectively in vivo. 
Overall, the work conducted by Ahmed et. al., suggested that the synergistic co-
operation of SOX2, EYA1 and SIX1 is required to activate the transcription of mouse 
Atoh1 both in vitro and in vivo.  
Confirming the results from the previous study, Neves et. al., also found that the 
transcription factor SOX2 induces Atoh1 transcription. Overexpression of SOX2 in 
HEK293T cells and in chick otic vesicles was seen to activate mouse Atoh1 enhancer 
activity (Neves et al. 2012).  
                                                                                                                         Chapter 1: General Introduction 
 
63 
 
1.7.4 Signalling pathways, ATOH1 expression and sensory cell 
fate in the inner ear  
The development of the inner ear is a complex process regulated by multiple genes and 
signalling pathways. The Notch signalling pathway (see section 1.5.2), transcription 
factors such as ATOH1, SOX2, POU4F3 and GFI1 (discussed in sections 1.5.3 and 
1.7.3) as well as other proteins combine to regulate supporting cell/hair cell fate during 
inner ear development. In addition to these, the BMP, SHH, FGF and WNT signalling 
have been linked to the activation of Atoh1 expression and therefore participate in the 
determination of hair cells and supporting cells.   
 
The role of the bone morphogenetic protein (BMP) signalling pathway on the control of 
Atoh1 expression is still unclear. The BMP signalling pathway induces Atoh1 
expression in early stages of cell differentiation in dorsal neurons (Alder et al. 1999; 
Lee et al. 2000) and rhombic lips (Krizhanovsky and Ben-Arie, 2006). However, in 
contrast the BMP signalling pathway reduces ATOH1 protein expression during the 
developing of cerebellum (Zhao et al. 2008) and in medulloblastoma (Grimmer and 
Weiss 2008). One of the mechanisms proposed for ATOH1 downregulation in the inner 
ear was suggested to be mediated by BMP4 and BMP7. These molecules may induce 
the phosphorylation of SMAD1,5,7, leading to the induction of the inhibitor of DNA-
binding proteins Id1-3 to consequently reduce ATOH1 expression in hair cells (Kamaid 
et al. 2010; Zhao et al. 2008).   
The Sonic Hedgehog (Shh) and WNT signalling pathways have also been suggested to 
play a role on hair cell fate by regulating Atoh1 expression. Data suggests that SHH 
contributes to the differentiation of cochlear neural progenitors by activating Atoh1 
expression and Pou4f3 activity to promote hair cell differentiation (Hu et al. 2010).   
WNT signalling pathway induces Atoh1 expression during embryonic development 
(Landsberg et al. 2005). As discussed in section 1.7.3, β-catenin, a key mediator of the 
canonical WNT pathway, binds to the mouse Atoh1 3’ enhancers to activate ATOH1 
expression in neural progenitor cells (Shi et al. 2010).  
In zebrafish, Fgf3 and Fgf8 signals have also been proposed to activate ATOH1 
expression during the development of the pre-otic placode and later during the 
development of the otic vesicle (Millimaki et al. 2007). In mouse, FGF20 was also 
suggested to activate ATOH1 expression since its expression overlaps with SOX2 
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expression in the otic vesicle (Hayashi et al. 2008). FGF20 signals activate downstream 
members of the Ets-domain transcription factor family, PEA3 and ERM, and thereby 
activate ATOH1 expression.  
In summary, the interaction of different signalling pathways is thought to have diverse 
effects on the expression of genes, like Atoh1, to control hair cell fate in the inner ear.  
In addition, other regulatory mechanisms such as epigenetic regulation (discussed in 
section 1.7) are likely to contribute to the complex network which regulates ATOH1 
involvement in the proliferation and differentiation of sensory cells in the inner ear.  
1.7.5 Can Atoh1 restore hearing?  
Beyond its developmental role as a gene required for the formation of hair cells, Atoh1 
was chosen as a potential candidate for regenerating hair cells and thereby restoring 
hearing (Zheng and Gao 2000; Woods et al. 2004; Gubbels et al. 2008; Shou et al. 
2003). Hair cells are delicate structures, susceptible to ototoxic drugs and chronic noise 
exposure. In addition, in ageing animals, hair cell numbers decline leading to age-
related hearing loss. The identification of mechanisms that can restore hearing by 
stimulating regeneration of functional hair cells is one of the most difficult challenge 
that faces inner ear biology but one of immense clinical potential.  
Non-mammalian vertebrates, including birds, can produce new hair cells through direct 
or indirect transdifferentiation of surviving supporting cells into hair cells. (Cotanche 
1987; Corwin 1989; Ryals 1988; Stone 1998; Adler and Raphael 1996; Taylor and 
Forge 2005).  As in mammals, ATOH1 expression is not seen in the basilar papilla of 
post-hatch birds in which no new hair cells are formed. However, upon hair cell 
damage, ATOH1 expression is re-activated in the chick auditory epithelium (Cafaro et 
al. 2007; Daudet et al. 2009) and as a consequence hair cells are spontaneously 
regenerated. This was shown in experiments using immunofluorescence in chick after 
ototoxic drug exposure where ATOH1 expression was observed in regenerated hair 
cells in comparison to untreated animals where ATOH1 was not detected. Moreover, 
this re-activation was observed in both direct and indirect mechanisms of trans-
differentiation of supporting cells into hair cells. In addition, ongoing production of 
vestibular hair cells has also been observed in birds (Jorgensen et al. 1988). 
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In contrast, in mammals hair cell regeneration is very limited. To date, only vestibular 
hair cells have been demonstrated to have some potential to regenerate (Forge et al. 
1993; Rubel et al. 1995; Lopez et al. 1998; Kawamoto et al. 2009).  
Therefore, due to the different regenerative capabilities found in mammals and avians, 
one of the main questions that remain unsolved is elucidating the mechanisms that 
differentiate the regenerative capabilities of avian and mammalian hair cells. The 
upregulation of Atoh1 was suggested to be, at least in part, responsible for the 
spontaneous regeneration of hair cells after injury in birds as a recapitulation of the 
events that occur during the embryonic development of hair cells in which ATOH1 is 
expressed (reviewed in Groves, 2010). Based on this hypothesis, several groups studied 
the ability of ectopic ATOH1 to generate new hair cells mainly by the use of three 
different techniques: ectopic transfection of an Atoh1 expression construct, in utero 
electroporation of Atoh1 or adenovirus-mediated expression of Atoh1.  
In Drosophila, ectopic expression of atonal was observed to promote extra sense organs 
such as scolopales, the fundamental units of the mechanoreceptor organs in insects 
(Jarman et al. 1993). In mammals, the overexpression of Atoh1 resulted in the 
production of extra hair cells in the greater epithelial ridge of P0 rat cochlear explants 
(Zheng and Gao 2000). Ultrastructural analysis and immunohistochemistry of post-natal 
cultures electroporated with a mouse Atoh1 construct suggested the presence of 
ectopically induced hair cells in the greater epithelial ridge. In utero electroporation of 
Atoh1 into an embryonic mouse otocyst was also suggested to generate ectopic hair 
cells in the organ of Corti showing the electrophysiological properties of normal hair 
cells (Gubbels et al. 2008) 
The conversion of non-sensory cochlear cells into sensory hair cells after adenovirus 
induction of Atoh1 was also investigated in young adult guinea pigs. Different studies 
conducted by Raphael’s group attempted to induce hair cell regeneration by the 
inoculation of an Atoh1 expressing adenovirus into the cochlear endolymph (Kawamoto 
et al. 2003; Izumikawa et al. 2005; Izumikawa et al. 2008). In the first study conducted 
by this group, it was assumed that the injected volume of virus into the endolymph was 
sufficient to generate a mechanical trauma that caused degeneration of the majority of 
the hair cells (Kawamoto et al. 2003). It was not clear whether the Atoh1 positive cells 
shown by immunohistochemistry or scanning microscopy after the inoculation of the 
virus were new hair cells or surviving hair cells after the mechanical trauma. Following 
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this work, a subsequent study by the same group performed Atoh1 adenovirus 
inoculation into the cochlea of young adult guinea pigs that had been deafened by the 
administration of kanamycin (Izumikawa et al. 2005). Kanamycin is an aminoglycoside 
antibiotic that causes permanent damage to sensory cells (Erol 2007). Some deafened 
animals showed a recovery in hearing with Atoh1 inoculation according to auditory 
brain-stem responses (ABRs). However, the lack of controls showing that cochlear hair 
cells were completely eliminated after the ototoxic insult, and the fact that the study did 
not show whether or not ATOH1 positive cells were found in the cochleae inoculated 
with an empty adenovirus means these data should be interpreted with caution. 
Additional studies also conducted in guinea pig were unable to detect new hair cells in 
the flat cochlear epithelium after neomycin treatment and Atoh1 virus inoculation which 
suggests that differentiated supporting cells are required for transdifferentiation to occur 
(Izumikawa et al. 2008).   
Although these results suggest potential for an Atoh1 therapeutic approach in restoring 
hearing, they remain controversial. The main concern with these studies is that some 
deafened animals still show normal patterning of IHC, OHC and supporting cells in the 
cochlear epithelium right after the ototoxic treatment to differing extents. Therefore the 
cochlear epithelium in these animals could have retained some of the features that are 
required for the recovery of hair cells which might explain the hearing recovery rather 
than Atoh1 induced regeneration. The plasticity of cochlear cells to respond to Atoh1 
and the ability of hair cells to recover after injury could also change as the organ of 
Corti matures (Groves 2010). Embryonic and neonatal animals both birds and 
mammals, showed a greater capability to transdifferentiate supporting cells into hair 
cells in comparison to mature animals. It is also possible that there is a short time frame 
after hair cell damage in which Atoh1 can be introduced before the supporting cells 
degenerate and a flat and non-regenerative epithelium is formed which may influence 
these results. Other factors in addition to Atoh1 could also be required to 
transdifferentiate supporting cells into hair cells. All these considerations might limit 
the therapeutic potential of this regenerative approach to correct hearing loss in humans.    
Atoh1 therapy as a method to regenerate hair cells is still being investigated by many 
groups as an approach toward the recovery of hearing. Currently, a clinical trial based 
on Atoh1 gene therapy is being conducted on human volunteers with hearing loss by 
University of Kansas Medical Center in collaboration with the pharmaceutical company 
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Novartis. A group of 45 volunteers will have the Atoh1 adenovirus injected into their 
cochleae and the study will test whether the hearing is improved after the inoculation of 
the Atoh1 virus. The trial results are expected in 2017 (Information found at the 
Novartis website: https://www.novartis.com/stories/discovery/can-we-unlock-bodys-
ability-regenerate-lost-hearing).  
1.8 New perspectives and treatments for hearing 
loss 
There are several advantages to the use of gene therapy approach described above to 
treating hearing. Gene therapy offers the possibility of introducing a transgene to 
specific cells via cell specific promoters to produce the desired protein in the correct 
location for long periods. However, as discussed above there are major challenges to be 
overcome. First, the injection of an adenovirus can damage the delicate cochlear 
epithelium. In addition, there is a short time frame of approximately one week after 
severe ototoxic injury at which the efficacy of the gene therapy starts to decrease 
(reviewed in Groves 2010).  
 
In addition to gene therapy, a regenerative approach is currently being investigated by 
the introduction of stem cells into the damaged ear with the aim of differentiating them 
into functional hair cells. Promising protocols have been established to demonstrate that 
mouse embryonic stem cells can be directed toward the formation of an ectodermic 
epithelium which is able to respond to otic-inducing growth factors to form hair cell-
like cells (Oshima et al. 2010; Rivolta 2012).  
A more recent study also showed that mouse embryonic stem cells can be differentiated 
into a three-dimensional inner ear-like epithelium (Koehler et al. 2013). It is hoped that 
the use of these protocols that can be applied to human stem cells.  In vitro studies 
conducted with human stem cells, isolated mainly from bone marrow-derived 
mesenchymal stem cells or adipose-derived stem cells can be induced to express 
different otic markers including ATOH1, POU4F3, SOX2, PAX2, PAX8, GATA3 and 
MYOSIN7a (Boddy et al. 2012; Durán Alonso et al. 2012). A key factor of the stem cell 
approach is the delivery of the correct signals in order to mimic the normal inner ear 
environment during development. Therefore to achieve this, a combination of different 
factors in an embryonic or stem cell environment must be added to achieve the correct 
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re-programming of stem cells into the hair cells. Recent studies have shown that the 
combination of the transcription factors ATOH1, GFI1 and POU4F3 can have the 
potential to re-programme mouse stem cells into sensory hair cell-like cells (Costa et al. 
2015). However, isolating human stem cells is challenging, as is re-programming them 
in vivo or re-introducing in vitro re-programmed stem cells to the inner ear which makes 
this approach very difficult in a clinical scenario (Chen et al. 2009; Hu et al. 2012).  
 
Regardless of the approach, a major challenge is the delivery of stem cells or genetic 
material into the inner ear. Transplanted cells might not be integrated into the organ of 
Corti or may die in the process (Muller and Barr-Gillespie 2015). The therapeutic 
approach also needs to consider the different forms and degrees of hearing loss. Many 
forms of hearing loss are not just a result of hair cell defect but also due to defects in 
other structures in the cochlear epithelium, such as the stria vascularis or the auditory 
nerve (Yamasoba et al. 2013; Fetoni et al. 2011).  
The use of pharmacological drugs as a treatment for some forms of hearing loss is also 
being studied. Over a thousand compounds have already been tested in a screen 
conducted in zebrafish to identify biological and chemically designed drugs that can 
modulate hair cell regeneration (Namdaran et al. 2012).     
Finally, cochlear implants and 3D printing will bring together functional electronic 
devices with the use of reconstructed/bionic ears (Mannoor et al. 2013) and may also 
provide a mechanism in which to deliver therapeutic agents to the inner ear.  
There is no doubt that the market for therapeutics toward the cure for hearing loss will 
bring new exciting and novel approaches. The combination of science and technology 
will be highly important, which will be expanded over the next coming years.  
1.9 Investigation of inner ear biology 
1.9.1 The challenge of studying the inner ear 
The study of the auditory and vestibular system is necessary for understanding inner ear 
dysfunctions. However, the inner ear is located deep inside in the temporal bone and 
therefore its accessibility is complex. Accessing the inner ear requires extensive training 
and advance dissecting skills in order to reach such a small structure. Moreover, the 
inner ear epithelium is composed of different cell types including hair cells and 
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supporting cells formed by extremely fragile structures which can be permanently 
damaged under mechanical and environmental changes. The use of animal models, 
usually mouse, rat or guinea pig, is a common approach in the study of biomedical 
research. Depending on the animal model used, many inner ears would be required for 
experimentation based on the low number of hair cells per ear (approximately 20,000 
depending on species) (Slepecky 1996). The use of cell lines overcomes some of these 
problems and disadvantages.    
1.9.2 The use of cell lines as a model to study gene regulation 
To overcome the difficulties outlined above on the study of the inner ear, cell lines were 
used in molecular experimentation. Cell lines have proven to be a valuable source in 
many research areas including studies on visual (Seigel 1999) and olfactory (Barber and 
Ronnett 2000) systems. The use of cell lines generates many advantages in comparison 
to animal experimentation. For instance, they require minimal care in comparison to 
animal work, decreasing the cost invested on their maintenance and can also provide a 
higher cell population in comparison to the number of cells obtained from dissected 
inner ears. However, as any other approach, the use of cell lines also has some 
limitations. Cell lines are in vitro preparations, isolated from specific cell populations at 
a precise developmental stage. Therefore, all the surrounding epithelium, intercellular 
factors and connective tissue that they would normally experience in vivo, are absent in 
these cellular preparations. In spite of these disadvantages, cell lines retain many of the 
characteristics and gene expression profiles possessed at the time they were established. 
Therefore, cell lines are useful tools on the study of gene regulation since they express 
many of the genes, transcription factors and other protein molecules that are required for 
the study of a precise stage of development (Rivolta and Holley 2002).  The use of inner 
ear cell lines commenced in the late nineties with the development of immortalized cell 
lines (Rivolta and Holley 2002). UB/OC1 and UB/OC2 cell lines, named after 
University of Bristol, are conditional immortalized cell lines derived from E13 primary 
cultures of the developing organ of Corti (Rivolta et al. 1998). They are derived from a 
transgenic mouse (H-2K
b
-tsA58) which carries a temperature-sensitive oncogene which 
regulates the differentiation of the cells based on temperature changes (Jat et al. 1991). 
Therefore, when these cells are cultured at 33
o
C in the presence of a γ-interferon, the 
proliferative state of these cells is maintained, but if the temperature is increased to 
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39
o
C and the γ-interferon is removed the cells stop proliferating and start to differentiate 
(Rivolta and Holley 2002). This generates a specific time window that retains some of 
the in vivo characteristics possessed after the last mitosis of hair cells and before they 
start to differentiate. UB/OC2 cells were used for some experimental procedures 
conducted in this thesis. The expression of different hair cell markers such as POU4F3, 
α9AChR, Myo7a and Myo6 were detected by RT-PCR (Rivolta and Holley 2002) 
which makes this cell line a valuable source for the study of hair cell gene regulation 
and physiological studies (Jagger et al. 1999). 
1.10 Project aims 
Over 5% of the world’s population (360 million people) are affected with a moderate 
degree of hearing loss (WHO-March 2015), with the loss of cochlear hair cells as one of 
the major causes of deafness. Understanding how hair cells are formed and the 
mechanisms required for its differentiation and regeneration is therefore critical to find a 
cure for deafness. The general aim of this project is to identify transcription factors 
involved in the regulation of Atoh1, the pro-hair cell master gene required for the 
formation of hair cells in the inner ear (Bermingham et al. 1999). Though a few 
candidates have been identified for controlling Atoh1 expression in different tissues 
(Helms et al. 2000; Ebert et al. 2003; Briggs et al. 2008; Mutoh et al. 2006; Shi et al. 
2010), very little is known about the regulation of Atoh1 expression in the inner ear 
(Neves et al. 2012; Ahmed et al. 2012). There are clearly some differences in the 
regenerative capabilities of hair cells in mammalian and avian species. This condition 
appears to be linked to the re-activation of the expression of Atoh1, a mechanism that 
spontaneously occurs in avians (Cafaro et al. 2007; Daudet et al. 2009) but that is 
extremely limited in mammals including humans (Wang et al. 2010). It was 
hypothesized that these differences may be found in the regulatory mechanisms that 
govern its expression. To test this hypothesis, the investigation was sub-divided in to 
three different objectives:  
 To compare and identify common and distinct regulatory elements and 
putative transcription factor binding sites in the Atoh1 gene locus in avians and 
mammals (Chapter 3). 
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 To investigate whether four of these candidates YY1, NF-κB, ATOH1 and E2F 
transcription factors are involved in the regulation of Atoh1 expression 
(Chapter 4 and 5). 
 
 To investigate the role of a novel avian conserved region, putative enhancer C 
and the effect of E2F1 on Atoh1 regulation in the chick inner ear in vivo      
(Chapter 6).  
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Chapter 2  
2 Material and Methods 
2.1 Material 
General equipment and stock solutions are described in the following sections. Specific 
equipment used to conduct some of the techniques performed for this project, are stated 
in the corresponding section. All water used is type III ultrapure purified water unless 
otherwise stated. Restriction endonucleases were purchased from Promega
® 
or Sigma-
Aldrich unless otherwise stated.          
2.1.1 General Equipment 
 
Autoclaves: Prioclave PS/MVA/C60 and  
PS/QVA/EH150 
 
Bench-Top microbiological Incubator:  
Genlab MINI/100/CLAD  
 
C25 Incubator Shaker: New  Brunswick 
Scientific 
 
Centrifuges: Eppendorf 5417C, 5417R 
and 5804R. SORVALL® 
RC 5Cplus centrifuge 
 
Concentrator:  Eppendorf 5301 
 
Cryostat CM1850: Leica 
Ice Maker: Porkka KF 165 
 
Mini- Plus horizontal Gel  
Electrophoresis: Jencons 
 
R100 rotatest shaker: Luckham 
Nanodrop®  1000  
spectrophotometer: Thermo 
Scientific 
 
Thermal cyclers: Eppendorf 
Mastercycler  gradient and 
Mastercycler personal  
 
Upright -80C Freezer uLT2586-
9W ultima II Series: Revco 
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Dishwasher:  Miele G7883CD 
 
Dri-Block ®  DB-2D heat block: Techne 
 
Elix  and  Milli-Q®   water  purification 
System: Millipore 
 
3UV
TM
 Transilluminator GelDoc-
It Imaging System: UVP 
 
2.1.2 Stock solutions  
Luria-Bertani Broth (LB) 
1%  Bacto-tryptone  
0.5% yeast extract 
0.17M NaCl 
pH 7.5  
 
LB-Agar 
98.5%  LB 
1.5%  Micro Agar 
 
Phosphate-Buffered Saline (PBS) 
10 mM Na2HPO4 
2.7 mM KCl 
137 mM  NaCl 
2 mM KH2PO4 
pH 7.4 
 
50x TAE 
2M  Tris base 
1M  Glacial acetic acid 
50mM  EDTA pH 8.0 
2.1.3 Safety  
All procedures were carried out according to UCL safety regulations.  
2.1.4 Primers 
Primers used for plasmid construction, quick change site-directed mutagenesis and 
sequencing are listed in Table 2.1  
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Table 2.1. Summary of the primers used in this study. Primers containing a SalI restriction enzyme 
sites are marked in red. Primers containing SacI overhangs are marked in green. Primers where mutations 
were introduced are underlined.   
 
Oligo  Primer Sequence (5' to 3') Location 
Length 
(bp) 
Tm 
(°C) 
1 TAAGCGTCGACAGATCTCAATGAAGTTTGCATAACAA Atoh1 Mouse AB 37 60.1 
2 ATTCGTGTCGACGCTAGCCCGGGCGAATG Atoh1 Mouse AB 29 59.8 
3 TAGAAGTCGACGCAGCGCATTTCCATGTTGAG Atoh1 Chick AB 32 61.2 
4 ATTCGTGTCGACCATGGGAGCACGCACACG Atoh1 Chick AB 30 60.8 
5 TAAGCAGTCGACTGTCCTCTCGCCCGCCCTG Atoh1 Chick C 31 66.1 
6 ATTCGTGTCGACGGTTACAGTGTCGGTGAGCTGC Atoh1 Chick C 34 65.8 
7 GCGGAGCAAATCGCACCCACTTAC Atoh1 Chick C 24 66.1 
8 CGTTGGCATGGGCGGTTCTAAGC Atoh1 Chick C 23 66 
9 TCGACCAGCTGTACGACAGCTGCATCTCAGCTGG Non-coding 34 79 
10 TCGACCAGCTGAGATGCAGCTGTCGTACAGCTGG Non-coding 34 79 
11 TCGACATTCTGTACGAATTCTGCATCTATTCTGG Non-coding 34 71.6 
12 TCGACCAGAATAGATGCAGAATTCGTACAGAATG Non-coding 34 71.6 
13 
TCGACTAGAGGGTATATAATGGAAGCTCGACTTCCGGTCGAC
GAGCT 
Minimal promoter 47 82.4 
14 CGTCGACCGGAAGTCGAGCTTCCATTATATACCCTCTAG Minimal promoter 39 78.8 
15 ATTCGTGTCGACGGAAGTCGAGCTTCCATTATATACCCT Non-coding 39 76.7 
16 TCCCGCGCCCAACTTGGGACAGCGACGC   Non-coding 28 78.7 
17 GCGTCGCTGTCCCAAGTTGGGCGCGGGA Non-coding 28 78.7 
18 
CGCTTTAAAGAAATGCCTCAAAAAAAGATAAAAAATGGCACA
AAGCAAAGC 
Non-coding 51 76.4 
19 
GCTTTGCTTTGTGCCATTTTTTATCTTTTTTTGAGGCATTTCTTT
AAAGCG 
Non-coding 51 76.4 
20 ACAATTGCATTCATTTTATGTTTCAGGT Atoh1 Mouse AB 28 60.5 
21 ATATGGGGAATGAGCGCTCCGA Atoh1 Chick AB 22 64.2 
22 TTCTTCTGCGCCTTAGTC Minimal promoter 18 53.8 
23 CAACTCTGCGGTGCAAGCTAAG Non-coding 22 64.5 
24 TGCGTATGAAATGATGGTAAAT Non-coding 22 54.7 
25 ATCTATGACATCACCAACGTCCTT E2F1 coding sequence 24 62 
26 TCCGAAGAGTCCACGGCTTG E2F1 coding sequence 20 62.5 
27 AACGGGAAGCCCATCACC GAPDH coding sequence 18 58.4 
28 CAGCCTTGGCAGCACCAG GAPDH coding sequence 18 60.8 
 
 
2.2 Methods 
2.2.1 DNA purification 
Different procedures were followed according to the amount and type of genetic 
material to be prepared.  
                                                                                                                       Chapter 2: Material and Methods 
 
75 
 
2.2.1.1 Genomic DNA preparation from animal tissue 
Brain tissue from chicken was cut into small pieces and placed in a 1.5ml eppendorf 
tube. 20µl of proteinase K was added to the tissue, homogenised by vortexing and 
incubated at 56
 o
C until the tissue was completely lysed. The mixture was then vortexed 
for 15s and 200µl of Buffer AL from the QIAGEN DNeasy Blood and Tissue Kit was 
added. The sample was mixed again by vortexing and 200µl of 100% ethanol was added 
to the mixture. The tissue mixture was then transferred into a DNeasy Mini spin column 
with a collection tube and was centrifuged at 6,000 x g for 1 min. The flow-through in 
the collection tubes was discarded and the DNeasy Mini spin column was placed in a 
new collection tube. 500µl of Buffer AW1 were added onto the column and 
centrifugation was conducted for 1min at 6,000 x g. The flow-through was again 
discarded and the DNeasy Mini spin column was placed onto a new collection tube. 
500µl of Buffer AW2 was added and centrifugation was conducted for 3min at 20,000 x 
g in order to dry the DNeasy membrane in the column. The flow-through was discarded 
and the column was dried at 55
 o
C in a hot block for 2min. The DNeasy Mini spin 
column was placed in a clean 1.5 eppendorf tube and 200µl of Buffer AE was added in 
the centre of the column. The sample was centrifuged for 1min at 6,000 x g to collect 
the genomic DNA.    
2.2.1.2 Small scale plasmid DNA purification from transformed E. Coli 
Approximately 1ml of an 8h or overnight bacterial starter culture was harvested and 
centrifuged at 6000 x g for 15 min at 4
 o
C. The supernatant containing the growth 
medium was discarded and the bacterial pellet was re-suspended in 250µl of Buffer P1 
according to the QIAGEN plasmid purification protocol. After a complete re-suspension 
of the bacterial pellet by vortexing or pipetting, 250µl of Buffer P2 was added and 
vigorously mixed by inverting the tube 4-6 times. The mixture was then incubated at 
room temperature for 5 min. 350µl of chilled N3 buffer were then added and mixed by 
vigorously inverting the tube 4-6 times and incubated on ice for 5 min. The bacterial 
mixture was then centrifuged at 13000 rpm for 10 min. The supernatant containing the 
plasmid DNA was collected and placed in QIAprep spin column and centrifuged for 1 
min. The flow-through was discarded and the spin column where the DNA is retained 
was washed by adding 500µl of Buffer PB and centrifuged for 1 min. The QIAprep spin 
column was then washed with 750µl of Buffer PE and centrifuged for 1 min. The flow-
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through was again discarded and the column was spun for an additional minute to 
remove any residual trace of Buffer PE. The QIAprep column was then placed in a fresh 
1.5ml eppendorf tube and incubated at 55
 o
C for 2 min in order to remove any traces of 
ethanol contained in the Buffer PE. 50µl of Nuclease-free water was then added to the 
centre of the QIAprep column and centrifuged for 1min. After centrifugation, the 
QIAprep column was discarded and the flow-through containing the bacterial DNA was 
collected and stored at -20 
o
C.  
2.2.1.3 Medium scale plasmid DNA purification from transformed         
E. Coli 
Approximately 50ml of the 8h or overnight bacterial starter culture was harvested and 
centrifuged at 6000 x g for 15 min at 4
 o
C. After removing the supernatant, the pellet 
was re-suspended in 4ml of Buffer P1 supplied by the Plasmid MIDI Kit from 
QIAGEN. The complete re-suspension of the bacterial pellet was carried out before 
adding 4ml of Buffer P2. The tube was vigorously inverted 4-6 times, sealed and kept at 
room temperature for 5 min. After this incubation, 4ml of chilled Buffer P3 was added 
to the mixture and mixed by inverting the tube 4-6 times and placed on ice for 10 min. 
The mixture was then centrifuged at 13,000 rpm for 30 min at 4
 o
C in a SORVALL
®
 RC 
5Cplus centrifuge. The supernatant was then filtered through a membrane cloth in order 
to remove any trace of lysed bacterial components. The filtered mixture was loaded onto 
a QIAGEN-tip column which was previously equilibrated with 4ml of QBT Buffer. 
After leaving the filtered mixture in the resin of the column to be filtered by gravity 
flow, column was washed twice with 10ml of Buffer QC. The QIAGEN-tip columns 
were transferred to a new tube and 5ml of Buffer QF was added in order to elute the 
DNA. The DNA was then precipitated by adding 3.5ml of isopropanol and the tube was 
sealed with parafilm. The tube was then centrifuged at 15,000 x g for 30 min at 4
 o
C. 
The supernatant was carefully removed without disturbing the DNA pellet. The pellet 
was then washed with 2ml of 70% ethanol and centrifuged at 15,000 x g for 10 min at 
room temperature. After centrifugation, ethanol was removed and the pellet was air-
dried for 10 min. The DNA pellet was then re-dissolved with 200µl of TE buffer, pH 8 
and the tube was labelled accordingly.  
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2.2.1.4 DNA clean up 
2.2.1.4.1 From PCR product 
When using DNA fragments from PCR products, the QIAquick
®
 PCR purification Kit 
from QIAGEN was used. To the final volume of the PCR mixture, 5 volumes of Buffer 
PB was added. The mixture was then placed in a QIAquick
®
 spin column and 
centrifuged for 1 min. The flow-through was discarded and the column was washed 
with 750µl of Buffer PE and centrifuged for 1 min. Flow-through was discarded again 
and column was dried in a heating block for 2 min at 55
 o
C. The column was then 
placed in a clean 1.5ml eppendorf tube and the DNA retained in the column was eluted 
by adding 50µl of nuclease free water in the center of the column before centrifuging 
for 1min. Purified DNA was quantified by a Nanodrop or analysed on an agarose gel. 
2.2.1.4.2 From Agarose Gel 
DNA bands were excised from the gel with a clean sharp scalpel. The gel band was 
weighed in a 1.5 ml eppendorf tube and 3 volumes of Buffer QG were added following 
the MiniElute 
®
 Gel Extraction Kit protocol from QIAGEN. The mixture was incubated 
at 50
 o
C for 10 min in order to completely dissolve the agarose gel. Then 1 volume of 
isopropanol was added to the sample and mixed by pipetting. The mixture was then 
placed in a MiniElute column for DNA fragments no bigger than 4 kb or in a QIAquick 
spin column for DNA samples up to 10 kb and centrifuged for 1 min. The flow-through 
was discarded and 500µl of Buffer QG was added to the column and centrifuged for 1 
min. The flow-through was discarded again and 750µl of Buffer PE was added to the 
column and centrifuged for 1 min. The flow-through was discarded and column was 
placed in a heating block for 2 min at 55
 o
C. The column was then placed in a clean 
1.5ml eppendorf tube and 10-30µl of nuclease free water was added to the center of the 
column before centrifuging for 1 min. The purified DNA was quantified by a Nanodrop 
or analysed on an agarose gel. 
2.2.1.5 Quantification of prepared DNA material 
DNA material was measured using a Nanodrop 1000 spectrophotometer. Typically, 2µl 
of water was used to obtain the baseline reading (blank) and then between 1 to 2µl of 
DNA were measured. The intensity of the light transmitted through the sample is 
recorded. The sample and the bank measurements were used to calculate sample 
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absorbance at a given wavelength. The concentration was then given by the Nanodrop 
based on Beer-Lambert equation:   
c = (A x e) / b 
where A is the absorbance represented in absorbance units, e is the wavelength-
dependent extinction coefficient in ng-cm/µl and b is the path length in cm.  
2.2.2 Plasmid construction 
Plasmids generated for this project were made by either TA cloning or restriction digest.  
2.2.2.1 TA cloning  
The pDrive vector from QIAGEN (Figure 2.1) or pGEM® T Easy Vector System from 
Promega (Figure 2.2) were used to insert PCR products. These are linearized plasmids 
containing either U or T-overhangs respectively at their 3’ terminal ends which are 
capable of ligating with the A-overhangs produced at the end of PCR products 
generated by certain DNA polymerases.   
 
Figure 2.1: pDrive vector. Schematic representation of the pDrive cloning vector.  Purchased from 
QIAGEN, the pDrive vector was used for the cloning of PCR products that has a single A overhang at 
each 3' end.  
Picture removed for copyright purposes 
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Figure 2.2: pGEM
®
-T Easy Vector. Schematic representation of the pGEM
®
-T Easy PCR cloning vector 
with T-overhangs at the multiple cloning site.  
 
 
Ligation of PCR products 
Ligation using PCR products was performed according to the manufacturer’s protocol 
with the following components:  
 1µl of cloning vector  (pDrive or pGEM®T easy) 
 2µl of (5X) Ligation buffer  
 1-4µl of PCR product 
 1µl T4 ligase 
 up to 10µl of water  
The reaction was mixed by pipetting and incubated for 1h at room temperature.  
Bacterial transformation was then performed as described on section 2.2.2.3.  
Picture removed for copyright purposes 
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2.2.2.2 Restriction digest cloning 
The general procedure for producing constructs generated by restriction digestion is 
described in the following sections.   
Restriction endonuclease digest  
DNA material was digested as follows: 
 1µg DNA material 
 1µl of 10x enzyme buffer 
 1unit of enzyme 
 up to 10µl of water 
The digestion mix was incubated for 1h at the optimal activity temperature for the 
enzyme, usually 37
o
C.  
DNA Polymerase I Large (Klenow) method to generate blunt ends 
Depending on the cloning strategy used to generate new constructs, in some cases it was 
necessary to create blunt ends. After conducting restriction digest, the reaction was 
incubated for 10min at 65
o
C in order to inactivate the enzyme. 2mM of deoxynucleotide 
triphosphates (dNTPs) from Promega were added to the reaction with 1 unit of DNA 
Polymerase I Large (Klenow). The reaction mix was incubated at room temperature for 
30 min. After this, the reaction mix was kept for 10 min at 75
 o
C in order to inactivate 
the Klenow enzyme. The reaction was then subjected to agarose gel electrophoresis and 
the DNA band was purified as described in section 2.2.1.4.2.  
Dephosphorylation of the vector 
In order to prevent self-ligation of the digested plasmid dephosphorylation was 
conducted to remove the 5’ phosphate group prior to ligation. By doing this, ligation 
will favour the incorporation of an insert as a result of the formation of a phosphodiester 
bond between the 3’-hydroxyl group in the plasmid and the 5’-phosphate group in the 
insert. Calf Intestinal Alkaline Phosphatase (CIAP) from Promega
®
 was used in the 
following reaction: 
 1-5µg of DNA 
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 3µl of CIAP (0.03units per 1µg of DNA)   
 3µl of 10x reaction buffer 
 up to 30µl of water     
Reaction was incubated for 1h at 55
 o
C.  
Ligation 
Typically, a 1:3 molar ratio of vector: insert DNA was used when cloning an insert into 
a vector. The following equation was used to convert molar ratio to mass ratio for kb of 
DNA: 
ng of vector x kb size of insert    x  molar ratio of    insert   =  ng of insert 
           kb size of vector                                             vector 
 
The following reaction was then set up: 
 1µl of ligase 10x buffer 
 1µl (1unit) of T4 DNA ligase from Promega 
 1-5µl vector 
 1-5µl insert 
 up to 10µl water 
The reaction was incubated overnight at 4
 o
C in order to improve ligation efficiency.  
2.2.2.3 Bacterial Transformation 
Alpha-selected chemically competent cells from Bioline were used to transform DNA 
material. Cells were removed from the -80
 o
C freezer and kept on ice. 50µl of competent 
cells and 5µl of DNA material were used per reaction in pre-chilled 17 x 100mm 
polypropylene tubes, (Falcon catalogue no. 2059). The cells were gently mixed and 
incubated on ice for 30 min. The cells were then incubated in a 42
 o
C in a water bath for 
30s and then for 2min on ice. 500µl of pre-warmed SOC media was added to the 
reaction mix. The cells were incubated in a shaker at ~200rpm for 60 min at 37
 o
C. The 
culture mix was then plated by spreading the transformation mixture on LB agar plates 
containing the appropriate antibiotic. The plates were left at room temperature for 2min 
and then incubated overnight at 37
 o
C.  
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2.2.2.4 Bacterial culture 
Single colonies were picked from transformed plates and inoculated in a 5ml culture 
tube containing LB medium with 5µl of a 1000x stock of the appropriate selective 
antibiotic. The culture was kept in a shaking incubator at 37
 o
C for a minimum of 8h to 
overnight with vigorous shaking (225rpm). After 8h, the bacterial cultures typically 
reach the exponential growth phase and can be used to prepare small scale plasmid 
DNA as described in section 2.2.1.2.  
For the preparation of medium scale plasmid DNA, 1/500 to 1/1000 of the starter 
culture was transferred to 50 to 100ml selective LB medium in a flask and grown at    
37
 o
C for 12-16h with vigorous shaking.    
2.2.3 Screening of bacterial recombinants  
Recombinant clones were screened using one or both of the following methods.  
2.2.3.1 Blue-white selection of transformed colonies 
Blue-white colour selection was used when the destination vector contained a lacZα 
gene, in the multiple cloning site (MCS). The lacZα peptide which encodes the N-
terminal amino acid sequence of β-galactosidase, will function in trans to complement 
β-galactosidase activity in the E. coli host strain.  The E.coli strain used to transform the 
ligated products carries a lacZ deletion mutant (lacZΔM15) but also an F’ episome 
which provides the complementary element to the lacZα in the vector to produce a 
functional lacZ gene product, the β-galactosidase.  
If the vector incorporates an insert in the MCS, the lacZα is disrupted and therefore it 
will fail to produce β-galactosidase. In contrast, if the vector fails to incorporate the 
insert, a functional β-galactosidase is produced. This will be visualized if using plates 
containing X-gal, a colourless analog of lactose that may be cleaved by the β-
galactosidase to form 5-bromo-4-chloro-indoxyl, producing a blue colour.  Isopropyl β-
D-1 thiogalactopyranoside (IPTG) was also used on the bacterial plates in order to 
enhance the blue phenotype of the indicator by activating the promoter.  
Using this method, colonies that incorporated the insert (white colonies) can be 
discriminated from colonies that failed to introduce the insert (blue colonies). 
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2.2.3.2 By Restriction digest  
Restriction digest was conducted in order to verify the cloning of the desired insert in 
the destination vector as well as its orientation. The reaction was performed as described 
in section 2.2.2.2.  
2.2.4 Sequencing of plasmid constructs 
Plasmids generated for this project were sequenced by Source Bioscience. DNA 
sequences and chromatograms were analysed and aligned against the appropriate DNA 
regions in order to verify the presence of the desired region.  
2.2.5 Reverse Transcriptase Polymerase Chain Reaction          
(RT-PCR) 
2.2.5.1 RT-PCR primer oligonucleotide design 
Primers used for RT-PCR were designed to be as sequence specific as possible,  
maintaining the optimal melting temperatures to avoid non-specific amplification. The 
optimal requirements for a successful RT- PCR are described below: 
 Primer length between 20-35 nucleotides 
 G/C content between 40-60%  
 Salt-adjusted melting temperature (Tm) > 60 oC.  
 Multiple runs of 3 or more G or C at the 3' end 
 The use of complementarity of two or three bases at the ends of primer pairs was 
avoid to reduce primer–dimer formation  
 Mismatches between the 3' end of the primer and the target-template sequence 
were avoided.  
 Complementary sequences within a primer sequence and between the primer 
pair were avoid.  
All these parameters were checked using the web based software Oligocalc 
(http://biotools.nubic.northwestern.edu/OligoCalc.html). In addition the primers were 
designed to cross exon boundaries to span an intron. Therefore any product amplified 
from genomic DNA (gDNA) will be much larger than the product amplified from the 
cDNA since the intron between the two exons will be spanned. The primers were also 
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designed to generate an amplicon large enough to be size-separated by agarose gel 
electrophoresis in order to distinguish it from any gDNA amplification.  
2.2.5.2 Purification of RNA from animal cells 
The RNeasy Mini kit from QIAGEN was used to purify RNA from UB/OC2 cells. 
UB/OC2 cells were grown in T75cm
2
 flasks or 6 well plates until 80% confluent. The 
cells were then disrupted with Buffer RLT according to the manufacturer’s instructions, 
collected and homogenized in a QIAshedder spin column at full speed for 2 min. To the 
homogenized lysate, 1 volume of 70% ethanol was added and mixed by pipetting. The 
mixture was then transferred to an RNeasy spin column and centrifuged for 15s at 
10000 rpm. The flow-through was discarded and the column was washed with buffer 
RW1 and spun for another 15s at 10000 rpm. Two more additional washes with buffer 
RPE were conducted in order to remove any traces of ethanol from the column. Finally, 
the spin column was placed in a new microcentrifuge tube and was eluted with 30-50µl 
of RNase-free water.  
2.2.5.3 Reverse transcription procedure 
RNA was reverse transcribed into cDNA using the Omniscript Reverse Transcriptase 
kit from QIAGEN. The master mix reaction was prepared according to the 
manufacturer’s instructions with the following reagents: 
 1x Buffer RT 
 0.5M of each dNTP  
 1uM Oli-dT primer  
 10 units of RNase inhibitor  
 4 units of Omnistript Reverse Transcriptase 
 up to 20µl RNA 
 water up to 20µl  
The reaction was incubated for 1h at 37
 o
C.  
2.2.5.4 PCR design and parameters 
Typically PCR reactions were performed as follows: 
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 10µl of 5x GoTaq® Flexi buffer 
 8µl (4mM) of MgCl2 
 1µl dNTPs  
 1µl sense primer (10µM) 
 1µl antisense primer (10µM) 
 1µl of cDNA from UB/OC2 cells (approximately 500ng) 
 0.25µl GoTaq® polymerase 
 27.75µl of water 
 
PCR parameters were set as follows: 
 
1. Initial denaturation:   95 oC for 2 min 
2. Denaturation:             95 oC for 1 min 
3. Annealing:                 62-65 oC for 30 sec 
4. Extension:                  72 oC for 1 min 
Steps 2-4 were repeated for 30 cycles 
5. Final extension          72 oC for 5 min 
6. Hold                           4 oC 
 
2.2.6 Cell culture 
Materials and procedures for cell culture experiments are described in the following 
sections. 
2.2.6.1 Equipment for cell culture 
 
Centrifuge:  ALC PK 110 Galaxy 170S CO2 incubators: New 
Brunswick 
Hera safe KS15 fume hood: Kendro Eclipse TS100 microscope: Nikon 
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2.2.6.2 Culture of UB/OC2 cells 
The UB/OC2 cell line,  derived from E13 Immortomouse organ of Corti (Rivolta and 
Holley 2002), obtained from University of Bristol,  was cultured in Minimum Essential 
Medium (MEM-gibco
®
) supplemented with  10% Fetal Bovine Serum (heat inactivated; 
EU approved) and 50U/ml of gamma-interferon and incubated at 33
o
C and 5% CO2.  
Cells were trypsinized when 80% confluent with 10% Trypsin in Hanks’ Balance Salts 
solution (supplemented with CaCl2 and MgCl2) for 5 min at room temperature. To the 
detached cells, an equal volume of growth medium was added before centrifuging at 
1000g for 3min. Supernatant was removed and the cell pellet was re-suspended in fresh 
medium. Cells were divided between new culture flask at the desired seeding density, 
typically at 1:5 ratio.   
2.2.6.3 Preparation of nuclear extracts 
UB/OC-2 cells were grown in T175 flasks until 90% confluent. Flasks were placed on 
ice and the cells were washed with 15ml of PBS (calcium magnesium free). After 
removing the PBS, 3ml of cold cytoplasmic lysis buffer (section 2.2.8.2) was added to 
each flask and incubated on ice for 5 min. The cells were then collected using a cell 
scraper and transferred to eppendorf tubes. While keeping eppendorf tubes on ice, 0.6% 
of NP-40 was added to the cell-lysis buffer mixture and vortexed for a few seconds. The 
cells were subjected to centrifugation at 4
 o
C for 30 seconds. The supernatant containing 
the cytoplasmic proteins was removed from nuclear pellet before adding a 1:1 volume 
of nuclear lysis buffer (2.2.8.2). The amount of nuclear lysis buffer differed depending 
on the size of the pellet but was typically 40-50µl. The tubes were then flicked gently to 
dislodge the pellet and to ensure that the pellet was surrounded by the nuclear lysis 
buffer. Proteins were extracted from the pellets by conducting three freeze-thaw cycles 
using an ethanol-dry ice bath and a 37
 o
C water bath. After this, samples were subject to 
centrifugation for 10min at 4
 o
C. The supernatants containing nuclear proteins were 
pooled in a single eppendorf tube and protein concentration was estimated using the 
following formula: 
Concentration (µg/µl) = (1.55 x A280) – (0.76 x A260) 
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The nuclear extracts were then aliquoted into pre-chilled eppendorfs, snap frozen in 
liquid nitrogen and stored at -80
 o
C.  
2.2.7 In vitro transcription and translation procedure 
The TNT Quick-coupled Transcription/Translation System from Promega was used in 
order to make in vitro translated protein from plasmid DNA. Components supplied in 
the TNT System were thawed out at room temperature and then placed on ice. For the 
reaction, 40µl of the TNT Quick Master Mix was combined with 1mM of Methionine, 
1µg of the plasmid DNA and up to 50µl of Nuclease-Free water according the 
manufacturer’s protocol. After mixing, the reaction was incubated at 30 oC for 90 min. 
The translated protein was then used in EMSA experiments.    
2.2.7.1 DP1_pcDNA3 constructs generated to make in vitro translated 
protein  
The DP1_pcDNA3 contains the human DP1 cloned into the expression construct 
pcDNA3 described in Figure 2.5  under the control of the T7 promoter. This construct 
was produced as follows: the pCMV-Neo-Bam1 (kindly provided by Dr Tony 
Kouzarides, University of Cambridge, UK) containing the human DP1 was digested 
with EcoRI in order to isolate the DP1 fragment (accession number L23959). The 
fragment was inserted into pcDNA3 by restriction digest cloning as described in section 
2.2.2.2.   
2.2.8 The electrophoretic mobility shift assay (EMSA) 
2.2.8.1 Equipment for EMSA assays 
 
Protean IIxI cell for PAGE (20cm glass 
plates, 3mm spacers): Bio-Rad Protean II 
Gel Dryer: Scie-Plas (GD4534)  
 
 
Gel Master Dyer Vacuum System 
(1428): Rietschle Thomas  
 
Mini 900 Ratemeter: Thermo 
 
Micro G-25 spin columns (sc 202390): 
Santa Cruz  
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2.2.8.2 Solutions for EMSA assays 
Cytoplasmic lysis buffer 
10mM HEPES pH 7.6  
1mM EDTA 
0.1mM EGTA 
10mM KCl 
1mM DTT 
1mM Na pyrophosphate 
1mg/ml vanidate 
ddH2O 
10x Maniatis Medium 
Salt Buffer 
2x Parker buffer 
0.5M  NaCl 
0.1M  Tris-HCl pH7.5 
0.1M  MgCl 2 
0.01M  DTT 
 
16%  Ficoll  
40mM  HEPES pH7.9  
100mM  KCl  
2mM  EDTA  
1mM  DTT 
4mM  MgCl2 
Nuclear lysis buffer  10x TBE 3µg/µl Poly(dI-dC) 
20mM HEPES pH7.6 
0.2mM EDTA 
0.1mM EGTA 
25% Glycerol 
0.42M NaCl2 
1mM DTT 
1mM Na pyrophosphate 
1mg/ml SP1 
1mM vanidate 
ddH2O 
0.89M  Tris-borate  
20mM  EDTA pH 8.0 
10Units poly          
(deoxyinosinic-
deoxycytidylic) acid sodium  
salt (15Units/mg)  
222.2µl   H2O 
2.2.8.3 EMSA Probe design  
Double stranded oligonucleotides were designed and synthetized by Eurofins MWG 
Operon (HPSF purified). Oligonucleotides were re-suspended in MilliQ water to a stock 
concentration of 1µg/µl.  
2.2.8.4 Annealing EMSA probes 
10µg of sense and antisense oligonucleotides were combined in 1x Maniatis Medium 
Salt buffer to a final volume of 22µl. The double stranded oligonucleotide mixture was 
incubated at 95
o
C on a heating block for 10min. The reactions were allowed to cool 
down overnight to room temperature. To verify that sense-antisense oligonucleotides 
were annealed, 1µl of each double stranded oligonucleotide was run on a 3% agarose 
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gel alongside the single stranded oligonucleotides. The annealed probes were then 
diluted to 25ng/µl and stored at -20
 o
C. 
2.2.8.5 EMSA probe labelling  
50ng of the double stranded oligonucleotides (EMSA probes) were labelled with ɣ32 P-
ATP (0.37MBq/µl, total of 1.11MBq) in the following reaction: 
 50ng of probe  
 2µl 10x T4 kinase buffer  
 3µl of ɣ32 P ATP 
 1µl T4 kinase enzyme (5-10U/µl) 
 to 20µl of water 
The reaction mix was incubated for 30 min at 37
 o
C in a heating block. The reaction was 
then diluted to 50µl, loaded onto a micro G-25 spin column and spun at 1500rpm for 2 
min to separate the labelled probe from unincorporated nucleotides. The labelled probes 
were stored at -20
 o
C.  
2.2.8.6 EMSA binding reaction  
Each binding reaction contained: 
 10µl of 2x Parker buffer 
 1.5µg of poly dI/ dC 
 10µg of nuclear extract protein  
 0 to 500ng non-labelled competitor oligonucleotide 
 water to 20µl  
 
The binding reaction was incubated at room temperature for 10min. 
 
For competition assays, an excess of 500ng of cold competitor was added to the reaction 
and incubated for 20min to 2h at room temperature. Following incubation with the 
competitor, 2µl (50ng) of labelled probe was added to the reaction and left for 30min at 
room temperature. For supershift assays, 1µl of antibody was added to the binding 
reaction either 1h before or 30min after the probe was added. Antibodies were 
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purchased from Santa Cruz Biotechnology, Inc: rabbit polyclonal anti-E2F1 (C-20 SC-
193X) and rabbit polyclonal anti-SP1 antibody (H-225X).   
The addition of glycerol to the gel produced, in some cases, an improvement in DNA-
protein complexes (Sidorova et al. 2010). For EMSA experiments with E2F probes, a 
number of publications were found where glycerol was added to the poly-acrylamide 
gel to describe the binding affinities of E2F to putative binding sites (Pasteau Stephane 
1995) (Tanaka et al. 2002) (Kherrouche et al. 2006) (Fontemaggi et al. 2009). 
Therefore, 10% glycerol was added to the poly-acrylamide gel in EMSAs performed to 
detect E2F-DNA binding. Other modifications were also introduced in the EMSA 
protocol such as the duration of the incubation between the nuclear protein extracts and 
the cold competitor in order to optimise the particular binding reaction.  
2.2.8.7 EMSA poly-acrylamide gel electrophoresis 
A 4% 0.25x TBE acrylamide gel (29:1) was made with the following mixture: 
 10ml of 40% acrylamide (29:1 bis ratio) 
 2.5ml of 10x TBE 
 700µl of 10% ammonium persulphate 
 37µl TEMED 
 10% glycerol 
 water to 100ml 
 
The mixture was poured to a 20cm Bio-Rad gel cast and allowed to set for 45min. The 
gel was then pre-run in a cold cabinet for 30min at 4°C in 0.25x cold TBE at 200 volts.  
Before loading samples, the wells were rinsed with TBE buffer to remove any non-
polymerised acrylamide inside the wells. The samples were then loaded and the gel was 
subject to electrophoresis for 2.5-3 hours.  
2.2.8.8 Gel drying and autoradiography 
The EMSA gel was carefully removed from the glass plates, placed onto Whatman       
3mm paper, covered with cling film and dried in a vacuum gel dryer (Scie-Plas) at 80
 o
C 
for 1-2 hours until dry. The dried gel was then placed into a X-ray film cassette and 
exposed to a X-ray film at -80
 o
C for between 10h to 5 days. Following exposure, films 
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were developed using Kodak film developing reagents according to the manufacturer’s 
instructions.  
2.2.9 Reporter Gene Assay 
Reporter Gene Assays were used in order to quantify enhancer response. Procedure and 
material used are described in the following sections.  
2.2.9.1 Equipment for Reporter Gene Assays 
Turner TD-20e Luminometer 
2.2.9.2 Stock solutions for Reporter Gene Assays 
 
10x HEPES-Buffered Saline (HBS) 
8.18% NaCl (w/v) 
5.94% HEPES (w/v) 
0.2% Na2HPO4 (w/v) 
Solution was sterilised through a 
0.2µN filter, diluted to 2xHBS and pH 
adjusted to 7.12.  
1x Phosphate Buffered Saline 
(PBS)  
137mM NaCl  
2.7mM KCl 
10mM Na2HPO4 
1.8mM KH2PO4 
pH adjusted to 7.4  
2.2.9.3 Constructs for Reporter Gene Assays 
A description of commercial plasmids and recombinant vectors generated for reporter 
gene assays are described in the following sections. 
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Commercial plasmids  
pGL4.23[luc2/minP]  
The pGL4.23[luc2/minP] vector (Promega
®
) encodes the luciferase reporter gene luc2 
(Photinus pyralis), a minimal promoter and contains a multiple cloning site to introduce 
the desired regulatory element. The pGL4.23[luc2/minP] vector also contains an 
ampicillin resistance gene to allow for selection in E. coli. Schematic representation of 
the pGL4.23[luc2/minP] vector map is represented in Figure 2.3. 
 
 
 
 
 
 
 
 
 
Figure 2.3: pGL4.23[luc2/minP].  Vector map of the pGL4.23[luc2/minP] luciferase vector used to 
insert the Atoh1 enhancer elements. The pGL4.23[luc2/minP] vector contains a synthetic luciferase gene  
driven by a minimal promoter.  
 
Picture removed for copyright purposes 
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pSI Mammalian expression vector 
The pSI vector (Promega®) is a mammalian expression vector that was used to generate 
the Atoh1 expression construct described below and also to equilibrate the amount of 
DNA in some of the transfection experiments. The pSI vector was designed to produce 
constitutive expression of the cloned insert in mammalian cell lines. The vector contains 
the simian virus 40 (SV40) enhancer and an early promoter region to control the 
expression of the cloned insert. A schematic map of the pSI expression vector is 
represented in Figure 2.4.  
 
 
 
 
 
 
 
 
 
Figure 2.4. pSI Mammalian expression vector. Schematic representation of the pSI vector containing a 
multiple cloning site, a SV40 enhancer/early promoter region and an Ampicillin resistance gene to allow 
for selection in E. coli 
 
 
 
Picture removed for copyright purposes 
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pcDNA3 Mammalian expression vector 
The pcDNA3 vector (Invitrogen
TM
) is a mammalian expression vector designed for high 
level stable and transient expression in mammalian cell lines. The pcDNA3 is controlled 
by a human cytomegalovirus immediate-early (CMV) and T7 promoter and contains a 
multiple cloning site, neomycin and ampicillin resistance genes. The pcDNA3 vector 
was used to equilibrate the amount of DNA used in some of the transfection 
experiments.  
 
 
 
 
 
 
 
Figure 2.5. pcDNA3 expression construct. Schematic representation of the pcDNA3 expression vector. 
The pcDNA3 is controlled by CMV and T7 promoter and contains a multiple cloning site to facilitate 
cloning strategy.  
 
Picture removed for copyright purposes 
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Novel constructs generated for reporter gene assays 
MouseAB_downstreamluciferase_pGL4.23 (MouseAB_down_luc)  
The MouseAB_down_luc plasmid was generated by amplifying mouse genomic DNA 
(Promega) with the primers 1 and 2 listed in Table 2.1. The amplified PCR product was 
digested with SalI to generate a 1402 bp fragment corresponding to the mouse Atoh1 
AB enhancer and inserted into the SalI in the pGL4.23[luc2/minP] vector (Figure 2.3) 
as described in 2.2.2.2. Sequencing with the primer 20 (Table 2.1) confirmed the 
presence and orientation of the mouse Atoh1 enhancer cloned downstream of the 
luciferase sequence. 
ChickAB_downstreamluc_pGL4.23 (ChickAB_down_luc) 
The ChickAB_down_luc was generated by amplifying chick genomic DNA as 
described in 2.2.1.1 with primers 3 and 4 (Table 2.1). The amplified product was 
digested with SalI to generate a linearized fragment of 957 bp which was cloned into the 
SalI site downstream of the luciferase sequence in the pGL4.23[luc2/minP] vector 
(Figure 2.3). Sequencing results confirmed the presence of the chick Atoh1 enhancer 
downstream of the luciferase sequence.  
ChickC_downstreamluc_pGL4.23 (ChickC_down_luc) 
The vector containing the putative enhancer C was generated by amplifying chicken 
genomic DNA using primers 5 and 6 (Table 2.1) and inserted into the pDrive cloning 
vector (Figure 2.1). The putative enhancer C fragment was then isolated from pDrive by 
restriction digest with BamHI/SalI and subcloned into the SalI/BamHI sites in the 
pGL4.23[luc2/minP] vector (Figure 2.3). 
ChickABC_downstreamluc_pGL4.23 (ChickABC_down_luc) 
The ChickABC_down_luc was also generated by amplifying chick genomic DNA as 
described in section 2.2.1.1 with primers 3 and 6 listed in Table 2.1. After PCR 
amplification of the enhancer fragment ABC (1905 bp), the fragment was cloned into 
the SalI site downstream of the luciferase sequence in the pGL4.23[luc2/minP] vector. 
The cloning and orientation of the Chick ABC fragment downstream of the luciferase 
sequence was confirmed by sequencing. 
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MouseAB_upstreamluc_pGL4.23 (MouseAB_up_luc) 
The MouseAB_up_luc contains the Mouse Atoh1 enhancer upstream of the minimal 
promoter of the basic pGL4.23[luc2/minP] luciferase vector (Figure 2.3). This construct 
was produced as follows: A J2XnGFP vector kindly provided by Professor Jane 
Johnson (University of Texas Southwestern Medical School, USA) containing the 
mouse Atoh1 enhancer was digested with SacI and XbaI (1408 bp) in order to isolate the 
enhancer region. The resultant fragment was cloned into the pGL4.23[luc2/minP] 
luciferase vector previously digested with SacI and NheI. Sequencing results with a T7 
primer confirmed the cloning and orientation of the mouse Atoh1 enhancer upstream of 
the basic pGL4.23[luc2/minP] luciferase vector.  
ChickAB_upstreamluc_pGL4.23 (ChickAB_up_luc) 
The ChickAB_up_luc vector contains the Chick Atoh1 enhancer upstream of the 
minimal promoter of the basic pGL4.23[luc2/minP] luciferase vector (Figure 2.3). This 
construct was generated by digesting the PE1-chick homology-AB, kindly provided by 
Professor Jane Johnson (University of Texas Southwestern Medical School, USA), with 
SalI and EcoRI in order to isolate the chick Atoh1 enhancer (1015 bp). The enhancer 
fragment was then sub-cloned into the XhoI/EcoRV located upstream of the luciferase 
sequence in the basic pGL4.23[luc2/minP] luciferase vector after the 3’ end was blunted 
using Klenowed enzyme (see section 2.2.2.2). Sequencing results with the primer 21 
(Table 2.1) confirmed the presence and orientation of the Chick AB enhancer upstream 
of the minimal promoter in the pGL4.23[luc2/minP] vector.           
ChickC_upstreamluc_pGL4.23 (ChickC_up_luc) 
The ChickC_up_luc vector contains the putative enhancer C fragment upstream of the 
minimal promoter of the basic pGL4.23[luc2/minP] luciferase vector. Putative enhancer 
C was generated by amplifying chicken genomic DNA using primers 5 and 6 (Table 
2.1). Amplified PCR product was digested with SalI to isolate putative enhancer C   
(383 bp) and cloned into the basic pGL4.23[luc2/minP] luciferase vector digested with 
XhoI. Diagnostic digest with SmaI/EcoRV and also with HaeII confirmed the insertion 
and orientation of the putative enhancer C upstream of the minimal promoter.    
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ChickABC_upstreamluc_pGL4.23 (ChickABC_up_luc) 
The ChickABC_up_luc vector was generated by amplifying chick genomic DNA with 
primers 3 and 6 listed in Table 2.1. After PCR amplification, restriction digest was 
conducted with SalI to isolate the ABC fragment (1905 bp) and then cloned into the 
basic pGL4.23[luc2/minP] luciferase vector digested with XhoI. Diagnostic digest with 
BamHI and also with BamHI/Bgl II confirmed the insertion and orientation of the 
region ABC upstream of the minimal promoter.    
Atoh1_pSI 
The Atoh1_pSI construct contains the mouse Atoh1 coding putative enhancer cloned 
into the pSI mammalian expression vector (Figure 2.4). In order to generate this 
construct, the pBlueScript II SK (+) vector containing mouse Atoh1 (kindly provided by 
Dr. Aida Costa, Institute of Molecular Medicine, Lisbon University, Portugal) was 
digested with EcoRI and NotI to produce a fragment containing the mouse Atoh1 coding 
region. The resulting fragment was cloned into the multiple cloning site of pSI digested 
with EcoRI/NotI. A diagnostic digest with EcoRI/NotI confirmed the insertion of the 
mouse Atoh1 coding region.    
Atoh1_3xBS_pSI and Atoh1_3xmutBS_pSI 
Double stranded oligonucleotides containing three Atoh1 binding sites (primers 9 and 
10) and the mutant version (primers 11 and 12) containing three mutated Atoh1 binding 
sites are listed in Table 2.1 (Sal I restriction enzyme site are marked in red. The Atoh1 
binding sites are underlined and mutations in the Atoh1 binding sites are marked in 
bold). These oligonucleotides containing SalI overhangs were ligated into the 
pGL4.23[luc2/minP] luciferase vector previously digested with SalI. Therefore, the 
Atoh1 binding sites were cloned downstream of the luciferase cDNA sequence in the 
pGL4.23[luc2/minP] vector. 
2.2.9.4 UB/OC2 transient transfection by calcium phosphate 
UB/OC2 cells were grown in T75 flasks, trypsinized and re-suspended in fresh medium 
as described in section 2.2.6.2. Cells were plated at 2x10
5 
cells per well in 6-well plates 
and incubated overnight at 33
o
C. 
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Following overnight incubation, the cell culture media was changed to DMEM + 10% 
FCS. These were incubated at 37
 o
C for at least 1h before transfecting with the DNA 
material.  The DNA precipitate to be transfected was prepared as follows: 
 Tube A: Purified DNA mixture, 49.6µl of 2M CaCl2, up to 400 µl of water 
 Tube B: 400 µl of 2x HBS   
The reaction in tube A was mixed by pipetting up and down and then the content of tube 
B was added to tube A in a drop-wise manner. The combined tube A and tube B 
solution was mixed and 200µl was added to each reaction well. Plates were then gently 
swirled to mix with media before incubating at 37
 o
C overnight. The following day, 
cells were subjected to a glycerol shock. The media and precipitate was removed from 
the cells and replaced by 2ml of DMEM containing 15% glycerol for 2min and 30s. The 
cells were then washed twice with 2ml of HBSS in order to remove any traces of 
glycerol. Then 2ml of MEM complete media was added to each well and the plates were 
incubated overnight at 33
 o
C.  
2.2.9.5 Luciferase Assay System 
Following overnight incubation, the Dual-Luciferase
® 
kit (Promega) was used to assess 
the luciferase activity according to the manufacturer’s protocol. This dual system offers 
the advantage of sequential assays of both Firefly luciferase (the experimental reporter 
gene) and the Renilla luciferase (an internal control reporter) within a single sample 
(Bruce A. Sherf 1996). Briefly, the cells were harvested 24h after the glycerol shock. 
The culture medium was removed and cells were washed twice in PBS. Following 
washes, 100µl of 1x Passive Lysis Buffer (PLB) was added to each well and the cells 
were scrapped and collected in a 1.5ml eppendorf tube. The lysed cells were then frozen 
at -20
 o
C for 15min and then thawed at room temperature for 10min. The lysed mix was 
then centrifuged for 1min and the supernatant was collected. 
Prior to taking luciferase readings, the Luminometer was adjusted to the following 
settings: 
 Delay = 5s 
 Read for 30s 
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20µl of lysed mix was added to 50µl of LARII from the Dual Luciferase
®
 Reporter 
Assay System for each sample and the Firefly Luciferase readings were recorded by the 
luminometer. Following this, 20µl of Stop&Glo was added to the reaction and the 
Renilla Firefly readings were collected.  
2.2.9.6 Statistics 
Student’s paired t-tests were conducted to compare data sets obtained in the transfection 
assays to determine the statistical difference. Analysis was determined by the group 
average values, sample size and the standard error of the mean. A p-value < 0.05 was 
considered to be statistically significant.  
2.2.10 Quick Change Site-Directed Mutagenesis 
The QuikChange II Site-Directed Mutagenesis Kit (Agilent Technologies) was used in 
order to introduce point mutations in a vector. Oligonucleotides for this technique were 
designed using the primer design tool provided on the manufacturer’s website 
(http://www.genomics.agilent.com/primerDesignProgram.jsp). Oligonucleotides were 
synthesized by Eurofins MWG Operon as DNA cloning oligonucleotides for being this, 
the most optimised method for this application. The oligonucleotides used for this 
method are shown as 16 to 19 in Table 2.15.4.2. Sample reaction for the Site-Directed 
Mutagenesis was: 
 5µl of 10x reaction buffer 
 5-50ng of dsDNA template (construct to be mutated) 
 125ng of oligonucleotide primer 1 
 125ng of oligonucleotide primer 2 
 1µl of dNTP mix 
 ddH2O to a final volume of 50µl 
Then, 1µl of PfuTurbo DNA polymerase (2.5U/µl) was added.   
Cycling parameters were set as follows: 
 Segment 1 (1 cycle):          95°C for 30sec  
 Segment 2 (18 cycles):      95°C for 30sec 
                                           60°C for 1min 
                                           68°C for 1min/kb of plasmid length 
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Following temperature cycling, the reaction was placed on ice for 2min. Then 1µl of 
DpnI (10 U/µl) was added to the amplification reaction and mixed by pipetting. The 
mixture was then centrifuged for 1min and incubated at 37
o
C for 1h to digest the 
parental methylated DNA. Following incubation, 5µl of reaction mixture was 
transformed in 50µl of competent cell as described in section 2.2.2.3. except that NZY
+
 
broth rather than LB-broth was used in the transformation. After overnight incubation at 
37
 o
C, colonies were grown and DNA was purified as described in section 2.2.1.3. The 
DNA material was then sequenced with primers 23 and 24 (Table 2.1) in order to verify 
whether the mutations were successfully introduced.    
2.2.11 Dissections of animal material 
Both mammalian and avian specimens were used for this project. All procedures were 
approved by University College London and by the UK Home Office (Scientific 
Procedures Act 1986). Dissections were conducted as described in the following 
sections.  
2.2.11.1 Mouse tissue 
The mouse inner ear dissections for cryosections were conducted by NH. Mouse 
specimens were sacrificed followed by decapitation. Using a scissors and a pair of 
curved forceps, the skull was cut along the top of the head in order to separate the left 
and right ear. The tissue containing the cochlea on each side was cut and brain was 
removed. The tissue was then transferred to a 35mm dish containing M199 Hanks 
media (Gibco
®
). The tissue around the auditory bulla was gradually removed in order to 
access the auditory and vestibular system. The tissue was then transferred to another 
dish with fresh and sterile M199 Hanks media. The cochlear wall was removed and the 
organ of Corti separated from the modiolus. Once the organ of Corti was isolated, the 
stria vascularis was removed and the tissue transferred to glass-bottomed dishes 
(MatTek
®
) with culture medium and incubated at 37ºC under 5% CO2.  
The ex-vivo mouse cochlear explants dissections were conducted by CG. Cochleae were 
isolated from post-natal day 0 (P0) from C57BL/6 mice. After isolating the organ of 
Corti, both modiolus and stria vascularis were removed. The hook and apex regions 
were cut for culture purposes. The cochlear explants were cultured in glass-bottomed 
dishes (MatTek
®
) coated with CellTak (BD Biosciences) and sodium bicarbonate. The 
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explant cultures were incubated in DMEM F-12 medium supplemented with 1% FBS at 
37ºC under 5% CO2 atmosphere, during 18-20h, before any treatments had been 
applied. 
2.2.11.2 Chick tissue 
Fertilized White Leghorn chicken (Gallus gallus) eggs were obtained from Henry 
Stewart UK and incubated at 37.8
o
C. Embryonic stages were listed as embryonic days 
(E) with E1 corresponding to 24h of incubation. Samples older than E5 were sacrificed 
by decapitation. When ear dissections were conducted, decapitated chicken heads were 
cut in half to separate left and right hemispheres and the brain and eyes removed before 
fixation. Typically, tissue was fixed in PFA for 2h unless otherwise stated. The samples 
were then rinsed twice in PBS. Following this, all superficial tissue and cartilage around 
the inner ear area was carefully removed using a pair of fine tweezers. The cartilage 
surrounding the sensory organs was also removed to maximize tissue exposure to 
immunolabeling reagents.  
2.2.12 Tissue processing for cryo-sections 
Fixed tissue was rinsed three times in PBS and then kept in serial dilutions of 10% 
followed by 20% sucrose in PBS at room temperature with rotation. Once specimens 
were sunk at the bottom of the tube, samples were transferred into a 30% sucrose 
solution and left overnight at 4
o
C. The samples were then embedded in 1% low melting 
point agarose with 18% sucrose using 15x15x5mm cryo-moulds (VWR). Embryonic 
heads were orientated, usually with heads facing down (for chick specimens) and 
samples were kept at room temperature until the agarose was set. Samples blocks were 
then frozen in isopentene and stored at -80
o
C. Before proceeding to cryo-sectioning, the 
specimens were left in the cryostat (Leica CM1850) for 1h to equilibrate. The moulds 
were then removed and the frozen blocks were attached to cryostat chucks using OCT 
embedding gel (VWR). Sections of 20µm thickness were then collected onto 
Superfrost
®
 plus slides (VWR). Slides were dried at room temperature for 30 min and 
then stored at -80
o
C until used.      
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2.2.13 Immunohistochemistry 
2.2.13.1 Equipment for immunohistochemistry 
 
LSM 510 META inverted laser 
scanning confocal microscope and laser 
module: Carl Zeiss  
Dissecting microscopes: Leica  
MZ125  & MZ75 
2.2.13.2 Reagents for immunohistochemistry 
Blocking solution 
0.8% Goat or horse serum (Invitrogen)  
0.4% Triton X-100 solution (Sigma-Aldrich)  
2% Albumin from Bovine Serum (Sigma-Aldrich)    
96.8% PBS solution 
Antibodies 
(see Table 2.2) 
2.2.13.1 Immunohistochemistry in UB/OC2 cells 
UB/OC2 cells were seeded in 6 well plates containing 13mm diameter uncoated glass 
coverslips (VWR) and cultured as described in section 2.2.6.2. The cells were grown on 
coverslips until 80% confluency and fixed in 4% PFA for 15-20min. Following fixation, 
cells were washed three times in PBS for 5 min to eliminate any traces of fixative 
reagent. Cover slips containing adherent cells were then transferred onto a petri dish 
covered with parafilm. Cells were incubated in blocking solution for 1h at 28
o
C to 
prevent non-specific binding of immunoglobulins. Following this, primary antibodies 
were added to the cells at the appropriate concentration and incubated for 1h at 28
o
C. 
After incubation with the primary antibodies, coverslips were rinsed three times in PBS. 
Secondary antibodies were then added to the cells and incubated overnight at 4
o
C. 
Following incubation, coverslips were rinsed three times in PBS and then mounted onto 
glass slides using Fluoromount G (Cambridge Bioscience). 
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2.2.13.2 Immunohistochemistry in animal tissues 
Cryo-sections 
Cryosectioned tissue was taken from the -80
o
C freezer and equilibrated at room 
temperature for 30 min. An hydrophobic pen was used to draw around the tissue 
sections in order to keep the tissue immersed in the immunohistochemistry reagents. 
Sections were incubated in blocking solution for 1h at room temperature. After 
incubation, the blocking solution was removed and the primary antibody was added at 
the desired concentration and incubated overnight at 4
o
C. Following this, three rinses of 
30min in PBS were conducted before adding the secondary antibody for 2h at room 
temperature. After incubation, tissue was rinsed three times in PBS before mounting in 
Fluoromount G under a coverslip (N° 0 thickness 22mmx50mm from VWR).  
Whole mounts 
Dissected tissue samples were kept in eppendorf tubes or MatTek dishes for 
immunohistochemistry. The incubation procedure with blocking solution and antibodies 
was as described in section 2.2.13.1. Following immunohistochemistry, samples were 
mounted by placing a drop of Fluoromount G in the middle of a 76mmx26mm slide 
(Thermo Scientific) surrounded by silicone lubricant for glass (Dow Corning Co.). 
 
Table 2.2: Summary of the antibodies selected in this study.  
 
 
Antibody  Host 
species 
Isotype Immunogen Clonality Dilutions Provider 
 
E2F1 
 
Rabbit 
 
IgG 
 
Peptide 
mapping at the 
C-terminus of 
E2F-1 of human 
origin 
 
 
Polyclonal 
 
For 
immunohistochemistry: 
1:400 
For gel supershifts: 1ug 
 
Santa Cruz: E2F-1 (C-
20): sc-193 
MyosinVIIa Mouse MIgG1, 
kappa 
light 
chain 
amino acids 
927-1203 of 
human myosin-
VIIa 
 
Monoclonal 1:250 Developmental Studies 
Hybridoma Bank (Soni 
et al. 2005) 
Atoh1 Chick chicken 
anti-
peptide 
antibody 
amino acids 
330– 
351 of mouse 
ATOH1 
Polyclonal 1:5000 Kindly provided by 
Matthew Kelley (Driver 
et al. 2013) 
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Tissue was then placed in the right position and orientation inside the Fluoromount G 
solution and covered by a N° 0 thickness 22mmx50mm coverslip.  
2.2.14 In ovo electroporation 
All procedures and material used for electroporation experiments are described in the 
following sections. 
2.2.14.1 Equipment for electroporations 
Egg incubator set at 37.8°C 
 
Electrodes 
Cathode = Tungsten needle 
Anode = Gold-coated platinum 
electrode 
 
Electro Square Porator
TM
 
ECM830:  Harvard Apparatus 
 
Electrodes: Series CUY611  and   
CUY613: Sonidel 
 
Glass capillary tubes 1.2mm x 
0.94mm:  Harvard Apparatus 
 
Hera guard fume hood: Heraeus 
 
Magnetic base x2:  RS 
Microloader tips (0.5-20µl):  
Eppendorf  
 
Microinjection  Electrode  Holder:   
Harvard Apparatus    
 
       Microscope MZ16F: Leica  
 
       One-port  holder: MP  series  
 
Sellotape 
Cellulose 48mm x 66mm 
 
Small handheld lens 
 
Standard three-dimensional    
manipulators 
 Stereomicroscope (40×):  WPI 
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2.2.14.2 Solutions for electroporations 
Injection solution 10X 
Distilled water containing 20% 
sucrose 
1–2% Fast Green.  
PBS 
Phosphate Buffered Saline 
2.2.14.3 Plasmid construction for electroporation experiments 
 
Empty pT2K-MinProm-bicolor (Empty pT2K-bicolor) 
The empty pT2K-bicolor vector was generated as a modified construct of the Tol2-
Hes5: H2B-mCherry-2A-nD2EGFP (generated by ND). To generate the empty pT2K-
MinProm-bicolor, the following procedure was conducted: SalI restriction digest of the 
Tol2-Hes5:H2B-mCherry-2A-nD2EGFP and subsequent SacI digestion to remove the 
Hes5 promoter (772 bp) from the parental construct. A minimal promoter sequence was 
inserted as a manufactured double stranded oligonucleotide to produce the Empty 
pT2K-bicolor (primers 13 and 14 in Table 2.1; Eurofins MWG Operon). Sequencing 
with the primer 22 (Table 2.1) confirmed the substitution of the Hes5 promoter by the 
minimal promoter.      
Atoh1-ChickAB-down::nEGFP-mCherry 
The Chick AB Atoh1 enhancer was cloned into the empty pT2K-bicolor vector by PCR 
amplification of chick genomic DNA with primers 3 and 4 (Table 2.1). The amplified 
product was digested with SalI to isolate the 957 bp fragment containing the chick 
Atoh1 enhancer and ligated into the XhoI site in the empty pT2K-bicolor vector. The 
purified DNA was sequenced to confirm the cloning and orientation of the chick Atoh1 
enhancer.  
Atoh1-ChickC-down::nEGFP-mCherry  
The Chick C Atoh1 region was cloned into the empty pT2K-MinProm-bicolor by 
amplifying chick genomic DNA with the primers 5 and 6 against chick Atoh1 enhancer 
C containing SalI overhangs as described in Table 2.1. Purified DNA was sequenced to 
confirm the cloning and orientation of the Chick C region. 
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Atoh1-ChickABC-down::nEGFP-mCherry  
The Chick ABC Atoh1 enhancer was cloned into the empty pT2K-MinProm-bicolor by 
amplifying chick genomic DNA with the primers 3 and 6 as listed in Table 2.1. 
Sequencing confirmed the cloning and orientation of the chick ABC enhancer. 
Atoh1-ChickAB-up::nEGFP-mCherry  
The Chick AB enhancer plus minimal promoter sequence was amplified from the 
ChickAB_upstreamluc_pGL4.23 construct using  primers 3 and 15 listed in Table 2.1. 
Amplified DNA product was digested with SalI to produce a fragment of 1048 bp 
containing Chick AB and Minimal promoter sequences together and then cloned into 
the Empty pT2K-MinProm-bicolor where minimal promoter was removed by SalI 
digestion. Sequencing confirmed the insertion and orientation of the Chick AB plus 
minimal promoter fragment. 
Atoh1-ChickC-up::nEGFP-mCherry  
The Chick C region plus minimal promoter sequence was amplified from the 
ChickC_upstreamluc_pGL4.23 construct using primers 5 and 15 listed in Table 2.1. 
Amplified DNA product was digested with SalI to produce a fragment of 457 bp 
containing Chick C and minimal promoter sequences together and then cloned into the 
Empty pT2K-MinProm-bicolor where minimal promoter was removed by SalI 
digestion. Sequencing confirmed the insertion and orientation of the Chick C plus 
minimal promoter fragment. 
2.2.14.4 In ovo electroporation in the otic cup 
Procedure for electroporation was performed as described by Freeman et al. (2012). 
Fertilized White Leghorn chicken (Gallus gallus) eggs were obtained from Henry 
Stewart UK and incubated at 37.8
o
C in a humidified incubator for approximately 48h 
(control) corresponding to stage 12-15 Hamburger–Hamilton. The eggs were removed 
from the incubator, sprayed with 70% ethanol and kept horizontally for 5-10 min.  
While keeping the eggs in horizontal position, a band of 15 mm wide of Sellotape tape 
was put on the surface of the eggs.  Using a pair of forceps, two holes were made 
through the tape and eggshell, one in the middle part of the egg and one at the more 
rounded end of the egg. Through the hole made in the round end of the egg, 3-4 ml of 
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albumen was removed using a 20ml syringe and an 18G needle. The eggs were then left 
for 10min.  Using the hole made in the middle part of the egg, a window of about 15x 
30 mm was opened using a pair of fine scissors to perform the electroporation.  8µg of a 
Tol2-transposase vector containing the Atoh1 conserved elements was co-electroporated 
with 8µg of a vector expressing membrane GFP (in order to label the plasma membrane 
of electroporated cells). Plasmid DNA used for electroporation was purified as 
described in section 2.2.1.3 to a ﬁnal concentration of 1–3 μg/μl.   
Briefly, 10μl of the DNA solution was mixed with 1μl of the 10×Fast Green solution for 
easy visualization of the DNA mix during electroporation. Approximately, 5µl of the 
DNA solution was pipetted using a Microloader tip into the glass needle in the 
electroporation rig. The tip of the glass needle was gently cut with a fine tweezers and 
the tungsten needle was adjusted to a posterior position to the glass needle. During the 
electroporation, the opened egg was placed under the stereomicroscope and lighting 
adjusted to clearly visualize the otic cup. The vitelline membrane was excised by using 
a 25G needle and a few drops of PBS were added. Following this, the vitelline 
membrane was removed from the otic cup and surrounding areas for better visualization 
of the right otic cup. Once the otic cup was well visualized, the injection glass needle 
and the tungsten needle (cathode) were placed on top of the right otic cup whereas the 
left electrode (anode) was placed in the left side of the embryo. The DNA mixture was 
then injected by air-blowing into the right otic cup and subjected to three electric pulses 
of 10V of 100ms with 500ms interval between each pulse. The electrodes were then 
carefully removed from the embryo, a few drops of PBS were added, the egg was sealed 
with the tape and finally returned to the incubator. Eggs were kept in the incubator at 
37.8
o
C until reaching the desired development stage and examined by microscopy.  
2.2.15 In situ hybridization (ISH) 
2.2.15.1 Solutions for in situ hybridization 
AP Buffer 
100mM Tris-HCl  pH9.5 
50mM MgCl2 
100mM NaCl2 
0.1% Tween or Triton 
PBT 
PBS + 0.1% Tween20 
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ISH buffer  
50% Deionized Formamide 
5% Sodium Saline Citrate buffer (Giese et al. 
1995) 
2% Boehringer Blocking powder 
0.2% Triton x100 
50µg/ml Heparin 
50µg/ml Yeast t-RNA 
5mM EDTA 
 
TBST 
50mM Tris-HCl  
150mM NaCl 
0.1% Tween 
pH 7.6 
 
 
 
2.2.15.2 DIG-labelled RNA probe synthesis 
Digoxigenin-labelled RNA probe (Halaban et al. 1998) were from plasmid DNA 
containing partial cDNA sequences of the chick E2F1 gene (a gift from Dr. Matthew 
Towers, University of Sheffield, UK). The plasmid was digested with NotI and DNA 
was purified as described in section 2.2.1.4. The linearized plasmid was then used for 
transcription of DIG-ribo-probe in the following reaction: 
 1µg of linearized E2F1 plasmid 
 4µl of 5x transcription buffer (Promega) 
 1µl of DIG nucleotide mix (Roche) 
 2µl of 10x DTT (Promega) 
 1µl of RNasin  
 1µl of T3 RNA polymerase (Promega) 
 up to 20µl of water 
 
The transcription reaction was incubated for 2h at 37
o
C. The DIG-ribo-probe was then 
diluted in ISH buffer to a final concentration of 1µg/ml and stored at -20
o
C until used.   
2.2.15.3 In situ hybridization on cryo-sections 
Sections were removed from the -80
o
C freezer and dried for 30min onto a microscope 
slide box containing Whatman paper soaked in 50% formamide + 2x SSC solution. The 
box had previously been rinsed with 5% hydrogen peroxide water and RNase free water 
in order to prevent RNase contamination of the tissue. The diluted DIG-ribo-probe was 
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denaturated by incubating at 70
o
C for 10min. About 100-200µl of DIG-ribo-probe was 
applied to each slide and incubated overnight at 70
o
C. Following the overnight 
incubation, slides were immersed in rinse buffer (1XSSC, 50% formamide, 0.1% tween, 
pre-heated to 70
o
C) in a coplin jar. The slides were rinsed twice by gently rocking at 
65
o
C for 30min with 2XSSC + 0.1% Triton and then rinsed two more times with 
0.2XSSC + 0.1% Triton. Following this, the slides were rinsed twice in TBST solution 
at room temperature for 10min. The slides were then incubated in blocking solution 
(TBST + 10% goat serum) for 1h at room temperature followed by overnight incubation 
in mouse anti-DIG (1:2000, Roche) at 4
o
C. After incubation, slides were rinsed at least 
4 times in PBT for 20min at room temperature, incubated twice in AP buffer for 10min 
at room temperature and then incubated in AP buffer containing 4.5µl/ml of NBT 
(nitroblue tetrazolium, 75mg/ml in 70% dimethylformamide) and 3.5µl/ml of BCIP (5-
bromo-4-chloro-3-indolyl-phosphate, 50mg/ml in 100% dimethylformamide). Colour 
development was carried out in the dark and monitored periodically under the 
microscope. The colour reaction was stopped by several rinses in TBST and in some 
cases with washes in acetone to remove any remaining traces of developing reagents. 
The slides were then mounted in Fluoromount G solution under a N° 0 thickness 
22mmx50mm coverslip and stored at -20
o
C until imaged.  
2.2.15.4 In situ hybridization on whole mounts 
Tissue was dissected and fixed in 4% of PFA for between 2h to overnight and rinsed 
twice in PBT for 5min. For inner ear specimens, dissection of the membranous and 
cartilaginous caps was performed. Tissue was then either dehydrated in 50%, 75% and 
100% methanol for storage at -20
o
C or immediately used for in situ hybridization 
following the protocol described in section 2.2.15.3.  
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Chapter 3  
3 Bioinformatic analysis 
3.1 Strategy of the investigation 
The spatial and temporal expression of a gene relies on regulatory mechanisms which 
are conducted at many different levels to ensure that the correct protein is delivered at 
the appropriate time and in the right location. Understanding how gene expression is 
controlled under physiological conditions has been an intensive focus of research. Over 
the past decade, the rapid development of bioinformatic tools has helped in the study of 
the mechanisms that control gene expression in different biological systems. Based on 
the use of various computational analysis combined with functional experimentation, 
my investigation aimed to identify evolutionary conserved regions (ECRs) in the Atoh1 
gene locus and transcription factor binding sites that could potentially contribute to the 
species-specific regulation of Atoh1 expression. As described in section 1.6, Atoh1, the 
pro-hair cell master gene, is required and sufficient for hair cell formation (Bermingham 
et al. 1999). Significantly, there is also correlation between re-activation of ATOH1 
expression when hair cell damage occurs and the generation of new hair cells right after 
damage. The mechanism that re-activates the expression of ATOH1, leading to the 
formation of new hair cells and consequently restoration of hearing occurs 
spontaneously in lower vertebrates including avians (Cafaro et al. 2007; Daudet et al. 
2009). However, the re-activation of ATOH1 (Wang et al. 2010) and consequently the 
formation of new hair cells after damage is limited in mammalian species (Forge et al. 
1993; Rubel et al. 1995; Kelley et al. 1995; Lopez et al. 1998; Kawamoto et al. 2009). 
The molecular mechanisms and the potential differences between avian and mammals 
that mediate re-activation of ATOH1 expression to produce new hair cells in avians but 
not in mammals are poorly understood. Therefore, in order to gain a better 
understanding of the regulation of Atoh1, a combination of bioinformatic analysis, 
EMSA (electrophoretic mobility shift assay) and reporter gene assays were used to 
identify the different Atoh1 regulatory networks in mammalian and avian species.  
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3.2 Identification of conserved elements by 
comparative genome analysis 
Cross-species sequence alignment has been widely used to identify evolutionary 
conserved regions that may be enriched with regulatory elements since essential 
functional information is contained in their sequences to control the spatial and 
temporal the expression of nearby genes (Chinwalla et al. 2002; Chiaromonte et al. 
2003). ECRs outside protein coding regions therefore often contain high affinity 
binding sites for transcription factors which are essential components in gene 
regulation. Since there are well-stablished differences in the capacities of mammalian 
and avian species to reactivate ATOH1 expression after hair cell injury, the differences 
and homologies in the ECRs of Atoh1 within and between these two groups were 
investigated.  
3.2.1 Comparative alignment of the human and mouse Atoh1 
locus 
Previous work has shown that the regulation of mammalian ATOH1 expression is 
largely dependent on two ECRs downstream of the Atoh1 locus which are sufficient to 
drive the expression of an Atoh1/lacZ reporter in most of the ATOH1 tissue-specific 
regions (Helms et al. 2000). As expected, these two regions, known as the Atoh1 
enhancer A and enhancer B (or the Atoh1 promoter in some publications) are highly 
conserved between mouse and human genomes (Helms et al. 2000). Based on these 
findings, the region downstream of the Atoh1 coding sequence was suggested to be a 
major component in the control of ATOH1 expression. In contrast, the region 
immediately upstream of the Atoh1 coding region has not been shown to drive 
expression of a Atoh1/lacZ reporter (Helms et al. 2000).      
In order to investigate whether any additional conserved elements are located within the 
mammalian Atoh1, a comparative alignment was performed between the mouse and 
human Atoh1 locus (Ensembl version 63, June 2011). As shown in Figure 3.1, the 
comparison of the human Atoh1 genomic sequence to ~22 kb to the mouse Atoh1 gene 
locus identified two regions with high homology. These regions corresponded to the 
previously reported Atoh1 enhancers A and B. The sequence homology between the 
human and mouse sequences is 90.73% and 88.79% for enhancer A and B, respectively. 
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It is notable that this degree of enhancer sequence homology is even higher than the 
homology found in the Atoh1 coding region which is 83.19% between human and 
mouse (Figure 3.1b). Other less well conserved ECRs were found in the mouse and 
human Atoh1 locus (see asterisks in Figure 3.1a).  For example, approximately 2 kb and 
4 kb downstream of enhancer B two more conserved regions were found of about 100 
bp in length and with ~70% homology between mouse and human. However, because 
these regions are shorter in length and since the degree of homology is not as high as the 
one found in the A and B enhancers, further investigations were not conducted to test 
the functionality of these regions. The 20 kb sequence 5’ of the Atoh1 coding region 
appears to have several short regions with a limited degree of homology between mouse 
and human but these are shorter and less well conserved than the 3’ regions (regions 
marked with asterisks in Figure 3.1a). Since the region upstream of the Atoh1 sequence 
did not show Atoh1/lacZ expression in the transgenic line investigated by Helms et al. 
2000, my investigation and consequent analysis focused on the study of the 3’ region of 
the Atoh1 locus.    
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Figure 3.1. Alignment comparison between the human and mouse Atoh1 genome sequences. a) Sequence conservation analysis showing the degree of homology of the Atoh1 
human and mouse genome sequences including the promoter region (chromosome 6: 64,729,085-64,729,333 in mouse), the Atoh1 coding region (marked in purple- chromosome 
6:64,729,125-64,731,245 in mouse and chromosome 4: 93,828,753-93,830,964 in human), UTR (untranslated region; marked in pale blue) and non-coding evolutionary conserved 
regions (marked in pink). The schematic extracted from mVista (Mayor et al. 2000) shows that among all the non-coding evolutionary conserved regions, the Atoh1 enhancer A 
and B (chromosome 6: 65,155,797-65,156,046 in mouse) share the highest degree of homology when comparing the mouse and human Atoh1 locus. Other non-coding regions 
with a lower degree of homology are shown either upstream or downstream of the Atoh1 enhancers (marked with an asterisk). Parameters for mVista show conservation level in 
the y axis (in percentages) and length of the conserved regions in the x axis (minimum length 100 bp). b) Schematic representation (not scaled) of the position of the Atoh1 coding 
region and Atoh1 enhancers showing the percentages of homologies using Clustal2.1.      
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3.2.2 Comparative alignment of the chick and zebra finch Atoh1 
locus 
A comparative analysis was performed to assess the degree of conservation of the Atoh1 
locus in avian species. The Atoh1 coding sequence in chick has recently been 
characterized (Mulvaney et al. 2015) and the studies conducted by Ebert et al., 2003 
identified and cloned the genomic 3’ sequence corresponding to the chick Atoh1 
enhancers (accession number, AF467292). Therefore, a 7.5 kb of the chick genomic 
sequence was aligned to other avian species. At the time this investigation was initiated, 
only the zebra finch and turkey sequences were available. However, the turkey genome 
sequence was incomplete and therefore initially, only the zebra finch sequence was 
compared against the chick sequence (extended analysis was conducted later on and is 
described in the discussion). Outside the coding sequence there are regions of high 
conservation between the chick and zebra finch Atoh1 genomic loci (Figure 3.2a). The 
length and relative position of these two regions in the zebra finch sequence was very 
similar to the location of the chick Atoh1 enhancers as shown in Figure 3.2b. Also, the 
degree of homology shared between the chick Atoh1 and zebra finch ECRs (89.6% and 
88.36%) suggests that these conserved regions represent enhancer A and B and are 
therefore conserved across mammals and avians. In addition, a third highly conserved 
region of almost 400 bp is present which shares a 79.61% homology between the chick 
and zebra finch genome. This conservation is of a similar level to the chick Atoh1 
enhancer A and B annotated by Ebert et al. 2003 and was designated putative enhancer 
C (genomic location chromosome 4:36496979-36497355 in chick). This region is 
located 705 bp downstream of the enhancer B in chick and about 1.5 kb downstream in 
zebra finch. Four other much smaller regions of conservation were identified, less than 
100 bp, two downstream of the Atoh1 enhancers and two regions upstream, in close 
proximity to the Atoh1 coding sequence (see asterisks in Figure 3.2). Based on these 
findings, my investigation primarily focussed on whether putative enhancer C plays a 
role in the regulation of Atoh1.    
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Figure 3.2. Alignment comparison between the chick and zebra finch Atoh1 genome sequences. a) Sequence conservation analysis showing the degree of homology 
between chick and zebra finch Atoh1 sequences. The schematic extracted from mVista (Mayor et al. 2000) shows conserved regions highlighted in pink, conservation level in the 
y axis (in percentages) and length of the conserved regions in the x axis (minimum length 100 bp). The chick Atoh1 coding region (Chromosome 4: 36,493,650-36,494,082) 
shares some degree of homology with the zebra finch genome (Atoh1 coding region in zebra finch is yet to be characterized). Two highly conserved regions shown correspond to 
the chick Atoh1 enhancers A and B which were previously characterized by Ebert et al. 2003. An additional non-coding region with a high degree of homology between chick 
and zebra finch is shown annotated as putative enhancer C. Other non-coding regions with a lower degree of homology are marked with an asterisk. b) Schematic representation 
(not scaled) of the position of the Atoh1 enhancers show the percentage homologies (using Clustal2.1 between chick and zebra finch). c) DNA sequences of the chick Atoh1 
evolutionary conserved elements (Atoh1 AB enhancers and putative enhancer C).       
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CTTTCTTTCTTTCTTTCTTTCTTTTTCTTTTCTTTTCTTTTCTTTTCTTTTCTTTTTTTTTTTCCCTAACACATCTCTGAAAGAGATGCGC
AGCGCATTTCCATGTTGAGGTTCAGCCCCGGAGTTTGCATAACAACCGCTTGGCAGCCCCCTCTCCCTCCCCCCGTTAACAAGCTGGAACG
TAGAGCTGCAGGTTGCTCTAATCTCATTAATATTTTGGAAAGTTGAATATTGAGCGTTTCGGAGCGCTCATTCCCCATATGCCGGGCCGCT
CCCGCTATGCTGGCTGCTTCCTTTCTCTCCATTATTAGCAATTAGCTCCTACCTTCCAAAGTGGGATCCAAGTATCCAAGATACTAGCAAA
GGCATCAACTCTGCGGTGCAAGCTAAGCACGCTCCCAAACAAACAAAGAGACAACATTTCTTTAAGTAATGAAGATGGATAAATCGCTTTA
TTGAGCTCGCGACAGTGTTTGTTTTGCACGGACGAGCGCAAAGTTTGCAAAGCGGAGAGCGCGCACTTCGCGGCTGCTTTGCTTTGTGCCA
TTTTTTATCGCTTTTTGAGGCATTTCTTTAAAGCGGGTCCGCTCGGTTTCGGCCGTAATGCTCCGTTTTCTTCGGGGTGCGGTTCTCCGGC
TGCTGTTTGCCCAACATCTGGCCCCGGGGATAGAAGGAAGGAAGGAGGGGGGGGAGAAAGGGTTAACCCCGGAGCTTCTTAATTAGAGCGG
GGCGGACAATGCGGCGGGGCGGCCCGGGGGGGGCTGGCCGCGCTCCCGGCCGCGGTGCGCCGTGTCTGGAGTGGAGCACGCGCTGTCAGCT
GGTGAGCGCGGCGCGGCGGCCTTTCAGGCGGCGCCCCGGGGAGCTGCGGCCCGCGGGGAGCTCCGCCGTGCTCCCCCCCCTCCCCCTCCGC
CCCGGCAGCCCGCGCTCGGGTCTCCCCCCGGCCCCCTCCTCGCCTCGCCCGAGGAGCGACGGCCGTCGGAGTGGGATACAAAAGCAACGCC
TGCTTGCGCGGGGGGGTCTCACGCGTGTGCGTGCTCCCATGGCTCCTCTCCCTTTAGCCTCTTGCACACGTGGGGAGCCGGCGGAGCTCTC
CAGGGACGCGCGGCTCTCGCATCTGCTGCAAAGCTCTGCGATATCGCCGCCGCTCCCCTGCAGGAATGTCACCGGCGGGGCCGCGCGGAGC
CCCAAGATCCCTCCTCGCCGAGGGCAACCCCCCGCTGACTCGACTCCGGGGAAGGCAGAGAGCCCCTTCCGAAGGGCTATCGGGTGGCAGA
GGGACGCCTTTGGGAGCGCGGCCAGGACGTGTCAACACGTCGAAGCGTTTCCTCGCTGCCCCCGCTGCCTTTCTGCCGTGCGCTCCCTCCC
TCCCGGCTCGGGACGGGAACACCGGAGCCCTTCGCACCGGGCTGCCGCCGCTCGGAGCCGTGCCCCCGTGCGCCGGGCAGGGAAACCGAGA
CCTGGGTCTAGGAGAGCGACATTCGGGACTAGGAAAACGAGTTTTGGGGCTGGCGGAGCAAATCGCACCCACTTACAACGACCTAATTTCT
CATTCATCCAAACTTCCTTCTTTATCGTTTATTGTATTTGTGTTTAATCGCTGTAATCCCCGTGTCCTCTCGCCCGCCCTGGTGCGCGCTC
CCGCGCCCAACGCGGGACAGCGACGCGCACCCGAGCGGTGCTGCCGCGCTTTATGGAGCGGTTAATCAACTGCGCATCAGCGAGACAGCGC
ATCAGCCCATCTGCTTGATATATATTCAGGAGGGCTCCAGCCCTTTTGAAGTCTAATTTCTTCCCCGGGAGAACGCGCCGGGTAATTTACC
ATCATTTCATACGCATCGCGGCCACCGAGTTAACCCTTTCCCCAAGCGCTGCCCGCACGGGATTTTCCTCCCGAAAAACGCCGGGTGCAAC
GCTACAAACTTGTCAAAGCGTCTTTCCGATGATGCTCCTTGAAATAAGAGATCGCAGCTCACCGACACTGTAACCCCTTGGATCTGTCGGG
TTAGAAAGGAGGGGTTGTGAAAGATCTGCTTGGGATAAGCAAACGCTTAGAACCGCCCATGCCAACGCGCATCATTTCATCCCCAACCACC
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3.2.3 Multi-species alignment of the Atoh1 genomic sequence  
Comparative alignment of the Atoh1 loci sequence in avian species resulted in the 
identification of an additional conserved region, putative enhancer C, a region with a 
similar degree of conservation as the functionally characterized Atoh1 enhancers A and 
B. A multi-species alignment analysis across the mammalian and avian Atoh1 
sequences was conducted in order to compare the conserved regions across both groups.   
As shown in Figure 3.3, the chick Atoh1 sequence was aligned to the human, mouse 
and zebra finch sequences. Two regions appeared to be highly conserved across all four 
species. These sequences corresponded to the previously characterized Atoh1 enhancers 
A and B. It was notable to find that the enhancers have retained their sequence identity 
even in species that are evolutionary distinct like human and chick. Several smaller 
regions were also found with a high degree of homology corresponding to the Atoh1 
coding region, as might be expected. However, there were no additional conserved 
regions downstream of the Atoh1 enhancer that matched both the mammalian and avian 
sequences. Therefore, the putative enhancer C appeared to be unique to the avian 
genome.   
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Figure 3.3. Alignment comparison between the chick, human, mouse and zebra finch Atoh1 genome sequences. a) The chick Atoh1 sequence was used as the basis for 
comparison and conserved regions are highlighted in pink. Conservation levels are represented in the y axis (in percentages) and the length of the conserved regions is presented in 
the x axis (minimum length 100 bp). The diagram extracted from mVista (Mayor et al. 2000) shows that some regions within the Atoh1 coding sequence are highly conserved 
among chick, human, mouse and zebra finch (Atoh1 coding sequences correspond to chromosome 6:64,729,125-64,731,245 in mouse, chromosome 4: 93,828,753-93,830,964 in 
human and chromosome 4: 36,493,650-36,494,082 in chick; forward strand). The two highly conserved regions previously characterized by Helms et al. 2000 and Ebert et al. 
2003 and defined as the Atoh1 enhancer A and B are also conserved among the four species including zebra finch. Two additional non-coding regions located ~500 bp 
downstream of the Atoh1 coding region are conserved among chick, human, mouse and zebra finch (marked with an asterisk). The additional non-coding region (annotated as 
putative enhancer C; genomic location 4:36496979-36497355) with a high degree of homology between chick and zebra finch does not share homology with the 3’ region of the 
mouse and human Atoh1. b) Schematic representation (not scaled) of the position Atoh1 enhancers showing the percentages of homologies using Clustal2.1 between chick, 
human, mouse and zebra finch.     
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3.3 Identification of putative transcription 
binding sites within ECRs 
MatInspector from Genomatix is a bioinformatic software program that predicts 
transcription factor binding sites in DNA sequences (Cartharius et al. 2005). This 
software uses a matrix similarity approach in order to locate matches based on the 
nucleotide conservation of functionally proven binding sites (Quandt et al. 1995).  This 
approach results in the construction of a library of transcription factor matrices based on 
experimental data from transcription factors binding sites that have previously been 
tested.  At the time this investigation was conducted, the MatInspector library contained 
1381 weight matrices classified in 411 families (version 9.0, August 2012) representing 
the largest database available to identify binding sites. In addition, unpublished 
experimental data conducted in our laboratory suggested that this software has a good 
accuracy in predicting transcription factor binding sites in comparison to other software 
packages. Therefore, the ECRs identified previously by mVista including enhancer A, B 
and putative enhancer C were analysed using MatInspector to identify transcription 
factor binding sites.   
3.3.1 Predictions within Atoh1 Enhancer A and Enhancer B 
Using MatInspector, transcription factor binding sites common to both mammalian and 
avian species in enhancers A and B were predicted (Figure 3.4). The matches given by 
MatInspector were grouped into matrix families corresponding to functionally related 
transcription factor binding sites. A total number of 52 common matches were found in 
enhancer A and 62 transcription factor binding sites in enhancer B. Some of the 
transcription factors already shown to regulate Atoh1 were predicted in this analysis. 
This includes ATOH1 binding sites necessary for autoregulating Atoh1 expression 
(Helms et al. 2000). As shown in Figure 3.4c a V$NEUR matrix family match was 
predicted within mouse and human Atoh1 enhancer B. This matrix family is categorized 
by MatInspector as a potential binding site for bHLH transcription factors. When 
checking the predicted binding site sequence for the V$NEUR site, it was found that it 
matched the E-box sequence where ATOH1 binds (Figure 3.4c). Other predictions in 
the Atoh1 enhancers that matched functional transcription factors involved in the 
regulation of Atoh1 were SOX2 (Family V$SORY in enhancer A), ZIC1 (Family 
Chapter 3: Bioinformatic Analysis 
 
 
121 
 
V$GLIF in enhancer B) (Figure 3.4). A number of additional conserved motifs 
consistent with the potential binding of POU3 and POU4 transcription factors (Family 
V$BRNF), BARHL1 (Family V$HOMF), GATA (Family V$GATA), LHXF (Family 
V$LHXF) and Id transcription factors (V$NEUR) were also predicted within enhancers 
A and B (highlighted by red boxes in Figure 3.4). These are transcription factors that are 
known to play roles during hair cell fate, differentiation and maturation of the sensory 
epithelium (see section 1.5.3). Hence, based on the analysis conducted by MatInspector, 
these transcription factor candidates could potentially bind to the Atoh1 enhancers and 
are within sequences conserved across avian and mammalian species.     
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Figure 3.4. Common transcription factor binding sites predicted within Atoh1 enhancer A and B. MatInspector predictions for common transcription factors in human, mouse, 
chick and zebra finch. The family names are given as a unique identifier for each match and displayed with a first letter corresponding to the section family they belong to (e.g. 
vertebrates (V$), other (O$). Each matrix match is represented by a coloured half round symbol with can be found in the positive or negative strand. Additionally, matrix family are 
presented in a list at the bottom of the figure. The matrix similarity is a parameter established by MatInspector showing how similar a prediction is in comparison to the consensus 
matrix a) Common transcription factor binding sites predicted within the Atoh1 enhancer A in human, mouse, chick and zebra finch. A total number of 52 common transcription 
factor families matches were predicted on the enhancer A. b) Common transcription factor binding sites predicted within the Atoh1 enhancer B in human, mouse, chick and zebra 
finch. A total number of 62 common transcription factor families matches were predicted on the enhancer B. c) A V$NEUR matrix family match was predicted for binding the 
mouse and human Atoh1 enhancer B. The sequence of the predicted V$NEUR matrix family matched an E-box sequence which is the functional binding site for ATOH1. Other 
matrix families with roles in cell fate, differentiation and maturation are predicted for binding the Atoh1 enhancers. These include the POU3 and POU4 transcription factors (Family 
V$BRNF), BARHL1 (Family V$HOMF), GATA (Family V$GATA), LHXF (Family V$LHXF), the Id transcription factors (Family V$NEUR), YY1 (Family V$YY1) and E2F 
(Family V$E2FF) (marked in red boxes in the list of matrix families).  
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c) 
Human         TGCGGAGCGT CTGGAGCGGA GCACGCGCTG TCAGCTGGTG AGCGCACtct 
Mouse         TGCGGAGCGT CTGGAGCGGA GCACGCGCTG TCAGCTGGTG AGCGCACtcg 
Chick         TGCGCCGTGT CTGGAGTGGA GCACGCGCTG TCAGCTGGTG AGCGCggcgc 
Zebra finch   TGCGCCGTGT CTGGAGCGGA GCACGCGTTG TCAGCTGGTG AGCGCA---- 
E-box 
Mouse 
Human 
tcccCAGCTGcgc 
V$NEUR 
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3.3.2 Predictions within putative Enhancer C 
The additional conserved region found in the Atoh1 sequence of chick and zebra finch, 
the putative enhancer C, was also examined by MatInspector. As in the previous 
analysis with the Atoh1 enhancers, the putative enhancer C sequence from chick and 
zebra finch was retrieved from mVista and exported in FASTA format into 
MatInspector.  
A total number of 53 transcription factor matrix families were identified by 
MatInspector within putative enhancer C in both chick and zebra finch. It was 
interesting to find that some of the predictions found in the Atoh1 enhancer A and B 
were also found within putative enhancer C. This includes V$NEUR, V$E2F and 
V$NFKB matrix families (marked in Figure 3.5).  
3.3.3 Predictions within other evolutionary conserved regions 
In addition to the Atoh1 enhancers and putative enhancer C, other evolutionary 
conserved regions were also found in the multi-species alignment of the Atoh1 locus 
(Figure 3.3). Two regions (named ECR1 and ECR2 in Figure 3.6) were found at +1153 
and +1246 downstream of the start codon of the chick Atoh1 coding sequence. ECR1 
and ECR2 were analysed for transcription factor binding sites with MatInspector to find 
8 and 9 matches respectively. Some of the predictions identified correspond to binding 
sites for the POU transcription factor family (Family V$BRNF), BARHL1 (Family 
V$HOMF), GATA (Family V$GATA) and SOX transcription factor family (Family 
V$SORY) all known to be involved in controlling inner ear gene expression.  
MatInspector analysis was also extended to another region of 83 bp (named ECR3 in 
Figure 3.6). The ECR3 is located 500 bp downstream of the putative enhancer C in 
chick and zebra finch and a low similarity was found against the mouse or human Atoh1 
locus using the set threshold given by mVista (50% similarity threshold). Only 2 
putative binding sites were predicted in the ECR3 corresponding to the matrix family 
V$NACA (Nascent polypeptide associated complex and coactivator alpha) and 
V$NFAT (Nuclear factor of activated T-cells) (Figure 3.6).  
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Figure 3.5. Common transcription factor binding sites predicted within Atoh1 putative enhancer C in chick and zebra finch. MatInspector matches were grouped into matrix 
families. The family names were given as a unique identifier for the family and displayed with a first letter corresponding to the section family they belong to (e.g. vertebrates (V$), 
other (O$). As in the previous analysis, each matrix match was represented by a coloured half round symbol with can be found in the positive or negative strand. Additionally matrix 
families were presented in a list at the bottom of the figure. The matrix similarity is a parameter established by MatInspector showing how similar a prediction is in comparison to the 
consensus matrix. A total number of 53 common transcription factor families matches were predicted on putative enhancer C in chick and zebra finch. Some of the family matrices 
found in the putative enhancer C were also predicted for binding the Atoh1 enhancer A and enhancer B. Some examples were marked in red squares such as the V$NEUR, V$E2F 
and V$NFKB matrix families. 
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Figure 3.6. Common transcription factor binding sites within other evolutionary conserved regions at the Atoh1 locus. Based on an Atoh1 multi-species alignment, two small 
evolutionary conserved regions are found upstream of the Atoh1 enhancers (ECR 1 and ECR2) which are present in chick, human, mouse and zebra finch.  An additional conserved 
region among chick and zebra finch is also found downstream of the putative enhancer C (ECR3). The relative position of these regions is represented in the chick Atoh1 sequence 
which is used as the basis for comparison. The transcription factor binding sites predicted for each region are listed using a low matrix similarity threshold. Some of the predictions 
identified in these regions include the POU3 and POU4 transcription factors (Family V$BRNF), BARHL1 (Family V$HOMF), GATA (Family V$GATA) and SOX transcription 
factor binding sites (Family V$SORY). 
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3.4 Refinement of predictions  
Prioritization of novel candidates involved in the regulation of genes has always been a 
crucial as well as a difficult step for researchers. The complexity of regulatory gene 
networks makes the choice of potential candidates a very challenging and time 
consuming task. However, at different stages of any research project, scientists have to 
decide which genes will be experimentally tested and which ones will be left out 
because of limited resources. As many candidates were predicted in the bioinformatic 
analysis, it was necessary to simplify my investigation and prioritize some of the 
putative candidates for further experiments. 
 
The first selection criteria was on the basis of the matrix similarity threshold. The 
matrix similarity score given by MatInspector shows how similar a prediction is in 
comparison to the consensus matrix. The highest matrix similarity score given by 
MatInspector is 1 and therefore is defined as the “perfect match” since all the base pairs 
in the binding site are identical to a functional consensus binding site. On the contrary, a 
low matrix similarity predicts more matches the predicted binding sites allow a lower 
percentage match to the consensus matrix which results in false positives as well as 
functional binding sites. As shown in Figure 3.7, the number of transcription factor 
families predicted within enhancer A of mouse and human was reduced from 73 to 28 
when the matrix similarity was increased. Only the candidates with a predicted binding 
site close to the consensus matrix were retained, for example, transcription factor YY1 
(marked with a red box in Figure 3.7). The position of this predicted binding site is also 
conserved across these two species.  
As shown in the schematic diagram of Figure 3.8, the number of predicted candidates 
binding sites in both chick and zebra finch putative enhancer C was reduced from 53 to 
13 when the matrix similarity was increased from low to high. Notable remaining 
predictions include multiple binding sites for the E2F and NF-κB transcription factors 
(marked with a red box in Figure 3.8).  
Having completed a comparative alignment to identify highly conserved regions in the 
Atoh1 locus followed by a MatInspector analysis to predict potential candidates binding 
to these regions, my investigation continued to select candidate transcription factors to 
investigate further based on the known biological functions in which they are involved.  
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Figure 3.7. Common transcription factor binding sites predicted within Atoh1 enhancer A of mouse and human. A total of 73 common matches were predicted in the Atoh1 
enhancer A with the lowest matrix similarity represented by a coloured half round symbol. When the matrix similarity was increased, the number of predictions was decreased to 28 
since only the matches that were closer to the consensus matrix were displayed. Each matrix family is presented in the list at the bottom of the figure and the matches with a high 
matrix similarity are displayed in bold. As an example, the YY1 transcription factor (marked with a red box) was predicted as a strong candidate binding to the Atoh1 enhancer A.  
Predictions within Enhancer A (Low matrix similarity)  
Mouse 
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Figure 3.8. Common transcription factor binding sites predicted within putative enhancer C of chick and zebra finch. A total of 53 common matches were predicted for 
binding putative enhancer C with the lowest matrix similarity. Each coloured half round symbol corresponds to a predicted matrix family represented in the list. When the matrix 
similarity was increased to the highest parameter given by MatInspector, the number of predictions was decreased to 13 since only the matches that were closer to the consensus 
matrix were displayed. Multiple binding sites were predicted for the E2F and NFKB transcription factors (marked with a red box) which were predicted as strong candidates binding 
putative enhancer C.   
 
Chick 
Zebra finch 
Predictions within putative Enhancer C (Low matrix similarity)   
Chick 
Zebra finch 
E2F 
E2F 
NFKB 
NFKB 
E2F 
NFKB 
Predictions within putative Enhancer C (High matrix similarity)  
E2F 
Chapter 3: Bioinformatic Analysis 
 
 
131 
 
3.5 Prioritization of YY1, NFKB, E2F and ATOH1 
Following the bioinformatics predictions, four transcription factor candidates were 
prioritized based on their expression profiles and functions during hair cell development 
and survival. For the prioritization process, gene expression profiles were checked for 
most of the predicted transcription factors candidates that showed a high stringency in 
the bioinformatic analysis. Different gene expression databases were used for this 
purpose. For mammalian gene expression, the Allen Brain Atlas (www.brain-map.org) 
was used. The interactive Atlas viewer application provides a rapid method to assess 
gene expression based on annotated RNA sequencing and exon microarray techniques 
combined with high-resolution in situ hybridization image data from developing and 
adult human brain and brain section from 8-week old C57Bl/6J male mice. Gene 
expression profiles were also checked using GEISHA (Gallus Expression In Situ 
Hybridization Analysis: http://geisha.arizona.edu/geisha) and echick atlas 
(http://www.echickatlas.org/ecap/home.html) in order to obtain gene expression profiles 
from avian databases. Having checked gene expression from different mammalian and 
avian databases, transcription factor candidates whose expression was shown in the 
brain or inner ear were prioritized for follow-up. However, the possibility that 
expression data may not be available for all the candidates was taken into account. 
Hence, experimental and functional data from previous publications were also assessed 
in order to select potential regulators of Atoh1. The final prioritization criteria, was the 
selection of candidate genes involved in developmental pathways and biological 
processes that could be relevant to the inner ear.  
Based on these criteria, four candidates were selected: YY1, NF-κB, E2F and ATOH1. 
The various reasons for their individual selection are described below.   
3.5.1 YY1 
The first selected candidate was YY1 (Ying Yang-1). YY1 is a zinc finger transcription 
factor that has the capacity to act as an activator or repressor of the transcription of its 
target genes (Shi et al. 1991). At the time my investigation started, expression of YY1 
in the mouse and chick cochlea had been described (Street et al. 2011). In this study, 
immunohistochemistry data showed that YY1 is expressed in hair cells as well as in the 
spiral ganglion of mice aged 2 months. In chick, YY1 was also detected in different 
Chapter 3: Bioinformatic Analysis 
 
 
132 
 
tissues including brain and the basilar papilla (Street et al. 2011). Previous studies in 
Xenopus also observed YY1 protein in the neural tube at embryonic stages (Kwon and 
Chung 2003). YY1 has also been shown to be a transcriptional repressor of the MYO7A 
promoter. A single nucleotide polymorphism (SNP) was found at the position -4128 in 
the MYO7A promoter allele which is linked to severe hearing loss. The study 
conducted by Street et al., suggested that the SNP in the MYO7A promoter controls 
differential binding and regulation by the YY1 transcription factor. To confirm this, 
EMSA and reporter gene assays were carried out to demonstrate that the direct binding 
of  YY1 to the -4128 SNP produces the transcriptional repression of the MYO7A 
expression in comparison to the wild-type allele. As hair cells are sensitive to the level 
of MYO7A expression, the reduction of MYO7A resulted in a hearing loss phenotype. 
Since YY1 seems to be involved in the transcriptional response of MYO7A, it may also 
be involved in the regulation other genes in the auditory system. As described in section 
3.4, a YY1 binding site was identified with the highest matrix similarity in the 
mammalian Atoh1 enhancer A (Figure 3.7). Therefore, based on the study by Street et 
al., the YY1 expression pattern in the auditory system in mouse and chick and the 
predictions from bioinformatic analysis, YY1 was selected for further experimentation 
and as putative candidate regulating Atoh1.  
3.5.2 NF-κB  
NF-κB (NF-kappa-B) is a well characterised transcription factor which has been 
described as a key regulator of genes involved in many biological processes including 
immunity and inflammation, cell survival, apoptosis, differentiation and development 
(Karin and Lin 2002; Gilmore 2006). In the inner ear NF-κB has been shown to be 
required for the survival of immature hair cells (Nagy et al. 2005). Expression studies 
conducted by Nagy et al. 2005 detected mRNA in the organ of Corti of p5 rats and 
protein expression by immunohistochemistry for some of the subunits that form NF-κB. 
Therefore, specific antibodies are commercially available for NF-κB as well as 
expression constructs from collaborators. Availability of reagents for further 
investigation was a secondary consideration taken into account in the selection of 
candidates. In addition, NF-κB binding sites were predicted with a high stringency 
within putative enhancer C (Figure 3.8). Therefore, based on the predictions given by 
the bioinformatic analysis combined with the biological roles of NF-κB and the 
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existence of reagents for functional studies, NF-κB was selected for further 
investigations in the transcriptional regulation of Atoh1.     
3.5.3 E2F  
The E2F transcription factor family was also predicted by the bioinformatics analysis to 
bind the mouse and chick Atoh1 enhancer A and B (Figure 3.4) as well as the chick 
Atoh1 putative enhancer C (Figure 3.8). E2F and its partner protein, the Retinoblastoma 
(Rb) play a critical role in the control of the cell cycle, cell proliferation and apoptosis 
(Bandara and La Thangue 1991; Chellappan et al. 1991; Kaelin Jr et al. 1991). Analysis 
of conditional knockout mice for a genetic deletion of Rb has demonstrated that their 
post-mitotic hair cells can re-enter the cell cycle and consequently proliferate for a 
longer period (Sage et al. 2006). The partnership role of E2F/Rb controlling 
developmental and proliferative processes has also been well established in other 
tissues. In addition, E2F1 expression has been described in the stria vascularis and spiral 
ganglion in mouse suggesting that E2F could have a significant role in the auditory 
organ (Raimundo et al. 2012). Therefore, the E2F family was selected for further 
investigation. Results from E2F experiments are presented in Chapter 5.   
3.5.4 ATOH1 
Finally, the ATOH1 transcription factor was also selected for further investigation. The 
interaction between ATOH1 and an E-box site located in the Atoh1 enhancer B has been 
previously described as an autoregulatory feed-back system to control ATOH1 
expression (Helms et al. 2000). The bioinformatic analysis performed here detected the 
presence of bHLH binding sites in the mouse and chick Atoh1 enhancers (the V$NEUR 
matrix) which verified the efficiency of this approach to predict functional binding sites. 
Since the interaction between ATOH1 and its enhancer has already been proven 
(Jarman et al. 1993; Akazawa et al. 1995; Helms et al. 2000) but its response has not 
been quantified in an auditory cell line, the response of the Atoh1 enhancers upon 
overexpression of ATOH1 was investigated in UB/OC2 cells. In addition, a bHLH 
binding site was also predicted in the chick Atoh1 putative enhancer C (Figure 3.5, 
V$NEUR matrix). Previous studies conducted by Helm et al., suggested the possibility 
of additional autoregulatory elements in the Atoh1 sequence beyond the Atoh1 
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enhancers. Therefore, this possibility was investigated by quantifying the response of 
the chick putative enhancer C, upon overexpression of ATOH1.    
3.6 Binding profiles for YY1, NF-κB and ATOH1 
transcription factors  
The genomic location and the conservation profiles of the binding sites for YY1, NF-κB 
and ATOH1 were examined in more detail. This information was required for further 
experimentation especially for the design of EMSA probes or the mutagenesis of their 
binding site for reporter gene assays. Based on the data collected from the MatInspector 
analysis, the location of the predicted binding sites for YY1, NF-κB and ATOH1 was 
annotated (Figure 3.9). The degree of homology of the predicted binding sites across 
mammalian and avian species was also assessed by the use of DiAlign, one of the 
features included in the Genomatix software package. The YY1 binding site shows a 
high degree of homology in mammalian and avian species. The NF-κB and ATOH1 
binding sites predicted in the putative enhancer C, were also almost identical in chick 
and zebra finch (Figure 3.9). In addition and in support of matrix predictions, Table 3.1 
shows the binding sites for these transcription factor candidates. The matrix and core 
similarity scores are also shown which are between 0.8 and 1 respectively. 
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Figure 3.9.  Location of the YY1, NF-κB and ATOH1 predicted binding sites within the Atoh1 conserved regions. Summary of the genomic location of the binding sites 
predicted by MatInspector. A YY1 binding site was predicted within the Atoh1 enhancer A whereas an ATOH1 and a NF-κB were predicted within putative enhancer C. The 
degree of homology across the mammalian and avian species is shown. The predicted YY1 binding site is highly conserved in mouse and human Atoh1 enhancer A whereas the 
ATOH1 and NF-κB binding sites were highly conserved in chick and zebra finch Atoh1 putative enhancer C.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 450 683 827 1490   1956 
Enhancer A Enhancer B Putative Enhancer  C 
Atoh1 conserved elements 
YY1                                                                                                                                                                   ATOH1       NF-κB Predicted Binding Sites 
Chick           TAACCCTTTC CCCAAGCGCT GCCCGCACGG GATTTTCCTCC 
Zebra finch     TAACCCTTTC CCCAAGCGCT GCCGTCGC-G GGTTTTCCTCC 
Human           ---------- ---------- ---------- ----------- 
Mouse           ---------- ---------T GTCTGCAGGG GTGGTGAGGA- 
Chick          ATCAGCGAGA CAGCGCATCA GCCCAT CTGCTTGATA 
Zebra finch    ATCAGCGAGA CAGCGCATCA GCCCAT CTGCTTGATA 
Human          ATCCCTGAGA CACTAATGTA AGGGAGTTTC TATCAG 
Mouse          ACCGCTGAGC CATCTCACCA GCC------- ------ 
Human        CTCATTCCCC ATATGCCAGA CCACTTCTGC CATGCTGACT GGTTCCTTTC 
Mouse        CTCATTCCCC ATATGCCAGA CCACTCCTGC CATGCTGACT GGTTCCTTTC 
Chick        CTCATTCCCC ATATGCCGGG CCGCTCCCGC TATGCTGGCT GCTTCCTTTC 
Zebra finch  CTCATTCCCC ATATGCCAGG CCACTCCCGC TATGCTGGCT GGTTCCTTTC 
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Table 3.1. MatInspector analysis of candidate genes. Conservation profiles of the binding sites for the different transcription factor candidates against a consensus binding site are 
represented by the Matrix and Core Similarity scores (> 0.8). The core base pairs of the predicted binding sites are represented in capital letters.  Start and end positions represent the 
location of the binding sites relative to start of the enhancer A.  
 
Candidate 
gene  
Family/Matrix 
 
Stringency 
level 
Predicted 
expression 
Start 
position 
End 
position 
DNA 
Strand 
Matrix 
similarity 
Core 
similarity 
Predicted binding site 
 
YY1 
V$YY1F/V$YY1.01 0.05 Ubiquitous 179 200 + 0.853 1 
 
 
 
tcctgCCATgctgactggttc 
 
NF-κB 
V$NFKB/ 
V$NFKAPPAB65.01 
0.05 
Blood 
cells, bone 
marrow 
cell, 
immuno 
system 
1792 1902 + 0.982 1 acgggattTTCCtcc 
ATOH1 V$NEUR 0 
Brain, 
central 
neural 
system 
 
1589 1606 + 0.985 1 agcccatCTGCtt 
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3.7 Binding profiles for the E2F transcription 
factor family 
Nine putative E2F binding sites were identified by MatInspector at the chick and 
three at the mouse Atoh1 gene locus (Figure 3.10). Based on the potential role that 
the E2F family could have in the regulation of Atoh1, these predictions were 
examined in greater detail.    
 
 
 
Figure 3.10. Predicted E2F binding sites in the mouse and chick Atoh1 conserved regions. 
Summary of the E2F binding sites predicted by MatInspector. a) Three E2F binding sites were 
predicted in the mouse Atoh1 conserved regions, one located within mouse Atoh1 enhancer A and two 
located in the sequence between enhancer A and B. b) In the chick, nine E2F binding sites were 
predicted. One within chick Atoh1 enhancer A, one in the sequence between enhancer A and B, two 
within chick enhancer B and five within putative enhancer C.   
 
 
The genomic location of the predicted binding sites is summarized in Figure 3.10. In 
chick, four potential E2F binding sites were predicted within the chick Atoh1 
enhancer AB (sites 1-4 in Table 3.2) and five binding sites were predicted within the 
chick putative enhancer C (sites 5-9 in Table 3.3). In some cases, two or more 
overlapping E2F binding sites were predicted in the same genomic region and 
therefore were grouped as a single site (e.g. site 2 and 5 predicted in the chick Atoh1; 
Table 3.2 and Table 3.3). Almost all the predicted matches for E2F have a matrix 
similarity score higher than 0.8 which classify them as a good match. A few E2F 
binding sites within putative enhancer C score lower than 0.8 (Table 3.3). However, 
since the value is close to the 0.8 threshold and in some cases two or more binding 
1 432 665 816 1526 1903
Enhancer A Enhancer B Putative Enhancer   C
Atoh1 evolutionary conserved regions in chick
S1 S2 S3             S4                      S5 S6  S7      S8    S9
E2F Binding sites
1 549 968 1386
Enhancer A Enhancer B
Atoh1 evolutionary conserved regions in mouse
S1         S2 S3 E2F Binding sites
a)
b)
Chapter 3: Bioinformatic analysis 
 
 
138 
 
sites overlapped at the same DNA site, they were included as a potential E2F match 
(sites 5, 6, 8 and 9 in putative enhancer C). The core similarity scores described by 
MatInspector are also annotated in Table 3.2 and Table 3.3. As with the matrix 
similarity, the score for the core similarity is measured from 0 to 1 and in most cases 
were above or close to 0.8 for the E2F binding site predictions in the chick sequence.  
A similar strategy was also conducted with the putative E2F binding sites predicted 
at the mouse Atoh1 locus. Table 3.4 shows the three E2F binding sites that were 
predicted at the mouse Atoh1 locus and their relative positions within the mouse 
Atoh1 enhancer A and B region. The binding sites predicted in mouse were 
compared against those predicted in the chick Atoh1 locus however no sequence 
homology between the chick and mouse E2F binding sites was found.   
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Table 3.2.  Predicted E2F binding sites within chick Atoh1 enhancer region. Summary of the MatInspector analysis with the location of the different E2F sites that were 
predicted in the positive and/or negative strand of chick Atoh1 enhancer sequence. Conservation profiles of the different predictions against a consensus E2F site are 
represented by the matrix and core similarity.  The matrix scores for all the E2F sites are > 0.8 and the core similarity is 1 which defines these predictions as good matches. 
The core of the binding site is presented in capital letters and the names given for each E2F binding site is represented from S1 to S4 based on the relative position within the 
chick Atoh1 locus.      
 
Family/Matrix 
Predicted 
expression 
Start 
position 
End 
position 
DNA 
Strand 
Matrix 
similarity 
Core 
similarity 
Predicted binding site Given name 
V$E2FF/E2F2.01 
V$E2FF/E2F3.01 
 
ubiquitous 420 437 + and - 0.934-0.944 1 ggagaGCGCgcacttcg Site 1 (S1) 
V$E2FF/E2F.02 
V$E2FF/E2F1_DP2.01 
V$E2FF/E2F4_DP2.01 
 
ubiquitous 457 474 - 0.8 1 aaaaAGCGaTAAAaaat Site 2 (S2) 
V$E2FF/E2F2.01 
V$E2FF/E2F3.01 
 
ubiquitous 688 705 - 0.8 1 acacgGCGCaccgcggc Site 3 (S3) 
V$E2FF/E2F3.02 ubiquitous 756 773 + 0.8 1 aggcgGCGCcccgggga Site 4 (S4) 
 
  
 
 
1
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Table 3.3. Predicted E2F binding sites within chick Atoh1 putative enhancer C. MatInspector also predicted E2F binding sites in the chick putative enhancer C which 
were grouped in five sites (S5-S9). Matrix and core similarity scores were close or higher than 0.8 and therefore were considered as a potential match. The core of the binding 
site is presented in capital letters and the different E2F sites that were predicted in the positive and/or negative strand of chick putative enhancer C sequence.  
 
Family/Matrix 
Predicted 
expression 
Start 
position 
End 
position 
 
DNA 
Strand 
Matrix 
similarity 
Core 
similarity 
Predicted binding site 
Given 
name 
V$E2FF/E2F1_DP2.01 
V$E2FF/E2F2.01 
V$E2FF/E2F3.01 
ubiquitous 1526 1553 + and - 0.78-1 0.77-1 
cctCGCGCGtggtcCCGCCcgctctcc 
 
Site 5 
(S5) 
V$E2FF/E2F.03 
V$E2FF/E2F1_DP2.01 
V$E2FF/E2F2.01 
V$E2FF/E2F3.01 
V$E2FF/E2F4_DP2.01 
ubiquitous 1543 1580 + and - 0.79-1 0.79-1 
tgcgcgctcccGCGCccaaCGCGGgacagcgacgcgc 
 
Site 6 
(S6) 
V$E2FF/E2F2.01 ubiquitous 1589 1606 - 0.8 1 ataaaGCGCggcagcac 
Site 7 
(S7) 
V$E2FF/E2F.01 ubiquitous 1702 1719 + 0.75 0.75 cttccccggGAGAacgc 
Site 8 
(S8) 
V$E2FF/E2F.01 
ubiquitous 1797 1814 + 0.78 1 tttcctcccGAAAaacg 
Site 9 
(S9) 
 
 
 
 
 
1
4
1
 
Table 3.4. Predicted E2F binding sites within mouse Atoh1 enhancer region. Summary of the MatInspector analysis of the different E2F sites predicted in the sequence region of 
the mouse Atoh1 enhancers. Conservation profiles of the different predictions against a consensus E2F site are represented by the matrix and core similarity.  The matrix scores for 
all the E2F sites is > 0.8 and the core similarity is close to 0.8 or above which define these predictions as good matches. The core of the binding site is presented in capital letters and 
the names given for each E2F binding site is represented from S1 to S4 based on the relative position within the mouse Atoh1 locus.      
 
 
 
 
Matrix Detailed Matrix 
information 
Tissue Start 
position 
End 
position 
DNA 
Strand 
Core 
similarity 
Matrix 
similarity 
Predicted binding 
site 
Given name 
V$E2F.02 E2F-myc activator/cell 
cycle regulator 
E2F, involved in cell 
cycle regulation, 
interacts with Rb p107 
protein 
ubiquitous 499 516 - 1 0.849 gtggtgagcCAAAaccc Site 1 (S1) 
V$E2F.02 E2F-myc activator/cell 
cycle regulator 
E2F, involved in cell 
cycle regulation, 
interacts with Rb p107 
protein 
ubiquitous 712 729 + 1 0.849 actgagcccCAAAgttg Site 2 (S2) 
V$E2F1_DP2.01 E2F-myc activator/cell 
cycle regulator 
E2F-1/DP-2 
heterodimeric 
complex 
ubiquitous 844 861 + 0.795 0.831 agatCGCGggcaaagac Site 3 (S3) 
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3.8 Discussion 
In this chapter a comparative analysis of the sequences at the Atoh1 locus was 
conducted across mammalian and avian species. The 3’ region downstream of the Atoh1 
coding sequence contains two evolutionary conserved elements, enhancer A and 
enhancer B, which have previously been described to be sufficient to drive Atoh1 
expression (Helms et al. 2000). By contrast, the same study showed that the 5’ region, 
upstream of the Atoh1 coding sequence, was not required for Atoh1 expression (Helms 
et al. 2000). Based on this work using reporter constructs in transgenic mice, Helms et 
al. hypothesized the existence of other regulatory elements that participate in the 
regulation of Atoh1, in addition to the Atoh1 A and B enhancers (see section 1.7.2). 
Therefore a comparative analysis was conducted to identify evolutionary conserved 
regions in mammalian and avian species. The results of this analysis supported the 
previous work (Helms et al. 2000; Ebert et al. 2003). Hence, in mammals the sequences 
within the Atoh1 enhancer A and B share a high degree of conservation between mouse 
and human (90.73% for enhancer A and 88.79% for enhancer B) (Figure 3.1). Similarly, 
the comparison of the Atoh1 enhancers in avian species showed that the homology of 
these enhancers was 89.76% and 88.36% respectively for enhancer A and B between 
chick and zebra finch suggesting that these also exist in avians (Figure 3.2). 
Interestingly, an additional highly conserved region was identified in chick and zebra 
finch. This region, termed putative enhancer C, is located about 700 bp downstream of 
enhancer B and shares 79.61% homology between chick and zebra finch (Figure 3.2). 
This putative enhancer C is a unique region to avian species and was not found in any of 
the mammalian species analysed in this study (Figure 3.3). Based on the degree of 
conservation of the putative enhancer C in avians, my investigation presented in 
subsequent chapters focused on determining whether putative enhancer C is involved in 
the regulation of Atoh1 in chick (described in chapters 5 and 6).    
Following the comparative alignment, a bioinformatic analysis was conducted using 
MatInspector from Genomatix (version 9.0) to identify putative transcription factors 
binding to the mammalian and avian Atoh1 evolutionary conserved regions. In the inner 
ear, very little is known about which transcription factors contribute to the regulation of 
Atoh1 expression (Ahmed et al. 2012; Neves et al. 2012). Having predicted over 200 
putative candidates that potentially could bind to the Atoh1 enhancer AB or putative 
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enhancer C, four candidates were selected for further functional analysis based on the 
conservation profiles of their predicted binding sites and their potential roles in auditory 
hair cell maintenance and survival.  
The ability of these candidates to regulate Atoh1 expression was subsequently tested in 
reporter gene assays and EMSA experiments (Chapter 4). In addition, expression data 
are also presented for one of these transcription factor candidates, providing strong 
evidence that this candidate could be involved on the regulation of Atoh1 (Chapter 5).  
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Chapter 4  
4 Investigation of putative candidates 
regulating Atoh1 
 
Having identified the presence and location of YY1, NF-κB and ATOH1 binding site 
predictions within the Atoh1 locus and based on the expression profiles and functions of 
the selected transcription factor candidates, I investigate whether YY1, NF-κB and 
ATOH1 do bind and regulate the Atoh1 expression using electrophoresis mobility shift 
assays (EMSAs) and reporter gene assays.  
4.1 EMSA analysis of candidate binding sites   
To assess the ability of YY1 and NF-κB to bind the Atoh1 conserved regions, EMSAs 
were conducted. This technique is used to detect interactions between protein 
complexes and nucleic acids based on the observation that the electrophoretic mobility 
of a protein-DNA complex is less than that of the free nucleic acid (Hellman and Fried 
2007). In addition, sequence specificity of a given transcription factor binding site can 
be investigated in competition assays with known or consensus binding sites.   
To perform these experiments, double stranded oligonucleotides were designed against 
the predicted binding site sequences for YY1 and NF-κB (Table 4.1). Oligonucleotides 
were radiolabelled as described in section 2.2.8.5 and incubated with nuclear extracts 
from UB/OC2 cells, either alone or in a competition assay with an excess of an 
unlabelled competitor.  
The ability of YY1 to bind the Atoh1 enhancer A was assessed using EMSA analysis 
shown in Figure 4.1. Several DNA-protein complexes (referred to as bandshifts) were 
observed when the radiolabelled oligonucleotide containing the predicted YY1 binding 
site was incubated with UB/OC2 cell nuclear protein extracts (Figure 4.1 bandshifts A1, 
B1, C1). The banding pattern showed two slow-migration DNA-protein complexes 
(Figure 4.1 A1 bandshifts) and two protein-DNA complexes with a faster migration 
(Figure 4.1 B1 and C1). On competition with an unlabelled YY1 consensus binding site, 
the A1 and B1 complexes were slightly attenuated by an excess of unlabelled YY1 
                                                                   Chapter 4: Investigation of putative candidate regulators of Atoh1 
 
145 
 
consensus (lanes 3-6) whereas the C1 protein-DNA complex was completely attenuated 
by x500 excess of unlabelled YY1 (lane 6). Competition with 500-fold of unlabelled 
non-specific competitor, had no effect on the A1, B1 and C1 bandshifts (lane 7). This 
pattern suggests that the protein-DNA complex C1 contains the YY1 transcription factor 
bound in a sequence dependent manner. The A1 and B1 protein-DNA complexes are less 
likely to be produced by YY1 since the level of competition by an excess of a YY1 
consensus probe was much lower.   
 
 
 
Table 4.1. Oligonucleotides for YY1 and NF-κB EMSA analysis. EMSA oligonucleotides containing 
the predicted binding sites given by MatInspector. Oligonucleotides for the consensus binding sites for 
YY1 and NF-κB were also designed and synthesised for EMSA competition assays. The sequences of 
the binding sites for the transcription factor candidates are presented and the core of the binding site is 
underlined.  
 
Oligo name Probe Sequence (5' to 3') 
Length 
(bp) 
Prediction 
YY1_Sense ACCACTCCTGCCATGCTGACTGGTTCCTTTC 31 Enhancer A 
YY1_Antisense GAAAGGAACCAGTCAGCATGGCAGGAGTGGT 31 Enhancer A 
YY1_Con_Sense CGCTCCCCGGCCATCTTGGCGGCTGGT 27 Consensus 
YY1_Con_Antisense ACCAGCCGCCAAGATGGCCGGGGAGCG 27 Consensus 
NF-κB _Sense CCCGCACGGGATTTTCCTCCCGAAA 25 Putative enhancer C 
NF-κB _Antisense  TTTCGGGAGGAAAATCCCGTGCGGG 25 Putative enhancer C 
NF-κB _Con_Sense AGTTGAGGGGACTTTCCCAGGC 22 Consensus 
NF-κB _Con_Antisense GCCTGGGAAAGTCCCCTCAACT 22 Consensus 
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Figure 4.1. Binding of YY1 to Atoh1 enhancer A binding site. A radiolabelled probe containing the 
predicted YY1 binding site sequence was incubated in the absence of nuclear extracts (lane 1) or with 
10µg of UB/OC2 cell nuclear extracts (lanes 2-7) either in the absence of competitor (lane 2) or in a 
competition with an excess of unlabelled consensus YY1 (lanes 3-6) or with an unlabelled non-specific 
competitor (lane 7). The different shifted DNA-protein complexes were named as A1, B1 and C1 and 
labelled on the right of the figure.   
 
Cold YY1 Consensus
0x     50x   100x  200x  x500  x500
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As with YY1, the ability of NF-κB to bind to the Atoh1 putative enhancer C was also 
tested on EMSA assays. In EMSA analysis shown in Figure 4.2, the predicted NF-κB 
binding site sequence produced several distinct protein-DNA complexes when  
incubated with UB/OC2 cell nuclear extracts  (Figure 4.2, lane 2 bandshifts A2-D2). On 
competition with unlabelled consensus NF-κB oligonucleotide, the A2 and C2 protein-
DNA complexes were attenuated even at 50 fold competition (Figure 4.2, lanes 3-6) 
whereas bandshift D2 was only significantly attenuated by 200 fold excess competition 
(Figure 4.2, lane 6). By contrast, competition was not seen in the complex that 
generated the bandshift B2 suggesting that B2 is not NF-κB sequence specific (Figure 
4.2, lanes 3-6). Competition with 500-fold unlabelled non-specific competitor showed 
that both A2 and C2 bandshifts were not attenuated suggesting that the protein-DNA 
complexes A2 and C2 are NF-κB sequence specific (Figure 4.2, lane 7). In contrast, the 
D2 bandshift was competed in a similar manner by both a consensus NF-κB (Figure 4.2, 
lane 6) and non-specific competitor (Figure 4.2, lane 7) suggesting that the protein-
DNA complex D2 is not NF-κB sequence dependent.   
In summary, EMSA experiments suggested that YY1 and NF-κB have the capacity to 
bind to the putative binding sites identified by MatInspector in the Atoh1 conserved 
elements. Given the evidence of an interaction between both YY1 and NF-κB with 
Atoh1, this regulation was investigated in reporter gene assays.  
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Figure 4.2. Binding of NF-κB to putative enhancer C. A radiolabelled probe containing the predicted 
NF-κB binding site sequence was incubated in the absence of nuclear extracts (lane 1) or with 10µg of 
UB/OC2 cell nuclear extracts (lanes 2-7) either in the absence of competitor (lane 2) or in a competition 
with an excess of unlabelled consensus NF-κB (lanes 3-6) or with an unlabelled non-specific competitor 
(lane 7). The different shifted DNA-protein complexes were named as A2, B2, C2 and D2 and labelled on 
the right of the figure.  
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4.2 Transcriptional activation of Atoh1 conserved 
regions by candidate regulators 
EMSA analysis showed evidence of specific binding of two of the transcription factor 
candidates to the Atoh1 conserved regulatory elements. To further investigate the 
functional properties of the candidate genes in the regulation of Atoh1, reporter gene 
assays were conducted. The ability of the potential candidate regulators (NF-κB, YY1 
and ATOH1) to control Atoh1 was therefore tested in luciferase assays. Expression 
constructs for all the transcription factors, were obtained from different laboratories and 
used in co-transfections with the Atoh1 luciferase reporters that had been constructed 
(see section 2.2.9.3 and section below). The UB/OC2 cell line derived from auditory 
epithelia pre-cursors was used for this functional analysis (kindly provided by Professor 
Matthew Holley, University of Sheffield). UB/OC2 cells represent a valuable resource 
for the study of gene regulation since they express several hair cell markers such as 
POU4F3, α9AChR, Myosin7a and Myosin6 (Rivolta and Holley 2002). In addition, 
Atoh1 mRNA production was also detected in our laboratory by q-PCR in UB/OC2 
cells (data not shown) which confirms that all the physiological machinery necessary to 
transcribe Atoh1 is present in this cell line.    
4.2.1 Cloning of the mouse and chick Atoh1 conserved elements 
To investigate the regulation of the mouse and chick Atoh1 conserved regions by the 
selected transcription factor candidates, luciferase constructs containing the chick and 
mouse Atoh1 conserved regions were produced. At the time my investigation started, a 
few publications reported studies with the mouse Atoh1 enhancer A and B cloned into 
the pGL3 luciferase constructs (Shi et al. 2010; Terrinoni et al. 2013). However, 
luciferase constructs containing the chick Atoh1 enhancer A and B and the novel 
putative enhancer C did not exist. Hence, the pGL4 luciferase constructs (Promega
®
) 
were chosen for the cloning of the Atoh1 conserved regions. This generation of reporter 
vector has advantages in comparison to the pGL3 luciferase constructs. These include 
engineered the removal of many consensus transcription factor binding sites in the 
vector backbone reducing the risk of artefactual regulation of the base vector. Therefore 
the mouse and chick Atoh1 enhancers and the chick putative enhancer C were cloned 
into the pGL4.23 luciferase construct. The pGL4.23 vector contains a minimal promoter 
32 bp upstream of the transcription start site to drive basal expression of the luc2 
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reporter gene and facilitates the analysis of enhancer sequences cloned into the vector. 
The cloning strategy that was followed to generate all these constructs was described in 
detail in methods section 2.2.9.3. All Atoh1 conserved regulatory elements were 
positioned either upstream or downstream of the minimal promoter sequence in the 
pGL4.23 luciferase construct. The position of the Atoh1 conserved regulatory elements 
is shown for each reporter assay since it varies for each experiment. The dual luciferase 
assay system was used for these experiments because it allows sequential measurement 
of two independent luciferase reporters within a single sample. Hence, the activity of 
the Firefly luciferase (Photinus pyralis) from the experimental reporter is determined 
relative to the activity of the Renilla luciferase (Renilla reniformis) which is used as an 
internal control to adjust for differences in transfection rate and cell number.  
4.2.2 Effect of YY1 on the Atoh1 conserved non-coding elements 
The ability of YY1 to regulate the mouse and chick Atoh1 conserved regions was tested 
in luciferase assays. To conduct these experiments an expression construct containing 
the open reading frame of the human YY1 was obtained from Dr Yang Shi, Boston 
Children’s Hospital, US (Shi et al. 1991). The response of the different Atoh1 luciferase 
constructs (shown in Figure 4.3a) to YY1 expression was investigated.  A modest 
upregulation of 1.3 and 1.2-fold activation was detected on co-transfections of the YY1 
expression vector via the mouse and chick Atoh1 AB enhancers respectively (Figure 
4.3b). A similar 1.3-fold activation was also observed via the chick putative enhancer C. 
However, when a construct containing the chick Atoh1 enhancer AB together with the 
putative enhancer C (construct referred to as chickABC in Figure 4.3a), the activation 
previously observed through the chick Atoh1 enhancer AB was reduced and instead a 
20% downregulation was obtained after co-transfecting YY1. The base pGL4.23 
luciferase vector did not show a response when co-transfected with YY1. Therefore, the 
responses observed in the Atoh1 luciferase constructs were due to the presence of Atoh1 
conserved regions and not due to an artefactual response of the backbone of the 
pGL4.23 construct.  
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Figure 4.3. Effect of the YY1 transcription factor on the activity of the mouse and chick Atoh1 
enhancers and putative enhancer C. a) Schematic representation of the luciferase constructs containing 
the mouse or chick Atoh1 conserved regions cloned into the luciferase vector pGL4.23 (referred as empty 
pGL4.23 luc). Both mouse and chick Atoh1 conserved regions were located upstream of the luciferase 
gene for this reporter gene assay (constructs are referred as “up_luc”). b) UB/OC2 cells were co-
transfected with 200ng of empty pGL4.23 and the different Atoh1 luciferase constructs, 10ng of pRL-null 
and 1200ng of the expression constructs (pSI or YY1). The luciferase activity of each reporter is 
normalized to its response in the absent of stimulation (set at 100). Error bars on charts represent the 
standard error of the mean. Statistical significance was assessed using a paired Student t-test (**p< 0.01 
or *p<0.05). Experiments were conducted in triplicate in two separate assays with different DNA 
preparations for each construct (n=6).  
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4.2.3 Effect of NF-κB on the Atoh1 conserved non-coding 
elements 
The ability of NF-κB to regulate the mammalian and avian Atoh1 conserved regions 
was also tested in luciferase assays. An expression vector containing the human NF-κB 
p65 cDNA sequence was obtained from University of Michigan Medical Center, US 
(Schmid et al. 1991) and co-transfected with the Atoh1 luciferase constructs (Figure 
4.4a). The results from this experiment showed no significant response of mouse and 
chick Atoh1 AB enhancers to NF-κB (Figure 4.4b). A similar response was obtained for 
the construct containing the chick putative enhancer C. However, the construct 
containing the chick Atoh1 enhancer AB and putative enhancer C (referred to as chick 
ABC) showed a modest 25% downregulation when it was co-transfected with NF-κB.  
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Figure 4.4. Effect of the NF-κB transcription factor on the mouse and chick Atoh1 enhancers and 
putative enhancer C. a) Schematic representation of the luciferase constructs containing the mouse or 
chick Atoh1 conserved regions cloned into the luciferase vector pGL4.23 (referred as empty pGL4.23 
luc). Both mouse and chick Atoh1 conserved regions were located upstream of the luciferase gene for this 
reporter gene assay (constructs are referred as “up_luc”). b) UB/OC2 cells were co-transfected with 
200ng of the empty pGL4.23 and the different Atoh1 luciferase constructs, 10ng of pRL-null and 1200ng 
of the expression constructs (pSI or NF-κB). The luciferase activity of each reporter is normalized to its 
response in the absent of stimulation (set at 100). Results showed a 1.3-fold downregulation when the 
Chick ABC construct is co-transfected with NF-κB (**p< 0.01). Error bars on charts represent the 
standard error of the mean. Statistical significance was assessed using a paired Student t-test. Experiments 
were conducted in triplicate in two separate assays with different DNA preparations for each construct 
(n=6).  
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4.2.4 Effect of ATOH1 on the Atoh1 conserved non-coding 
elements 
The interaction between ATOH1 itself and the Atoh1 A and B mouse enhancers has 
been shown (Helms et al. 2000). ATOH1 has the ability to bind to E-box consensus 
sites (Jarman et al. 1993) (Akazawa et al. 1995). Interactions between ATOH1 and E-
box sites within mouse Atoh1 enhancer B, are essential for ATOH1 expression in the 
neural tube at E10.5 (Helms et al. 2000). ATOH1 is also required for the correct 
regulation of the Atoh1 enhancers in the neural tube according to transgene studies in 
mice conducted at E10.5 (Helms et al. 2000). Expression of an Atoh1/lacZ reporter 
transgene in the neural tube is absent in an Atoh1 knockout mouse model suggesting an 
autoregulatory feedback loop requiring ATOH1.  
However, how the Atoh1 A and B mouse enhancers and other regulatory elements 
respond in other tissues/cells expressing ATOH1 and at other stages during 
development still remains unexplored. Therefore the effect of ATOH1 on the Atoh1 
conserved regions was investigated under in vitro conditions by the use of reporter gene 
assays in UB/OC2 cells. It is important to consider that an approach based on in vitro 
techniques possess some limitations (discussed further in 4.3). However it can provide a 
useful insight into the molecular mechanism of Atoh1 gene regulation in a cell line were 
ATOH1 is expressed.  
Hence, to assess whether ATOH1 is able to activate the Atoh1 A and B enhancers under 
in vitro conditions, luciferase assays were conducted. In addition, the effect of ATOH1 
on the putative enhancer C was also investigated since a bHLH binding site (a putative 
ATOH1 binding site) was predicted in the putative enhancer C.  
4.2.4.1 Investigating the autoregulation of ATOH1 via the Atoh1 
conserved elements 
An initial investigation was carried out to quantify the response of the various mouse 
and chick Atoh1 evolutionary conserved elements with increasing amounts of 
transfected ATOH1 in order to identify whether this response is dose-dependent. A dose 
response effect is a characteristic mechanism of direct binding between transcription 
factors and regulatory regions. Since previous evidence suggested the binding of 
ATOH1 to the E-box site in the Atoh1 enhancer B (Helms et al. 2000), a gradient effect 
on the response of Atoh1 enhancer AB was expected when the amount of ATOH1 was 
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increased. However, as shown in Figure 4.6, the expected activation of the mouse and 
chick Atoh1 enhancer AB constructs was not observed. The experiments showed no 
significant effect on the response of the mouse Atoh1 enhancer AB and the chick Atoh1 
enhancer AB constructs. Only a modest downregulation was observed when the highest 
amount of ATOH1 was co-transfected (1200ng of ATOH1 in Figure 4.6b). Similar 
results were obtained with the chick putative enhancer C construct giving a 10% 
downregulation when 800ng or 1200ng of ATOH1 were co-transfected. Only the 
construct containing both the chick enhancer AB and putative enhancer C (construct 
referred as chick ABC), showed a small upregulation of 1.2-fold when 400ng of 
ATOH1 were co-transfected. This effect was not observed when the amount of ATOH1 
was increased to 800ng whereas a 30% downregulation was seen when 1200ng of 
ATOH1 were co-transfected. It is notable that a modest downregulation was obtained 
for all the Atoh1 regulatory elements constructs when the highest amount of ATOH1 
was used (1200ng). In addition, this small downregulation is only statistical significant 
in the chick Atoh1 constructs but not in the mouse (Figure 4.5b).  
In summary, these results were unable to demonstrate the predicted upregulation of 
ATOH1 on the various Atoh1 regulatory elements and the observations vary between 
mouse and chick although none are dose dependent. One possible explanation for these 
results could be the relative position of the Atoh1 conserved regions in the different 
luciferase constructs that were generated. For example, the mouse and chick Atoh1 
enhancer are cloned upstream of the minimal promoter whereas the putative enhancer C 
and the construct containing enhancers AB and putative C altogether were inserted 
downstream of the minimal promoter (Figure 4.5a). Therefore, the possibility of 
obtaining different results based on the relative position of the inserted regions in the 
luciferase constructs was considered. Hence, to minimize this possibility, the putative 
enhancer C and region ABC upstream of the minimal promoter were relocated and a 
new set of luciferase constructs was constructed (see section 2.2.9.3). Further 
experiments from this point on were conducted with the luciferase constructs containing 
all the Atoh1 conserved elements upstream of the minimal promoter (constructs were 
referred with theirs corresponding name and as “up-luc” to indicate the position of the 
regulatory region).    
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Figure 4.5. Dose-response effect of ATOH1 on the Atoh1 conserved elements. Initial investigation was 
conducted to assess response of the mouse and chick Atoh1 enhancers and the putative enhancer C. a) 
Relative position of the Atoh1 conserved elements in the luciferase constructs. The mouse and chick 
Atoh1 enhancer were positioned upstream of the minimal promoter whereas the chick putative enhancer C 
and chick enhancer plus putative enhancer C were located downstream of the minimal promoter. b) Dose-
responses of the different luciferase constructs when co-transfected with increasing amounts of ATOH1.  
The luciferase activity of each reporter is normalized to its response in the absent of stimulation (set at 
100). Error bars on charts represent the standard error of the mean. Experiments were conducted in 
triplicate (n=3).  
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4.2.4.2 Effect of ATOH1 on the mouse and chick Atoh1 enhancers AB 
and chick putative enhancer C  
Having relocated the chick putative enhancer C and chick Atoh1 enhancers plus putative 
C region upstream of the minimal promoter, all the Atoh1 conserved elements were 
positioned in a similar relative location within the luciferase construct (Figure 4.6a).  In 
order to assess the effect of ATOH1 on these new reporters, an additional set of 
luciferase experiments was conducted. Only the highest amount of ATOH1 was used in 
these experiments (1200ng) and the response of the Atoh1 conserved elements was 
compared against the response with the same amount of the pSI construct (in the 
absence of exogenous ATOH1). In this experiment, no significant effect was observed 
on the mouse and chick Atoh1 conserved elements when co-transfected with ATOH1 
(Figure 4.6b). In addition, the relocation of the putative enhancer C and the putative 
enhancer C containing the ABC fragment did not give any significant differences in 
comparison to what it was observed before in previous experiments (Figure 4.5). These 
results suggest that ATOH1 on its own was not able to cause an upregulation on the 
Atoh1 conserved elements in UB/OC2 cells. Consequently, I investigated whether 
ATOH1 needs the co-operation of other DNA binding proteins to produce the up-
regulatory effect suggested in the literature (Akazawa et al. 1995) (Helms et al. 2000).   
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Figure 4.6.  Effect of ATOH1 on the Atoh1 non-coding conserved elements. a) Schematic 
representation of the Atoh1 luciferase constructs. The putative enhancer C and the chick Atoh1 plus 
putative enhancer C were repositioned upstream of the minimal promoter in comparison to previous 
experiment. b) UB/OC2 cells were co-transfected with the different Atoh1 luciferase constructs (200ng) 
with and without ATOH1 (1200ng of ATOH1 or 1200ng of pSI). Luciferase activities are represented in 
comparison to the response without ATOH1 (set at 100) but transfecting the empty mammalian 
expression vector pSI to maintain the same amount of transfected DNA. Renilla expression vector phRL-
null (10ng) was used as an internal control to correct differences in transfection efficiencies across 
experiments. Error bars on charts represent the standard error of the mean. The experiment was performed 
in triplicate and repeated twice with two different preparations of DNA (n=6).    
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4.2.5 Investigation of the effect of E47, the ATOH1 co-factor 
In the previous section, it was observed that ATOH1 was not able to up-regulate the 
mouse or chick Atoh1 enhancers. Previous transcriptional experiments using a mouse 
embryonic mesenchymal cell line, C3H10T1/2, have observed that interactions between 
ATOH1 and E-box sites are only possible when ATOH1 forms an heterodimer with the 
ubiquitous protein E47/E12 (Akazawa et al. 1995). In this study an upregulation of a 
construct containing seven sequential E-box sites was shown under the control of the β-
actin promoter when ATOH1 was co-transfected with E47. In addition, EMSA 
experiments conducted by the same group and subsequent studies conducted by Helms 
et al., 2000, suggested that ATOH1 on its own cannot physically bind to E-box sites and 
that the binding is only possible when the ATOH1/E47 complex is formed. One 
explanation for the lack of activation of the Atoh1 constructs therefore may have been 
the absence of E47. Based on these studies, I aimed to investigate whether the 
heterodimer formed by ATOH1 and E47 can activate consensus E-box sites and the 
Atoh1 conserved regions in an auditory cell line (UB/OC2 cells).  
4.2.5.1 Response of 3x Atoh1 binding sites and mutant 3x Atoh1 
binding sites with and without E47 
To investigate whether the heterodimer formed by ATOH1/E47 can activate consensus 
E-box sites in UB/OC2 cells, a luciferase construct was generated by cloning three 
sequential E-box sites downstream of a minimal promoter (described in section 2.2.9.3) 
and compared to a construct in which point mutations in the E-box sites had been 
introduced (Figure 4.7a). These two constructs were co-transfected with ATOH1 alone, 
E47 alone or ATOH1 and E47 together and compared against co-transfections without 
ATOH1 (transfected with the empty pSI expression vector).  As observed in Figure 
4.7b, transfection of ATOH1 alone did not show a significant effect on the response of 
the luciferase construct containing three E-box sites. However, co-transfections of E47 
alone caused an upregulation of about 8-fold difference (p<0.01).  By contrast, when 
both ATOH1 and E47 were co-transfected only a 4-fold upregulation was observed 
(p<0.01). For the construct containing the mutated E-box sites, none of the transfected 
expression constructs produced an effect. Since co-transfection of E47 activated the 
minimal promoter construct via  E-box sites, I further investigated whether a similar 
response may be produced on the different Atoh1 enhancers constructs as a consequence 
of the presence of E-box sites in these regions.    
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Figure 4.7. Effect of ATOH1 and E47 on the regulation of E-box sites. a) Schematic representation of 
the luciferase construct containing 3x E-box sites (represented in red) and the mutant version which 
carries 3xmutant E-box sites (in blue and marked by asterisks). Both luciferase constructs are driven by a 
minimal promoter sequence. b)  UB/OC2 cells were co-transfected with either the 3x E-box sites or the 
3x mut E-box sites luciferase construct with no ATOH1, ATOH1 alone,  E47 alone or ATOH1 and E47 
together. Luciferase responses are represented in comparison to the response given in the absence of 
stimulation with the empy pSIexpression vector (0ng of ATOH1). The empty pSI expression vector was 
also used to standarize concentrations of DNA across the different experiments. The renilla expression 
vector (phRL-null) was used as an internal control to normalize differences in transfection efficiencies. 
Error bars on charts represent the standard error of the mean. Statistical significance was assessed using a 
paired Student t-test (**p<0.01). The experiment was performed in triplicate and repeated twice with 
different preparations of DNA.   
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4.2.5.2 Effect of ATOH1 and E47 on the Atoh1 enhancer and putative 
Enhancer C 
Having observed an activation of the E-box sites by the E47, a further investigation was 
conducted to test whether similar results can be obtained on the mouse and chick Atoh1 
enhancer AB. Although, this approach would not verify the effectiveness of the E-box 
site in enhancer B, it would demonstrate the effect of E47 and the E47/ATOH1 complex 
on the entire enhancer sequence in an inner ear derived cell line. As shown in Figure 
4.8, a 1.16-fold upregulation of the mouse Atoh1 enhancer AB was observed when E47 
was co-transfected, in comparison to the response observed in the absence of exogenous 
ATOH1. A greater effect on the mouse Atoh1 enhancer AB was shown when ATOH1 
and E47 were co-transfected together however, this response was small and not 
statistically significant (1.36-fold difference in Figure 4.8). The effect of ATOH1 and 
E47 on the chick Atoh1 enhancer AB, chick putative enhancer C or on the chick Atoh1 
enhancer and putative enhancer C was also minimal and not statistically significant 
(chick AB, chick C and chick ABC constructs respectively in Figure 4.8).  
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Figure 4.8. Effect of ATOH1 and E47 on the Atoh1 evolutionary conserved regions. a) Schematic 
representation of the luciferase construct containing the Atoh1 conserved regions upstream of the minimal 
promoter sequence. b)  UB/OC2 cells were co-transfected with the luciferase construct containing the 
Atoh1 conserved regions with the following expression constructs: ATOH1 alone, E47 alone or ATOH1 
and E47 together. Luciferase responses are represented in comparison to the response given in the 
absence of exogenous ATOH1 (set at 100). The empty pSI expression vector was used to standardize 
concentrations of DNA across the different experiments. The Renilla expression vector (phRL-null) was 
used as an internal control to normalize differences in transfection efficiencies. Error bars on charts 
represent the standard error of the mean. Statistical significance was assessed using a paired Student t-
test. No statistical differences were found in any of the constructs for all the treatments tested. The 
experiment was performed in triplicate and repeated twice with different preparations of DNA.   
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4.3 Discussion 
Previous in-vivo studies have demonstrated that the Atoh1 enhancers AB are sufficient 
to drive mouse ATOH1 expression (Helms et al. 2000). However, very little is known 
about how the interaction of different transcription factors may affect the regulation of 
the enhancers and consequently how this could influence the expression of ATOH1. 
Among others, YY1, NF-κB, and ATOH1 are transcription factors that were prioritized 
as putative candidates to bind to the Atoh1 conserved elements based on the 
bioinformatic analysis conducted in this project. To define the strategy of the 
investigation, these candidates were prioritized for further investigation on the basis of 
their potential roles in hair cell development, maintenance and survival.  
Ying Yang-1 (YY1), a zinc finger transcription factor was selected as a putative 
candidate to regulate Atoh1 expression. It was predicted to bind the mammalian Atoh1 
enhancer A with the highest stringency given by MatInspector and therefore prioritized 
for being a strong putative candidate. Results from competition EMSA experiments 
demonstrated that some protein-DNA complexes (visualized on the gel as bandshifts) 
were YY1 sequence specific (Figure 4.1). However, further experiments with a YY1 
antibody will be required in order to confirm whether the binding between YY1 and the 
Atoh1 enhancer A is protein specific to confirm the presence of YY1 protein in the shift. 
In reporter gene assays, a 1.3 and 1.2-fold upregulation of the mouse and chick Atoh1 
enhancer AB constructs was observed in response to exogenous YY1 respectively 
(Figure 4.3). Although this modest upregulation was statistical significant when 
compared to the activation seen in the absence of exogenous YY1, it may not be 
physiologically relevant and may be within experimental error. In other studies, YY1 
has been shown to stimulate promoters and regulatory regions with a stronger effect to 
that with the Atoh1 reporter constructs. For instance, overexpression of YY1 
upregulates via a 5-fold increase the response of the human liver DnaJ-like protein 
promoter (HLJI) in human lung cancer cells (Wang et al. 2005) and with a 25-fold 
increase the response of the ganglioside-induced differentiation associated protein 1 
promoter (GDAP1) in HEK293 cells (Ratajewski and Pulaski 2009). Moreover, if a 
small effect is seen in in vitro experiments with other expression of proteins, the 
physiological response in vivo could be even lower. A binding site in vitro might not be 
accessible in an in vivo environment by the presence of histones and other chromatin 
modifiers. In addition, reporter gene assays, for example, were performed by cloning a 
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DNA fragment which was isolated from its endogenous form. The interaction with other 
regulatory regions could influence the cloned fragment might affect the observed 
response. Also the use of artificial promoters such as the minimal promoter used in the 
luciferase reporters may also influence the transcriptional response of genes to an 
altered signal that could be different to the response obtained by an endogenous 
promoter.  
Nevertheless, the small activation of the mouse and chick Atoh1 enhancer AB 
confirmed that the approach choosing the high stringency of the predicted binding site 
(Table 3.1) and the high grade of conservation of the binding site across mammalian 
and avian species (Figure 3.9) were appropriate to prioritize YY1 as a candidate to 
regulate Atoh1. However, the small upregulation seen in the putative enhancer C did not 
correlate with the MatInspector analysis since YY1 was not predicted to bind in this 
region. As with all other bioinformatics approach, MatInspector has limitations and it is 
possible that in this case the generation of matrices to detect a potential YY1 match 
were not accurate in predicting a binding site in the putative enhancer C. Another 
observation from the luciferase assays was the downregulation obtained when the three 
chick Atoh1 conserved elements were co-transfected with YY1 (Figure 4.3). This 
downregulation was also observed when co-transfections were conducted with other 
candidates like NF-κB or ATOH1 (Figure 4.4 and Figure 4.5). It is possible that other 
transcription factors bound at the Atoh1 conserved regions and promoter intervened in 
the formation of DNA loops and caused a differential transcriptional response in the 
construct containing the three chick Atoh1 conserved regions (the Chick ABC luciferase 
construct) in comparison to the construct with the putative enhancer C alone. Also, I 
cannot eliminate the possibility that YY1 could associate with other proteins to change 
its activity and consequently upregulate or downregulate the Atoh1 conserved elements. 
For instance, YY1 associates with the transcription factor SP1 to form a protein-protein 
complex to initiate the basal level of the transcription process (Lee et al. 1993) (Seto et 
al. 1993). There is also evidence of a physical interaction between YY1 and the basal 
transcription factor TFIIB which is involved in the formation of the RNA polymerase II 
complex (Usheva and Shenk 1994). Hence, since YY1 can work in co-operation with 
other proteins, it could also be possible that its activity can be modulated when binding 
to other partner proteins.  
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NF-κB, a member of the Rel/NF-κB family, is another transcription factor that was 
prioritized as a putative candidate to regulate Atoh1 expression. NF-κB is considered as 
the central mediator of the human immune response since it is involved in the response 
of diverse effects including cell inflammation, proliferation and apoptotic processes 
(Karin and Lin 2002) (Gilmore 2006). If cell damage is produced, the different subunits 
that form NF-κB, which are inactive in the cytoplasm are translocated into the nucleus 
to activate a downstream cascade of target genes in an attempt to block cell death (Pahl 
1999). As part of this protective role, the NF-κB pathway was seen to protect cochlear 
cells after aminoglycoside-induced ototoxicity (Jiang et al. 2005). This was concluded 
by the detection of NF-κB in hair cells and supporting cells after kanamycin-induced 
damage in comparison to controls where the nuclear translocation of the NF-κB 
subunits was not seen. In addition, the selective inhibition of NF-κB in vitro caused the 
degeneration of hair cells in P5 rats. Therefore, it is possible that NF-κB is also required 
for the survival of immature hair cells in an in vitro environment (Nagy et al. 2005). 
However, the role of NF-κB in the inner ear is still poorly understood.       
A high stringency NF-κB binding site was predicted in the putative enhancer C, the 
additional evolutionary conserved element downstream the Atoh1 enhancers found in 
avians. Since evidence was found in the literature of the role of NF-κB in the survival of 
hair cells, the potential of NF-κB to bind and regulate Atoh1 expression was 
investigated. EMSA experiments suggested that NF-κB could have the potential to bind 
to the predicted site in the putative enhancer C. However, supershifts experiments with 
an antibody specific for NF-κB will be required in order to confirm the presence of   
NF-κB in the observed UB/OC2 protein shifts.    
Co-transfections experiments were unable to demonstrate a significant activation of the 
mouse and chick Atoh1 enhancers or the chick putative enhancer C in the presence of 
exogenous NF-κB (Figure 4.4). The chick ABC luciferase construct did show a 
repressive response (Figure 4.4) but this was not observed when the putative enhancer C 
was tested independently from the Atoh1 AB enhancers. The selective effect of NF-κB 
on the putative enhancer C when it is on its own or along with the Atoh1 enhancers 
could be tested by mutating the predicted NF-κB binding site on the putative enhancer 
C. This would verify whether the downregulation observed in the luciferase construct 
containing the Atoh1 enhancer and putative enhancer C is due to the NF-κB binding site 
predicted in the putative enhancer C.  
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The ATOH1 transcription factor has been characterized by previous publications for 
autoregulating Atoh1 expression in the neural tube (Helms et al. 2000). However, little 
evidence exists as to whether this is also true in other tissues such as the inner ear. 
Therefore, the ability of ATOH1 to activate the Atoh1 regulatory elements was assessed 
in an in vitro inner ear cell line environment. The use of cell lines as a method to 
quantify the response of regulatory elements is frequently applied in molecular biology 
and it is a relatively fast procedure to explore the effect of a candidate gene. Initial 
experiments showed ATOH1 on its own had no effect on all the constructs tested 
including one containing consensus E-box binding sites. This suggests that the   
UB/OC-2 cell line did not contain the correct regulatory environment in which to 
investigate ATOH1’s mechanism of action although further studies are necessary to 
confirm this. When ATOH1 co-factor E47 was used in co-transfection experiments a 
significant ~7 fold activation via consensus Atoh1 E-box sites was observed (Figure 
4.7). However, this activation was repressed when ATOH1 was co-transfected with 
E47. Whether E47 activation of E-box sites in UB/OC-2 requires endogenous ATOH1 
or is independent of ATOH1 is unclear. It is possible that ATOH1 prevents E47 binding 
to repress its effect on the E-box sites. Subsequent transfections to test the effect on the 
mouse and chick Atoh1 enhancers constructs showed only small and none are 
significant changes (Figure 4.8).   
The results obtained in the in vitro experiments have some correlations with studies 
conducted by other authors in an in vivo system. Masuda et al., 2012 demonstrated in 
electroporations in mouse cochlear explants that ATOH1 or E47 have the capacity to 
induce Pou4f3/GFP expression in the greater epithelia ridge, a non-sensory region of the 
cochlea. Interestingly, E47 by itself also induced Pou4f3/GFP expression. In addition, 
electroporation with both ATOH1 and E47 induced more Pou4f3/GFP positive cells in 
the greater epithelia ridge than ATOH1 alone. It is possible therefore that the 
combination of ATOH1/E47 is necessary for the activation of Atoh1 target genes like 
Pou4f3 (Masuda et al. 2012) or Atoh1 itself. The expression and function of E47, one of 
the protein products of the gene TCF3 (also known as E2A) (Massari and Murre 2000; 
Sun and Baltimore 1991) has not been well studied in the cochlea. However, E47 could 
interact with other bHLH transcription factors including ATOH1. Dimerization between 
bHLH proteins is a common mechanism that is mediated through the HLH domains 
(Massari and Murre 2000). To further investigate the effect of E47 on the Atoh1 
enhancers, a dose effect of E47 and ATOH1 could be investigated since only single 
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doses (500ng) were tested in this study (Figure 4.8). In addition, a number of factors 
may have impacted on the results obtained in reporter gene assays. For example, 
proliferating UB/OC2 cells endogenously express ATOH1 which may have been 
sufficiently expressed to mask the variation induced by the co-transfected ATOH1 
expression construct. Furthermore, the potential squelching effect of ATOH1 could be 
tested in order to demonstrate that high levels of ATOH1 may prevent the expected 
upregulatory effect on the mouse and chick Atoh1 enhancer constructs and prevent the 
upregulatory effect of E47. Given these possibilities, the effect of ATOH1 on the Atoh1 
enhancers could be tested in other cell lines that do not endogenously express ATOH1.  
Overall, the results presented in this chapter demonstrate that experimental validation of 
the binding sites predicted and prioritised in the bioinformatic analysis was not fully 
achieved. Although some evidence was obtained for interactions between the 
transcription factors and the predicted binding sites in EMSA analysis this was limited 
and not substantiated in reporter gene assays. The lack of a strong effect of the 
candidates tested so far suggests that a true physiological response may not be probable 
but it may also be the case that the cell line used does not provide an appropriate 
environment to explore ATOH1 gene regulation. My results so far confirm the need for 
experimental validation before predicted binding sites can be assessed as functionally 
important.
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Chapter 5  
5 Investigation of the E2F transcription 
factor family as a putative candidate 
regulator of Atoh1 
 
Having identified several predicted putative E2F binding sites within the evolutionary 
conserved elements of mammalian and avian Atoh1, the E2F family was selected for 
further investigation. The prioritization of the E2F family as a candidate for follow-up 
was on the basis of its potential relevance to the inner ear and the high stringency of 
some of its predicted binding sites extracted from the bioinformatic analysis. The 
expression pattern of E2F in the inner ear has been poorly investigated previously with 
only one publication reporting E2F1 expression in the stria vascularis and spiral 
ganglion of adult mouse (Raimundo et al. 2012). However, the E2F binding partner Rb 
is known to control hair cell proliferation and cell cycle exit during development (Sage 
et al. 2006). Investigating the potential roles of E2F and the Rb/E2F pathway during the 
development, maturation or regeneration of hair cells could have a profound impact on 
the understanding of the process of normal cell growth and cell fate determination in the 
inner ear epithelium. 
5.1 Introduction to the E2F family  
5.1.1 Initial studies  
The E2Fs are described as a family of transcription factors that are critical for the 
control and progression of the cell cycle. Originally known as the E2 promoter binding 
factor, E2F1 (the primary member of the E2F family) was first discovered as a cellular 
factor binding to the adenovirus E2 promoter (Kovesdi et al. 1986; Kovesdi et al. 1987). 
Following studies in human adenovirus, E2F1 was investigated for being involved in 
the changes that occur during the cell cycle progression. Further characterization of the 
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function of E2F1 was conducted when E2F1 was described as one of the binding 
proteins of the Retinoblastoma tumour suppressor gene (Rb), one of the key factors 
regulating the cell cycle. E2F1 was found to form a complex with Rb during the G1 
stage in the cell cycle and this complex is disrupted upon the entry into the DNA 
synthesis phase (stage S) (Chellappan et al. 1991; Bagchi et al. 1991).  
5.1.2 E2F family members 
The E2F family has been described in different organisms including mammals with a 
conserved protein structure. In mammals, the E2F family is composed of eight members 
(E2F1-E2F8) represented in Figure 5.1.  
The E2F family is divided in to two subclasses based on their sequence homology and 
transcriptional functions. E2F1-E2F3a are known as transcriptional activators since they 
participate in the activation of the expression of their target genes (Attwooll et al. 2004; 
Ivey-Hoyle et al. 1993; Lees, 1993). By contrast, E2F4-E2F6, the other subclass of the 
E2F family, were identified as repressors. They were originally identified for binding 
Rb and the other structural related pocket proteins, such as p107 and p130 
(Beijersbergen et al. 1994; Hijmans et al. 1995; Trimarchi et al. 1998). E2F4 and E2F5 
were mainly detected in quiescent (G0) cells in contrast to E2F1-3 that are mainly 
restricted to dividing cells (Ikeda, 1996; Moberg et al. 1996). In addition, E2F4 and 
E2F5 lack the capacity to drive cells into the cell cycle (Müller et al. 1997). Among 
their functions, the cellular localization of the activating and repressing E2F members is 
also another representative characteristic of the two subclasses. In the molecular 
structure of E2F1-3, a canonical basic nuclear localization signal is found (NLS in 
Figure 5.1) that confers the nuclear localization of this subgroup (Müller et al. 1997; 
Verona et al. 1997; Magae, 1996). By contrast, the molecular structures of E2F4 and 
E2F5 contain a leucine/isoleucine-rich hydrophobic nuclear exporting signal (NES in 
Figure 5.1) which promotes the cytoplasmic localization of these E2F members 
(Gaubatz et al. 2001). Recently two more members of the E2F family have been 
identified, E2F7 and E2F8, which hold a separate conserved structure in comparison to 
the rest of the group. They contain two distinct DNA binding domains (DBD1 in Figure 
5.1) and lack the dimerization and transactivation domains. Therefore they bind to their 
targets without forming a complex with the DP co-factors. The different molecular 
structures of E2F7 and E2F8 suggest that they probably have unique roles in 
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comparison to the other members, as transcriptional repressors of cellular proliferation 
(de Bruin et al. 2003; Di Stefano et al. 2003; Logan et al. 2004; Logan et al. 2005).                      
 
5.1.3 E2F co-factors: The DP family 
The majority of the members of the E2F family enhance their functionality when they 
bind to their partners, the DP family (DP1, DP2 and DP4). DP1, the primary member of 
the family, was originally discovered as DRTF-polypeptide-1, a partner for E2F1 
(Girling et al. 1993). It was observed that DP1 shared the same binding domains as the 
E2Fs and it was able to recognize the same binding sites in the DNA.  
 
 
 
 
 
 
Figure 5.1. The E2F family. Representation of the E2F family members and their molecular structure 
as reviewed in Chen, 2009. The molecular structure of the E2F family is characterized by the presence 
of winged-helix DNA binding domain (DBD), a DP binding domain consisting in a leucine zipper (LZ) 
and a marked box motif (MB). These sequences are required for the dimerization of the E2F-DP 
complex. The E2F1-6 members are also characterized by the presence of a transactivation domain 
located in the C-terminal region which mediates the interaction with the Retinoblastoma tumour 
suppressor (RB). Figure reproduced from Chen et al. 2009.  
 
Picture removed for copyright purposes 
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Following the discovery of DP1, it was demonstrated that E2F1 was able to form a 
complex with the co-factor DP1, improving the binding capabilities of E2F1 (Helin et 
al. 1993; Girling et al. 1993). The human DP2 was characterized as the second member 
of the DP family (Ormondroyd E 1995; Zhang Y 1995). Unlike DP1, this new member 
produces different transcripts (called α β γ) and their cellular localization varies 
depending on the tissue or cell line. However, like the previous member, DP2 also plays 
important roles in enhancing the binding affinities of E2F members during the 
regulation of the cell cycle. On the contrary, DP4 has been described for reducing DNA 
binding properties of E2F. It was also suggested that DP4 delays cell cycle progression 
when binding to E2F1 (Milton et al. 2006).  
5.1.4 E2F functions 
The E2F family is characterized for being involved in different regulatory and cellular 
events. However, the role and functions of E2Fs are complex and in some cases not well 
understood. Therefore, a summary of the more relevant aspects of the E2F family are 
described in the following sections.  
5.1.4.1 E2F as controllers of the cell cycle 
The role of E2Fs in the control of the cell cycle is in part linked to Rb, a protein that 
belongs to a family known as the “pocket” proteins. The Rb-E2F complex is one of the 
main components responsible for the progression of the cell cycle. The cell cycle is 
divided into four different stages (Sherr and Roberts 1999): G1 is the growth phase, S 
phase corresponds to the stage at which DNA replication occurs, followed by G2 which 
precedes to the M (mitosis) phase during which cell division occurs. During the G1 
phase, positive and negative growth factors are produced in order to undergo DNA 
replication or to maintain the cell in a latent stage. During the G0/early G1 phase of the 
cell cycle, the unphosphorylated Rb binds to E2F1-3 to form the Rb-E2F complex 
(Bagchi et al. 1991; Bandara and La Thangue 1991; Chellappan et al. 1991). The 
formation of the Rb-E2F complex inhibits the activation of the genes required for the S-
phase and therefore the progression of the cell cycle is blocked. Growth-inhibitory 
signals, including the transforming growth factor (TBF-β) and the p53/p21 pathway 
block the phosphorylation of the Rb protein (DeGregori et al. 1995; Schwarz et al. 
1995; Mann and Jones 1996).   
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By the late G1 phase, the sequential activation of the cyclin-dependent kinases (CdKs) 
Cdk4/Cdk6-cyclin D (Ewen et al. 1993; Jun-ya  Kato 1993) and Cdk2-cyclin E 
(Akiyama et al. 1992; Hinds et al. 1992) produces the phosphorylation of Rb. The 
centrosome duplication in mammalian somatic cells requires the phosphorylation of Rb 
and the activity of E2F and Cdk2 (Meraldi et al. 1999). The phosphorylated Rb releases 
the E2F transcription factors which results in the activation of genes required for the 
entry into S-phase including genes coding for enzymes needed for the synthesis of 
dNTPs and DNA such as thymidylate synthase, ribonucleotide reductase 2 and DNA 
polymerase α (Dimova and Dyson 2005). It is also known that in quiescent (G0) cells, 
E2F4 and E2F5 associate with Rb to maintain the repression of S-phase genes as well as 
the activation of genes required for the exit out of the cell cycle and cell differentiation 
(Mann and Jones 1996; Gaubatz et al. 2001; Wu et al. 2001).  
 
 
 
 
Figure 5.2. Schematic representation of the role of the E2F/Rb complex in the control of the cell 
cycle. Cell cycle progression and therefore the entry into S-phase is dependent on the phosphorylation 
of Rb by cyclin D1–cyclin-dependent kinase (CDK)-4, cyclin D1–CDK6 and cyclin E–CDK2 
complexes. This causes the release of the free E2F1-3 and consequently the activation of downstream 
target genes required for the progression of the cell cycle. Image adapted from Coller, 2007. 
 
Picture removed for copyright purposes 
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All these events, including the phosphorylation of Rb and consequent release of the E2F 
transcription factors are essential steps for the progression of the cell cycle.  
5.1.4.2 E2F and cell proliferation 
The role of the E2F family in cell proliferation has been described by different studies. 
Initial evidence was found by the identification of E2F binding sites in the promoters of 
genes directly linked to cell proliferation. Among others, this is the case of various gene 
promoters such as adenovirus E2 (Kovesdi et al. 1986), human Thyrimide kinase (Kim 
and Lee 1991), the dihydrofolate reductase gene (DHFR) (Blake and Azizkhan 1989) 
and DNA polymerase α (Pearson et al. 1991) whose promoter sequences were 
functionally validated in EMSA competition assays for having the ability to be bound 
by E2F and consequently activate the transcription of these genes.  
E2F1 has also been described to activate cell proliferation upon ectopic overexpression 
in quiescent cells. The transfection of an E2F1 cDNA plasmid resulted in an increase of 
BrdU positive cells as a consequence of newly synthesized DNA in comparison to cells 
transfected with a mutant E2F1 protein (Johnson et al. 1993). Moreover, studies in 
serum-starved cells co-transfected with an E2F1 expression construct along with other 
constructs containing promoters that are known for containing E2F binding sites, 
resulted in the up-regulation of those promoters. Hence, it was concluded that E2F1 has 
the potential to stimulate transcription and therefore proliferation of genes without the 
action of normal growth stimulation signals. In addition to the previous studies it was 
also demonstrated that the combined loss of E2F1, E2F2 and E2F3 is sufficient to 
abolish cell proliferation in mouse embryonic fibroblasts (Wu et al. 2001).  
More recent studies also associated E2F1 in proliferative activities during the melanoma 
and metastasis progression. It was observed that when endogenous E2F1 is knocked 
down via E2F1 small hairpin RNA (shRNA), metastatic cells reduced their invasive 
potential and melanoma progression was decreased (Alla et al. 2010).   
5.1.4.3 E2F and apoptosis 
The relationship between E2F1 and apoptosis has been defined by at least three 
different mechanisms. Firstly, E2F1 can inhibit survival signals from the death receptor 
pathway. It is unclear whether E2F1 directly induces the degradation of these signals or 
whether E2F1 actives the expression of downstream genes to produce these events 
(Phillips et al. 1999). Secondly, ectopic or endogenous E2F1 can induce the 
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transcriptional activation of tumour suppressor proteins such as p53 and p73 and 
consequently programme cell death (Stiewe and Putzer 2000). Thirdly, and in addition 
to the previous one, E2F1 can also induce the p53 tumour suppressor protein by an 
indirect mechanism. In normal cells, the level of p53 protein is low and is controlled by 
a feed-back loop mechanism. However, under stress conditions, p53 is unable to auto-
regulate correctly and eventually is degraded (Ashcroft et al. 2000). E2F1 has been 
linked with promoting the stabilization of p53 under stress conditions and therefore may 
extend the apoptotic function of the p53 protein. This mechanism was shown to occur 
via the p14
ARF 
protein which is a downstream target of E2F1 (Bates et al. 1998).  
In summary, it is unclear whether the contrasting proliferative and apoptotic roles of 
E2F1 are due to the loss of potential activators or due to the up-regulation of negative 
factors of the cell cycle.  
5.1.5 E2F and the inner ear 
Most of the studies focused on the control of the cell cycle in the inner ear have been 
linked to the Rb protein and its function during early development and maturation of 
hair cells. Whether the E2Fs are also involved in these processes remains unexplored. 
However, based on the partnership that E2F and Rb share (see section 5.1.4) it seems 
logical to think that their functions in the inner ear are somehow connected.  
Studies with Rb homozygous mutant mice (Rb
-/-
) revealed that these mice die at 
embryonic stages and show multiple defects including in brain and nervous system 
(Classon and Harlow 2002). A more recent study carried out by Sage et al. with a 
conditional Rb knockout where the Rb was deleted in the inner ear, showed that in 
embryonic stages, hair cells appear normal but continue to divide for a longer period.
At early post-natal stages, conditional Rb
 
 knockout mice, showed an increased number 
of IHC and OHC in the organ of Corti but in a disorganized distribution in comparison 
with normal cochleae (Sage et al. 2006). Vestibular and cochlear hair cells were still 
proliferating at post-natal stages as detected by a proliferating cell nuclear antibody 
(anti-PCNA) in comparison to controls where PCNA was not detected in neither hair 
cells nor supporting cells. Multiple rows of HCs and SCs were also observed in the Rb
 
conditional knockout cochlear explants at P4. Whether the increase in the number of 
hair cells is due to the effect of “free” E2F inducing cell proliferation is unknown. In the 
vestibular system, anti-PCNA was shown only in hair cells but not in supporting cells, 
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suggesting that in the absence of Rb in the inner ear, there are different mechanisms 
controlling the proliferation of vestibular hair cells and supporting cells.  
At late post-embryonic stages it was shown that Rb is required for the maturation and 
survival of both cochlear and vestibular hair cells. The lack of prestin expression, a 
protein essential in auditory processing, in Rb conditional knockout
 
mice confirmed the 
requirement of Rb to form a functional inner ear.  
In summary the work conducted by Sage et al. showed that post-natal vestibular hair 
cells undergo cell division up to 6 weeks and survived for 6 months in the absence of 
Rb. However whether E2F is involved in the maintenance of hair cells within the cell 
cycle due to the lack of Rb was not studied.  
 
In mouse, hair cells stop dividing between embryonic day 13 (E13) and E14. It has been 
shown that the expression of p27
kip1
, a cyclin-dependent kinase inhibitor, is upregulated 
in the organ of Corti between E13-14 which correlates with the cell cycle withdrawal 
(Chen and Segil 1999). As mentioned in section 1.5.1, this was demonstrated by 
immunohistochemistry of an anti- p27
kip1
 antibody showing an up-regulation of this 
inhibitor protein between E12 and E14. In differentiated hair cells, p27
kip1
 is 
downregulated however its expression remains in mature supporting cells suggesting 
that p27
kip1
 is perhaps involved in maintaining supporting cells in a quiescent state 
(Chen and Segil 1999). The loss of p27
kip1 
was also examined in mutant mice. In these 
animals, cells in the developing epithelium continue dividing for a longer period in 
comparison to controls and an increase in the number of hair cells and supporting cells 
was observed. However, p27
kip1
 mutants also showed a severe hearing impairment, 
revealing the importance of p27
kip1 
in the control of exit from the cell cycle.   
In addition to Chen et al. studies, another group showed that the loss of p27
kip1 
reduces 
Cdk4/6-cyclin D complexes (Cerqueira et al. 2014). Cdk4/6-cyclin D complexes are up-
stream regulators of Rb and responsible for causing its phosphorylation and 
consequently the release of E2F from the Rb-E2F complex. If Rb is not phosphorylated 
appropriately because of the absence of p27
kip1
, it is possible that the control of the exit 
from cell cycle is disrupted and cells continue proliferating.  
 
A recent study conducted by Raimundo et al. showed that E2F1 could be linked to a 
mechanism of maternally inherited deafness. In this investigation it was found that a 
Chapter 5: Investigation of the E2F transcription factor family as a putative candidate regulating Atoh1 
 
 
176 
 
mutation in human mitochondrial DNA leads to a dysfunction of the mitochondrial 
ribosome which results in the activation of AMP kinases and E2F1 (Raimundo et al. 
2012). The mechanism involved in this process has been linked to the hypermethylation 
of rRNA which triggers a form of mitochondrial stress signalling. This upregulates 
E2F1 transcriptional activity which results in the apoptosis of cells involved in hearing 
such as the stria vascularis cells and spiral ganglion neurons. A microarray was also 
conducted and showed an enrichment of E2F1 target genes after the hypermethylation 
of the rRNA. On the other hand the hypermethylation of rRNA leads to an increase of 
phosphorylated Rb. In addition when the hypermethylation of rRNA was suppressed via 
knock down in mice, the upregulation of E2F1 is no longer seen and apoptosis 
measured by the Caspase 3/7 activity is reduced.  Altogether results from Raimundo’s 
group concluded that cell-type-specific mitochondrial stress produced by the 
hypermethylation of rRNA induces the Rb-E2F apoptotic pathway. This process leads 
therefore to an inner ear pathology affecting some cells involved in hearing and as a 
result causes deafness.  
To summarise the role of E2F in the inner ear, different studies have investigated the 
function of Rb in various tissues and organisms however very little is known about the 
function of E2F itself. Both E2F and Rb proteins appear to be involved at multiple 
levels of the complex regulatory pathway controlling the cell cycle. Therefore, the 
investigation of E2F and Rb and the interaction with other upstream and downstream 
proteins could bring new insights in the study of hair cell formation, maintenance and 
proliferation.  
5.1.6 The E2F family and the study of Atoh1 regulation 
One of the key questions that remains poorly understood in hair cell development and 
maintenance is the identification of genes that regulate the permanent exit of the cell 
cycle and genes that maintain the quiescent post-mitotic state of hair cells and 
supporting cells. Investigating whether the E2F family is responsible for the re-entry 
into the cell cycle of quiescent post-mitotic supporting cells to reactivate ATOH1 
expression could provide insights to understand the regeneration process of the inner ear 
sensory epithelium.  
Target genes of the E2F family were identified in a microarray experiment for changing 
expression when E2F1, E2F2 or E2F3 were overexpressed (Muller et al. 2001). 
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However, up to date, it is unknown whether ATOH1 is one of the downstream targets of 
the E2F family. Since Rb, the partner protein of E2F1-3, plays important roles in the 
cell cycle as well as in differentiation and survival in the inner ear, it would be 
important to investigate whether the E2F family is also involved in these processes.  
Hence, in order to elucidate the role of the E2F family in the inner ear, E2F was 
prioritized as a putative regulator of Atoh1 transcription. If the re-activation of ATOH1 
expression due to E2F1-3 could be demonstrated, then the manipulation of the Rb/E2F 
pathway could be a potential strategy to regenerate hair cells in the mature inner ear.   
5.2 Regulation of the mammalian and avian Atoh1 
conserved regions by E2F1 
The ability of E2F1 to regulate the mouse and chick Atoh1 enhancers and putative 
enhancer C was investigated to verify the predictions extracted from the bioinformatic 
analysis. To test this, luciferase plasmids containing the mouse and chick Atoh1 
enhancers and putative enhancer C were generated (cloned upstream of the minimal 
promoter; see section 2.2.9.3) and co-transfected with increasing amounts of a human 
E2F1 expression construct cloned in pcDNA3 (kindly obtained from Professor Kristian 
Helin, University of Copenhagen, Denmark) (Helin et al. 1992).   
Figure 5.3 (in blue) shows the responses of the different luciferase constructs containing 
specified mouse or chick Atoh1 conserved regions when transfected with increasing 
amounts of the E2F1 expression construct (from 0 to 1200ng of E2F1). The mouse 
Atoh1 AB enhancer construct showed 2, 2.4 and 3.1-fold activation when co-transfected 
with increasing amounts of E2F1. In the same luciferase assay, the response of the chick 
Atoh1 conserved regions was also assessed. The chick Atoh1 AB enhancer construct 
showed 8, 17 and 23-fold activation when co-transfected with increasing amounts of 
E2F1. In a similar way, the chick Atoh1 putative enhancer C construct showed a 10, 18 
and 34-fold activation with increasing amount of E2F1. The highest response was 
obtained with the construct containing all three chick Atoh1 conserved elements, 
construct ABC, which gave a response of 27, 61 and 145-fold activation when the 
amount of E2F1 was increased from 400 to 1200ng. The response observed for all 
Atoh1 luciferase constructs, both mouse and chick, correlates with a dose-dependent 
activation. However, the response obtained by the chick Atoh1 AB enhancer, chick 
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Atoh1 putative enhancer C and chick Atoh1 ABC constructs is much larger than the 
response obtained by the mouse Atoh1 AB enhancer construct (145 fold compared to 
3.1 fold). Moreover, the empty luciferase vector (pGL4.23) showed an increase of 2, 
2.47 and 2.44-fold activation when co-transfected with increasing amount of E2F1 
similar to the one observed in the mouse Atoh1 AB construct suggesting that the 
activation in the mouse Atoh1 AB could be due to effects on the base vector.   
The results so far suggest that E2F1 is a powerful activator of the chick Atoh1 
conserved elements potentially by binding to one or more of the E2F binding sites 
predicted by the bioinformatic analysis. To further investigate whether the activation of 
the mouse and chick Atoh1 conserved regions is dependent on a functionally active 
E2F1, another series of luciferase assays were performed but with a mutant E2F1 
expression construct (Yu et al. 2011). This mutant E2F1 contains a change in the DNA 
binding domain located in exon 3 of the E2F1 gene which results in the substitution of 
an arginine into a histidine residue in the E2F1 protein. This amino acid site is highly 
conserved across different species, including mouse and chick and is essential for the 
binding of E2F1 to its targets genes (Yu et al. 2011). When the mutant E2F1 construct 
was co-transfected, the large up-regulation that was previously observed in the chick 
Atoh1 constructs was no longer seen, confirming that the activation is dependent on a 
functional E2F1 (Figure 5.3 in red). In contrast, for the mouse Atoh1 AB enhancer a 
similar response was observed when co-transfected with the wild type E2F1 or the 
mutant E2F1 expression construct (in Figure 5.3 comparing mouse AB response with 
wild type E2F1-in blue and  mutant E2F1-in red). Therefore, the small upregulation 
seen in the mouse Atoh1 AB enhancer when co-transfecting the wild type E2F1 is still 
observed when the mutant E2F1 is used.  
In summary, although the mouse Atoh1 AB enhancer construct demonstrated a small 
upregulation when E2F1 was co-transfected, a similar response was observed when 
using the mutant E2F1. This activation is statistically significant but might not reflect a 
physiological response since similar response was observed with the empty luciferase 
construct (pGL4.23 in Figure 5.3) suggesting that this response may be artefactual.  
In chick, since an up-regulation was observed with the chick Atoh1 AB construct and 
also with the construct containing the chick Atoh1 putative enhancer C, at least two 
independent E2F binding sites may be functional in the chick Atoh1 sequence. 
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Moreover, since the response is much larger in the chick ABC construct, the effect of 
E2F1 is greater when both, the chick Atoh1 AB enhancer and putative enhancer C are 
present sustaining the hypothesis of multiple and independent E2F binding sites. In 
addition, the response observed with the chick Atoh1 conserved regions is much larger 
and beyond any artefactual response produced by the luciferase backbone. Therefore, 
since the response in chick is large and dependent on active E2F1, further investigation 
was conducted to examine which of the predicted binding sites in the chick Atoh1 
mediates this E2F regulation.  
  
 
 
  
 
 
1
8
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Figure 5.3. Dose-response effect of the E2F1 transcription factor on the Atoh1 conserved regions. UB/OC2 cells were transfected with increasing amounts of an E2F1 
expression construct (in blue) or a mutant E2F1 (in red). 10ng of the pRL-null luciferase construct (Promega) were co-transfected for all conditions and the pcDNA3 expression 
construct was also used to maintain the same amount of DNA across experiments. Each dose of E2F1 was normalized against the luciferase activity obtained when E2F1 was 
absent (0ng of E2F1 and therefore 1200ng of pcDNA3). Experiments were conducted in triplicate in two separate assays with different DNA preparations for each plasmid in 
each assay (n=6). Student t-test was conducted. (*p< 0.05; **p < 0.01; #p<10
-5
; ## p< 10
-10
). The mean value and standard error of the mean from 6 experiments are presented. 
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5.3 EMSA analysis of the predicted E2F binding 
sites in the chick Atoh1 conserved regions. 
In total nine E2F binding sites were predicted by the Genomatix MatInspector analysis 
in the chick Atoh1 enhancers A and B and putative enhancer C (Figure 3.10, Table 3.2 
and Table 3.3). Having shown an activation of the chick Atoh1 enhancer AB and chick 
putative enhancer C by E2F1, the investigation was focused on characterizing which of 
the nine predicted binding sites can be bound by the E2F transcription factors. 
Interactions between DNA-protein are typically a sign of regulatory mechanisms and 
therefore can result in a functional response such as the regulation of the transcriptional 
process to activate or repress the expression of a gene. Identifying whether the E2F 
family can bind to the chick Atoh1 regulatory regions to activate transcription and 
where exactly this interaction takes place, will provide additional evidence of a direct 
interaction of E2F1 with Atoh1 to regulate ATOH1 gene expression.  
To test this interaction, EMSA experiments were conducted using UB/OC2 nuclear 
protein extracts. As previously mentioned, different hair cell markers are expressed in 
these cells (Rivolta et al. 1998) in addition to Atoh1 which was detected by q-PCR in 
our laboratory (data not shown). This suggests that the transcriptional background for 
Atoh1 transcription is present in UB/OC2 cells. However, expression of E2F1 has never 
been tested in UB/OC2 cells and therefore before proceeding with the EMSA 
experiments E2F1 expression was examined in this cell line. 
5.3.1 Analysis of E2F1 expression in UB/OC2 cells 
The expression of the best characterized member of the E2F family, E2F1, was tested in 
proliferating UB/OC2 cells by immunohistochemistry and E2F1 mRNA production was 
assessed by RT-PCR.  
Figure 5.4 shows endogenous expression of E2F1 protein in UB/OC2 cells. 
Immunolabeling is predominantly nuclear or perinuclear in proliferating UB/OC2 cells 
cultured at 33
o
C as would be expected for E2F1. 
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Figure 5.5 shows the results of the RT-PCR to detect E2F1 and GAPDH expression 
(using primer 25-28; Table 2.1 in material and methods). When cDNA from 
untransfected UB/OC2 cells was used for the PCR reaction, a very faint band of 341 bp 
can be visualized on the agarose gel corresponding to the expected size based on the 
E2F1 transcript amplification. When cDNA from UB/OC2 cells transfected with E2F1 
was used, a stronger band of the same size was produced confirming that the signal of 
 
  
Figure 5.4. Endogenous expression of E2F1 in UB/OC2 cells.  Confocal images of proliferating 
UB/OC2 cells immunostained with E2F1 (in green) and DAPI (in blue). Immunostaining was 
conducted with a rabbit polyclonal anti-E2F1 antibody. Alexa Fluor 488
® 
provided the fluorescent 
labelling of the E2F1 antibody (in green) and 4′,6-diamidino-2-phenylindole (DAPI- in blue), was 
used to label nuclear DNA. Immunohistochemistry results show endogenous expression of E2F1 in 
proliferating UB/OC2 cells cultured at 33
o
C.  
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the band correlates to the correct E2F1 transcript in transfected and untransfected 
UB/OC2 cells but suggesting it may be lowly expressed in UB/OC2 cells under normal 
conditions (Figure 5.5).  E2F1 protein expression was also analysed and compared in 
untransfected UB/OC2 cells and cells transfected with an E2F1 expression vector. As 
shown in Figure 5.6, E2F1 immunolabeling in transfected UB/OC2 cells was stronger in 
some cells after transfection of the E2F1 expression plasmid since a higher amount of 
E2F1 protein was detected by the E2F1 antibody. In summary, the presence of E2F1 
mRNA and E2F1 protein was confirmed in UB/OC2 cells. Therefore, nuclear extracts 
from UB/OC2 are suitable to conduct EMSA experiments as they contain E2F1 and the 
regulatory machinery that is required for its activity and production. The comparison 
between non-transfected and E2F1 transfected cells demonstrates the successful 
exogenous expression of E2F1 in UB/OC2.  
 
 
 
 
 
Figure 5.5.  RT-PCR for E2F1.  RT-PCR of non-transfected UB/OC2 cells and cells transfected with the 
E2F1 expression construct generate a band of the same size (341 bp). A faint band is observed in the non-
transfected cells indicating that the presence of endogenous E2F1 is low. However, the band is much 
stronger when using cDNA from cells transfected with E2F1. Expression levels of GAPDH were used as 
a reference to verify that mRNA content did not vary under the different experimental conditions (in non-
transfected and transfected cells).   
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Figure 5.6.  Comparison between E2F1 transfected and non-transfected UB/OC2 cells.  Confocal 
images of UB/OC2 cells immunostained with E2F1 (in green) and DAPI (in blue). a) Untransfected 
UB/OC2 cells and b) transfected cells with an E2F1 expression construct. Immunostaining was conducted 
with a rabbit polyclonal E2F-1 antibody incubated overnight in a 1:400 dilution. Alexa Fluor 488® 
provided the fluorescent labelling for the E2F1 antibody (in green) and 4′,6-diamidino-2-phenylindole 
(DAPI- in blue), used to label nuclear DNA, were incubated in a 1:1000 dilution for 2h at room 
temperature. E2F1 protein expression was stronger in cells transfected with E2F1 and the nuclei of some 
cells are notably stronger possibly due to greater transfection efficiencies (red arrowheads). Images in a) 
and b) were taken using identical confocal microscopy settings. 
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5.3.2 Binding of E2F in EMSA experiments 
After confirming expression of E2F1 in UB/OC2 cells, EMSA experiments were 
conducted to investigate interactions between E2F and the chick Atoh1 enhancers and 
the putative enhancer C. 
Initial results of EMSA experiments to assess E2F binding were problematic and 
required a great degree of optimization. These included changes in the incubation 
temperature, nuclear extract protein concentration, optimization of salts in buffer 
solutions and EMSAs with E2F1 and DP1 in vitro using translated proteins (see 
appendix section for these experiments). For the optimization procedure and further 
EMSA experiments, double stranded oligonucleotides were designed. Table 5.1 shows 
the oligonucleotide sequences corresponding to E2F1 consensus and mutant sequences 
(Lees et al. 1993) as well as the “A2 probe”, an experimentally verified site located in 
the imprinted tumor suppressor gene promoter which has been shown to be bound by 
E2F1 (Lu et al. 2006). These oligonucleotides were used in competition EMSA assays.  
 
The first aim in the EMSA analysis was to demonstrate that known E2F binding sites 
and consensus probes were able to be bound by E2F in the assay conditions. 
Preliminary tests with DP1 (the co-factor for E2F) and E2F1 in vitro translated proteins 
incubated into the same binding reaction showed a small improvement in the E2F-DP1 
complex interacting with a consensus E2F binding site (see appendix section). 
Therefore, an EMSA experiment was conducted comparing nuclear extracts from non-
transfected UB/OC2 cells and nuclear extracts from UB/OC2 cells transfected with 
 
Table 5.1: Consensus oligonucleotides for EMSA experiments. E2F binding sites are underlined.  
 
Oligo name Primer Sequence (5' to 3') 
Predicted Binding 
site 
E2F1_Cons_Sense ATTTAAGTTTCGCGCCCTTTCTCAA Consensus E2F 
E2F1_Cons_Antisense TTGAGAAAGGGCGCGAAACTTAAAT Consensus E2F 
E2F1_MutCons_Sense ATTTAAGTTTATATCCCTTTCTCAA Mutant E2F 
E2F1_MutCons_Antisense TTGAGAAAGGGATATAAACTTAAAT Mutant E2F 
A2_Sense TTATTTTTGGCGGGGGGGAATCTATAG E2F1 (Z Lu et at) 
A2_Antisense CTATAGATTCCCCCCCGCCAAAAATAA E2F1 (Z Lu et at) 
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E2F1 and DP1 when incubated with a radiolabelled E2F probe (the A2-E2F1) alone or 
in competition with non-radiolabelled probes.   
In Figure 5.7, an EMSA assay is presented showing the comparison of the different 
protein-DNA complexes (referred to as bandshifts) produced by both non-transfected 
and transfected UB/OC2 nuclear extracts when incubated with a radiolabelled probe 
known for being bound by E2F (the A2-E2F1 probe). When incubating the A2-E2F1 
probe with non-transfected nuclear extracts, several different protein-DNA complexes 
were generated (bandshifts A, B, C and D in lane 2). In order to demonstrate which, if 
any, of these bandshifts corresponds to the E2F complex, a competition assay was 
performed where the nuclear extracts were incubated with a non-radiolabelled A2-E2F1 
probe for 1-2h before adding the radiolabelled A2-E2F1 probe. Since the extracts were 
incubated first with the cold probe, less E2F protein would be available to bind to the 
radiolabelled probe. This resulted in competition between both probes for E2F binding 
and consequently the disappearance of one the bandshifts (Figure 5.7 bandshift B, lane 
3). To confirm that the competed bandshift B is E2F-sequence dependent, rather than 
due to competition for a non-specific protein, a probe containing a mutated E2F1 
consensus probe was incubated with nuclear extracts before adding the radiolabelled 
A2-E2F1 probe. The mutated E2F1 consensus probe did not compete for the binding 
suggesting that bandshift B is sequence specific (Figure 5.7 bandshift B, lane 4). To 
further analyse the specificity of the E2F complex, a similar experiment was performed 
using a non-specific probe instead of the mutated E2F1 probe. This non-specific probe 
was designed using a distal sequence relative to the E2F binding site sequence. As 
expected, the non-specific probe caused the same effect as the mutated E2F1 consensus 
probe verifying that both probes do not compete for bandshift B (Figure 5.7 bandshift 
B, lane 5). A supershift was also performed to further confirm the presence of E2F 
protein in complex B. 1µg of E2F1 antibody was incubated for 1h before adding the 
radiolabelled probe. This resulted in an attenuation of the complex B suggesting that the 
addition of the antibody interfered with the binding between E2F protein and the 
radiolabelled probe (Figure 5.7, bandshift B, lane 6). Further supershift assays will be 
described in subsequent sections. 
Competition and supershift assays were also performed using nuclear extracts from 
UB/OC2 cells transfected with E2F1 and DP1 expression constructs (Figure 5.7 lanes 7-
12). Similar results were observed to the non-transfected extracts. The bandshift B 
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generated by the protein-DNA complex was competed when using the consensus A2-
E2F1 probe as a competitor (lane 9). As it was previously observed, the radiolabelled 
probe incubated with nuclear extracts cells transfected with E2F1 and DP1 did not 
compete for binding when incubated with the mutated E2F1 consensus probe (lane 10) 
or a non-specific probe (lane 11). Furthermore, bandshift B was more intense when 
using nuclear extracts from UB/OC2 cells transfected with E2F1 and DP1 in 
comparison to the bandshift B generated using non-transfected nuclear extracts. 
Conversely, the rest of the bandshifts (A, C and D) remained with the same intensity 
when using transfected and non-transfected nuclear extracts suggesting that these are 
not E2F dependent.  
 
In summary when taken together the competition assays with a known E2F probe (the 
A2-E2F1 probe), the supershift with the E2F1 antibody and the increased binding of the 
same shift when using transfected nuclear extracts, were consistent with bandshift B 
corresponding to E2F.  
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Figure 5.7. Comparison of the binding of a known E2F1 binding site incubated with nuclear 
protein extracts from non-transfected UB/OC2 cells or nuclear protein extracts from UB/OC2 
cells transfected with E2F1 and DP1. EMSA was performed using the A2 probe (referred to as A2-
E2F1), known for containing a functional E2F1 binding site, labelled with [γ-32P] ATP. The labelled 
A2-E2F1 probe was incubated with nuclear protein extracts from non-transfected UB/OC2 cells or 
nuclear protein extracts from UB/OC2 cells transfected with E2F1 and DP1, in the absence of 
competition (lanes 2 and 8) or in competition with an excess of 500ng of non-radiolabelled 
competitors (A2-E2F1 in lanes 3 and 9; mutant E2F1-lanes 4 and 10; non-specific probe (N/S)-lanes 5 
and 11). For supershift assays (lanes 6 and 12), 1µl of rabbit polyclonal anti-E2F1 (C-20) sc-193X 
(Santa Cruz Biotechnology, Inc) was added to the binding reaction 1h before the labelled A2-E2F1 
probe was added.   
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5.3.3 Characterization of binding affinities of the predicted E2F 
sites in the Atoh1 regulatory elements 
Having confirmed that a known E2F probe can be bound by the E2F protein in nuclear 
extracts from UB/OC2 cells, the investigation then focused on assessing which of the 
E2F binding sites predicted in the chick Atoh1 enhancers and putative enhancer C can 
also be bound by E2F. In order to test whether there is such interaction between E2F 
and the chick Atoh1 regulatory elements, oligonucleotides were designed containing the 
E2F binding sites located in the chick Atoh1 conserved regions predicted by 
bioinformatics analysis. These probes are represented in Table 5.2, referred to as probe 
1 to probe 9 based on the relative position within the chick Atoh1 enhancers and the 
putative enhancer C shown in Figure 5.8.  
 
 
Table 5.2. EMSA oligonucleotides containing the putative E2F sites in the Atoh1 regulatory regions. 
Each probe contains an E2F binding site predicted by the Genomatix analysis. The predicted E2F binding 
sites are underlined in each probe. Probes were referred to as probe 1-9 corresponding to the nine E2F 
sites predicted in the chick Atoh1 regulatory elements. 
 
 
Oligo name Primer Sequence (5' to 3') 
Predicted Binding 
site 
   
Probe 1_Sense  AGCCGCGAAGTGCGCGCTCTCCGCTTTGC E2F2 and E2F3 
Probe 1_Antisense GCAAAGCGGAGAGCGCGCACTTCGCGGCT E2F2 and E2F3 
Probe 2_Sense GCCTCAAAAAGCGATAAAAAATGGCACA E2F1&E2F4 
Probe 2_Antisense TGTGCCATTTTTTATCGCTTTTTGAGGC E2F1&E2F4 
Probe 3_Sense TCCCGGCCGCGGTGCGCCGTGTCTGGA E2F2 and E2F3 
Probe 3_Antisense TCCAGACACGGCGCACCGCGGCCGGGA E2F2 and E2F3 
Probe 4_Sense CTTTCAGGCGGCGCCCCGGGGAGCTGC E2F3 
Probe 4_Antisense GCAGCTCCCCGGGGCGCCGCCTGAAAG E2F3 
Probe 5_Sense TGTCCTCTCGCCCGCCCTGGTGCGCGCTCCCGC E2F1, E2F2 and E2F3 
Probe 5_Antisense GGAGCGCGCACCAGGGCGGGCGAGAGGACA E2F1, E2F2 and E2F3 
Probe 6_Sense TGCGCGCTCCCGCGCCCAACGCGGGACAGCGACGCGC E2F1 and E2F4 
Probe 6_Antsense GCGCGTCGCTGTCCCGCGTTGGGCGCGGGAGCGCGCA E2F1 and E2F4 
Probe 7_Sense GAGCGGTGCTGCCGCGCTTTATGGAGC E2F2 
Probe 7_Antisense GCTCCATAAAGCGCGGCAGCACCGCTC E2F2 
Probe 8_Sense ATTTCTTCCCCGGGAGAACGCGCCGG E2F1 
Probe 8_Antisense CCGGCGCGTTCTCCCGGGGAAGAAAT E2F1 
Probe 9_Sense GATTTTCCTCCCGAAAAACGCCGGGT E2F1 
Probe 9_Antisense ACCCGGCGTTTTTCGGGAGGAAAATC E2F1 
  
 
1
9
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Figure 5.8. Location of the predicted E2F binding sites in the chick Atoh1 enhancers and putative enhancer C. Summary of the relative position of the nine E2F binding 
sites predicted by MatInspector.  When two predicted binding sites were close to each other, we defined them as a single site (e.g. site 5 and site 6). The core of the binding 
site is represented in red capital letters. Two or more overlapping binding sites were marked in green/red (e.g. site 2).  
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As in the previous EMSA experiment, a known E2F probe (the A2-E2F1 probe) was 
radiolabelled and incubated with nuclear extracts from UB/OC2 transfected with E2F1 
and DP1 expression constructs. As shown in Figure 5.9, one protein-DNA complex 
(bandshift B in lane 3) was competed by the cold consensus E2F probe (the A2-E2F1 
probe). This bandshift was not competed by the mutated E2F1 probe or the non-specific 
probe (Figure 5.9, bandshift B, lane 4-5).  
To investigate whether the predicted E2F sites in the chick Atoh1 regulatory regions can 
compete with the known E2F probe (the A2-E2F1 probe) for binding E2F, the 
oligonucleotides (probes) containing the putative E2F sites in the chick Atoh1 were used 
in competition assays (probes 1-9 and lanes 7-15 from Figure 5.9). Competition was 
performed by adding an excess of x500 of the cold competitors to the nuclear extracts 
before the addition of the radiolabelled A2-E2F1 probe. As shown in Figure 5.9, two 
probes, probe 2 and especially probe 6, showed signs of competition for E2F binding in 
EMSA suggesting that these sites could be bound by E2F1 (Figure 5.9 bandshift B, 
comparing lane 3 with lanes 8 and 12).  
In contrast to probes 2 and 6, the rest of the probes predicted to be bound by E2F did 
not show any competition when incubated with the A2-E2F1 probe and therefore were 
not further analysed. To further investigate the specificity of probes 2 and 6 and to 
confirm that E2F can bind to these sites in the Atoh1 regulatory elements, additional 
competition assays and supershift assays were performed.   
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a)  
b)  
 
Figure 5.9. EMSA analysis of the predicted E2F sites in the chick Atoh1 conserved regions. a) Nine 
probes were designed (P1-P9) corresponding to the E2F binding sites predicted in the chick Atoh1 
conserved regions. b) EMSA was performed using the A2-E2F1 probe, known for containing a functional 
E2F1 binding site, labelled with [γ-32P] ATP. The labelled A2-E2F1 probe was incubated alone (lane 1) 
or with nuclear extracts transfected with E2F1 and DP1 (lanes 2-15). Competition assays were performed 
with an excess of 500ng of non-radiolabelled competitors (A2-E2F1-lane 3), mutant E2F1 (lanes 4), non-
specific (N/S) probe (lane 5). For supershift assays (lane 6), 1µl of rabbit polyclonal anti-E2F1 was added 
to the binding reaction 1h before the labelled A2-E2F1 probe was added. A competition assay was also 
performed using an excess of 500ng of non-radiolabelled E2F probes sequences predicted in the chick 
Atoh1 conserved regions (lanes 7-15) corresponding to sites 1 to 9 as described in a).   
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5.3.4 Further analysis of Atoh1 probes 2 and 6 as putative E2F 
binding   sites  
The preliminary results presented so far show that two of the E2F binding sites 
predicted by Genomatix, probe 2 and 6, have some capacity to compete for E2F 
proteins when incubated with a probe containing a known E2F binding site. To further 
investigate the specificity of probe 2 and 6, a competition gradient experiment was 
conducted where the radiolabelled probe 2 and 6 were incubated with increasing 
amounts of cold competitors.  
An EMSA assay with radiolabelled probe 2 and nuclear extracts from UB/OC2 cells 
transfected with E2F1 and DP1 is shown in Figure 5.10. Increasing amounts of cold 
probe 2 and cold A2-E2F1 were used as competitors for E2F protein. This resulted in 
faint attenuation of bandshift A when incubated with increasing amounts of cold probe 
2 (Figure 5.10b lanes 2-4). However, no competition was observed when the 
radiolabelled probe 2 was incubated with the cold A2-E2F1 probe (Figure 5.10b, lanes 
5-7). A mutated probe 2 (mut P2) was designed containing a mutation in the core 
sequence of the predicted E2F binding site of probe 2 (Table 5.3). The mutated P2 
probe was used in order to test whether competition was dependent on presence of the 
E2F binding site. However, mutated P2 probe still competes with the labelled P2 for 
E2F protein suggesting is not specific to E2F. 
The presence of E2F protein in the complex with probe 2 was also investigated in a 
supershift assay by the addition of an E2F1 antibody to the nuclear extracts before or 
after adding the labelled probe 2. As is shown in Figure 5.10c, lane 9, when the E2F1 
antibody was incubated before adding the labelled probe 2, the formation of a heavier 
“supershifted” complex was observed in shift A. This larger DNA probe-protein-
antibody complex was observed as a result of a slower migration on the gel after the 
addition of the E2F1 antibody to the DNA probe-protein complex. When using a non-
specific antibody against E2F1, no supershift was formed (Figure 5.10c, lane 10). The 
supershift assay was also performed by adding the antibody after the radiolabelled probe 
2. When the E2F1 antibody was added after the labelled probe 2, a supershift was also 
observed although fainter than when adding the antibody before the radiolabelled probe 
2 (Figure 5.10c, lane 11). When adding a non-specific antibody after the radiolabelled 
probe 2, a supershift was not observed (Figure 5.10, lane 12).   
The supershift results suggest that shift A includes an E2F transcription factor.  
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Table 5.3. Oligonucleotides used for EMSA experiments containing point mutations in Probe 2 
and Probe 6. Mutations were introduced into the core of the predicted E2F binding sites. In site 6, two 
E2F binding sites were predicted therefore the binding sites were mutated alternatively (Probe6mut_a 
and Probe6mut_b). The core of the binding site is underlined and the mutations are in bold.   
 
 
 
Oligo name Primer Sequence (5' to 3') 
Predicted 
Binding site 
Probe 2mut_Sense  GCCTCAAAAATTGATAAAAAATGGCACA E2F1 and E2F4 
Probe 2mut_Antisense TGTGCCATTTTTTATCAATTTTTGAGGC E2F1 and E2F4 
Probe 6mut_a_Sense TGCGCGCTCCCGTTCCCAACGCGGGACAGCGACGCGC E2F1 and E2F4 
Probe 6mut_a_Antisense GCGCGTCGCTGTCCCGCGTTGGGAACGGGAGCGCGCA E2F1 and E2F4 
Probe 6mut_b_Sense TGCGCGCTCCCGCGCCCAACTTGGGACAGCGACGCGC E2F1 and E2F4 
Probe 6mut_b_Antisense GCGCGTCGCTGTCCCAAGTTGGGCGCGGGAGCGCGCA E2F1 and E2F4 
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Figure 5.10. Competition assay to test specificity of Probe 2. a) Schematic representation of the 
location of the predicted E2F binding site, named site 2, in the chick Atoh1 3’ sequence. Site 2 was 
predicted between the chick Atoh1 enhancer A and B. An oligonucleotide probe (Probe 2) was designed 
containing the sequence of the predicted E2F binding site 2 for EMSA experiments. b) The radiolabelled 
Probe 2 was incubated with nuclear extracts from UB/OC2 transfected with E2F1 and DP1 in competition 
with cold P2 (lanes 2-4), cold known E2F1 (A2-E2F1 probe) (lanes5-7) or a cold mutant for Probe 2 (mut 
P2) (lane 8). c) Enlarged image of the supershift represented in b). Supershift was conducted with a rabbit 
polyclonal anti-E2F1 (C-20) sc-193X (lanes 9 and 11) and rabbit polyclonal anti-SP1 antibody H-225X 
(lanes 10 and 12) used as a non-specific control added before or after the addition of the labelled Probe 2.  
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Probe 6 contains two putative E2F binding sites in the putative chick enhancer C 
located downstream of the Atoh1 enhancers (see Figure 5.8) and was also analysed in 
EMSA experiments. A gradient competition assay was performed using increasing 
amounts of cold probe 6 and cold A2-E2F1 probe as competitors. Both probes 
competed for binding with the labelled P6 probe and caused a slight attenuation of 
bandshift B (Figure 5.11, lanes 2-7). To further investigate whether E2F binding is 
specific to the presence of the E2F site within probe 6, a mutated probe 6 was designed. 
Since probe 6 contains two putative E2F binding sites (Figure 5.8), two different 
mutated probes were designed containing independent mutations in the E2F binding 
sites located in probe 6 (referred to as mutant probe 6_a and mutant Probe 6_b in Table 
5.3). These two mutated probes were used in the competition assay (lane 8 and 9 in 
Figure 5.11).  As shown in Figure 5.11 lane 9, when the cold mutant corresponding to 
probe 6_mut_b was used as a competitor, the attenuated bandshift B was slightly 
restored suggesting that E2F binding is specific to site b in probe 6. In contrast, the 
probe containing a mutation in the first E2F site in probe 6 (probe6_mut_a) still 
competes with probe 6 for bandshift B suggesting that E2F binding is not specific to site 
a in probe 6.  
In addition, a supershift was conducted in order to confirm the presence of E2F protein 
in the E2F-probe 6 binding complex (Figure 5.11). In the presence of an E2F1 antibody, 
added before or after the radiolabelled probe 6 (lane 10 and 12), a shifted complex was 
observed (SS on Figure 5.11) confirming that E2F is a component of the binding 
complex.   
 
 
 
 
 
     Chapter 5: Investigation of the E2F transcription factor family as a putative candidate regulator of Atoh1 
197 
 
 
  
   
Figure 5.11.  Competition assay to test specificity of Probe 6. a) Schematic representation of the 
location of the predicted E2F binding site (site 6) in the chick putative enhancer C.  An oligonucleotide 
probe (probe 6) was designed containing the sequence of the predicted E2F binding site 6 for EMSA 
experiments. b) The radiolabelled probe 6 was incubated with nuclear extracts from UB/OC2 cells 
transfected with E2F1 and DP1 in competition with cold P6 (lanes 2-4), cold known E2F1 (A2-E2F1 
probe) (lanes 5-7) or with a cold mutant for probe 6 (mutP6a or mutP6b) (lanes 8 and 9). c) Enlarged 
image of the supershift represented in b). Supershift was conducted with a rabbit polyclonal anti-E2F1 
(C-20) sc-193X (lanes 10 and 12) and rabbit polyclonal anti-SP1 antibody H-225X (lanes 11 and 13) used 
as a non-specific control added before or after the addition of the labelled probe 6. 
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The evidence provided by the EMSA experiments suggests that two of the nine E2F 
binding sites predicted by the Genomatix analysis have the capacity to be bound by 
E2F. Combining the results obtained so far, it can be hypothesized that these two 
binding sites may be responsible for the upregulation observed in the luciferase assays. 
It is notable that the location of these binding sites correlates with the responses 
obtained by the different chick Atoh1 conserved regulatory regions when co-transfected 
with E2F1. For example, the chick Atoh1 enhancer AB was upregulated when co-
transfected with E2F1 and one of the specific binding sites defined by the EMSA 
experiments, site 2, is located between these two enhancers, a sequence that is present in 
the chick Atoh1 enhancer AB luciferase construct. Similarly, a response was obtained 
with the putative enhancer C when co-transfected with E2F1 and site 6 located in this 
region, was found to be bound by E2F1 in EMSA experiments.   
 
To finally confirm whether E2F upregulates the chick Atoh1 enhancer AB and putative 
enhancer C via these two sites, point mutations were introduced into the two specific 
E2F binding sites in the luciferase constructs (site 2 and site 6 represented on Figure 
5.8).  
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5.4 Site Directed Mutagenesis of sites 2 and 6 
within the avian Atoh1 conserved regions 
EMSA experiments suggested that two of the putative E2F binding sites (site 2 and site 
6) were the most likely sites to be bound by E2F. Having predicted and tested these two 
sites, the investigation was focused on verifying whether site 2 and site 6 were 
functional binding sites by creating point mutations in their sequences in the Atoh1 
luciferase constructs.  
5.4.1 Design of mutagenesis sites  
In order to identify which nucleotides need to be mutated, the sequence of site 2 and site 
6 was compared against the consensus E2F1 binding site (Tao et al. 1997) (Figure 5.12a 
and b). In addition, a cross species alignment was performed to identify which 
nucleotides are evolutionary conserved in site 2 and site 6 and therefore more likely to 
be necessary for binding and regulation of E2F (Figure 5.12b).  
A reduction of the E2F binding activity when some base pairs of the E2F binding site 
are mutated has already been demonstrated in previous studies (Lu et al. 2006). Based 
on this analysis, it was found that the GCGC sequence within the core of the E2F 
binding site is the most effective site in abolishing E2F binding in EMSA experiments. 
Moreover, the GCGC sequence is well conserved across different avian and mammalian 
species (Figure 5.12b) and it is contained within the consensus E2F1 (Figure 5.12a). 
Thus, two point mutations were incorporated in the GCGC sequence of site 2 and site 6 
by site-directed mutagenesis (Figure 5.12c).    
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Figure 5.12. Comparison between the consensus E2F1 binding site and the predicted site 2 and site 
6. a) Consensus E2F1 binding site given by MatInspector, Genomatix. The core of the binding site is 
defined as the most critical part of the sequence for E2F binding. b) Cross species alignment of site 2 and 
site 6 in the Atoh1 regulatory regions. Alignments were conducted against different avian and mammalian 
species in order to find out which nucleotides are more likely to be required for the binding of E2F. 
Conserved nucleotides within the core sequence of site 2 and site 6 were marked in red. c) Mutations 
(marked in blue and with asterisk) incorporated in the core of the predicted E2F binding site (core shown 
in red and blue) of site 2 and site 6.   
 
Conservation profile of Site 2
Chick            tgtgccatttTTTATCGCTTttt
Zebra finch      cgtggggtttTATCATCCTAaac
Human            agacaagtttaAACACGATTtct
Mouse            aggcaagttt-AACACGTTCttc
Site 2
Chick           GCGCCCAACGCGGgacagcgac
Zebra finch     GCCGCCGGGGTGCccggagaga
Site 6
Core of the 
Binding site
Conservation profile of Site 6
Core of the 
Binding site
Consensus E2F1 binding site
b)
a)
c)
Mut Site 2          tgtgccatttTTTATCTTTTttt
Mut Site 6          GCGCCCAACTTGGgacagcgac
* *
* *
Picture removed for copyright purposes 
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5.4.2 Site-directed mutagenesis of sites 2 and 6  
The in vitro site-directed mutagenesis kit from Stratagene (QuikChange II Site-Directed 
Mutagenesis) was used to introduce modifications into the Atoh1 luciferase constructs 
containing the chick Atoh1 conserved elements (see section 2.2.10). The technique 
requires the design of primers containing the desired mutation in the E2F binding sites 
in site 2 and site 6 (primers 16-19 in Table 2.1). Mutagenic primers were designed using 
Stratagene’s  web-based QuikChange® Primer Design  Program available  online  at 
http://www.stratagene.com/qcprimerdesign.  
 
The mutations in E2F predicted binding sites 2 and 6 were introduced in the GCGC 
region of the E2F binding site, as is the most likely region to abolish E2F binding based 
on previous experiments. Only two nucleotide changes were introduced in each site 
since the site-directed mutagenesis technique has some limitations and the success of 
the protocols is, in part, defined by the number of base pairs to be mutated 
(Novoradovsky et al. 2005). Mutations were introduced in the construct containing all 
three Atoh1 conserved elements found in chick (construct referred to as Chick ABC 
containing the chick conserved regions upstream of the luciferase). This is because this 
construct contains both E2F site 2 and the E2F binding site corresponding to site 6 so 
the effect of mutating each of these could be assessed in the same construct. Following 
the manufacturer’s protocol with the thermal conditions described in section 2.2.10, 
mutations were successfully integrated in both sites. The Chick ABC construct 
containing the mutations in the E2F binding sites in probe 2 and 6 was sequenced in 
order to verify that mutations were incorporated in the desired location. The primers 
used for the sequencing (primers 23 and 24 in Table 2.1) and chromatograms 
confirming the introduction of the point mutations are presented in Figure 5.13.  
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Figure 5.13.  Verification of the nucleotide substitutions by Site-directed mutagenesis. Sequencing 
chromatograms showing that the two point mutations were successfully introduced in site 2 and site 6 
(marked with an asterisk).  
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5.5 Response of the Atoh1 conserved regions to 
E2F1 when putative E2F sites are mutated 
As previously shown, the chick Atoh1 enhancers and putative enhancer C were 
upregulated when co-transfected with E2F1 (Figure 5.3). Since mutations were 
successfully introduced in two putative E2F binding sites in the chick ABC luciferase 
construct, I aimed to assess whether these mutations were sufficient to reduce the 
upregulation observed in the wild type luciferase construct containing the chick Atoh1 
conserved regions by E2F1.  
In section 5.2, a large upregulation of 27, 61 and 145-fold difference was observed 
when the luciferase construct containing the chick Atoh1 conserved regions was co-
transfected with increasing amounts of E2F1 (from 400ng to 1200ng respectively). To 
examine the effect of the mutations on each putative binding site, the mutated 
constructs, denoted Chick ABC_ p2mut and Chick ABC_p6mut, were co-transfected 
with increasing amounts of E2F1 in UB/OC2 cells. The ability of the mutated constructs 
to respond to E2F1 was quantified and compared against the response obtained with the 
wild type construct (denoted as Chick ABC_wt).  
As shown in Figure 5.14, the wild type construct (Chick ABC_wt) generated a large 
response when co-transfected with E2F1 (Figure 5.14b). This response was similar to 
the one previously observed and described in section 5.2. However, the large response 
observed in the wild type luciferase construct was attenuated when using the constructs 
containing the E2F binding site mutations. The mutation of the putative E2F site 2 for 
instance, reduced the upregulatory effect of E2F1 by 37%. This reduction was observed 
only when 1200ng of E2F1 was transfected in comparison to the response given by the 
wild type construct (p<0.05 in Figure 5.14b). By contrast, the Chick ABC_p6mut 
showed a 77% decrease when 1200ng of E2F1 was co-transfected. The mutation in site 
6 within the putative enhancer C also attenuated the effect by 40% and 68% 
downregulation when 400 and 800ng of E2F1 were co-transfected respectively (Figure 
5.14b). This reduction in the response of the construct containing the mutation in site 6 
(chick ABC_p6mut) was statistically significant in comparison to the response given by 
the wild type construct (p<0.001 in Figure 5.14b).  
Based on these results, a direct interaction between the E2F1 transcription factor and 
site 2 and site 6 in the Atoh1 regulatory regions can be suggested. 
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Figure 5.14. Response of the Atoh1 regulatory regions to E2F1 when the putative E2F sites are 
mutated. a) Diagram representing two of the putative E2F sites: site 2 which contains two overlapped 
putative binding sites for E2F1 or/and E2F4 (in green and red respectively) and site 6 which also contains 
a putative binding site for E2F1 and/or E2F4 (in red). Point mutations were introduced in these sites 
(positions marked with asterisks). b) Luciferase assays show a reduced response of the Chick_ABCp2mut 
(*p<0.05) and the Chick_ABCp6mut (***p<0.001) when E2F1 is co-transfected in comparison with the 
wild type luciferase construct. The experiment was conducted in triplicate in two separate assays with 
different DNA preparations. Student t-test was conducted.  
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5.6 Transcriptional regulation of the Atoh1 
conserved regions by other E2F transcription 
factors 
In addition to the study of E2F1, other members of the E2F family were also analysed in 
luciferase assays to assess their putative regulatory roles on the Atoh1 conserved 
elements. Based on the similarity of the binding site sequence of the different E2F 
members and their similar functions (see section 5.1.2), it may be possible that they also 
play roles in the regulation of Atoh1. 
To assess this possibility, luciferase plasmids containing the mouse and chick Atoh1 
regulatory elements cloned upstream of the firefly luciferase reporter gene (section 
2.2.9.3) were co-transfected in UB/OC2 cells with 1200ng of E2F2, E2F3 and E2F4 
expression constructs in separate assays. Expression constructs for E2F2, E2F3 and 
E2F4 have been previously described and therefore were obtained from other 
laboratories to perform these experiments. The E2F2 is a pCMV-Neo-Bam construct 
(Wu et al. 1995), the E2F3 is a pcDNA3 construct (Lui and Baron 2013) and the E2F4 
is a pcDNA3 construct (Beijersbergen et al. 1994). The ability of the E2Fs to activate 
the Atoh1 luciferase constructs was compared against the response with the empty 
pcDNA3 expression construct (Figure 2.5).   
As shown in Figure 5.15a, E2F2 activated the mouse Atoh1 AB enhancer 2-fold. The 
response obtained, was almost identical to the response obtained in the empty luciferase 
construct, suggesting that although the response was statistically significant, it could be 
artefactual and not due to the mouse Atoh1 enhancer. However, E2F2 has the capacity 
to activate the chick Atoh1 AB enhancer as well as the putative enhancer C with a 15.3-
fold and 17.8-fold activation respectively. Moreover, the response given by the 
construct containing the three Atoh1 conserved regions, the Chick ABC luciferase 
construct, showed a greater response, giving a 66.3-fold upregulation. The ability of 
E2F2 to activate the luciferase construct containing the mutation in the putative E2F site 
6 was also tested. The mutant ChickABC_p6 (ChickABC_p6mut) showed a significant 
decrease in its response when co-transfected with E2F2 showing a 34.4-fold difference 
in comparison to the 66.3-fold upregulation shown in the wild type ChickABC construct 
(Figure 5.15a). These results support the hypothesis that the E2F binding site 6 located 
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in the putative enhancer C can also be directly be bound by E2F2 as these luciferase 
experiments demonstrate.  
The response obtained when E2F3 was co-transfected with the Atoh1 luciferase 
constructs was also tested (Figure 5.15b). The E2f3 locus encodes two gene products, 
E2F3a and E2F3b, which are transcribed through two different promoters (Adams et al. 
2000). Only the effect of the E2F3a product was tested. The effect of E2F3 on the 
mouse and chick Atoh1 enhancers was very similar to the one obtained with E2F2. The 
mouse Atoh1 enhancer showed a response of 3-fold difference in comparison to the 
response in the absence of exogenous E2F3. However, E2F3 had a higher capacity to 
activate the chick Atoh1 enhancer AB and putative enhancer C showing a response of 
14.2-fold and 22.3-fold difference in comparison with the response obtained with the 
basal empty pcDNA3. When the chick Atoh1 AB enhancer and putative enhancer C 
were present in the same construct, the Chick ABC luciferase construct, the response 
observed when co-transfected with E2F3 was a 51.8-fold activation. The ability of E2F3 
to activate the mutant ABC_p6 construct was also tested which showed a 30-fold 
activation. This response was close to reaching statistical significance (p=0.098) when 
compared to the response obtained by the wild type construct.  
Finally, the response of the Atoh1 luciferase constructs was also tested with E2F4 
(Figure 5.15c). As described in section 5.1.2, E2F4 has been defined as a repressor 
(Ginsberg et al. 1994). E2F4 did not cause a statistically significant effect on the mouse 
and chick Atoh1 enhancer AB (Figure 5.15c). However, a repressive effect was 
observed in the putative enhancer C by E2F4. This downregulation was also observed in 
the empty luciferase construct however, the level of repression was greater in the 
putative enhancer C by the effect of E2F4. The downregulation was not observed in the 
Chick ABC luciferase construct however, it is observed when site 6 located in the 
putative enhancer C is mutated.  
Altogether, the luciferase results suggested that E2F2 and E2F3 have the potential to 
activate the chick Atoh1 enhancers and chick putative enhancer C but not the mouse 
Atoh1 enhancer. Although this activation is lower than the response observed by E2F1 
(145-fold), it seems that based on the homology of the binding site sequence of these 
three E2F members and their activation functions, E2F1, E2F2 and E2F3 have the 
potential to upregulate Atoh1 transcription in chick. Moreover, it was observed that the 
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transcriptional response is enhanced when the putative enhancer C is combined with the 
chick Atoh1 AB enhancers. By contrast, E2F4 causes the downregulation of the putative 
enhancer C and this downregulation may be partially dependent on the E2F site 6. 
 
Figure 5.15. Effect of E2F2, E2F3 and E2F4 on the Atoh1 conserved regions. UB/OC2 cells were 
transfected with 1200ng of E2F2 (a), E2F3a (b) and E2F4 (c) expression constructs. 10ng of the pRL-null 
luciferase construct (Promega) were co-transfected and 1200ng of the empty pcDNA3 expression 
construct was also used to compare with E2F. a) A significant response was observed when the Chick 
Atoh1 luciferase constructs were co-transfected with E2F2 in comparison to the response obtained with 
the empty pcDNA3 construct. b) A significant response was also observed when the Chick Atoh1 
luciferase constructs were co-transfected with E2F3 in comparison to the response obtained with the 
empty pcDNA3 construct. c) No significant response was obtained with E2F4. Experiments were 
conducted in triplicate in two separate assays with different DNA preparations for each plasmid in each 
assay (n=6). The luciferase activity of each reporter is normalized to its response in the absent of 
stimulation (set at 100). Student t-test was conducted. The mean value and standard error of the mean 
from 6 experiments are presented **p < 0.01 or *p<0.05. 
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5.7 Characterization of E2F1 expression in the 
mammalian and avian developing inner ear 
epithelium   
The results presented so far, suggest that E2F1, as well as E2F2 and E2F3, are strong 
candidates for regulating Atoh1 expression in the avian inner ear. Based on this 
hypothesis, the investigation focused on characterizing the expression of E2F1, the 
primary member of the E2F family, to assess potential correlations between E2F1 and 
ATOH1 expression. 
All E2F transcription factors are expressed during embryonic development of the 
murine central nervous system (Dagnino et al. 1997; Kusek et al. 2001; Li et al. 2008). 
The expression of E2F1, E2F2 and E2F5, as assessed by in situ hybridization, is 
enriched in neural proliferating progenitors such as the neuroblastic layer of the retina, 
neuroepithelium and spinal cord (Dagnino et al. 1997). On the other hand, expression of 
E2F3 and E2F4 was found in proliferating as well as non-proliferating regions (Dagnino 
et al. 1997; Ruzhynsky et al. 2007).  
 
The Єmage database (http://www.emouseatlas.org/emage) and the Allen Brain Atlas 
(http://www.brain-map.org) also provide evidence of E2F1 expression in embryonic and 
adult mouse tissues by in situ hybridization. These databases indicate that E2F1 mRNA 
is expressed in the hindbrain, spinal cord and in the developing limbs of mouse 
embryonic tissue whereas in the adult mouse, E2F1 was observed in different parts of 
the nervous system including the isocortex, hippocampus and cerebellum. In chick, the 
GEISHA database (Gallus Expression In Situ Hybridization Analysis 
(http://geisha.arizona.edu/geisha) and the echick atlas (http://www.echickatlas.org) 
provide some expression data for the E2F family. According to these databases,     
E2F1-8 mRNA is expressed in the hindbrain of embryonic chick stage 21, 24 and 27 
(embryonic day 3.5, 4 and 5). In addition E2F1 mRNA appears to be expressed in the 
inner ear at E3.5 and E4.  
Apart from the minimal data shown in the above websites, no reports in the inner ear 
describing expression of E2F1 in avian species and in mammals were found. E2F1 has 
been described only in adult mouse where it was suggested that it is expressed in the 
stria vascularis and spiral ganglion (Raimundo et al. 2012).  Therefore, E2F1 expression 
was assessed in the mammalian and avian inner ear during development.  
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5.7.1 E2F1 expression in the developing chick inner ear 
epithelium 
As described in section 5.3.1, E2F1 was found to be expressed in UB/OC2 cells, a 
conditional immortalized cell line derived from E13 primary cultures of the developing 
mouse organ of Corti. This expression was described using a rabbit polyclonal anti 
E2F1-1 (C-20) from Santa Cruz which was also used to assess E2F1 expression in chick 
and mouse inner ear tissue. 
E2F1 expression was tested in the chick inner ear at E7 and E10. At E7, vestibular hair 
cells are already formed whereas cochlear hair cells in the basilar papilla are formed at 
around E10 (Goodyear and Richardson 1997). Therefore, cryosections were prepared 
from E7 and E10 chick specimens (see section 2.2.12) for immunofluorescence with the 
E2F1 antibody described above and anti-Myosin7a which was used as a hair cell 
marker. Figure 5.16a shows E2F1 expression in an E7 developing crista. The Myosin7a 
antibody strongly labelled the hair cells in the crista whereas E2F1 expression was 
relatively ubiquitous in the epithelium.  
To test E2F1 expression in hair cells at a more advanced stage in development, 
expression of E2F1 was assessed at E10 (Figure 5.17a). At E10 vestibular hair cells in 
the crista labelled with E2F1 antibody showed that E2F1 expression still remains 
relatively weak and uniform throughout the developing crista epithelium. To test the 
specificity of the E2F1 antibody in chick tissues, controls were performed without the 
E2F1 antibody (primary antibody) and only with the Alexa Fluor® 488-conjugated anti-
rabbit IgG (secondary antibody). The controls examined at embryonic day 7 and 10 (E7 
and E10) showed a similar staining pattering in the crista as the samples labelled with 
the E2F1 antibody (Figure 5.16b and Figure 5.17b). Therefore, it is possible that the 
E2F1 antibody is not recognizing the chick E2F1 and the stain observed represents non-
specific secondary antibody staining.  
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Figure 5.16. Immunolabeling of E2F1 in E7 chick crista. Transverse sections of chick embryonic 
tissue through the hindbrain and inner ear. a) E7 chick specimens were immunolabeled with a rabbit 
polyclonal anti E2F1-1 (1:400) and Myosin7a (1:250) which was used as a hair cell marker (in pink in the 
merged image). Alexa Fluor 488
®
-conjugated anti-rabbit IgG (secondary antibody) provided the 
fluorescent labelling for the E2F1 antibody (in green) and 4′,6-diamidino-2-phenylindole (DAPI- in blue), 
was used to label nuclear DNA (1:1000). The confocal images show an E7 crista (enlarged image is 
shown in the second row; magnification 63X) with vestibular hair cells labelled with Myosin7a. E2F1 
labelling is weak and does not appear to be specific to hair cells (n= 4). b) Controls for the 
immunolabeling of E2F1. Confocal images of cross sections of E7 crista shows immunohistochemistry 
with DAPI (1:1000), Alexa 488 (1:1000) without E2F1 antibody and the hair cell marker Myosin7a 
(1:250). In the absence of E2F1 antibody (primary antibody), the Alexa Fluor 488®-conjugated anti-
rabbit IgG (secondary antibody) provided a similar labelling as the experiment where the primary E2F1 
antibody was used (n=3). Magnification 20X. 
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Figure 5.17. Immunolabeling of E2F1 in E10 chick crista.  Cross sections of E10 immunolabeled with 
an anti E2F1-1 antibody (1:400) and Myosin7a (1:250) which was used as a hair cell marker (in pink in 
the merged image). Alexa Fluor 488®-conjugated anti-rabbit IgG provided the fluorescent labelling for 
the E2F1 antibody (in green) and 4′,6-diamidino-2-phenylindole (DAPI- in blue) was used to label 
nuclear DNA (1:1000). The confocal images show an E10 crista (enlarged image is shown in the second 
row; magnification 63X) with vestibular hair cells labelled with Myosin7a. At this stage (E10) the 
number of hair cells is higher in comparison to the previous stage (E7). However, E2F1 labelling remains 
weak and does not appear to be specific to hair cells (n=4). b) Control specimens at E10 in the absence of 
the anti E2F1 antibody (no primary control) show a similar labelling of the Alexa Fluor 488®-conjugated 
anti-rabbit IgG in comparison to the previous experiment at the same stage (n=3). Magnification 20X. 
 
 
 
DAPI Myosin7aE2F1
DAPI Myosin7aE2F1
a)
DAPI No primary control Myosin7a
b)
Merge
Merge
Merge
     Chapter 5: Investigation of the E2F transcription factor family as a putative candidate regulator of Atoh1 
 
213 
 
Based on the control data (no primary antibody for E2F1) and the homology between 
the human and chick c-terminus amino acid sequence recognized by the E2F1 antibody 
(64%), it is possible that the human E2F1 antibody does not recognize chick E2F1. 
Additional tests (n=30) in chick retina and inner ear and subsequent controls were 
conducted to test the species specificity of the E2F1 antibody in chick tissues. Retinal 
tissue was chosen as a good positive control tissue since E2F1 is strongly expressed up 
to E10 in chick, as previously confirmed by in situ hybridization (Pasteau et al. 1995). 
Different fixation methods (MetOH and 4% PFA) and fixation times (5, 15, 30min, 
60min) were tested at different stages (E3, E5, E7, E10 and E16). However, no above 
background staining of E2F1 was observed in comparison with controls treated with 
Alexa Fluor® 488 secondary alone throughout the retinal development. Therefore, as an 
alternative method, E2F1 expression in chick was assessed by in situ hybridization 
(ISH). A chick E2F1 cDNA clone was obtained (Dr. Mathew Towers, University of 
Sheffield, UK) and used to generate an RNA probe labelled with digoxigenin (described 
in section 2.2.15.2). The same chick E2F1 cDNA clone has been successfully used to 
describe the expression of E2F1 during chick wing development (Towers et al. 2009) 
and therefore this procedure was used to examine E2F1 expression in the chick inner 
ear. 
The chick E2F1 RNA probe was first tested in the retina which was used as a positive 
control for E2F1 expression and confirmed that the signal given by the RNA probe was 
greater than the one achieved by the E2F1 immunolabeling (Figure 5.18). It also 
showed that the E2F1 mRNA probe labelled specifically the inner nuclear layer of the 
retina in comparison to other layers such as the ganglion where E2F1 is not expressed. 
In addition, negative controls with the use of a sense E2F1 probe demonstrated that the 
expression pattern given by the antisense E2F1 probe is sequence specific (Figure 5.18). 
These results were similar to those of Pasteau et al. 1995 in chick retinal tissue with the 
use of a chick E2F1 mRNA probe. Therefore the E2F1 mRNA probe was chosen as a 
suitable approach to investigate E2F1 expression in chick tissues by ISH.  
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E2F1 expression was investigated at different stages of chick inner ear development. At 
embryonic day (E) 3, E2F1 appears to be expressed in the otic vesicle (Figure 5.19 A 
and A’). At E7, hair cells have already emerged in the vestibular sensory patches and 
E2F1 transcripts were detected in the vestibular sensory system (Figure 5.19 B and B’). 
Moreover, the location of E2F1 transcripts was restricted to presumptive hair cells. 
Specimens were also analysed at E10. At this stage the sensory patches are well 
developed and contain a large number of more mature hair cells. At E10, E2F1 
expression was observed in the sensory patches of the vestibular system and also in the 
basilar papilla (Figure 5.19 C). In addition, E2F1 transcripts appear to be restricted to 
the hair cell layer (Figure 5.19 C’; C’’; C’’’, C’’’).  Although further tests are required 
 
 
Figure 5.18. E2F1 expression in chick retina assessed by in situ hybridization and by 
immunolabeling. a) Comparison of E2F1 expression by ISH and immunolabeling in the E7 chick retina. 
The ISH technique showed a greater E2F1 signal in comparison to immunohistochemistry results.  The 
antisense E2F1 mRNA probe labelled specifically at high levels the inner nuclear layer (INL) of the retina 
in comparison to other layers such as the ganglion cell layer (GCL) or the outer nuclear layer (ONL) 
where E2F1 is not expressed. The sense E2F1 probe did not show specific binding in any of these layers 
under the same experimental conditions. The lower thin layer corresponds to non-specific staining of the 
retinal pigmented epithelium (RPE) which was observed both with the sense or antisense probes. b) 
Example of E2F1 immunolabeling at E10 in the chick retina. Immunolabeling in retinal sections at 
different stages (E3, E5, E7, E10, E16) were tested giving similar expression results (data not shown). 
Different fixation methods (4% PFA or MetOH) and timings (15min, 30min, 60min) were also tested. 
Controls with no primary for E2F1 gave similar results to samples labelled with E2F1 antibody for all 
stages and fixation methods tested (n=2 for each stage and treatment).      
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to assess whether E2F1 is restricted to hair cells and whether its expression is associated 
with proliferative regions in the developing epithelium, this is the first report of E2F1 
expression in the avian inner ear. 
 
 
 
 
 
 
 
Figure 5.19. E2F1 expression in the chick inner ear by in situ hybridization (ISH). A and A’) E2F1 
mRNA showed faint levels of expression at E3 in the otic vesicle. B and B’) Transverse cryosections 
through the E7 cristae reveals E2F1 transcripts in the hair cell layer. C) Whole mount of an E10 chick 
inner ear showed that E2F1 transcripts are still expressed in the vestibular system and in the basilar 
papilla. C’ and C’’) Whole mount and transverse cryosections through an E10 crista revealed E2F1 
transcripts in the hair cell layer. C’’’ and C’’’’) Whole mount and transverse cryosections through the 
E10 basilar papilla showed E2F1 transcripts in the hair cell layer. Abbreviations: crista (cr); utricle (ut); 
basilar papilla (bp); hair cell layer (HC); supporting cell layer (SC).  
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5.7.2 E2F1 expression in the developing mouse inner ear 
epithelium 
Based on the luciferase assay experiments presented in previous sections, E2F1 was not 
able to activate the mouse Atoh1 enhancer construct. However, a recent publication 
showed that E2F1 is expressed in the stria vascularis and spiral ganglion of 1 year old 
mouse and its expression was suggested to be upregulated in response to mitochondrial 
malfunctions (Raimundo et al. 2012). Whether E2F1 is expressed in the organ of Corti 
remains unexplored. Since very few expression studies have been conducted in the inner 
ear, E2F1 expression was also tested in mouse at early post-embryonic stages, P0, P4 
and P8, and expression was followed up to P21 in order to examine whether E2F1 
expression changes as hair cells mature.  
 
Ex-vivo cochlear explants of P0 mouse were prepared (see section 2.2.11.1) and 
immunofluorescence was carried out with the anti-E2F1 and Myosin7a antibodies. At 
early post-natal stages such as P0, ATOH1 expression is still present (Lanford et al. 
2000; Matei et al. 2005; Scheffer et al. 2007) therefore it represents a good stage to 
investigate potential correlations between the expression of the E2F1 and ATOH1 
transcription factors. Figure 5.20a presents P0 cochleae explants immunostained with 
E2F1 and Myosin7a. Strong E2F1 expression was found in the three rows of outer hair 
cells and also in the single row of inner hair cells labelled with the hair cell marker 
Myosin7a. These results could suggest that expression of both transcription factors, 
ATOH1 and E2F1, overlaps in the cochlear epithelium. Control explants were also 
tested in the absence of the anti-E2F1 antibody (primary antibody) maintaining the 
same microscopy settings (Figure 5.20b). These controls were labelled with Myosin7a 
and the Alexa Fluor
®
 488-conjugated anti-rabbit IgG alone (secondary antibody). As 
shown in Figure 5.20b, a faint background expression is present, visualized by the 
green-fluorescent from the Alexa Fluor
®
 488-conjugated anti-rabbit IgG (secondary 
antibody). However, the E2F1 expression observed in the presence of the primary 
antibody was above the background levels produced by the secondary antibody. 
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1
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Figure 5.20. Expression of E2F1 in P0 cochlear explants. Cochleae were isolated from post-natal day 0 (P0) from C57BL/6 mice. Immunolabeling was performed with 
anti E2F1 (1:400) antibody and Myosin7a (1:250) which was used as a hair cell marker. The confocal pictures represent Z-stack images of a) E2F1 expression (in green) in 
outer hair cells (OHC) and inner hair cells (IHC) labelled with Myosin7a (in red) and DAPI (in blue) (n=3). b) Control experiments carried out in the absence of anti-E2F1 
antibody (primary antibody) but keeping the same microscopy settings as in a). In these explants, Myosin7a was only used with the corresponding secondary antibodies: 
Alexa Fluor® 488, Alexa Fluor® 568 and DAPI 405. The confocal image shows that the Alexa Fluor® 488-conjugated anti-rabbit IgG alone (secondary antibody) gave some 
background labelling in outer hair cells (OHC) labelled with Myosin7a using the same confocal setting as with the E2F1 immunostaining (n=3).  
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In addition to the cochlear explants, cryosections of native tissue from P0, P4, P8 and 
P21 mice were also tested to further assess E2F1 expression in the organ of Corti 
epithelium (Figure 5.21). The antibody concentration for the anti E2F1 and Myosin7a 
labelling was the same as previously used with the cochlear explants. As with the 
cochlear explants, E2F1 expression was observed in the inner and outer hair cells in the 
organ of Corti of P0 mouse. Nuclear and cytoplasmic E2F1 expression was present in 
hair cells whereas the rest of the organ of Corti epithelium did not appear to be 
specifically labelled with E2F1. Controls with the Alexa Fluor® 488-conjugated anti-
rabbit IgG alone (secondary antibody) suggested that weak background staining from 
the secondary antibody was present in hair cells in the mouse cochlea. 
 
E2F1 expression was also assessed at later stages. At P4 and P8, E2F1 expression was 
still observed and its expression appeared to be maintained at later stages, with         
post-embryonic day 21 (P21) being the latest stage analysed in this study (Figure 5.22). 
At these stages, both nuclear and cytoplasmic E2F1 expression was observed. In the 
stria vascularis and spiral ganglion, E2F1 was also present (Figure 5.22) which 
correlates with previous findings of E2F1 expression in 1 year old mouse (Raimundo et 
al. 2012). 
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Figure 5.21. Expression of E2F1 in the mouse organ of Corti. Cryosections were immunolabeled with anti E2F1-1 (C-20) from Santa Cruz (1:400) and Myosin7a (138-1-
c) from DSHB (1:250) used as a hair cell marker. E2F1 (green) was examined in post-embryonic stages at P0, P4, P8 and P21. In the organ of Corti, E2F1 was observed in 
the outer and inner hair cells labelled with Myosin7a (magenta) and DAPI (blue) (n=3 from different animals for each stage). Controls were performed in the absence of 
E2F1 antibody (primary antibody) using identical confocal microscopy settings (n=3 from different animals for each stage).  
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Altogether, these results describe E2F1 expression in the developing inner ear 
epithelium of chick and mouse for the very first time. In chick, E2F1 mRNA was 
detected at embryonic stages by in situ hybridization and in mouse, E2F1 protein was 
detected by immunohistochemistry. In chick, the embryonic expression of E2F1, 
combined with the known function of E2F1 as a controller of the cell cycle and the 
response caused in the chick Atoh1 enhancer, could suggest a potential role for E2F1 to 
regulate the transcription of Atoh1 during chick inner ear development. In mouse, E2F1 
was detected in early post-natal post-mitotic hair cells (P0) and its expression continued 
as the hair cells matured. This is similar to the expression found in chick at embryonic 
stages and therefore could suggest the potential role of E2F1 as a key candidate 
involved in the development of the inner ear.  
 
Figure 5.22. Cellular localization of E2F1 expression at P21. P21 cryosections immunolabeled with 
anti E2F1-1 (C-20) from Santa Cruz (1:400) and Myosin7a (138-1-c) from DSHB (1:250). E2F1 
immunoreactivity (green) was strongly observed in the spiral ganglion (SG) and stria vascularis (SV). In 
the organ of Corti, E2F1 was observed in the outer hair cells (OHC) and inner hair cells (IHC) labelled 
with Myosin7a (magenta) and DAPI (blue). E2F1 appeared to be expressed in the nuclei and cytoplasm in 
tissue sections, with cytoplasmic localization stronger in the inner hair cells (n=3). 
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5.8 Summary and Discussion  
The E2F family was identified as a putative candidate to regulate the transcription of 
Atoh1. Based on the known roles of the E2F family in the cell cycle and its partnership 
with the Retinoblastoma (Rb) protein, it was hypothesized that some members of the 
E2F family could participate in the Atoh1-driven mechanism that induces hair cells to 
either regenerate or transdifferentiate from supporting cells after inner ear injury in non-
mammalian species. If this regulatory mechanism occurs via E2F1-3, I first hypothesize 
that E2F would bind to the chick Atoh1 regulatory elements to activate its expression. 
Secondly, I would expect to observe E2F1 expression in the auditory system.  
Taking a bioinformatics approach, the E2F family was predicted to bind the 3’ Atoh1 
evolutionary conserved elements and it was further selected for its roles in the control of 
the cell cycle. The E2F transcription factor family is also involved in the Rb regulatory 
network which appears to be a critical pathway in the development and maintenance of 
hair cells and supporting cells in the inner ear (Sage et al. 2006). Based on these initial 
observations, the E2F family was investigated in functional in vitro experiments to 
further assess its role in the inner ear.  
E2F1, the primary member of the E2F family, was found to upregulate the chick, but 
not the mouse, Atoh1 regulatory elements according to in vitro luciferase reporter 
assays. Not only was it able to activate the chick regulatory Atoh1 enhancers AB, but 
also a highly conserved region identified in avians and defined as putative enhancer C. 
This up-regulation was observed when constructs containing the Atoh1 conserved 
regions were co-transfected with increasing amounts of E2F1 in UB/OC2 cells. 
Moreover this up-regulation was very large (145-fold) and dose dependent. A dose 
response effect is characteristic of a direct binding mechanism and therefore it suggests 
that E2F1 may directly interact with the chick Atoh1 3’ conserved elements.  
This interaction between E2F1 and the chick Atoh1 3’ conserved elements was further 
examined in EMSA experiments. These results suggested that at least two E2F binding 
sites could be involved in the up-regulation of the chick Atoh1. One E2F binding site 
was identified between the chick Atoh1 enhancer A and B (named site 2) and the other 
E2F binding site was located in the chick putative enhancer C (named site 6). To better 
characterize the effect of E2F on the chick Atoh1, independent point mutations were 
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introduced in these two E2F binding sites to determine their contribution to the 
regulation of Atoh1. A reduction in the activation of chick Atoh1 by E2F1 was observed 
when each of these mutations was introduced independently. The largest reduction was 
observed when the E2F site located in the putative enhancer C, site 6, was mutated. 
Therefore, it is possible that this binding site is a required site for the up-regulation of 
chick Atoh1. In future work, the ability of E2F to bind to their specific sites in the chick 
Atoh1 conserved elements could be further investigated by chromatin 
immunoprecipitation in UB/OC2 cells or in chick inner ear tissue. However, this 
technique may be restricted by the lack of specificity of the human anti-E2F1 antibody 
to recognize chick E2F1 protein.   
In summary, luciferase and EMSA experiments confirmed that E2F1 has the capacity to 
directly bind and activate the chick Atoh1 enhancers AB and the chick putative 
enhancer C but not the mouse Atoh1 enhancers AB. Therefore, the response caused by 
E2F1 is specific to chick Atoh1 and not to mouse.   
In addition to the activation of the chick Atoh1 conserved regions by E2F1, the ability 
of other members of the E2F family to regulate Atoh1 transcription was also 
investigated (Figure 5.15). Similar responses were obtained when the Atoh1 conserved 
regions were co-transfected with E2F2 and E2F3 confirming the activating roles of the 
E2F1-E2F3 sub-group (Figure 5.15a/b). Since E2F1-3 present a high grade of 
conservation in their DNA-binding domains for binding to the consensus motif (Helin et 
al. 1993), it was expected to find very similar binding capacities to the chick Atoh1 
conserved sequences and therefore similar responses. By contrast, E2F4 did not cause a 
statistically significant response in the mouse or chick Atoh1 enhancers AB. However, 
downregulation was observed in the chick putative enhancer C when transfected with 
E2F4 (Figure 5.15c). This downregulation is no longer observed in the chick ABC 
luciferase construct but the downregulation reappears when the E2F site 6 located in the 
putative enhancer C is mutated. Therefore, there must be a mechanism that explains the 
differential effect caused by E2F4 in the putative enhancer C and chick ABC luciferase 
constructs. As previously demonstrated, E2F1 directly binds to chick Atoh1 and this 
interaction is dependent on two E2F binding sites, site 2 in between the chick Atoh1 
enhancer AB and site 6 in the putative enhancer C. Therefore, it is possible that when 
overexpressing E2F4, a competition for binding to E2F sites takes place between 
endogenous E2F1 contained in UB/OC2 cells and exogenous E2F4. This would explain 
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the minimal response observed in the chick ABC luciferase construct since the effect of 
E2F4 could be masked by the upregulatory effect of endogenous E2F1 binding to E2F 
sites in the chick Atoh1 enhancer AB (for example via site 2). When site 6, located in 
the putative enhancer C, is mutated in the chick ABC luciferase construct, the binding 
of endogenous E2F1 is reduced in that E2F site and the repressive effect of E2F4 is 
observed again (Figure 5.15c). In fact, previous publications based on ChIP-seq 
experiments found that E2F4 showed strong binding affinities at promoters regulated by 
E2F1-E2F3, estimating that about 70% of the E2F1 target genes overlapped with E2F4 
targets (Lee et al. 2011). In future work, further experiments could be performed by co-
transfecting E2F1 and E2F4 expression constructs in UB/OC2 cells and evaluating 
whether E2F4 has the ability to block the E2F1 response in the chick Atoh1 enhancer 
AB and putative enhancer C luciferase constructs.  
The classical model for E2F regulation during the cell cycle indicates that E2F4 forms 
complexes with other proteins such as p130 and histone deacetylase during the G0/G1 
phase to repress E2F target genes and consequently to block cell cycle progression 
(Magnaghi et al. 1998; Brehm et al. 1998; Luo et al. 1998). Therefore, it is possible that 
E2F4 acts as a repressor of Atoh1 to keep hair cells and supporting cells in a quiescent 
post-mitotic state. Whereas, if hair cell damage occurs, it is possible that other E2Fs 
such as E2F1-3 take the place of E2F4 and mediate the re-entry of quiescent hair cells 
and supporting cells into the cell cycle and co-ordinate that with the re-activation of 
ATOH1 expression to specify a hair cell fate. Studies using chromatin 
immunoprecipitation to asses promoter occupancy in living glioblastoma cells entering 
the cell cycle from quiescence suggested that E2F4 represses the transcription of 
different gene promoters during G0 and early G1 whereas E2F1, E2F2 and E2F3 bind to 
those promoters, coincident with the activation of these genes (Takahashi et al. 2000).  
E2F1 expression was also investigated in this chapter, describing for the very first time 
expression of E2F1 in UB/OC2 cells and in the developing inner ear of chick and 
mouse. In proliferating UB/OC2 cells, the expression of E2F1 protein is localised in the 
nucleus. The canonical basic nuclear localization domain in the E2F1 molecular 
structure is a determinant nuclear targeting signal that could confer its nuclear 
localization (Marfori et al. 2011). However, E2F1 mRNA detected by RT-PCR was low 
in comparison to protein expression detected by immunohistochemistry. Poor 
correlations between the level of mRNA and the level of protein are often reported in 
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the literature (reviewed in Greenbaum et al. 2003). Post-translational mechanisms 
involved in turning mRNA into protein are not yet sufficiently understood to determine 
protein concentrations from mRNA. In addition, proteins may differ in their half-lives 
and stabilities in comparison to mRNAs. All these factors may explain the different 
E2F1 mRNA and protein levels found in UB/OC2 cells.    
In chick, E2F1 mRNA was detected in the developing inner ear at E3, E7 and E10. 
(Figure 5.19). Based on the known roles of E2F1 in cell proliferation and since E2F1 
was detected at stages where cell division is actively taking place, the potential role of 
E2F1 as a major component during ear development can be hypothesized.  
In chick wing development for example, E2F1-3 mRNA is detected between E2.5-E4 in 
the posterior-distal region of the wing bud which is consistent with the active cell 
proliferation taking place in this zone (Towers et al. 2009). At later stages, by E6-E7, 
E2F1-3 expression is less visible in the interdigital mesenchyme in the handplates 
whereas some of the repressing E2F members (E2F4-7) become more detectable in 
comparison to early stages. This could suggest that the balance between the activating 
E2Fs (E2F1-3) and the repressing E2F members (E2F4-8) can promote the transition 
between the activation of proliferation and the exit of the cell cycle. Therefore, the 
observations of Towers et al. are consistent with the proliferative role of E2F1-3 during 
the early phases of development in chick whereas the repressing E2F members 
including E2F4, might be functional at later stages when differentiation occurs. Further 
expression data are needed in order to fully characterize E2F1 expression as well as the 
expression of other members of the E2F family throughout the chick inner ear 
development. However, the lack of an E2F1 antibody to detect chick E2F1 protein 
limited the experimental expression data in the chick inner ear detailed in this chapter. 
Therefore, ISH was chosen as experimental procedure to investigate E2F1 mRNA 
expression in the chick inner ear. The E2F1 mRNA probe used for these expression 
studies has previously been characterized and validated in the scientific literature 
(Towers et al. 2009). In addition, when the E2F1 cDNA used to generate the E2F1 
probe is BLASTed against the chick genomic sequence, it was found to be, not only 
homologous, but 100% specific to E2F1. This was checked prior experimentation to 
confirm that the E2F1 mRNA probe is able to recognize specifically E2F1 and not other 
closely related mRNA sequences like for instance, other members of the E2F family. 
The expression of E2F1 in the chick retina was also shown with the use of a sense E2F1 
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probe as a negative control. The use of a sense probe, containing the same sequence as 
the target E2F1 mRNA provided information about non-specific probe binding to the 
tissue due to the chemical properties of the probe. Positive and negative controls are 
shown in retinal tissue where specific binding is observed in the inner nuclear layer of 
the retina with the use of the antisense E2F1 probe. This was not detected with the use 
of the sense E2F1 probe under the same experimental conditions which confirms that 
the expression pattern given by the antisense probe is not background signal (Figure 
5.18). This correlates with the studies conducted by Pasteau et al. 1995 at higher 
magnification with histological preparations of the whole thickness of the retina with 
sense and antisense chick E2F1 mRNA probes.  
Although further investigation is required, based on the initial data presented in this 
chapter and in addition to what has been found during chick development in other 
systems, it can be suggested that E2F1 is a putative transcription factor involved in the 
development of the chick inner ear.  
In mouse, E2F1 protein was detected by immunolabeling at different post-natal stages. 
Although E2F1 has already been described in the stria vascularis and spiral ganglion in 
adult mice (Raimundo et al. 2012), E2F1 expression was detected for the very first time 
in the organ of Corti. At P0, E2F1 expression was assessed in cochlear explants (Figure 
5.20) and in cochlear cryosections (Figure 5.21). At this stage, E2F1 was detectable in 
inner and outer hair cells and its expression overlaps with Myosin7a which was used as 
a hair cell marker. It is also clear that E2F1 is restricted to inner and outer hair cells in 
comparison with the signal observed in the rest of the inner ear epithelium and the 
controls in the absence of E2F1 antibody (Figure 5.21). Furthermore, cytoplasmic and 
nuclear E2F1 expression was detected at P4, P8 and P21 in mouse cochlear hair cells 
(Figure 5.21). Therefore, the expression pattern of E2F1 in hair cells supports the 
possibility of a potential regulatory relationship between Atoh1 and E2F1. Although the 
luciferase data demonstrates that E2F1 does not regulate the mouse Atoh1 enhancer and 
that specific activation was only found in chick, expression data for E2F1 in mouse can 
give insights into the expression of E2F1 in avians since a chick E2F1 antibody is not 
currently available. If E2F1 expression in chick overlaps with ATOH1, the potential 
role of E2F1 to control ATOH1 expression in avians can be sustained.   
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Having shown preliminary immunohistochemistry and ISH experiments which provided 
information about protein and mRNA localization of E2F1 expression within the inner 
ear, further experimentation should be focused on quantifying E2F1 expression by       
q-PCR. This will represent a more quantitative method to describe E2F1 mRNA 
expression. Furthermore, if E2F1 is expressed in the inner ear as our preliminary data 
suggest, additional experimentation could be also conducted to assess the expression of 
other member of the E2F family in the inner ear.   
In summary, the data presented in this chapter provide strong evidence that support a 
role for E2F1 as a novel transcription factor involved in the regulation of Atoh1. This is 
particularly relevant in chick where a direct interaction was suggested between E2F1 
and the Atoh1 conserved regions, resulting in a large activation of Atoh1 (145-fold 
activation). Although characterization of the E2F expression data requires further 
investigation, the initial expression data assessed in this chapter showed a good 
foundation for additional experimentation. A better characterization, for instance, of the 
precise time at which E2F1 is expressed will be required as well as the verification with 
a higher number of animal samples. It would also be interesting to investigate at which 
stage E2F1 begins to be expressed at embryonic stages and follow its expression 
throughout the inner ear development and so assess potential variations in comparison 
to post-natal and post-mitotic stages. Since expression of ATOH1 is downregulated as 
hair cells differentiate, the study of E2F1 expression will help us to reveal a more solid 
conclusion of the relationship between E2F1 and Atoh1 during the process of hair cell 
fate. This assessment could verify the involvement of E2F1 as a potential activating 
factor of ATOH1 expression at embryonic stages and its potential downregulation once 
hair cells exit the cell cycle and differentiate.  
Another interesting finding is the different effect that E2F causes in avian and 
mammalian Atoh1. Activation due to E2F1-3 is only seen in an avian Atoh1 enhancer 
and not in a mammalian Atoh1 enhancer. The differences obtained in the response of 
Atoh1 in avians and mammals may represent real differences in the responsiveness of 
the Atoh1 enhancers to E2F1. In addition, activation also occurs via a putative enhancer 
which is present in avians but absent in mammalian species. Therefore it is also possible 
that mammalian Atoh1 does not respond to E2F1-3 because of the lack of the putative 
enhancer C region. If proliferation of supporting cells after hair cell damage in the chick 
is linked with re-activation of Atoh1 via E2F factors binding to enhancer C, this could 
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lead to a hair cell fate explaining the different abilities of mammalian and avian species 
to regenerate hair cells via re-activation of Atoh1 after hair cell damage. 
Based on the activating roles of E2F1-3 and the repressive role of E2F4 observed in the 
luciferase experiments, it can be hypothesized that E2F4 is a component of the 
maintenance of the quiescent post-mitotic state of hair cells and supporting cells to 
repress ATOH1 expression whereas E2F1-3 could be responsible for the re-entry of 
supporting cells into the cell cycle to reactivate ATOH1 expression upon damage in 
avian species. Such investigations could identify a new Atoh1 regulatory network 
linking proliferation and ATOH1 re-activation and prompt novel approaches to the 
design of hair cell regeneration therapies. 
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   Chapter 6  
6 In vivo investigation of the role of 
putative enhancer C and E2F1 on the 
regulation of chick Atoh1 
 
In this chapter the activity of putative enhancer C found in avians but not mammals was 
investigated in hair cells. Having quantified the responses of the mouse and chick Atoh1 
conserved regions when co-transfected with different transcription factors in in vitro 
luciferase assays, the functional responses of the chick Atoh1 conserved regions were 
characterized in vivo. The investigation focused on testing whether putative enhancer C 
is active during chick inner ear development and if so how its activity is comparable to 
that of the previously characterized chick enhancers A and B. Activity of putative 
enhancer C in the inner ear could suggest a role for this regulatory element in the re-
activation of chick ATOH1 expression during formation or regeneration of hair cells. 
The in vivo characterization of the chick Atoh1 conserved regions, including putative 
enhancer C, was assessed by transfecting reporter constructs containing these regions 
into the chick inner ear using the Tol2 transposon vectors. The Tol2 vector system has 
been established as an efficient method to stably introduce DNA transgenes in chick 
embryos by in ovo electroporation (Sato et al. 2007).  
In addition, in this chapter the ability of E2F1 to activate Atoh1 in vivo in the chick 
inner ear was also investigated. Results presented in chapter 5 demonstrate that E2F1-3 
have the capacity to strongly activate the chick Atoh1 conserved regions in vitro, giving 
a response of 145-fold when E2F1 is co-transfected in UB/OC2 cells. Here, the effect of 
E2F1 on endogenous ATOH1 expression when transfected in vivo into the chick inner 
ear was investigated.  
6.1 Introduction to the Tol2 system 
The Tol2 system uses a transposon-mediated gene transfer technique in order to stably 
integrate an exogenous DNA sequence into nuclear DNA (Sato et al. 2007). Tol2 carries 
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in its sequence a transposon mobile element that is active only when transposase 
activity is present. Therefore, when the transposase encoding plasmid is co-
electroporated with a Tol2 transposon reporter, the transgene carried by the Tol2 is 
excised from the reporter and subsequently integrated into the cell’s genome (Sato et al. 
2007). This allows the stable expression of any gene cassette cloned in a Tol2 
transposon vector after electroporation.  
The Tol2 system offers several advantages over the conventional use of DNA plasmids 
or viral vectors. Firstly, several Tol2 vectors can be electroporated into the same cell. 
Therefore, here a constitutively expressed marker for transfection was also used in 
addition to the Tol2-Atoh1 enhancer constructs. The use of a Tol2-mEGFP vector was 
chosen, driving expression of a membrane localized GFP, as a marker to visualise the 
electroporated cells (generated in our laboratory by Dr Nicolas Daudet). Hence, Tol2-
mEGFP was expressed in the cellular membrane of the electroporated cells and its 
expression was maintained throughout inner ear development after electroporation (see 
Figure 6.1a). 
Secondly, the Tol2 vectors can accommodate larger inserts than retroviral RCAS 
vectors (Kiernan AE 1997). For the Tol2-Atoh1 reporters, for example, a fragment 
corresponding to the chick AB enhancers plus putative enhancer C (~2 kb) was inserted 
in addition to the sequences corresponding to the minimal promoter and fluorescence 
proteins, giving a total length of 4.3 kb inserted between the 5’ and 3’ Tol2 ends. 
Previous studies have demonstrated that the Tol2 vectors can carry fragments longer 
than 11 kb without reducing transcriptional activity of the reporter and without causing 
any anomalies in its structure (Urasaki et al. 2006).   
Finally, the transfection of the Tol2 is mosaic which allows gene expression and 
regulation at the single-cell level to be compared between transfected and non-
transfected cells in situ.  
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Figure 6.1. Constitutive expression of Tol2 reporters via in ovo electroporation. a) In ovo 
electroporations were conducted at embryonic day 2 (control) into the chick otic cup. Tol2-mEGFP was 
used as electroporation marker to label transfected cells. This is visible in the electroporated otic cups (in 
green). Reporter activity of the Tol2-mEGFP construct is constitutively maintained several days after 
transfection (see E2.5 to E4). At E7, the different structures of the dissected inner ear are visible by the 
expression of Tol2-mEGFP (see in green in E7 inner ear: basilar papilla-bp; crista-cr; utricle-ut; saccule-
sac). b) Constructs generated for the constitutive expression of the Atoh1 conserved regions. i) Initially 
three constructs were generated containing the Atoh1 conserved regions (chick Atoh1 enhancer AB, chick 
putative enhancer C and chick Atoh1 ABC) downstream of the minimal promoter. ii) Two more 
constructs were also generated containing the chick putative enhancer C and chick Atoh1 enhancer AB 
upstream of the minimal promoter.   
 
6.2 In vivo characterization of the chick Atoh1 
conserved regions by the use of the Tol2 
system.  
To test the activity of the various chick Atoh1 conserved regions in the inner ear in vivo, 
different Tol2 bi-colour fluorescent reporters driven by the Atoh1 conserved regions 
were constructed (see Figure 6.1b and 2.2.14.3). The Tol2 bi-colour reporters contain 
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two fluorescent proteins with different half-lives, a destabilized enhanced green 
fluorescent protein (nd2EGFP; referred to as nEGFP) and a much more stable H2B-
mCherry fusion protein (referred to as mCherry). nEGFP is localised to the nucleus and 
encodes for a protein in a destabilized form with a half-life of 2h (Li et al. 1998). The 
destabilization of the nEGFP protein is conferred by the addition of a PEST sequence 
which reduces the stabilization of the protein and increases its degradation rate. The 
other fluorescent protein, mCherry, is also localised to the nucleus but it is a stable 
protein with a longer half-life. These two fluorescent proteins are separated by a 2A 
self-cleaving sequence, a small viral polypeptide sequence which causes the self-
cleavage of both proteins after translation resulting in the expression of both fluorescent 
proteins at the same ratio (Stewart et al. 2009).    
This feature allows the dynamic temporal and spatial changes of Atoh1 reporter activity 
to be studied with EGFP marking cells with recent activation of Atoh1 reporters and 
mCherry marking cells with a previous history of Atoh1 activation through inner ear 
development. The activity of the chick Atoh1 conserved regions was therefore 
investigated by assessing the expression of the nEGFP and mCherry fluorescent 
proteins in electroporated chick inner ears. Initially, the Atoh1 conserved elements were 
cloned downstream of the nEGFP and mCherry fluorescent proteins coding sequences 
(see section 2.2.14.3), this being the most straightforward cloning strategy. 
Transcriptional activity of the chick Atoh1 regions and the fluorescent proteins coding, 
nEGFP and mCherry, was driven by a minimal promoter sequence (Figure 6.1b).  
To test whether the various chick Atoh1 conserved region constructs were functionally 
active during hair cell development, electroporation of the Atoh1-Tol2 constructs was 
conducted as described in section 2.2.14.4. Since hair cell formation in chick peaks at 
E9-E12 in the vestibular system (Goodyear et al. 1999) and between E5-E11 in the 
basilar papilla (Corwin 1989; Goodyear and Richardson 1997), Atoh1 reporter activity 
was assessed between E7 and E9 in the sensory patches of the inner ear.   
Experiments were conducted by co-electroporating two Tol2 reporters. (i) a Tol2-
mEGPF vector, driving expression of a membrane localized GFP, used as a marker to 
visualise transfected cells and (ii) a second Tol2 reporter containing two other nuclear-
localised fluorescent proteins (nEGFP and mCherry) driven by the Atoh1 conserved 
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regions (initially cloned downstream of the minimal promoter).  Myosin7a expression 
was used to mark hair cells in these experiments.  
Results from experiments conducted with the Tol2 reporter containing the chick Atoh1 
enhancer AB (designated as Atoh1-ChickAB-down::nEGFP-mCherry) showed that in 
all the samples where mEGFP expression was detected, mCherry fluorescence was 
visible in some differentiated hair cells indicating that the Atoh1-ChickAB-
down::nEGFP-mCherry had been active (Figure 6.2). Similar results were obtained for 
both E9 basilar papilla and crista. However, nuclear localised EGFP was not observed at 
E7 or E9 suggesting that AB reporter activity was historic rather than current or recent.  
Activity of the conserved putative enhancer C was also analysed at E7 and E9 after the 
electroporation of the Atoh1-ChickC-down::nEGFP-mCherry. In these experiments, 
cells positive for mEGFP were found in the crista, saccule/utricle and basilar papilla 
indicating successful transfection (Figure 6.3 and Figure 6.4). However, as shown in 
Figure 6.3, neither mCherry or nuclear EGFP were found in any of the transfected 
patches at E7 suggesting this construct was not active. Specimens were also examined 
at E9 and transfected hair cells marked with mEGFP were detected in the basilar papilla 
and crista. Once again, activity from the Atoh1 putative enhancer C was not detected 
since expression of the fluorescent proteins was not found (Figure 6.4).   
In order to test whether putative enhancer C has any influence on the activity of the 
Atoh1 enhancers AB, a construct containing the chick enhancer AB together with 
putative enhancer C was electroporated. Reporter activity of the Atoh1-ChickABC-
down::nEGFP-mCherry construct was observed in sensory patches indicated by the 
expression of mCherry, but as with the AB enhancer alone, nuclear EGFP was not 
detected suggesting the activity was not current or recent  (Figure 6.5).  
The activity of the enhancerless version of the Tol2 construct, pT2K-MinProm-bicolor 
vector, was tested between E7 and E9 after electroporation. No activity was detected in 
any of the samples that were successfully electroporated (marked by mEGFP 
expression, Figure 6.6). This confirmed the absence of background activity from the 
Tol2 reporters and that the activity detected in Figure 6.2-Figure 6.5 is due to the 
presence of the conserved enhancer elements.   
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Figure 6.2. Activity of the Atoh1-ChickAB-down::nEGFP-mCherry. Confocal images of E9 crista and basilar papilla electroporated with the Tol2-mEGFP and the                                      
Atoh1-ChickAB::nEGFP-mCherry. The Tol2-mEGFP reporter was used to mark the electroporated tissue (in green). In both, crista and basilar papilla, mEGFP (in green) was 
detected in tissue containing hair cells immunostained with Myosin7a (in blue). Activity of the chick Atoh1 enhancer AB reporter is observed in some transfected hair cells 
(arrowheads) by the expression of mCherry (in magenta). However, nuclear EGFP (nEGFP) was not observed suggesting no recent Atoh1 enhancer AB reporter activity. The levels 
of Atoh1-ChickAB::mCherry fluorescence varied greatly among the tissue. The images are representative of at least 7 well transfected sensory patches (marked by the mEGFP) from 
different animals.  
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Figure 6.3. Activity of the Atoh1-ChickC-down::nEGFP-mCherry at E7.  Confocal images of E7 crista and basilar papilla electroporated with the chick Atoh1 putative enhancer 
C and mEGFP Tol2 reporters. Multiple areas in the crista and basilar papilla were well transfected since mEGFP activity (in green) was expressed in different parts of the sensory 
patches containing hair cells immunostained with Myosin7a (in blue). In tissue that was mEGFP positive, no reporter activity from the chick Atoh1-ChickC::nEGFP-mCherry was 
observed in any of the sensory patches that were analysed. Data are representative from sensory patches of 4 different animals.  
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Figure 6.4. Activity of the Atoh1-ChickC-down::nEGFP-mCherry at E9. Confocal images of E9 crista and basilar papilla electroporated with the chick Atoh1 putative enhancer 
C and mEGFP Tol2 reporters. Vestibular and cochlear hair cells (in blue) immunostained with Myosin7a (1:250) were detected in this sensory patches. Multiple areas in the tissue 
were successfully transfected since the mEGFP Tol2 activity was observed in several parts of the sensory patches. Reporter activity from the chick Atoh1-ChickC::nEGFP-mCherry 
was also not observed at later stages in development (E9). Images are representative of at least 8 successfully electroporated animals.   
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Figure 6.5. Activity of the chick Atoh1-ChickABC-down::nEGFP-mCherry at E9. Embryonic otic cups of a two days old chick were electroporated with the construct 
containing the chick Atoh1 enhancers and putative enhancer C, the chick Atoh1-ChickABC::nEGFP-mCherry reporter, and the mEGFP construct. Samples were examined at E9 by 
confocal microscopy. Multiple areas in the tissue were successfully transfected since the mEGFP Tol2 activity was observed in different parts of the sensory patches. At this stage 
(E9) sensory patches contain hair cells marked by the Myosin7a antibody (1:250). Reporter activity of the chick Atoh1-ChickABC::nEGFP-mCherry reporter was still observed in 
hair cells labelled with Myosin7a in the sensory patches (n=8) indicated by the expression of mCherry (in magenta). Nuclear EGFP (nEGFP) from the Atoh1-ChickABC::nEGFP-
mCherry reporter was not observed.  
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Figure 6.6. Activity of the base Tol2 vector at E7.  The enhancerless Tol2 pT2K_MinProm::nEGFP-mCherry and the mEGFP construct were electroporated in the chick inner ear. 
Reporter activity was examined at E7 by confocal microscopy. Tissue that was successfully transfected produced mEGFP expression in different parts of the sensory patches. Tol2 
pT2K_MinProm::nEGFP-mCherry activity  was not found in any of the samples analysed (n=5 at E7 and n=5 at E9). Images are representative of the samples that were examined in 
the vestibular and cochlear system. Hair cells were immunostained with a Myosin7a antibody (1:250). 
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6.2.1 Effect of the relative position of the Atoh1 conserved 
regions on the Tol2 reporter activity 
Electroporation of the various Tol2-Atoh1 reporters demonstrated that chick Atoh1 
enhancer AB was active in the hair cells (Figure 6.2). However, activity was not 
observed with the reporter containing the putative enhancer C alone (Figure 6.3 and 
Figure 6.4). In these reporter constructs, the Atoh1 regulatory regions were located 2 kb 
downstream of the minimal promoter (Figure 6.1b). In principle, the relative position 
and orientation of the enhancers is irrelevant since enhancers have the capacity to work 
either upstream or downstream to the gene they regulate. However, a recent study 
suggested that in some cases, enhancers can be sensitive to the position and orientation 
within a reporter construct (Hozumi et al. 2013).  
To test this possibility, the chick Atoh1 enhancer AB and chick putative enhancer C 
were relocated upstream of the transcription start site (upstream of the minimal 
promoter). As described in section 2.2.14.3, both inserts were cloned in the same 
insertion site in the Tol2 pT2K-MinProm-bicolor vector.  
When electroporations were conducted with the chick Atoh1 enhancer AB            
located upstream of the transcription start site (construct referred to as                                    
Atoh1-ChickAB-up::nEGFP-mCherry), mCherry fluorescence was detected in the 
sensory patches at E7 (Figure 6.7). The mCherry positive cells co-localized with 
transfected regions marked by the Tol2-mEGFP. When compared with the previous 
results in Figure 6.2, these experiments show that Atoh1 enhancer AB activity in hair 
cells is independent of the relative position of the enhancer. The activity of the nEGFP 
fluorescent protein was also investigated 24h after electroporation at E7. As previously 
observed, nEGFP activity from the Atoh1-ChickAB-up::nEGFP-mCherry was not 
observed in any of the electroporated samples at E7 indicating that the activity is not 
current.  
The reporter containing putative enhancer C upstream of the transcription    start site, 
was also tested in electroporations (construct referred to as                                                 
Atoh1-ChickC-up::nEGFP-mCherry). However, as in the previous experiment, no 
reporter activity was observed from the Atoh1-ChickC-up::nEGFP-mCherry reporter 
containing the putative enhancer C upstream of the minimal promoter and fluorescent 
proteins. Successfully transfected areas were analysed as shown by the expression of the 
Chapter 6: In vivo investigation of the putative enhancer C and E2F1 on the regulation of chick Atoh1 
 
 
239 
 
mEGFP (Figure 6.8) which contained hair cells as shown by the Myosin7a 
immunostaining. However, no activity of the putative enhancer C reporter was detected 
in the sensory patches in spite of being relocated upstream of the minimal promoter.   
Taken together, these results showed that the position of the different Atoh1 conserved 
regions relative to the minimal promoter did not affect the reporter activity since similar 
results were obtained when the Atoh1 conserved regions were positioned either 
upstream or downstream of the reporter cassette.  
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Figure 6.7. Activity of the Atoh1-ChickAB-up::nEGFP-mCherry at E7. As in previous experiments, embryonic otic cups of a two days old chick were electroporated with the 
construct containing the chick Atoh1 enhancers AB located upstream of the minimal promoter (referred to as Atoh1-ChickAB-up::nEGFP-mCherry) and the Tol2 mEGFP construct. 
In this construct the Atoh1 enhancer AB was relocated in a closer position to the minimal promoter. Samples were examined at E7 by confocal microscopy. Multiple areas in the 
tissue were successfully transfected since the Tol2 mEGFP activity was observed in different parts of the sensory patches. At this stage (E7) sensory patches contain hair cells 
marked with the Myosin7a antibody (1:250) by immunohistochemistry. Reporter activity of the chick Atoh1-ChickAB-up::nEGFP-mCherry reporter was observed in hair cells 
labelled with Myosin7a in the cristae, observed by the expression of mCherry (in magenta).  The nuclear EGFP (nEGFP) from the Atoh1-ChickAB-up::nEGFP-mCherry reporter was 
not observed. Images are representative of 4 different samples (n=4).  
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Figure 6.8. Activity of the Atoh1-ChickC-up::nEGFP-mCherry at E7. Embryonic otic cups of two days old chick (control) were electroporated with the construct containing the 
putative enhancer C upstream of the minimal promoter (referred to as Atoh1-ChickC-up::nEGFP-mCherry). The Tol2 mEGFP construct (in green) was also electroporated to mark 
the tissue that was well transfected. Samples were examined at E7 by confocal microscopy. Different areas in the tissue (in this case a crista) were well transfected since the Tol2 
mEGFP activity was observed in different parts of the sensory patches. Hair cells (in blue) within sensory patches were labelled with the hair cell marker Myosin7a (1:250) by 
immunohistochemistry. Reporter activity of the chick Atoh1-ChickC-up::nEGFP-mCherry reporter was not observed in hair cells labelled with Myosin7a. The nuclear EGFP 
(nEGFP) from the Atoh1-ChickC-up::nEGFP-mCherry reporter was not observed. Images are representative from at least 13 examined sensory patches from different animals at E7.  
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6.3 In vivo effect of E2F1 in the chick inner ear at 
early stages 
In chapter 5, a transcriptional activation of the chick Atoh1 luciferase constructs 
containing the Atoh1 conserved regions, including the chick Atoh1 enhancers was 
observed when E2F1 is co-transfected in UB/OC2 cells. Furthermore, EMSA and site-
directed mutagenesis results suggested that this occurs via a direct interaction between 
E2F1 and its binding sites in the Atoh1 conserved regions. To assess whether E2F1 is 
able to activate ATOH1 expression in vivo, exogenous expression of E2F1 was 
performed in E2 chick inner ear using in ovo electroporation of the E2F1-pcDNA3 
expression construct (see section 2.2.14.4). After electroporation of the E2F1 construct 
in the inner ear, Atoh1 expression was investigated by immunohistochemistry at E4.  
E2F1-pcDNA3 was co-electroporated with i) a Tol2 construct driving constitutive 
expression of a membrane EGFP fusion protein (generated in our laboratory by Dr 
Nicolas Daudet) to visualize the cells that were successfully electroporated and ii) a 
 
Figure 6.9. Gene transfer by in ovo electroporation. a) In-ovo electroporations were conducted in two 
days old chick embryos (schematic) in order to transfect: the Tol2-mEGFP reporter, used to mark the 
electroporated tissue, a transposase encoding plasmid used for the stable integration of the Tol2 reporter 
and an E2F1-pcDNA3 expression construct. b) After electroporation, at E4, expression of the Tol2-
mEGFP is visualized in the otic cup (arrow) confirming that the transfection was successful. Only 
samples positive for mEGFP were examined in further experiments to assess Atoh1 expression.  
  
a)   In-ovo Electroporation                         b)           mEGFP expression
(E2)                                                                              (E4)                   
Transfected plasmids
Tol2-mEGFP (stable integration/ expression)
Transposase encoding plasmid
E2F1-pcDNA3
mEGFP
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transposase-encoding plasmid used for the stable integration of the Tol2-mEGFP (Sato 
et al. 2007).  
 
Figure 6.10. E4 chick otocyst electroporated with E2F1. a) Confocal microscopy images of cryo-
sections from an E4 chick inner ear. mEGFP (in green) marks cells that were successfully 
electroporated. E2F1 positive cells expressing the transfected human E2F1 were observed in the 
electroporated regions (in purple in the merged image or marked with an arrow in the black and white 
image). However, ATOH1 expression was not found in any of the cryo-sections from an entire inner ear 
processed for immunostaining (some red background staining is visible in the merged image). b) 
Enlarged confocal images showing cells overexpressing the exogenous E2F1. In these cells, ATOH1 
expression was not detected.  No other hair cell marker was used therefore it is not clear whether E2F1 
expressing cells are hair cells or any other inner ear cell type. The images are representative of 3 
electroporated samples (n=3) containing E2F1 expressing cells. The entire inner ear was cryo-sectioned 
and immunostaining was performed in all the sections (~60 sections of 15μm were obtained from a 
single E4 ear).  
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A summary of the plasmids used and an example of an electroporated E4 otic cup is 
represented in Figure 6.9. Following electroporation of the otic cup, embryos were 
incubated until E4, a stage at which the non-constitutive E2F1 construct was still 
present in the transfected cells. Previous studies have shown that the onset of ATOH1 
expression in chick occurs at E4 (Pujades et al. 2006; Stone et al. 2003). Therefore, E4 
represents a good stage to investigate the effect of exogenous E2F1 on ATOH1 
activation.  
At E4, embryos were sacrificed, fixed and processed for cryosectioning as described in 
section 2.2.13.2. Sections were then immunostained with a human E2F1 antibody and 
with a chicken anti-peptide generated against the mouse ATOH1 (Driver et al. 2013). 
As shown in Figure 6.10, an electroporated E4 otocyst showed expression of mEGFP in 
the cells that were electroporated. Moreover, in these regions, some cells exhibited 
strong E2F1 immunostaining, indicating that these cells had been transfected with the 
E2F1 pcDNA3 plasmid. It is clear that the E2F1 positive cells are those that were 
expressing the exogenous human E2F1 produced by the E2F1 pcDNA3 plasmid since 
the human E2F1 antibody does not recognize the chick E2F1 protein (see chapter 5). 
However, after examining the tissue expressing exogenous E2F1, upregulation of 
ATOH1 expression was not observed in the transfected regions. In fact, ATOH1 
expression was not found in any of the samples processed for ATOH1 immunostaining.  
To ensure that our assay was able to detect ATOH1, the hindbrain was analysed as a 
positive control for ATOH1 expression. As shown in Figure 6.11, ATOH1 expression 
was detected in the anterior part of the chick hindbrain which suggests that the fixation 
method and the ATOH1 antibody were appropriate to detect ATOH1 protein. However, 
ATOH1 expression was not detected in the E4 otic cup, perhaps due to the relative 
immaturity of hair cells at this stage.  
In summary the results presented here do not show that E2F1 has the capacity to 
upregulate ATOH1 expression in vivo. However, it remains possible that E2F1 
contributes to the regulation of ATOH1 after its initial onset of expression in committed 
hair cells. Therefore, performing similar experiments with E2F1 at later stages once 
ATOH1 expression is already present in the sensory patches could help to resolve this 
issue. However, my experiments were limited to the use of a non-stable E2F1-pcDNA3 
expression construct which is diluted in the inner ear epithelium as the cells divide. 
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Hence, the generation of new Tol2 constructs is required in order to induce E2F1 
expression at later stages, when ATOH1 expression is already present in the sensory 
patches, such as E5-6. This would provide a better insight into the function of E2F1 in 
the control of ATOH1 expression in vivo.  
 
 
 
 
 
 
Figure 6.11: ATOH1 expression in the E4 chick hindbrain. Confocal microscopy images of 
cryosections from an E4 chick hindbrain stained with an ATOH1 antibody. A short fixation time was 
used as described in Driver et al., 2013. As expected, endogenous ATOH1 expression was detected in the 
anterior part of the chick hindbrain (n=3) demonstrating that effectiveness of the staining protocol. DAPI 
stain marks the nucleus of the cells.    
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6.4 Summary and Discussion 
Based on the results obtained in previous chapters with the Atoh1 luciferase assays, the 
activities of the chick Atoh1 AB enhancers and putative enhancer C were investigated in 
the chick inner ear in vivo. The most common system to induce long term transgene 
expression in avian cells previously has involved the use of retrovirus. However, these 
systems present some limitations in terms of the size of the transgene to be transfected 
and they also have additional difficulties in ensuring long term expression. Hence, here 
the Tol2 transposon system was used. This system has proven to be an efficient method 
to induce transgene expression in different species including avians. Initially, three Tol2 
constructs were generated, one containing the chick Atoh1 AB enhancer region, one 
with the conserved putative enhancer C and another containing the chick AB enhancer 
and putative enhancer C altogether. The Atoh1 regions in these constructs were 
positioned downstream of the minimal promoter and with a spacing of 2 kb between 
promoter-enhancer.               
The results obtained for these constructs confirmed that the chick Atoh1 enhancers AB 
were functionally active during hair cell development. Initial studies conducted by 
Helms et al., 2000 defined the Atoh1 enhancers AB as being sufficient to recapitulate 
ATOH1 expression in most of Atoh1 expressing tissues. Later studies conducted by 
Ebert et al., 2003 described the activity of the mouse and chick Atoh1 AB enhancers in 
the neural tube in E10.5 chick embryos. Other studies have tested the functionality of 
the mouse Atoh1 enhancers AB in the inner ear (Chen et al. 2002; Freeman and Daudet 
2012; Neves et al. 2012; Driver et al. 2013).   
In my studies, the response of the Tol2 Atoh1-ChickAB-down::nEGFP-nEGFP-
mCherry reporter confirmed the importance of the chick Atoh1 enhancers AB in hair 
cells. Therefore, since the mammalian and avian Atoh1 AB enhancers have activity in 
hair cells, the phylogenetic conservation of the Atoh1 AB enhancers goes beyond the 
neural tube and also applies to the inner ear.  
However, in the results obtained with the various Atoh1 Tol2 reporters generated here 
the accumulation and stability of the fluorescence proteins was not as high as expected. 
Other Tol2 reporters generated in our laboratory with a Tomato fluorescent protein 
driven by the mouse Atoh1 AB enhancer generated a greater response in the embryonic 
hair cells (Freeman and Daudet 2012). It is therefore possible that the accumulation and 
stability of the nEGFP and mCherry fluorescent protein used in my Atoh1 Tol2 
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reporters were not as great as the Tomato protein. This was especially notable for the 
signal given by the nEGFP which I was not able to detect in any of the electroporated 
samples. If real, this result suggests that the Atoh1 reporter activity was not current or 
recent at any of the time points tested. This would be surprising based on the results of 
others described above and it may instead suggest that this nEGFP protein is not an 
efficient reporter for detecting activity in this system.    
 
The studies conducted by Helms et al., 2000 also suggested the possibility of additional 
regions outside the enhancers that could be important for the regulation of the 
expression of Atoh1 (Helms et al. 2000). Therefore, I aimed to investigate whether the 
conserved region found in avians, the putative enhancer C, could be an additional region 
involved in the regulation of Atoh1 in avians. The fact that it is a well conserved region 
across different avian species could suggest that it has potential roles in gene regulation. 
Therefore, in order to assess the activity of putative enhancer C in vivo, the Tol2 system 
was used to address this question. In ovo electroporations with the Tol2 Atoh1-ChickC-
down::nEGFP-mCherry construct were conducted. However, the putative enhancer C 
was unable to induce reporter activity in hair cells (Figure 6.3 and Figure 6.4). On the 
other hand, the presence of putative enhancer C did not prevent reporter activity from 
the Atoh1 enhancer AB. This was demonstrated by the electroporations conducted with 
the Tol2 Atoh1-ChickABC-down::nEGFP-mCherry reporter which still demonstrated 
functional activity in the hair cells even when putative enhancer C was present (Figure 
6.5).  
The relative position of the Atoh1 conserved regions in the Tol2 reporters was also 
investigated in this chapter. In the experiments mentioned previously, the Atoh1 
conserved regions in the Tol2 reporters were located downstream of the minimal 
promoter. Since the putative enhancer C downstream of the minimal promoter did not 
appear to drive reporter activity, I tested whether the relative position of putative 
enhancer C within the reporter could be responsible for the negative results. In fact, 
previous studies demonstrated the importance of enhancer-promoter communication 
(Palstra and Grosveld 2012). It appears that in some cases the spacing between 
promoter and enhancer is critical for the binding of transcription factors and therefore 
for the activity of the enhancer (Giese et al. 1995; Passamaneck et al. 2009). To test this 
possibility, the putative enhancer C was relocated upstream of the minimal promoter. 
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When the construct containing the Atoh1 enhancers AB close to the promoter was 
electroporated, reporter activity was still present in hair cells (construct referred to as 
Atoh1-ChickAB-up::nEGFP-mCherry) (Figure 6.7). However, the construct containing 
putative enhancer C in a closer position to the promoter (Atoh1-ChickC-up::nEGFP-
mCherry) did not report any activity when electroporated in the inner ear suggesting 
that the relocation of putative enhancer C did not have any effect on its response (Figure 
6.8). Altogether, these results do not mean that the putative enhancer C is not involved 
in Atoh1 regulation in chick, they show that it is not sufficient in itself to induce hair 
cell expression at the time points that were investigated.  
Based on the large activation of the Atoh1 putative enhancer C by E2F1 in the in vitro 
experiments in chapter 5, the activation of Atoh1 by E2F1 was also tested in in vivo 
experiments. However, evidence of the activation of endogenous ATOH1 expression 
was not found when E2F1 was electroporated in the chick inner ear (Figure 6.10). Some 
technical limitations could explain the negative results obtained in my experiments. One 
of the limitations was the use of a non-stable plasmid, the E2F1-pcDNA3 expression 
construct. This construct does not confer long-term expression since the plasmid does 
not integrate into the chromosomes and therefore is diluted in the inner ear epithelium 
as the cells divide. Even though the electroporation was successful as shown by the use 
of the electroporation marker, Tol2-mEGP, only a few of these cells exhibited increased 
E2F1 expression (Figure 6.10). It is possible that the amount of E2F1 present was not 
sufficient to activate endogenous ATOH1 expression. At early stages of development, 
the inner ear undergoes a very active process of cell division and therefore the amount 
of exogenous E2F1 within the cells may not be sufficient to produce the activation of 
ATOH1 expression (Figure 6.10). The use of a Tol2-E2F1 transposon vector as 
described by Sato et al. 2007, would have been a more appropriate reporter for these 
experiments in order to maintain E2F1 expression for a longer period of time. Due to 
time limitations, I was unable to generate a Tol2-E2F1 transposon vector in order to 
stably induce E2F1 in the chick inner ear and so maintain its expression at later stages.  
A further limitation on these experiments was the stage at which ATOH1 expression 
was examined. Previous authors showed expression of Atoh1 mRNA as early as E4 in 
the chick otic cup (Pujades et al. 2006) and demonstrated very low levels of ATOH1 
protein by the use of a rabbit anti-MATH1 antibody at the same stage (Stone et al. 
2003). Therefore, the level of ATOH1 protein present at E4 in the inner ear may be very 
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low. Confirming this, ATOH1 protein was not detected in non-electroporated ears with 
the use of the mouse ATOH1 antibody. In contrast, ATOH1 was detected by 
immunohistochemistry at E4 in the chick hindbrain however, expression reminded low 
at this stage confirming the ability to detect ATOH1 (Figure 6.11). Ideally, I would have 
liked to investigate the effects of E2F1 on ATOH1 expression in the mature avian 
epithelium after damage. However, such experiments were not possible because of the 
lack of a long term E2F1 expressing vector and the difficulties involved in post-natal 
experiments in the inner ear.  
There may be other explanations for the lack of an effect of E2F1 on ATOH1 in these 
experiments. During development, epigenetic modifications such as changes in 
chromatin structure, histone modifications and DNA methylation are mechanisms that 
participate on the control of gene expression (Arney and Fisher, 2004). During inner ear 
development, epigenetic changes are thought to allow/disable ATOH1 expression at 
different developmental stages as has recently been suggested by Stojanova et al. 2015. 
Such developmental dependent changes could prevent the ability of transcription 
factors, such as E2F1, to access their binding site in the Atoh1 sequence blocking its 
regulation at the stage tested in my experiments.  
In summary, the results obtained here show in vivo activity of the chick Atoh1 
conserved regions in hair cells in the developing chick inner ear. The investigations 
focused on the study of the putative enhancer C as a potential avian-specific regulatory 
region controlling ATOH1 expression. Although these experiments failed to detect 
enhancer C activity in vivo, the possibility that E2F1, may bind and upregulate this 
region under other circumstances cannot be excluded. For example, the putative 
enhancer C may be active only after hair cell damage in the mature epithelium and so 
contribute to the re-activation of ATOH1 expression. Further work would be needed to 
investigate whether the putative enhancer C is active during this process.   
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Chapter 7 
7 General discussion 
Transcription factors can regulate the expression of multiple genes to determine a 
specific cell fate or to organise a cell’s response to some stimulus. One of the 
approaches that has been suggested to artificially induce the regeneration of hair cells in 
mammals to restore hearing is the introduction of transcriptional regulators of Atoh1 to 
re-active its expression in differentiated hair cells or supporting cells (Ahmed et al., 
2012). To this end, the work presented in this thesis aimed to identify novel 
transcription factors involved in the regulation of Atoh1 expression. In particular, this 
work focused on identifying distinct Atoh1 regulatory mechanisms in avian and 
mammals that might be responsible for the ability of avian species to re-activate 
ATOH1 expression and regenerate hair cells after damage.  
These results suggest there may be different conserved elements in the mammalian and 
avian Atoh1 regulatory elements which might be critical for the understanding of the 
regenerative capabilities of hair cells. It is known that the pro-hair cell gene Atoh1,  is 
required for the formation of hair cells (Bermingham et al. 1999), however it is unclear 
whether there are variations in its transcriptional activity due to species-specific 
properties of its regulatory elements. Therefore, the differences between mouse and 
chick in the regulation of Atoh1 were explored to compare the function of evolutionary 
conserved regulatory sequences.  The outcome of this investigation can be separated in 
three main findings, however the data suggest that they are all related to each other.  
First, the investigation focused on a comparative analysis of the Atoh1 3’ sequence to 
identify non-coding conserved regions across divergent species. A highly conserved 
region was identified in different avian species as part of this comparative analysis. 
Since this region, named putative enhancer C, was found in avians but not in mammals, 
the putative enhancer C was further investigated to assess whether its sequence could be 
responsible for a differential regulation of Atoh1 across species.  However, the putative 
enhancer C was not sufficient on its own to drive expression of a reporter construct in 
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the developing chick inner ear during in vivo experiments. It remains to be investigated 
whether putative enhancer C plays a role in Atoh1 activation after hair cell damage in 
avian species, a possibility that would be very valuable to investigate. Subsequent to my 
original analysis, when the comparative analysis was extended to other avian species 
such as turkey and duck, only recently available in the ensembl database (Ensembl 
release 83 - December 2015), the putative enhancer C was also found to be present in 
turkey and with less homology in duck (Figure 7.1).  
 
 
 
 
 
Figure 7.1. Updated comparative analysis of the Atoh1 3’ sequence in mammalian and avian 
species. The comparative alignment described in Chapter 3 (Figure 3.3) was extended to further avian 
species whose sequences were recently released in the ensembl database (Ensembl release 83 - December 
2015). As shown, the putative enhancer C is a conserved region also present in duck and turkey. The 
diagram was extracted from mVista following the same procedure as described in Chapter 3.  
 
 
It is also possible that the putative enhancer C, although not sufficient on its own for 
driving Atoh1 expression at the stage of development tested, requires the presence of a 
group of transcription factors in order to activate Atoh1 which may not be present at this 
stage of development. A similar mechanism has recently been hypothesized in the work 
conducted by Ahmed and collaborators. In this work it was suggested that the 
cooperative interaction between the transcription factors SOX2, SIX1 and EYA1 at the 
Atoh1 AB enhancers mediates a specific conformation of the enhancers DNA to activate 
the transcriptional machinery and consequently induce hair cell fate in the cochlea 
(Ahmed et al. 2012).   
Human
Mouse
Zebra finch
Duck
Turkey
Enhancer A    Enhancer B      Putative enhancer C
Reference Sequence: Chick 3’ Atoh1 region
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Therefore, the second part of my results focused on identifying putative transcription 
factor binding sites in the various Atoh1 conserved regions. Vertebrate development is 
controlled by cis-regulatory elements which usually contain a large number of 
transcription factor binding sites to collectively create a regulatory network of 
developmental genes. Over 150 transcription factor candidates were predicted for 
potentially binding the Atoh1 conserved regions. Due to the time taken to follow up 
each of these candidates, four were prioritized: NFKB, YY1, ATOH1 and E2F. The 
method for which the four putative candidates were selected for investigation can be 
seen as a somewhat subjective approach. Inevitably, their selection was reliant on prior 
knowledge of the role of the transcription factors candidates in the inner ear. From the 
selected candidates predicted by the bioinformatics analysis, only one was found to be a 
true upregulator of Atoh1 in reporter gene assays and associated experiments.  
The third set of data presented in this thesis is based on the investigation of the E2F 
family as novel and putative candidates regulating Atoh1. As previously discussed, the 
E2F family and the product of the retinoblastoma tumour suppressor gene (Rb) are 
considered the major regulators of the cell cycle machinery (Dyson 1998; Nevins 1998). 
Based on the important roles on the control of cell cycle combined with the lack of 
studies in the inner ear, the E2F family was selected for investigation.  
There is solid evidence for a regulatory relationship between the E2F family and chick 
Atoh1 based on the results described in this thesis. First, a strong and significant 
upregulation was found in the chick Atoh1 enhancers when the E2F activating members 
E2F1-3 were co-transfected in proliferating UB/OC2 cells. This activation was not 
observed with the mouse Atoh1 enhancer sequences. Secondly, the level of activation 
by E2F1-3 was at its strongest via chick putative enhancer C, either on its own or when 
combined with the chick Atoh1 enhancers A and B and was highly attenuated when the 
E2F site in putative enhancer C was mutagenized. These data link the chick putative 
enhancer C as an Atoh1 regulatory region and the E2F family as a novel transcription 
factor controlling chick Atoh1 transcription via the same enhancer. Activation of the 
chick Atoh1 conserved regions was shown to occur at two identified binding sites tested 
by EMSA experiments and site-directed mutagenesis. These two E2F binding sites, 
previously predicted by a bioinformatics approach, are located between the enhancer A 
and B and also in the putative enhancer C. It would be interesting to investigate whether 
a similar response is obtained for the Atoh1 enhancers and putative enhancer C upon the 
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overexpression of E2F1-3 in cell lines derived from other tissues expressing ATOH1 to 
assess whether it is cell-specific. The use of cell lines that express ATOH1, such as 
H1770 (derived from lung carcinoma), LS 174T (derived from colorectal 
adenocarcinoma) and SNU-16 (derived from gastric carcinoma) could provide a 
potential strategy to conduct further experimentation to test the effect of E2F1-3 on 
Atoh1 in other tissues (data extracted from https://genevisible.com/cell-
lines/HS/Gene%20Symbol/ATOH1).   
 
Although the evidence of the ability of E2F to bind to the chick Atoh1 conserved 
elements through reporter gene assays, EMSAs and mutagenesis presented is strong it 
could be tested in a more physiological environment with the use of in vivo analysis. 
Chromatin immunoprecipitation would be the most suitable approach. Identification of 
novel E2F-regulated regions in DNA has been previously assayed using this technique 
(Weinmann et al. 2001). One major advantage of utilizing the chromatin 
immunoprecipitation approach is the selection of sites bound by the endogenous 
transcription factor of interest, eliminating the problem of indirect effects. Therefore, 
this method could be used to verify the in vivo binding of E2F to site 2 and site 6 in the 
Atoh1 sequence. However, the limited amount of tissue, particularly cell specific tissue 
which can be obtained from the avian and mammalian inner ear for such experiments is 
extremely limiting and insufficient for chromatin immunoprecipitation. It is possible to 
perform these experiments using material from a cell line instead, such as UB/OC-2 
cells but since this regulatory relationship is thought to be avian species and no such 
inner ear cell lines exist then it is difficult to envisage how they could be performed 
successfully given these limitations. 
 
Another possible approach to confirm the relationship between E2F and Atoh1 in the 
inner ear would be the use of E2F knockout mice. Knockout mice have been generated 
for almost all E2F members (Cooper-Kuhn et al. 2002; Tsai et al. 1998; Wang et al. 
2007; McClellan et al. 2007; Ziebold et al. 2001; Chong et al. 2009; Lindeman et al. 
1998). The study of E2F mutant mice suggested unique and tissue-specific roles for 
each E2F member during mouse development. For instance, E2F1 mutants have a 
decreased number of stem cell progenitors in the brain and in the proliferative zones of 
the hippocampus (Cooper-Kuhn et al. 2002). These results suggested the involvement of 
E2F1 in controlling proliferation and neural cell number in the brain. However, some 
Chapter 7: General discussion 
 
254 
 
E2F members have some redundant roles. In the absence of E2F1, there seems to exist a 
compensatory effect of E2F3 which results in the normal development of some tissues 
(Cloud et al. 2002).  
In spite of multiple studies with E2F mutant mice, the phenotype in the inner ear has not 
been examined in knockout animals (phenotypes in E2F mutants are summarized in 
Rocha-Sanchez et al. 2007). This is an area that should be explored. Only a few studies 
with Rb mutants examined the phenotype in the inner ear (Clarke et al. 1992; Sage 
2000; Mantela et al. 2005; Sage et al. 2006). One of the common features shared in 
these studies with Rb mutants is the abnormal proliferation of vestibular and cochlear 
hair cells. Whether this is caused by the effect of free E2Fs to stimulate the cell cycle in 
the absence of Rb is unknown.  
In addition, studies with Rb and p27
kip1
 mutant mice suggested that cochlear and 
vestibular hair cells as well as sensory cell progenitors in the developing inner ear 
epithelium continue dividing for a longer period (Chen and Segil 1999; Sage et al. 
2006). Again, it can be speculated that since both Rb and p27
kip1
 are proteins involved 
in the control of the cell cycle, it is possible that the deregulation of these proteins has 
an effect on other partner proteins including the E2Fs.   
 
One possibility that can be raised based on the well-known E2F family’s role in 
proliferation is whether the E2Fs are involved in the spontaneous regeneration of hair 
cells observed in lower vertebrates after damage. In the avian inner ear, the mechanisms 
controlling the maintenance of post-mitotic quiescent state of hair cells and supporting 
cells and the regulators of the cell cycle are not well characterized. Therefore, it would 
be very valuable to characterize the regulatory molecules involved in the re-entry of the 
cell cycle upon regeneration. The data presented here provide evidence of a link 
between E2F transcription factors and its potential role in the control of re-entry into the 
cell cycle to re-activate Atoh1 in the chick.  Although the role of any such relationship 
in regeneration of hair cells after damage is speculative, it is one is worthy of more 
investigation.    
Based on the data extracted from the literature and the results of this thesis, the 
following hypothesis can be raised. 
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Hypothesis: 
E2F1-3 may be involved in the re-entry of post-mitotic quiescent supporting cells into 
the cell cycle to reactivate ATOH1 expression upon damage in avian species via 
interaction with putative enhancer C. In contrast, E2F4, the repressive form of the E2F 
family could be involved in maintaining hair cells and supporting cells in a quiescent 
fate while repressing ATOH1 expression (Figure 7.2).  
 
To confirm this hypothesis additional experiments are necessary in order to demonstrate 
that endogenous ATOH1 expression is re-activated by the effect of the E2F1-3 
transcription factors. Based on the known functions of the E2F family as regulators of 
the cell cycle, it would be interesting to assess the role of E2F before and after hair cell 
damage in avians. Since one of the regenerative mechanisms after hair cell damage is 
conducted by mitosis of the remaining supporting cells to form new hair cells and 
 
Figure 7.2. Hypothesis of the role of the E2F1-4 on the control of Atoh1expression.  E2F1-3 could 
potentially be involved in the re-entry of post-mitotic supporting cells into the cell cycle (from G0 phase 
to G1 phase). The mitotic activity of the E2F1-3 may re-activate the chick Atoh1 enhancer and the 
putative enhancer C and consequently link re-entry if the cell cycle and the re-activation of ATOH1 
expression. This regulatory network could be responsible for the spontaneous hair cell regeneration in 
avian species. In contrast, mouse Atoh1 enhancers are not responsive to E2F1-3 and consequently cell 
cycle re-entry is not linked to Atoh1 activation and hair cell fate. The repressive effect of E2F4 could 
potentially be involved in maintaining hair cells and supporting cells in a quiescent state (G0 phase) once 
they have committed to their specific cell fates.  
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supporting cells, it would relevant to investigate whether the activating E2Fs (E2F1-3) 
are upregulated during this process in supporting cells. If this is the case, the likelihood 
of E2F1-3 driving supporting cells to re-enter into the cell cycle linked with a re-
activation of ATOH1 expression can be enhanced. 
One method that could be used to examine changes in endogenous ATOH1 mRNA 
levels is q-PCR. However, if using a mammalian cell line like for instance the UB/OC2 
cells used in this study, a major limitation is the potential low response expected in the 
endogenous mammalian ATOH1. Based on the luciferase data presented in this thesis, 
the mouse Atoh1 enhancer does not respond to the effect of E2F1 or E2F4. Therefore, 
minimal expression changes are expected in the mammalian endogenous ATOH1 
expression upon the overexpression of E2F1 if using UB/OC2 cells. To overcome this 
limitation, a suitable method of investigating the potential changes of the expression of 
ATOH1, E2F1 and E2F4 could be the use of q-PCR in differentiated chick inner ear 
tissue and compare this with regenerated chick inner ear epithelium after damage. This 
approach could be assessed after aminoglycoside treatment (to cause hair cell death) in 
mature chick basilar papilla explants leading to supporting cell proliferation and 
subsequent hair cell regeneration. Changes in E2F1, E2F4 and ATOH1 expression 
levels could then be assessed during this process by q-PCR.  
 
A recent study has demonstrated changes in some members of the E2F family during 
the process of hair cell regeneration in chick tissues. The RNAseq analysis revealed that 
almost 500 putative genes specific to hair cells are involved in the process of hair cell 
regeneration in chick (Ku et al. 2014). In addition, the analysis identified over 200 
transcription factors which are differentially expressed during the time course of hair 
cell regeneration. The data from this RNAseq analysis revealed that E2F1, E2F7 and 
E2F8 are significantly upregulated in chick utricle and cochlea just prior to re-activation 
of ATOH1 after hair cell damage induced by streptomycin (personal communication 
with Professor Michael Lovett and Mark Warchol) (Figure 7.3).  
In addition, a previous microarray study also demonstrated that E2F1 is significantly 
enriched in post-hatched chick basilar papilla cultures treated with forskolin in order to 
identify genes that are upregulated during the regeneration of the chick inner ear (Frucht 
et al. 2010). These findings support the hypothesis of the involvement of the E2F family 
during the process of hair cell regeneration in avians after post-natal hair cell damage.  
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If E2F1-3 are proven to be necessary for the re-activation of ATOH1 expression in 
chick tissues, then it would be necessary to investigate potential therapies to regenerate 
post-mitotic mammalian/human hair cells. Since evidence suggests that the mammalian 
Atoh1 enhancer is unable to respond to E2F1-3 as it lacks the putative enhancer C, it 
would be interesting to assess the effect of modifications at the mammalian Atoh1 locus, 
for instance, using CRISPR technology. The introduction of changes in genomic 
sequences into living cells has become a powerful tool to investigate different genetic 
diseases (review in Sander and Joung 2014). All these recent advances based on genome 
and epigenome editing could have an important role toward therapeutic applications to 
re-activate ATOH1 expression and therefore a potential avenue to reverse hearing loss 
in humans.  
In conclusion, this thesis has provided valuable information about transcription factor 
candidates regulating Atoh1. The work emphasizes the potential role that a novel chick 
regulatory region (the putative enhancer C) and novel transcription factor candidates 
(the E2F family) could have on the study of the Atoh1 regulatory network. The 
complexity of Atoh1 regulation is high and investigations in chick and mammalian inner 
 
 
 
 
Figure 7.3. Changes in ATOH1, E2F1, E2F7 and E2F8 during hair cell regeneration. The x-axis 
indicates individual time points. The y-axis shows the fold change of streptomycin-treated versus control 
samples on a log2 scale. Expression profiles of ATOH1, E2F1, E2F7 and E2F8 at 24h intervals (1 in 
graph) across the 168h time course (8 in the graph) in the utricle a) and in the cochlea b). In both utricle 
and cochlea, E2F1 expression is upregulated before the upregulation of ATOH1 in streptomycin-treated 
samples. Data kindly provided by Professor Michael Lovett and Mark Warchol.   
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ear are far from straightforward. So the challenge of regenerating human hearing cells to 
restore human hearing is still likely to be some distance away. Nevertheless, ATOH1 
remains the strongest candidate for such an approach and revealing the distinct 
regulatory mechanism of ATOH1 re-activation in avians is one method which should be 
pursued.     
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Chapter 8 
8 Conclusions  
The work performed during the course of this thesis contributes to the understanding of 
the regulation of ATOH1 expression in different species. The investigations undertaken 
within this PhD produced three major conclusions: 
A comparative analysis of the mammalian and avian Atoh1 locus identified evolutionary 
conserved regions that are both common to, and distinct to,  mammalian and avian 
species. In particular, a region was identified that was conserved within avian species 
but not in mammals, designated as putative enhancer C. This was subjected to further 
investigation and evidence suggests that this region is involved in the regulation of 
chick ATOH1 expression.  
Bioinformatic analysis identified several putative transcription factor binding sites 
within the mammalian and avian Atoh1 conserved regions. Some of these transcription 
factor candidates were selected for further investigation. Amongst all the candidates 
tested experimentally, evidence suggests that only the E2F1-3 transcription factors are 
regulators of chick Atoh1 but not mouse Atoh1 expression.  
Activation of chick Atoh1 by E2F1-3 is conducted primarily via a binding site in 
putative enhancer C suggesting a link between the avian-specific enhancer C and 
capacity to induce Atoh1 activation in avians but not in mammals. 
A plausible hypothesis can be built about the role of the E2F family and putative avian 
enhancer C in the regulation of Atoh1 and hair cell regeneration based on these results. 
The presence of E2F regulatory elements within avian-specific enhancer C links hair 
cell cycle re-entry with re-activation of ATOH1 in avians but not mammals. This 
ATOH1 re-activation could confer a hair cell fate upon the newly produced cells in 
avians whereas this relationship is absent in mammalian species so that new hair cells 
are not produced. This hypothesis needs further investigation in order establish whether 
the E2F family are involved in the mechanism that drives supporting cells in avians to 
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re-activate ATOH1 expression after hair cell damage. If confirmed, this may in time 
lead to the exploration of novel therapeutic approaches to regenerate post-mitotic 
human hair cells that could benefit those affected by hearing loss.   
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Appendix 
 
Optimization of the binding of E2F in EMSA experiments 
On EMSA analysis in Appendix Figure 1, all bandshifts produced by the interactions 
between nuclear extracts proteins incubated with a radiolabelled E2F consensus probe 
failed to be competed by a known E2F1 probe as a competitor (the A2 probe). This was 
performed by testing different salt concentrations in the Parker Buffer solution as well 
as different concentration of nuclear extracts and different temperatures for the binding 
reaction (data not shown). However, in spite of all our efforts, no competition was 
shown between the consensus E2F and nuclear extracts from UB/OC2 cells. 
Nevertheless, Parker B
o 
2 (see material and methods in section 2.2.8.2) gave stronger 
bands which could suggest that the addition of MgCl2 improved protein-DNA binding 
affinities. Therefore, Parker B
o 
2 was used for all the EMSA experiments.  
Since, no competition was observed with nuclear protein extracts from UB/OC2 cells, 
the ability of E2F to bind a consensus E2F site was tested by in vitro translated protein.  
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Appendix Figure 1: Attempt to show binding of UB/OC2 cell nuclear protein extract to a 
consensus E2F binding site. EMSA experiments were performed using a consensus E2F1probe 
labelled with [γ-32P]. Different Parker buffers were used to optimize the binding with different salt 
concentrations (Parker B
o
1 was as described in section 2.2.8.2, Parker B
o
2 was the same as B
o
1 but 
with an addition of 4mmM MgCl2 and Parker B
o
3 was same as B
o
1 but with the addition of 100mM 
of NaCl). Competition assay with the known E2F1 competitor (A2-E2F1 probe) failed to compete for 
any of the bandshifts (A-F) with all the Parker B
o 
tested. However Parker B
o
 2 gave stronger bands 
suggesting that the addition of MgCl2 improved protein-DNA binding affinities.    
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In vitro translation of E2F1 protein and its co-factor DP1 
Since the tests described in the previous section failed to demonstrate the ability of E2F 
to bind a consensus E2F probe, I tested whether in vitro translated E2F protein was 
capable to show binding capacities.  
E2F1 in vitro translated protein was made as described in section 2.2.7. as well as in 
vitro translated luciferase protein provided in the TNT
® 
Transcription/Translation 
System which was used as control to discriminate between any protein from the rabbit 
reticulocyte lysate system which might bind to the radiolabelled probe in EMSA 
experiments. The T7 TNT
® 
Transcription/Translation System was the chosen kit since 
the E2F1 expression construct is driven by the T7 promoter in the E2F1_pcDNA3 
construct. Therefore, this system will produce a transcript due to T7-driven transcription 
and subsequent translation to generate in vitro translated E2F1.  
The radiolabelled E2F consensus probe (Table 5.1) was incubated alone, with in vitro 
translated E2F1 protein or with in vitro translated luciferase protein and electrophoresed 
on a 4% polyacrylamide gel at room temperature for 2h. In Appendix Figure 2 a) 
represents the bandshifts (labelled A1, B1 and C1) generated by in vitro translated E2F1 
and in vitro translated luciferase. As it is shown in the figure, the bandshifts generated 
by both in vitro proteins were almost identical suggesting that all bandshifts in this 
experiment were possibly produced by proteins contained in the transcription/translation 
rabbit reticulocyte lysate system machinery (compare lane 2 and 3) binding to the 
radiolabelled consensus E2F probe.  
Following this experiment and since neither E2F1 from UB/OC cells nuclear extract nor 
E2F1 in vitro translated protein were capable of binding to a consensus E2F site, I 
further investigated whether DP1, the co-factor for E2F, is necessary for E2F binding. 
The DP proteins have been shown to form complexes with some members of the E2F 
family to activate transcription of genes containing E2F binding sites. Furthermore, the 
formation of E2F-DP complex enhances binding affinities and promote stable 
interactions to E2F sites in the DNA in comparison with the affinities of E2F alone  
(Helin et al. 1993). Since the presence of DP1 could be necessary to observe a specific 
binding between E2F and the predicted binding sites in the Atoh1 conserved regions, I 
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performed an EMSA experiment where E2F1 and DP1 in vitro translated proteins were 
incubated together.  
A human DP1 expression construct was obtained containing the human DP1 cDNA 
(accession number: L23959) cloned in a pCMV-Neo-Bam1 (a gift from Dr Tony 
Kouzarides, The Gurdon Institute, University of Cambridge, UK). The cDNA of the 
human DP1 was subcloned into the pcDNA3 expression construct (see section 2.2.7.1) 
to be able to produce in vitro translated DP1 using the T7 TNT
® 
Transcription/Translation System.  
Having successfully cloned the DP1 in pcDNA3, in vitro translated DP1 protein was 
used in EMSA experiments to test whether the E2F-DP complex improves the E2F 
binding capacity. DP1 and E2F1 in vitro translated proteins were incubated together for 
1h at room temperature in order for them to form the E2F-DP1 complex before adding 
the radiolabelled consensus E2F probe. As with the previous experiment, the luciferase 
in vitro translated protein was used as a negative control.  
The incubation of in vitro E2F with the DP1 co-factor resulted in the observation of a 
stronger bandshift in comparison with the bandshifts produced when in vitro translated 
E2F1 was incubated alone. In addition, an extra bandshift was generated when the in 
vitro E2F1 with the DP1 co-factor were incubated together in comparison to the 
bandshifts generated by the in vitro translated luciferase (bandshift B2, compare lane 2 
and lane 3 in Appendix Figure 2 b). Although this bandshift was weak, it was a small 
sign of improvement suggesting that the presence of DP1 enhanced the binding capacity 
of the E2F to the DNA. Based on these observations, EMSA experiments presented in 
chapter 5 were performed with UB/OC2 cells transfected with E2F1 and DP1.  
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Appendix Figure 2: EMSA with in vitro translated proteins. The ability of in vitro translated E2F1 to 
bind to a consensus E2F site was tested by EMSA analysis. a) in vitro translated E2F1 protein incubated 
on its own with the radiolabelled consensus E2F probe. b)  in vitro translated E2F1 protein incubated with 
in vitro translated DP1 protein incubated with the radiolabelled E2F consensus probe. In both analysis 
luciferase protein was used as a control for proteins possibly contained in the transcription/translation 
rabbit reticulocyte lysate system machinery binding to the radiolabelled consensus E2F1 probe. When in 
vitro translated E2F1 protein is incubated with in vitro translated DP1, an additional bandshift was 
observed in comparison to luciferase control (bandshift B2).  
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